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Abstract 
In this thesis the role of Myosin VI in epithelial morphogenesis was investigated. 
Myosins are motor proteins that move along actin filaments. Myosins are composed 
of a head domain (termed the motor domain), a neck domain (which serves as a lever 
arm), and a tail domain (which binds to the cargo). In Drosophila melanogaster eight 
myosins had been identified previously and we identified five new myosins when the 
Drosophila genome was published. The characterization of the new myosins is 
described. 
The Drosophila Myosin VI is encoded by the gene jaguar. This Myosin VI is unique 
as it moves to the minus end of the actin filament which is the opposite direction to 
the other myosins. Previous studies showed that Myosin VI is necessary for the 
organization and migration of the follicle cells during oogenesis and for the 
morphogenesis of the imaginal discs. In order to examine the function of the whole 
Myosin VI molecule in epithelial tissues, the whole Myosin VI molecule or its 
separate domains (the head+ neck domains or the tail domain) tagged to Green 
Fluorescent Protein (GFP) were expressed in somatic cells under the control of Ga14 
protein and their localisation in the cells was observed. The expression of the tagged 
proteins under the control of a Myosin VI-Ga14 line allowed us to observe all the 
epithelial cells that express Myosin VI during the whole life cycle. In many epithelial 
cells the head domain seems to pull the whole molecule towards the cell nucleus, 
where the minus end of the actin filaments is localised, however it was found that the 
tail is the domain that anchors the whole molecule to specific areas of the cells away 
from the nucleus, probably by the binding to cargo molecules. 
The role of Myosin VI in dorsal closure was found when four Myosin VI mutants 
that were produced in our laboratory failed to close the dorsal hole during 
embryogenesis. The genotype and phenotype of two of the mutants,jarl?39  and JanJ?23) 
are described. Depletion of Myosin VI caused detachment of cells in the leading 
edge and the amnioserosa and folding-in of the tissue. A similar phenotype was 
observed when a Myosin VI dominant negative was expressed. In regions of ruptured 
tissue DE-cadherin and Armadillo was mislocalised, therefore Myosin VI seems to 
interact with these proteins during cell adhesion. Actin filaments were found to be 
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disorganized at the leading edge and in the lateral epidermis at regions of ruptured 
tissue, suggesting that Myosin VI is also necessary for actin dynamics during dorsal 
closure. 
The mechanism of Myosin VI function during oogenesis was investigated, by a 
search for proteins that function downstream of Myosin VI. Myosin VI was 
necessary for the expression and localisation of Dlg, Bazooka, PS2a-integrin, PS3-
integrin and Ankyrin. These results suggest that through the interaction with these 
molecules, Myosin VI might maintain epithelium integrity by controlling follicle 
cells invasion, their adhesion to extracellular matrix, and cell polarity. The effect of 
Myosin VI on Clathrin and a-adaptin localisation suggest a possible role of Myosin 
VI in endocytosis. 
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All developmental processes involve the precise localisation of cells, organdies, 
proteins, nucleic acids and other molecules at specific times, and this is established in 
part by transportation using motor proteins. Thus motor proteins have the potential to 
play crucial roles in development. Nevertheless, in comparison to signal proteins, 
very little is known about the role of myosins in the patterning of epithelial tissues. 
Nonmuscle Myosin II was found to participate in the patterning of epithelial tissues 
in the fly life cycle (this is described below) and to be necessary for dorsal closure, 
imaginal discs morphogenesis and oogenesis (Young et al., 1993). 
The function of Myosin VI in epithelial morphogenesis emerged only five years ago. 
Disruption of the expression of Myosin VI caused changes in follicle cell shape, loss 
of the epithelial integrity and aberrant migration of the follicle cells (Deng et al., 
1999). Adult files had malformed legs and wings, suggesting that Myosin VI is also 
necessary for the morphogenesis of imaginal discs. In a recent study in our 
laboratory it was found that Myosin VI mutants fail to complete dorsal closure 
during embryogenesis (Leaper, 2003; Millo et al., 2004). All these results show that 
Myosin VI is crucial for the proper development of epithelial tissues. Myosin VI was 
also found to be necessary for the organization of actin filaments and to interact with 
proteins involved in actin dynamics in the individualization complex during 
spermatogenesis (Rogat and Miller, 2002), and mutations in Myosin VI cause male 
sterility (Hicks et al., 1999). 
During dorsal closure, the detachment of the cells at the leading edge, in the absence 
of Myosin VI suggested that Myosin VI regulates cell adhesion (Millo et al., 2004). 
This was supported by the interaction that was found between Myosin VI, DE-
cadherin and Armadillo in oogenesis (Geisbrecht and Montell, 2002). During 
oogenesis, the invasion of the follicle cell into the nurse cells cluster and the arrest of 
the cell migration suggest that Myosin VI might have additional roles (Deng et al., 
1999), such as mediation of cells invasion and cell polarity. Finally, the need for 
Myosin VI for the organization of the actin filaments in the individualization 
complex (Hicks et al., 1999; Rogat and Miller, 2002) could suggest that the 
maintenance of tissue integrity by Myosin VI is established by mediating the 
organization of the actin cytoskeleton in the cells. 
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The aim of this thesis was to further investigate how Myosin VI functions in 
epithelial cells. This was established by examining the localisation of Myosin VI 
molecule and its separate domains in epithelial cells and in the individualization 
complex. In addition, a screen was made for proteins that would function 
downstream to Myosin VI and that play a role in cell-cell and cell-matrix adhesion, 
cell polarity and cell invasion, during oogenesis and dorsal closure. 
This chapter reviews existing literature on the molecular structure and the function of 
myosins, in particular Myosin VI. The function of Myosin VI in Drosophila and in 
other species is described in detail along with several suggested mechanisms for how 
the whole molecule functions. The discussion about the various functions of Myosin 
VI is related to the studies in this thesis examining the function of Myosin VI 
molecule and it separate domains. 
Because this thesis describes the characterization of novel myosins, the Drosophila 
myosins that had been identified prior to these findings are also described. 
1.1 	The structure of myosins 
Myosins are molecular motors that move along actin filaments by converting energy 
obtained from adenosine triphosphate (ATP) hydrolysis to a mechanical force 
(Mooseker and Cheney, 1995). The myosin heavy chain molecule contains three 
domains: the head domain (also known as the motor domain) at the N terminus, the 
neck domain, and the tail domain at the C terminus. This structure, as it appears in 
Myosin VI is shown in figure 1.1. The various structures of all Drosophila myosins 
are seen in figure 1.3. 
The motor domain contains a catalytic core, which binds actin and ATP. Hydrolysis 
of ATP generates force that is translated into movement of myosin along actin 
filaments. The motor domain contains at its carboxylic terminus a converter domain 
that links the catalytic core to the neck domain. This region converts the energy of 
ATP breakdown into movement. The head domain also contains an actin-binding 
site. Within the actin-binding site there is a TEDS domain which includes serine, 
threonine, aspartic or glutamic acid. Most of the myosins have the acidic residues 
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(aspartic or glutamic acid). In myosins from classes I and VI this region regulates the 
enzymatic activity by phosphorylation of serine or threonine (Mooseker and Cheney, 













Figure 1.1: The structure of Myosin VI. The head, the neck and the tail domains are marked. The 
head domain contains actin binding site, ATP binding site and the converter, which converts the 
energy from ATP breakdown into mechanical movement. The TEDS domain lies within the actin-
binding site and in Myosin VI it contains the amino acid Threonine that is phosphorylated. Between 
the converter and the neck domain there is an insert of the "reverse gear" domain, which changes the 
angle between the head and the neck domain and subsequently the direction of movement of Myosin 
VI. The neck domain is composed one IQ motif, which binds Calmodulin. The tail domain contains a 
coiled-coil region and a globular tail domain which binds to cargo proteins. 
The neck domain serves as a lever arm. The movement of the converter, via ATP 
hydrolysis, is directly transmitted to the neck domain, so that a rotation of the 
converter will cause movement of the neck domain. The neck domain consists of a 
variable number of light - chain binding motifs, IQ motifs, containing the consensus 
sequence IQXXXRGXXXR (Fig. 1.1 shows one IQ motif in Myosin VI). Each IQ 
motif is a potential binding site for Calmodulin and/or tissue specific myosin light 
chains, which modulate the binding of the myosin head to actin and thus regulate 
myosin activity (Wolenski, 1995). 
The tail domain has a structure which is specific to its class and controls the 
interaction of a given myosin with its cargo. 
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1.2 	The motility of myosins along actin fragment 
The model suggested for the movement of myosin along the actin filament is called 
the 'swinging lever arm' (Rayment et al., 1993; Vale and Milligan, 2000; Volkman 
and Hanein, 2000). (Described in Fig. 1.2. 1) It proposes that the movement takes 
place through separate cycles, in each myosin makes one movement along the actin 
filament, through hydrolysis of one ATP molecule. According to the model the head 
domain that contains ADP + Pi in the catalytic domain, binds to the actin filament 
(a). The binding accelerates the release of Pi from the catalytic site, which is then 
followed by a conformational change - the power stroke (b). During the power 
stroke, the angle between the head domain and the lever arm (neck domain) changes, 
causing rotation of the neck domain, while the head domain remains attached to the 
actin filament. The swinging of the neck domain results in movement of the head 
domain and the attached actin filament by approximately 10 nrn. The replacement of 
ADP by ATP in the catalytic site causes a conformational change in the myosin head, 
and a dissociation of the myosin head from actin (c). ATP is hydrolysed to ADP and 
Pi, both of which remain tightly bound to the myosin head (d). The hydrolysis is 
accompanied by an additional conformational change and a movement of the neck 
domain in a reverse direction to the power stroke. Finally, the binding of the motor 
domain to actin initiates a new cycle. 
The figures in the following pages: 
Figure 1.2.1. The swinging lever arm cycle. (a) ADP + Pi are bound to the catalytic domain (ATP 
binding site), and the motor domain is weakly bound to actin. (b) Pi is released from the catalytic 
domain and the neck domain undergoes a power stroke, pulling the motor domain and actin (c) The 
attachment of ATP to the catalytic domain dissociates the motor domain from actin. (d) ATP 
hydrolysis results in the rotation of the neck domain to its original position, prior to the power stroke. 
Figure 1.2.2. In Myosin VI, the insert of 53 AA between the converter and the neck domain ("reverse 
gear", marked in red) changes the angle between the head and the neck domains, causing a change in 
the movement of the whole molecule towards the minus end of the actin filaments. This is in contrast 
to most other myosins that move towards the plus, barbed-end of the actin filaments. 
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Figure 1.2.1 
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Recently it was suggested that the movement of myosins along actin filaments 
combines the swinging lever arm cycle along with Brownian movement (Geeves, 
2002). Brownian movement causes the actin filament to move with respect to myosin 
and helps to re-locate myosin in a new actin site. The asymmetry of the actin 
filaments and the lever arm movement could bias the Brownian motion of the 
attachment/detachment in the same direction as the lever swings (Houdusse and 
Sweeney, 2001). 
Apart from Myosin VI, all other myosins move towards the barbed, plus end of the 
actin filaments (Fig. 1.2.2). As the next section explains, Myosin VI moves towards 
the minus-pointed end of Myosin VI. 
1.3 The classes of myosins found in Drosophila and their 
roles 
So far, thirteen myosins have been identified in Drosophila, classified into eight 
different classes. Five novel myosins were found in our laboratory: Myo28B (VIIB), 
MyolOA (XV), Myo89B (Mhcl-PDZ, class XVIII), Myo29D (which forms a class of 
its own) and Myo95E (IC) (Tzolovsky et al., 2002). The analysis of these proteins is 
described in chapter 3. This section focuses on the structure and function of the 
myosins that had been found previously. First, Myosin VI is described in detail, 
followed by a description of the rest of the myosins. 
1.3.1 Myosin VI 
1.3.1.1 	The structure and movement of Myosin VI 
Class VI myosins contain the amino acid threonine (Thr406) in the TEDS domain, 
which is phosphorylated by p21-activated kinase 3 (PAK) (Buss et al., 1998; 
Yoshimura et al., 2001). The phosphorylation of Thr406 accelerates the release of Pi. 
This does not seem to accelerate the movement of the motor domain along actin 
filaments (Morris et al., 2003). Nevertheless, the phosphorylation Myosin VI by 
PAK localises Myosin VI to sites of newly formed ruffles in human epidermal 
carcinoma cells (Buss et al., 1998), suggesting that the phosphorylation of Myosin VI 
does change the function of the molecule. 
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Figure 1.3. A: Drosophila myosins that have been identified so far. The name of the gene and the 
class type are indicated for every myosin: Myosin IA and TB (the gene location is indicated); muscle 
Myosin II, encoded by the gene mhc; nonmuscie Myosin II, encoded by the gene zipper (zip); Myosin 
III, encoded by the gene ninaC; Myosin V, encoded by the gene didum; Myosin VI, encoded by the 
gene jaguar (jar); and Myosin VITa, encoded by the gene crinkled (ck). B: the novel myosins that 
have been identified. Myo95E, Myo2813, MyolOA and Myo29D are named according to their 
chromosomal location. Mhcl-PDZ is an abbreviation for Myosin heavy chain like containing PDZ. 
Myo95E was classified as Myosin IC; Myo2813 was classified as Myosin VITB; MyolOA was 
classified as Myosin XV; Mhcl-PDZ (located in position 8913) was classified as Myosin XVIII and 
Myo29D that creates a class of its own (XIX). Motor proteins are marked in red, IQ motifs in the neck 
domains are marked in yellow and the different domains within the tail are marked according to the 
key. 
The neck domain includes one recognizable IQ motif that binds Calmodulin (Fig. 
1.1). The binding of Calmodulin is thought to allow regulation of Myosin VI by 
Calcium. A recent study showed that increased Calcium levels above 10 p.M slow 
Myosin VI motility (Morris et al., 2003). 
The tail domain includes a region predicted to form a coiled - coil and a globular C - 
terminal domain (Fig. 1.1 andi .3). Native Myosin VI was thus predicted to exist as a 
two-headed dimer of the -'140 kDa heavy chains (Buss et al., 1998; Cheney et al., 
1993; Mooseker and Cheney, 1995). However, gel filtration and sucrose density 
gradient experiments showed that the molecular weight of expressed and native 
Myosin VI was close to that of one single heavy chain molecule. Therefore it seems 
that Myosin VI may be a monomer and not a dimer (Lister et al., 2004). 
Myosin VI differs from other myosins in having an insert of 53 AA between the 
converter domain and the neck domain. Image analysis of electron micrographs of 
actin filaments in the rigor state (no ATP) revealed that the neck domain (lever arm) 
of Myosin VI is twisted towards the pointed end of actin filaments, the opposite 
orientation to that found in other myosins (Fig. 1.2.2). It appears that this insert 
completely changes the direction in which the lever arm of Myosin VI swings (Wells 
et al., 1999). This domain was found to bind a Calmodulin molecule, with four 




I: 	H 	1111111111 
II Thu 2ilt • 
111111 iii 	_IIIl. 
0 	 500 	 1000 	 1500 	 2000 	 2500 a 




LI IQ-motif 	 MyTH4 
LI Basic domain, TH1 
	LI Talin homology (FERM) 
N-terminal extensions 	SH3 domain 
or insertions 
0 Coiled Coil 	EI Glutamia rich domain 
PDZ domain EI Proline rich domain 
Kinase domain 	D Reverse gear 
Because the Calcium ions do not dissociate from the Calmodulin complex bound to 
the insert it is suggested that this complex is structural Calmodulin that does not 
regulate the motor movement. 
A recent study showed that Myosin VI moves in relatively big steps (36 nm) (Rock 
et al., 2001). According to the lever arm model, the size of the steps would be 
dependent on the size of the lever arm, which is defined according to the number of 
IQ motifs at the neck domain. This part of model is consistent with studies that 
showed a linear relation between the length of the lever arm and the speed of the 
movement in myosins engineered with different lever arm lengths (Geeves, 2002). 
Therefore, it was surprising to find that the size of steps made by Myosin VI-(which 
contains only one IQ motif), was similar to those of Myosin V that contains 6 IQ 
motifs. To resolve this discrepancy it was suggested that the movement of myosins 
along the actin filaments combines the swinging lever arm that drives the foreword 
steps of the head domain to bind in the next free actin site, along with Brownian 
movement that helps to locate and bind myosin to that site (Geeves, 2002). 
It is also difficult to explain with the lever arm model the large working stroke (18 
nm) of Myosin VI that was found recently, in the presence of its small neck domain 
(Lister et al., 2004), unless other regions in the molecule contribute to the lever arm. 
A possible model that explains the large stroke suggests that the size of the stroke is 
determined by a combination of lever arm length, orientation and position. The big 
stroke could be established through the swinging of the lever arm by 138°, to its final 
location at the rigor position or at the ADP bound position (the stroke between these 
two positions is only 1 nm) (Lister et al., 2004). 
One of the functions proposed for Myosin VI is as an anchor of vesicles and proteins 
to actin filaments. The observation of single Myosin VI molecules revealed that 
under a backward force (load) application the movement of Myosin VI stops as it 
binds tightly to actin. In this way, Myosin VI is converted from a transporter to an 
anchor (Altman et al., 2004). 
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1.3.1.2 	The roles of Myosin VI in Drosophila 
Drosophila Myosin VI was the first to be identified in this class (Kellerman and 
Miller, 1992). Myosin VI is found in other species, including human, mice, pigs, rat, 
chicken, fish, sea urchin primates, and C. elegans (Avraham et al., 1995; Breckler et 
al., 2000; Hasson and Mooseker, 1994; Kelleher et al., 2000; Melchionda et al., 
2001; Sirotkin et al., 2000; Wu et al., 2002). The structure and function of Myosin VI 
were described in the previous section. 
The Drosophila Myosin VI gene (jaguar) is found at locus 95F on the third 
chromosome (Kellerman and Miller, 1992). The jaguar transcript is alternatively 
spliced within the tail domain at a site adjacent to the C - terminus of the coiled - coil 
domain, suggesting that at least four different protein isoforms exist. Drosophila 
Myosin VI is expressed throughout the life cycle (Kellerman and Miller, 1992), and 
antisense studies showed that the disruption of Myosin VI expression at various 
stages of development result in lethality (Deng et al., 1999). 
Myosin VI seems to play a role in epithelial cell shape change and cell migration in 
various processes throughout life cycle. During embryogenesis, Myosin VI is 
expressed in the syncitial blastoderm, where it is necessary for the transport of 
particles (Fig. 1.3.1A), and participates in the formation of the pseudocleavage 
furrows between adjacent nuclei during division. Inhibition of Myosin VI function 
by antibody injection blocked the particle movements and caused severe defects in 
the syncitial blastoderm organization, including nuclear defects and disorders in 
cytoskeletal patterning (Mermall et al., 1994; Mermall and Miller, 1995). The 
invagination of the furrows could be achieved by pulling the membrane along the 
actin filaments towards its pointed end, which is located in the cell's interior; 
however the precise function of Myosin VI in this location is still not fully 
understood. 
During later stages of embryogenesis (stage 14), Myosin VI is detected in the dorsal - 
lateral epidermal cells, at the leading edge of the epithelial sheet involved in dorsal 
closure, and in the posterior spiracles (Kellerman and Miller, 1992). During stages 
14-16 Myosin VI is expressed in the central nervous system, where it is co-localised 
in the connectives and commissures with CLIP-190 (cytoplasmic linker protein 190), 
a homologue of CLIP-170. Co-immunoprecipitation studies in Drosophila showed 
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that Myosin VI interacts specifically with CLIP-190 in Drosophila embryos. Myosin 
VI and CLIP-190 are also co-expressed in the posterior pole of the early embryo 
(stage 2). CLIP-170 is a microtubule—binding protein and the similarity with CLIP-
190 suggests that Myosin VI may participate in Transferring particles from actin 
filaments to microtubules and may connect between the two filaments, although the 
localisation of Myosin VI and CLIP-190 in the posterior pole is dependent on actin 
but not on the microtubule cytoskeleton (Lantz and Miller, 1998). 
Myosin VI is also necessary for the asymmetric division of the neuroblasts (Petritsch 
et al., 2003). In Drosophila embryos proteins necessary for the determination of cell 
fate are targeted to the basal part of the neuroblasts, the spindle of the cells is rotated 
by 90° to align with the basal-apical axis, and the cells divide asymmetrically. In this 
process, Bazooka is localised to the apical region of the cell, where it recruits 
Inscuteable and other proteins that form the apical complex. This complex re-orients 
the spindle and targets the cell fate determining proteins and their adapter proteins-
like Miranda to the basal part of the neuroblasts. It was found that Myosin VI is 
necessary for the localisation of Miranda basally and for proper spindle orientation. 
In Myosin VI mutants Miranda is mislocalised and the spindle in the neuroblasts is 
disoriented, yet the apical localisation of Inscuteable is not disrupted (as observed in 
stages 14-16: disrupting Myosin VI through the expression of Myosin VI dominant-
negative caused Miranda mislocalisation and spindle misorientation at stage 9 
(Bownes, 1975)). The direct binding of Miranda to Myosin VI supports the 
suggestion that the localisation of Miranda and its associated proteins basally is 
achieved via Myosin VI (Petritsch et al., 2003). Immunostaining shows that Myosin 
VI is not localised strictly at the basal crescent and this suggests that Myosin VI 
transports Miranda but it does not anchor it to the basal crescent. It was also found 
that Myosin VI has a synergistic action with the tumour suppressor protein Lethal 
Giant Larvae (Lgl): in lgl mutant embryos Miranda is present in the cell cortex, in 
the spindle and in the cell cytoplasm, while in the double mutant for Myosin VT and 
Lgl, Miranda is mostly localised in the cytoplasm. 
During the third larval instar disruption in Myosin VI expression caused abnormal 
cuticle secretion, which suggests that Myosin VI is required for cuticle development 
(Deng et al., 1999). During metamorphosis, disruption in Myosin VI expression 
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resulted in malformed legs and wings in the adult fly, indicating that Myosin VI is 
essential for morphogenesis of the epithelial tissue in the imaginal disc during their 
development (Deng et al., 1999). 
Myosin VI is necessary in the adult fly ovaries for the migration and the 
morphogenesis of the follicle cells epithelium, as section 1.7.1 shows. Myosin VI is 
also necessary for the last stage of the sperm maturation, sperm individualisation. In 
this process each one of the 64 spermatids is separated by a membrane that forms 
around it and encapsulates it. The membrane is created by an individualization 
complex (IC), which contains actin filaments surrounding every spermatid in a cone 
shape, and assembly of Myosin VI protein in a ring - shape around the spermatid, at 
the basement of the actin cone, between the area of the actin filaments and the site of 
the membrane assembly (Fig. 1.3. 1 B).  The IC is formed at the edge of the spermatid, 
where the nucleus is located, and progresses along the spermatid while forming the 
membrane. In the Myosin VI mutants jar mmw4  and jar' sperm individualization is 
inhibited and as a result the IC does not move along the spermatid and in several 
cases the cone structure of the IC is disrupted, which causes male sterility. This 
suggests that Myosin VI maintains the actin filaments at the investment cones in an 
organized form, and drives the membrane along the length of the spermatid 
(Castrillon et al., 1993; Hicks et al., 1999). The male sterility phenotype ofjar'"'"4  
was rescued when Myosin VI cDNA was expressed, proving that this phenotype was 
caused as a result of Myosin VI depletion in the testes. 
Figure 1.3.1: Myosin VI is involved in many developmental events that require membrane trafficking 
and assembly. A: An embryo during syncitial blastoderm organization. The nuclei undergo division 
and are separated by the formation of pseudocleavage furrows between adjacent mitotic spindles 
(chromosomes are drawn in blue, surrounded by microtubules). In Drosophila, Myosin VI is required 
for the invagination of the pseudocleavage furrows and for the transport particles (drawn in red), near 
the pseudocleavage furrows. B: In the testes, Myosin VI is required for the final stage of 
spermatogenesis - sperm individualization. In the diagram a cyst containing two out of the 64 
spermatids is shown. The upper part of every spermatid is surrounded with membrane formed by the 
individualization complex, as it progresses towards the spermatid tail (arrow). C: A diagram 
presenting two stereocilia in the hair cells of the inner ear. Each stereocilia is separated by a coating 
membrane. Myosin VI is found in the circular plate, where the stereocilia are anchored (a region rich 
in actin filament), and in the permuclear necklace, which is located between the cuticular plate and the 
plasma membrane. In Snell's Waltzer mice, the stereocilia are connected without having a separating 
membrane, (shown in dashed line), indicating that Myosin VI is required to maintain individual 
stereocilia separated by a coating membrane. D: During endocytosis two possible roles are suggested 
for Myosin VI: 1: The larger isoform of Myosin VI plays a role in the creation of Clathrin coated 
vesicles, either by participating in the creation itself, or by cleaving the formed vesicles. 2: The 
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Myosin VI co-localises at the base of the IC with proteins that participate in actin 
polymerisation: Cortactin, Arp2/3 complex and Capping protein (Rogat and Miller, 
2002). Cortactin is a protein that links between actin dynamics and membrane 
signalling by interacting with actin polymerisation components and membrane 
associated-kinases; Arp2/3 is a complex of 7 proteins that binds to actin filaments at 
nucleation sites and initiates the synthesis of actin filaments, and Capping protein 
regulates actin assembly at the plus end or the filaments, at sites that Arp2/3 
promotes actin assembly. In the jar' homozygous mutants the distribution of 
Cortactin and Arp2/3 in the IC was abnormal, indicating that Myosin VI is necessary 
for the proper localisation of Cortactin and the Arp2/3 complex in the IC (Rogat and 
Miller, 2002). 
Another protein that binds to Cortactin, Dynamin, is also expressed in the 
individualisation complex. Dynamin regulates actin dynamics in membrane sites 
where actin filaments are synthesized. The mutations of Myosin VI (jar) and 
Dynamin (shi') interact genetically, causing a significant decrease in the number of 
IC in the testes and severe defects in the stability of the IC actin filaments. This 
suggests that Myosin VI and Dynamin work in concert in the stabilisation of actin 
filaments in the IC (Rogat and Miller, 2002). 
1.3.1.3 	The roles of Myosin VI in other species 
In the Golgi complex of mice fibroblast cells, Myosin VI is necessary for the 
secretion of Golgi-processed proteins and for maintaining the Golgi complex 
structure (Warner et al., 2003). Myosin VI is present in the leading edge and the 
Golgi complex of fibroblasts and epidermoid carcinoma A431 cells (Buss et al., 
1998). When A431 cell surface ruffling was stimulated by EGF (epidermal growth 
factor), Myosin VI was phosphorylated (possibly by p21-activated kinase-PAK) and 
recruited into newly formed ruffles. This suggests that Myosin VI participates in the 
membrane trafficking involved in the ruffles creation. In immortal fibroblasts lines of 
the mutant Snell's Waltzer mice lacking Myosin VI, the size of the Golgi complex 
was reduced by 40% in comparison to wild-type cells. In addition, the secretion of a 
reporter protein (Alkaline Phosphatase) from the Golgi apparatus was reduced by 
40%. When fully functional Myosin VI was expressed in these cells, the function and 
the morphology of the cells was restored (Warner et al., 2003). 
Myosin VI is not only involved in membrane trafficking, but it also plays a role in 
endocytosis. In intestinal enterocytes and kidney proximal tubules Myosin VI is 
expressed mainly at the base of the brush border, where endocytosis of Clathrin-
coated vesicles takes place (Biemesderfer et al., 2002; Buss et al., 2001; Heintzelman 
et al., 1994). This region of endocytosis occurs at the terminal web, where Myosin 
VI co-localises with Clathrin and Clathrin adapter-protein AP-2 (Biemesderfer et al., 
2002; Buss et al., 2001). Following the Clathrin-mediated endocytosis, Clathrin is 
uncoated from the vesicles, prior to its fusion in the endosome (Hasson, 2003). It is 
suggested that Myosin VI plays a role in the creation of Clathrin-coated vesicles and 
in addition it was shown that Myosin VI is necessary in the transport of the uncoated 
vesicles to the endosome (Fig. 1.3.1 D). 
In vertebrates two splicing forms are mainly expressed, a long form and a shorter 
one. The long form contains an insert of 23 amino acids between the coiled-coil 
region and the globular tail domain (Buss et al., 2001; Buss et al., 1998). The two 
splicing forms participate in endocytosis. The long spliced form is necessary for the 
formation of Clathrin-coated vesicles during endocytosis (Buss et al., 2001). This 
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form co-localises with Clathrin coated pits in cultured tissues and PCR analysis 
revealed that this is the main isoform that is expressed in the rat kidney and in 
polarised intestinal cells (Buss et al., 2001). Analysis of Myosin VI fragments 
revealed that the tail domain targets Myosin VI to Clathrin-coated pits only when the 
splice site insert is present. The expression of the long-spliced form of the tail 
domain dramatically reduced the endocytosis of Transferrin (a protein that undergoes 
receptor-mediated endocytosis), indicating that the long form of Myosin VI is 
necessary for the actual formation of the Clathrin coated vesicles (Buss et al., 2001). 
The shorter form of Myosin VI is expressed in epithelial cells under non-polarising 
conditions (Aschenbrenner et al., 2003), in uncoated endocytic vesicles (Clathrin 
coated vesicles that undergo uncoating). Domain analysis revealed that the shorter 
form of the tail domain is sufficient to target Myosin VI to uncoated vesicles and also 
in this case, over-expression of the tail domain significantly reduces Transferrin 
uptake, confirming that the short form of Myosin VI also plays a role in endocytosis 
(Aschenbrenner et al., 2003). Under these conditions, the uptake of Transferrin (a 
proteins that undergoes endocytosis in mammalian cells) by Clathrin-coated pits is 
normal, yet the uncoated pits remain stuck to the cell periphery, inhibiting the 
transfer of Transferrin cargo to the endosome. Recent study shows that Myosin VI 
transports the uncoated vesicles out of the actin-rich network located in the epithelial 
cell periphery and towards the early endosome (Aschenbrenner et al., 2004). In the 
absence of Myosin VI motor activity, the uncoated vesicles were trapped in the actin 
mesh and the vesicles reached the early endosome by diffusion (the movement was 
significantly slowed). Expression of a mutant Myosin VI that binds tightly to actin 
filaments blocked the transport while de-polymerisation of the filaments rescued the 
transport of the vesicles to the early endosome without affecting vesicle formation. 
Therefore, it can be concluded that Myosin VI is necessary for the trafficking of the 
vesicles through the actin barrier to transfer them to the endosome (Aschenbrenner et 
al., 2004). 
Three different proteins were found to associate with Myosin VI during endocytosis: 
Disabled 2 (Dab2), GAIP (G-alpha interacting protein)-interacting protein C 
terminus (GIPC) and synapse associated protein 97 (SAP97). Dab2 is a tumour 
suppressor protein implicated in cell receptor turnover, endocytosis and cell 
31 
signalling. The Dab2 molecule contains at its central region binding sites for Clathrin 
and AP-2 (the DFP motifs), which are sufficient for targeting Dab2 to Clathrin 
coated pits (Hasson, 2003). Dab2 also binds to Myosin VI at its C terminal serine and 
proline rich region (Inoue et al., 2002; Morris et al., 2002) (it binds to both splice 
forms although the insert is necessary for targeting to Clathrin coated pits). This 
result suggests that Dab2 serves as a bridge that links the longer form of Myosin VI 
with Clathrin-coated pits through association of Dab2 to Clathrin, AP-2 and other 
accessory proteins. 
GIPC is a PDZ containing protein that contains in its C and N terminus proline-rich 
domains. These domains are necessary for Myosin VI binding. GIPC binds to 
various transmembrane proteins, and GIPG was found to transfer transmembrane 
proteins through the Golgi stacks (Hasson, 2003). Myosin VI was found to bind 
GIPG in a two-hybrid screen (Bunn et al., 1999). The precise binding region on 
GIIPG was not defined however the PDZ domain in its own is not sufficient for 
binding Myosin VI in vitro. GTPC is present in small uncoated vesicles near the 
plasma membrane in cultured cell lines and Myosin VI co-localises with GIPC in 
these vesicles. 
GIPC is also present in Clathrin-rich invaginations and in endocytic compartments in 
the proximal tubule cells, where it overlaps with Clathrin, AP-2 and Myosin VI. This 
evidence proposes that GIPC plays a role of in the recruitment of Myosin VI to 
Clathrin coated pits. Unlike Dab2, GIPC remains associated with Myosin VI after the 
formation of Clathrin-coated and uncoated vesicles. Therefore, this can indicate that 
GIPC has a role in the transport of the vesicles (Bunn et al., 1999). 
Another protein that associates with Myosin VI in vesicular fractions of rat brain 
cells is SAP97 (synapse-associated protein 97), as described below (Wu et al., 2002). 
The binding of Myosin VI with Dab2 and GIPC raises the possibility that Myosin VI 
participates in the formation of the Clathrin coated pits (Hasson, 2003). During the 
formation of the vesicles, Myosin VI either participate in the building of the vesicles, 
either by the re-organisation of the actin filaments and the membrane during 
endocytosis, or by promoting fission of the vesicles through the dissociation of the 
membrane. The latter hypothesis is supported by the fact that the disruption in 
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Myosin VI function does not alter the morphology of the Clathrin-coated pits, but 
causes defects in the formation of Clathrin coated vesicles. 
In mice, Myosin VI was shown to play a role in maintaining the separated stereocilia 
membranes in cochlear hair cells (Fig. 1.3.1 Q. A recessive null mutation in the 
Myosin VI gene in Snell's Waltzer mice (Myo 6st)  cause deafness and reveal 
degeneration of the inner and outer hair cells of the cochlea and fusion of the 
stereocilia soon after birth (Avraham et al., 1995; Self et al., 1999). The bundles of 
stereocilia appear normal at birth but gradually become disorganised and eventually 
fuse. In wild-type mice Myosin VI is expressed only in the inner and the outer hair 
cells of the cochlea, where it is found in the cuticular plate of the hair cell (the part of 
the cell that support the stereocilia and anchors it to the cell body), but absent from 
the stereocilia itself. Myosin VT is also expressed in the cell body and it is highly 
concentrated at the perinuclear necklace, a region between the cuticular plate (where 
the stereocilia is anchored into the cell body) and the plasma membrane that is rich in 
vesicles and is highly active in membrane transport (Hasson et al., 1997, Rodriguez 
and Cheney, 2000; Titus, 2000). Accordingly, several suggestions were raised about 
the way Myosin VI could function in the separation of the stereocilia membranes: 
Myosin VI could pull down the membrane towards the base of the stereocilia and the 
actin-rich cuticular plate (a role that would fit with a point-end directing motor), or 
anchor the membrane to a certain region in the actin filament. It is also possible that 
Myosin VI participates in the building of the membrane by transporting the vesicles 
found in the perinuclear necklace. Interestingly, the fused stereocilia in Snell's 
Waltzer mice created giant stereocilia (Self et al., 1999). This suggests that Myosin 
VI also plays a role in anchoring the stereocilia to the cuticular plate. The Snell's 
Waltzer mice have other abnormalities apart from deathess, including skeletal 
defects, cropped pinnae (the part of the outer ear that projects from the head). The 
My06sv mutation has a deletion of 130 bp which cause a frame shift in the coding 
region and formation of a stop codon at the neck domain (Avraham et al., 1995). 
Hearing loss conditions in humans were connected with mutations in the human 
Myosin VI gene, Myo6. Patients suffering from a nonsyndromic dominant form of 
deaffiess (NSAD) were found to have a missense mutation in the human Myosin VI 
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gene, Myo6 (Melchionda et al., 2001) at the area encoding the core of the motor 
domain. Three other mutations in Myo6 were found in patients having recessively 
inherited deafness (Ahmed et al., 2003). Two of the mutations were found in 
different places in the motor domain (a missense mutation and a frame shift 
mutation) and one nonsense mutation was found in the tail domain. A recent study 
suggested a connection between a novel missense mutation in Myosin VI, 
sensorineural deafness and hypertrophic cardiomyopathy (Mohiddin et al., 2004). 
Hypertrophic cardiomyopathy is represented by left ventricular hypertrophy, 
diastolic dysfunction (diastole is the part of the cardiac cycle when the ventricles 
relax and fill with blood) and hypercontractility. This condition is often associated 
with disabling symptoms, arrhythmias, and sudden death. In the studied family, the 
inherited sensorineural deafness co-segregated with hypertrophic cardiomyopathy. 
Genetic analysis suggested a linkage between the cardio-auditory phenotype and the 
chromosomal region of Myosin VI. In addition, all the affected members had the 
Myosin VI missense mutation. 
The expression of Myosin VI in neurons is found not only in the Drosophila, but also 
in mammals. In rat brain cells, Myosin VI was found to associate with SAP97, a 
member of membrane associated guanylate kinase homologues (MAGUK5) (Wu et 
al., 2002). SAP97 associates Myosin VI through its N terminal. Myosin VI and 
SAP97 form a trimeric complex with AMPA (a-amino-3-hydroxy-5-
methylisoxazole-4-propionic acid) glutamate receptor subunit, Glurl, where SAP97 
links Myosin VI and Glurl. SAP97 may serve as an adaptor protein that connects 
Myosin VI to vesicular cargoes that carry AMPA-type glutamate receptors (Wu et 
al., 2002). The homologue of SAP97 in Drosophila is Discs Large (DIg) and the 
genetic interaction between Myosin VI and Dlg will be described in chapters 4 and 6. 
Myosin VI is expressed in the chicken brain, along with Myosin V during 
embryogenesis (Suter et al., 2000). In cultured dorsal root ganglion the two myosins 
are expressed in the cell body, the neurites and the growth cones. In the growth cones 
Myosin VI and Myosin V exhibit a punctate staining pattern, each protein has a 
distinct cellular distribution. 
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In Caenorhabditis elegans Myosin VI is necessary for the segregation of components 
during spermatogenesis (Kelleher et al., 2000). Mutation in Myosin VI inhibits the 
delivery of mitochondria and membrane organelles (derived from endoplasmic 
reticulum and/or Golgi) to the budding spermatids. In addition, it was found that 
actin filaments are not restricted to the residual body but also appear in budding 
spermatids. Spermatids dissected from the mutant animals had abnormal rod-like 
insertions through the cell body (which did not contain actin) and other aberrant 
morphologies, which seem to be related to the abnormal function of the spermatids 
(Kelleher et al., 2000). 
Recent research found that Myosin VI mRNA is expressed in the lungs of mice 
during embryogenesis. This expression is reduced when the levels of the 
transcription factor forkhead box (Fox) are low in Foxfl(+/-) mutant mice. Fox is 
essential for the development of the lung and reduced expression of Fox mRNA 
causes pulmonary hemorrhage and peripheral microvascular defects (Kalinichenko et 
al., 2004). 
Myosin VI is expressed in large quantities in the retinas of fish (bass and rainbow 
trout) and primates (Breckler et al., 2000). Antibody staining revealed that within the 
retina Myosin VI was expressed in the photoreceptors, in horizontal cells and in 
MUller cells in both fish and primates as well as in the retinal pigmented epithelium. 
Within the bass cones, Myosin VI expression is asymmetric, suggesting a role for 
Myosin VI in the motility of the cone and thus the whole retina. As shown in chapter 
4, Myosin VI is also expressed in the developing photoreceptors of the Drosophila 
eye disc, at the early pupal stage. 
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1.32 Myosin  
In Drosophila, two Myosin I members were identified (Fig. 3). Myosin IA belongs to 
subclass IV (Morgan et al., 1995; Morgan et al., 1994). The gene is located at locus 
3 1DF on the second chromosome. In contrast to most of the myosins, Myosin IA 
does not have the typical amino acids that compose the TEDS domain (glutamic or 
aspartic acids, threonine or serine) and its neck domain contains two IQ motifs. 
Myosin TB belongs to subclass III (Cheney et al., 1993; Morgan et al., 1995; Morgan 
et al., 1994). The gene is at 61F on the third chromosome. All the members of this 
group are characterised by a neck domain containing three IQ motifs. Like the tail 
domains of all other myosins from class I, the tails of Drosophila Myosin IA and lB 
contain basic residues that may affect the binding of these myosins to acidic 
phospholipids. Drosophila Myosin IA and lB are expressed in the gut epithelia: In 
the larval gut Myosin IA is expressed in the terminal web and Myosin lB is 
expressed in the apical microvilli; in the adult gut both myosins are expressed in the 
microvilli (Morgan et al., 1995). Myosin lB is expressed in the follicle cells during 
oogenesis (sectionl.7), initially in all the follicle cells, but by stage 10, only in the 
columnar cells surrounding the oocyte (Morgan et al., 1995). Antibody detection 
showed that the majority of Myosin TB is located at the basolateral region of the 
follicle cells until stage 8, and also in the apical region in subsequent stages. The role 
of Myosin TB in oogenesis is not clear yet. Based on the function of Myosin I in 
other species it is assumed that Myosin lB has a role in maintenance of the 
cytoskeleton of the follicle cells, or in secretion of yolk protein, the vitelline 
membrane and the chorion. 
In yeast and Dictyostelium type I myosins play a role in membrane traffic 
(endocytosis and exocytosis), cell growth and cell movement (Baker and Titus, 1998; 
Kaihammer and Bahler, 2000; Soldati, 2003). 
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13.3 Myosin II 
The Drosophila myosins of class II contain one IQ motif in the neck domain, 
although the myosins from class II usually contain two IQ motifs (Sellers, 2000). 
The tail domain consists of coiled - coil forming sequence, and terminates in a short 
globular non - helical segment (Fig. 1.3). Myosin II molecules have a two - headed 
structure, due to the dimerization of the heavy chain in the coiled - coil region of the 
tail. Myosin II differs from other myosins by its ability to form filaments, an ability 
that is based on the self-association of the rod-like coiled - coil a helical tail. 
One muscle Myosin II has been found in Drosophila. Its gene (mhc) is located at 
36B on chromosome 2 and produces more than 15 protein isoforms expressed in 
different muscles (Zhang and Bernstein, 2001). 
Drosophila has a second Myosin in class II, nonmuscle Myosin II, encoded by the 
gene zipper, which is expressed in the cell cytoplasm (Kiehart et al., 1989). The gene 
is at 60E9 on chromosome 2 (Kiehart et al., 1989; Young et al., 1993). The zipper 
gene contains two sites for alternative splicing, thus having the potential to generate 
four different isoforms (Mansfield et al., 1996). 
Myosin II participates in various developmental stages during the life cycle. During 
cellularization Myosin II is expressed in the formed pseudocleavage furrow and is 
necessary for basal membrane closure (Royou et al., 2004; Young et al., 1991); at the 
same stage Myosin II plays a role in the migration of the nuclei to the poles (Royou 
et al., 2002; Young et al., 1991). At later stages of embryogenesis, Myosin II controls 
the asyn-imetric localisation of proteins in neuroblasts (Barros et al., 2003) during the 
morphogenesis of the nervous system. Myosin II also participates in head involution 
(Young et al., 1993). 
Nonmuscie (NM) Myosin II was the first gene whose role in dorsal closure (section 
1.6) was analysed in detail (Young et al., 1993). Mutants of the zipper gene that lack 
NM Myosin II expression fails to complete dorsal closure. In the homozygous 
mutant zip'''3  that has a severe phenotype, the leading edge is disorganised, the 
lateral epidermis is not fused at the dorsal midline and the amnioserosa remains 
exposed. The shape of the cells in the lateral epidermis and the anmioserosa is 
aberrant, and in many cells the membrane is torn. 
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The strong expression of NM Myosin II at the leading edge and the co-localisation 
with the actin cable in that region suggested a model in which NM Myosin II pulls 
the epidermal cells during the hole closure like a purse string (Young et al., 1993). 
The function of the actin filaments in the constriction of the purse string was 
supported by the evidence that when the actin cable is deficient, the cells at the 
leading edge are not elongated as in wild type embryos (Harden et al., 1995). In NM 
Myosin II mutants, the cells at the leading edge remain elongated. The maintenance 
of the elongated cells could be established by maternal NM Myosin II (the 
expression level of NM Myosin II declines at late stages of embryogenesis although 
some material could remain in the embryos) (Young et al., 1993). 
There are several factors that were found to control NM Myosin II function and 
expression during dorsal closure: the phosphorylation of the regulatory light (MRLC) 
chain of NM Myosin II stimulates activity. Myosin phosphatase regulates the 
phosphorylation of MRLC, and is inactivated by phosphorylation of its Myosin-
binding subunit (MBS) (Mizuno et al., 2002). The Rho-associated kinases (ROKs), 
which function downstream of RhoA, activate NM Myosin II by promoting the 
phosphorylation of MRLC and MBS. Embryos lacking Drosophila MBS (DMBS) 
fail to complete dorsal closure; therefore the regulation of MRLC phosphorylation is 
necessary for correct dorsal closure (Mizuno et al., 2002). RhoA also regulates the 
expression and localisation of NM Myosin II in the lateral epidermis during dorsal 
closure. Expression of RhoA dominant negative reduces NM Myosin II level at the 
lateral epidermis and the leading edge (Bloor and Kiehart, 2002). 
At the larval and pupal stages Myosin II is necessary for cytokinesis (Karess et al., 
1991) and during imaginal disc morphogenesis, for normal development of the eyes 
and legs (Edwards and Kiehart, 1996). 
Nonmuscle Myosin II was found to play several important roles in oogenesis, 
(section 1.7), including follicle cell migrations and cytoplasmic transport from the 
nurse cells into the oocyte (Edwards and Kiehart, 1996; Wheatley et al., 1995). 
Myosin II is expressed in the migrating follicle cells and in the nurse cells in a 
similar pattern to Myosin VI, being mainly concentrated in the apical and the basal 
parts of the follicle cells. However, the expression of Myosin 11 was not reduced in 
the absence of Myosin VI, suggesting that Myosin VI does not control the expression 
of Myosin II (Deng et al., 1999). The localisation of Myosin II in the follicle cells 
was shown to be controlled by Lethal (2) Giant Larvae (1(2)gl). A temperature-
sensitive mutation in 1(2)gl gene has shown to disrupt the localisation of Myosin II in 
the follicle epithelium, creating aggregates and clumps along the apical and basal 
regions (De Lorenzo et al., 1999b). 
The evidence that nonmuscle myosin functions in oogenesis was provided from 
mutation analysis of spaghetti - squash (sqh), a gene encoding the regulatory light 
chain (RLC) of nonn-iuscle Myosin II (Edwards and Kiehart, 1996; Jordan and 
Karess, 1997; Wheatley et al., 1995). In adult females, mutations in the spaghetti - 
squash gene disrupted the migration of the border cells, the centripetal cells and the 
dorsal appendage follicle cells (Edwards and Kiehart, 1996). Furthermore, anterior 
chorion formation was disrupted, as the centripetal cells were not in the right position 
to secrete chorion material over the anterior end of the oocyte. The movement of the 
dorsal - anterior follicle cells to produce the dorsal appendages was also disrupted, 
and as a result, abnormal short appendages were formed. The mutation in sqh also 
changed the organisation of the follicle cells between the egg chambers: follicle cells 
that migrate between egg chambers failed to organize a proper stalk. 
The sqh mutants also cause a defect in 'dumping', the process of nurse cell cytoplasm 
transport into the oocyte (Edwards and Kiehart, 1996; Wheatley et al., 1995). In 
these mutants, there is no barrier in the ring canal. The distribution of Myosin II was 
abnormal, suggesting that Myosin II is needed for the cytoplasmic dumping. 
Mutation of sqh in the phosphorylation sites (serine 21 and threonine-20) causes 
abnormal formation of the ring canals in the nurse cells, and therefore it can be 
concluded that Myosin II is necessary for their establishment or maintenance (Jordan 
and Karess, 1997). As in dorsal closure, mutation in DMBS (Drosophila myosin-
binding subunit) also caused defects in ring canal formation, cytoplasm dumping and 
dorsal appendage morphogenesis, therefore the regulation of the phosphorylation of 
the myosin regulatory light chain is essential for the proper function of Myosin II in 
oogenesis (Tan et al., 2003). 
Mutations in sqh gene also caused severe defects in proliferation and cytokinesis of 
the cystoblasts (Jordan and Karess, 1997). 
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1.3.4 Myosin III 
The first myosin from this class was identified in Drosophila. The Myosin III gene 
(ninaC) encodes two isoforms, p174 and p132 that differ in their tail domains, which 
contain 420 and 54 aa, respectively, as a result of alternative splicing (Montell and 
Rubin, 1988). Both isoforms contain a kinase domain, N - terminal to the head 
domain, which seems to be needed for the phototransduction activity. Like Myosin 
IA, ninaC does not have the typical amino acids at the TEDS site (glutamic or 
aspartic acids, threonine or serine). The neck domains of the two isoforms contain 
two IQ motifs that bind Calmodulin (Fig. 1.3). The tail domain of p174 is rich in 
basic residues. Both p174 and p132 are exclusively expressed in photoreceptor cells; 
p174 is solely localized to the microvilli of the rhabdomere, and p132 is present in 
the cell body, which indicates that the tail domain of p174 is involved in targeting of 
this Myosin to the rhabdomere. In p174, the targeting of Calmodulin (bound to the 
IQ motifs) and the kinase domain to the rhabdomere is necessary in the deactivation 
of phototransduction process. In addition ninaC plays a role in the structural integrity 
of the rhabdomere (implicated by the motor domain) and P132 seems to function in 
membrane transport or in regulation of photoreceptor cell (Bahier, 2000). 
In human, Myosin lila is expressed in the retina and the cochlea and was found to be 
necessary for normal hearing. Three different recessive loss-of function mutations in 
Myosin lila have been shown to cause nonsyndromic hearing loss (nonsyndromic 
means that there are no other symptoms than deafness) (Walsh et al., 2002). 
1.3.5 Myosin  
Myosin V has been identified in Caenorhabditis elegans, yeast, rat, mouse, chicken, 
and human (Langford, 2002; Wu et al., 2000). The gene encoding this protein 
(didum) is on 43C, on chromosome 2. All genes corresponding to this region are 
essential genes and their mutants show an embryonic lethal phenotype (Maclver et 
al., 1998). The neck domain of Myosin V contains six IQ motifs (Fig. 1.3), and the 
tail domain has regions that form coiled - coil a helices, followed by a globular 
domain, containing two transmembrane regions. The gene has at least two transcripts 
that generate identical proteins (Bonafe and Sellers, 1998). 
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The expression of didum is most abundant in the adult germ line and in the early 
embryo (Maclver et al., 1998). didum is also expressed at stage 16 in the ectodermal 
tissue of the hindgut (Bonafe and Sellers, 1998). 
Myosin V was found as one of the genes expressed in oogenesis, by using the 
enhancer- trap technique (Maclver et al., 1998). After cloning didum cDNA, whole - 
mount in situ hybridisation experiments showed that didum mRNA is present in the 
oocyte from early stages of oogenesis, suggesting that Myosin V has a role in 
oogenesis. At the early stages of oogenesis didum is expressed in the oocyte: at mid-
stages (6-8) didum mRNA is located at the anterior pole of the oocyte; at stages 9 - 
10 didum is expressed strongly in the nurse cells, and later on the transcript is 
dumped from the nurse cells to the oocyte. This last finding suggests that didum has 
a subsequent role in embryogenesis (Maclver et al., 1998). 
Staining the egg chamber with a specific antibody for the Myosin V tail domain 
showed that Myosin V appears in the nurse cells during stages 1 - 13 (Tzolovsky and 
Bownes, unpublished). During stages 10 - 12 Myosin V appears in the oocyte- nurse 
cell border, forming a specific ring-shaped image, and in the anterior region of the 
oocyte. This supports the hypothesis that Myosin V might participate in particle 
transport from the nurse cells to the oocyte. Myosin V staining was also observed in 
the columnar follicle cells although mRNA expression was not detected there. It is 
likely that the concentration of mRNA was too low to be observed by the in situ 
hybridisation technique used. 
Myosin V was found to have various functions in different species, including 
membrane and vesicle trafficking, protein and mRNA transport, organelle 
distribution (melanosomes and smooth endoplasmic reticulum), and cellular 
extension (Langford, 2002; Wu et al., 2000). 
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1.3.6 Myosin Vita 
Drosophila Myosin VII was the first Myosin identified in this class. This Myosin, 
classified as subclass VIla, is encoded by the crinkled (ck) gene (Chen et al., 1998), 
and located at locus 35 B on chromosome 2. 
In this myosin, the neck domain has five IQ motifs and the tail region contains two 
FERM domains (formally termed talin homology domains), two MyTH4 (myosin tail 
homology 4) domains, and an SH3 domain. FERM (named for band 4.1, Ezrin, 
Radixin, Moesin) is a conserved domain in band 4.1 protein superfamily, found in 
Talin, Filopodin, Ezrin Radixin Moesin and other proteins in this family. FERM 
domains are believed to be involved in membrane attachment either directly, via 
binding to phospholipids, or through association with integral membrane proteins. It 
was shown that the FERM domain mediates membrane-cytoskeleton interactions 
through the binding to integral membrane proteins (Sun et al., 2002). FERM proteins 
also interact with other proteins from the ERM (Ezrin, Radixin, and Moesin) family 
by binding to the C-terminal actin-binding domain that appears in the ERM proteins 
(Sun et al., 2002). Geli (Geli et al., 2000) found that SH3 is required for the 
interaction of the tail domain with actin and for triggering actin polymerisation in 
yeast Myosin I. It is also believed that 5H3 plays a role in protein-protein 
interactions through the binding to proline-rich domains (Macias et al., 2002), 
although SH3 domains were also found to interact with non-proline peptides 
(Agrawal and Kishan, 2002). 
Many mutations in the crinkled gene are homozygous lethal. Non-lethal mutations 
show a variety of defects in different organs, including rough eyes, thick sets of 
forked denticles, hairs that are basally fused, sensory hairs that are blunt, abnormal 
bristles and crinkled wings (Kiehart et al., 1998). Moreover, the arista laterals in the 
fly antenna of crinkled mutants are shorter, thicker and branched, suggesting that 
Myosin VII plays a role in the cellular extension of the epidermal cells composing 
the laterals (He and Adler, 2002). Interestingly, the shape of the laterals was similar 
to that observed after cytochalasin D (actin polymerisation inhibitor) treatment. This 
may suggest that Myosin VII participates in the organisation of the actin 
cytoskeleton during the development of the laterals. 
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Mutations in Myosin VITa are responsible for hereditary deafness in both mouse and 
human. In mice containing a mutation in the Myosin VITa gene (Shaker-]), the hair 
cells degenerate, suggesting that Myosin Vila is important for the stereocilia 
integrity (Maniak, 2001; Wu et al., 2000). Myosin VITa was also found in the 
perinuclear necklace, implying that it has a role in membrane trafficking in the inner 
hair cells. In humans, Myosin VITa mutations are associated with Usher syndrome 
type 1B, an autosomal recessive disease resulting in hearing loss and gradual 
blindness, caused by degeneration of the photoreceptor cells. Myosin VII is localised 
in the apical domain of the retinal pigment epithelial (RPE) cells that extend long 
microvilli around the photoreceptor. It is possible that Myosin VITa takes part in 
maintaining the structural integrity of the RPE cells and the photoreceptor cells 
through adhesion of the microvilli to the photoreceptor tips, or by stabilising the 
structure of the microvilli structure (Maniak, 2001; Tuxworth et al., 2001; Wu et al., 
2000). 
In Dictyostelium Myosin VII is involved in cell adhesion (Tuxworth et al., 2001). 
During the early stages of phagocytosis, the particle to be swallowed adheres to the 
outer surface of the Dictyostelium cell and a phagocytic cup is formed around the 
particle. Mutation in Myosin VII reduced significantly the adhesion of the particles 
to the cell surface, while the phagocytic cup was formed normally. Mutation in 
Myosin VII also reduced the adhesion between the Dictyostelium cells during the 
growth phase and reduced the adhesion of the cells to the underlying glass layer 
during their migration (Tuxworth et al., 2001). 
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1,4 	Epithelial morpho genesis and the structure of epithelia 
in Drosophila melanogaster 
Epithelial morphogenesis is the process in which an epithelial tissue obtains its 
specific structure and shape during development. To reach the final structure there 
are several dynamic events that take place, such as changes in cell shape and size, 
cell migration, and cell adhesion. 
Epithelial tissues cover internal and external organs and serve as a barrier to the 
outside environment to maintain homeostasis within the developing and adult 
organism. Epithelial tissues are composed of cells joined to other cells via cell 
adhesion and through the binding to an extracellular matrix-the basal lamina. Some 
of the epithelial tissues are one cell thick (monolayer), like the follicle cell 
epithelium and the lateral epidermis (Kiehart et al., 2000), however epithelial tissues 
can contain several layers of cells- as in the stratified epithelium in the skin. 
Epithelial cells display planar polarity and basal-lateral polarity. The plasma 
membrane of epithelial cells contains the basal side, apical side and the lateral sides. 
These connect with other epithelial cells through the epithelial junctions: the 
adherens junction (zonula adherens) and the septate junction (Fig. 1.4). The epithelial 
cells connect to the extracellular matrix through their basal membrane. This structure 
appears in all epithelial tissues of invertebrates (Muller, 2000). 
The area apical to the adherens junction is often termed the sub-apical complex, and 
it contains two complexes of proteins: the Crumbs complex and the Bazooka 
complex. These complexes create protein interactions that stabilize the membrane 
structures, and participate in local signalling events (Muller and Bossinger, 2003). It 
was suggested that this area participates in the regulation of lateral diffusion of 
membrane components (a function analogous to the tight junctions in vertebrate 
cells) (Muller, 2000). 
The adherens junctions are the regions that interconnect cells by forming an adhesion 
belt (the zonula adherens) around each of the interacting cells in the sheet. The 
interaction between the cells membrane is made through the cell adhesion proteins: 













Figure 1.4. The structure of epithelial tissues. A: a diagram showing the basal-apical polarisation of 
epithelial tissues in invertebrates. Adherens junctions form the zonula adherens, a belt that surrounds 
the epithelial cells. The septate junctions, localised basal to the adherens junction, control the transport 
between the cells. Figure B shows the basal-apical orientation of the follicle cells epithelium in the 
ovaries and the lateral epidermis in the embryo. 
areas that connect the bundles of actin filaments surrounding each cell, through these 
proteins (Muller and Bossinger, 2003). 
The septate junctions control transport between cells and are often referred as gates 
or having a barrier function (Muller, 2000). The localisation of tumour suppressor 
proteins in the septate junction suggests that this area might also participate in 
growth control (Muller and Bossinger, 2003). 
In Drosophila embryos, the epidermis matures after germ band extension. In the 
mature epidermis, the baso-lateral membrane regions contain the proteins: 
Neuroactin, Fasciclin III and 13-spectrin (Muller, 2000). The apical membrane is 
specified by expression of the membrane protein Stranded At Second (SAS). The 
zonula adherens contains the adhesion proteins: DE-cadherin, Armadillo, Da-
catenin, H-Spectrin and phosphotyrosyl proteins. Dig, Scribble, Neurexin, and 
Coracle are localised at the septate junction. 
In the follicle cell epithelium the basal membrane of the cells is connected to the 
basal lamina via PSI-integrin and cell-cell adhesion is mediated through DE and 
DN-cadherin. As in the embryonic epidermis, DE-cadherin, Armadillo, Da-catenin 
localise to the zonula adherens. At the apical-lateral region, Crumbs, Bazooka and 
Discs Lost are present (as observed in early stages of oogenesis). H-Spectrin 
expression is restricted to the apical membrane, while 3-Spectrin and Ankyrin are 
localised to the lateral membrane and a-spectrin is present in the entire cell 
membrane (Lee et al., 1997). The septate junction contains the following proteins: 
Scribble, Dlg, Neuroglian and Fasciclin III (only in the polar cells). 
The following sections discuss three processes of epithelial morphogenesis: germ 
band retraction, dorsal closure and oogenesis, as Myosin VI is shown in this thesis to 
plays an important role in these events. 
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1.5 	Germ band retraction in Drosophila embryos 
Germ band retraction begins at stage 12 of embryogenesis (Bownes stages (Bownes, 
1975)) after the process of germ band extension. As germ band extension is 
completed, the amnioserosa, an epithelial tissue composed of large flat cells, is 
localised between two layers of extended germ band. The germ band tissue is 
composed of a mesodermal tissue and neurons of the central nervous system, covered 
with epidermis. During germ band retraction, the germ band tissue shortens, bringing 
the tail end of the germ band to the posterior of the embryo (Fig. 1.5A and the tail 
end is marked in figure 1.5C). The amnioserosa extends to its original position prior 
to germ band extension, covering the yolk sac on the dorsal side of the embryo (the 
yolk is shown in figure 1.5C). 
The morphologic changes that take place during germ band retraction were observed 
in living embryos, expressing GFP tagged to different proteins (Schock and 
Perrimon, 2002). These observations show that during shortening the germ band 
doubles its height along the dorsal-ventral axis, and its width shortens by 50%. The 
shortening of the germ band is achieved mainly through changes in cell shape, while 
the re-arrangement within the tissue is minimal. The cells in the germ band slightly 
shorten along the anterior-posterior axis, a furrow is formed at each segment 
boundary and a dorso-ventral elongation occurs in the germ band cells, mainly in a 
row of 8 cells adjacent to the amnioserosa (Fig. 1.513). 
The amnioserosa and the germ band move together as one uniform sheet. As the 
amnioserosa moves, it shortens along the dorso-ventral axis, through a massive 
shortening of the cells along their dorsal-ventral axis (Schock and Perrimon, 2002). 
A close inspection at the boundaries between the amnioserosa and the leading edge 
of the germ band reveals that the leading edge is pulled in areas where the plasma 
membrane of the amnioserosa was at a right angle with the leading edge, suggesting 
that the amnioserosa applies forces on the germ band at the boundary of the two 
epithelia. 
At the beginning of stage 12, the amnioserosa overlaps the germ band. As the 
shortening of germ band progresses, the overlap gradually decreases and at the same 
time the contact area between the amnioserosa and the yolk increases. Closer 
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inspection reveals that the connection between the amnioserosa and the germ band 
tissue is made through an adhesion between the tail end of the germ band and a small 
group of amnioserosa cells. The adhesion is made through lamellipodia that are sent 
from the amnioserosa, which migrates over the tail end of the germ band and adheres 
to it (Fig. 1.5C). 
The spreading of the amnioserosa cells over the tail end of the germ band tissue is 
dependent on the function of al,2 laminin and aPS3PS integrin, two types of 
proteins that participate in the adhesion of cells to the extracellular matrix (Schock 
and Perrimon, 2003). Live images of embryos that lack PPS integrin showed that 
lamellipodia formation is disrupted and that there is no extracellular adhesion 
between the amnioserosa and the tail of the germ band tissue (Schock and Perrimon, 
2003). The shape of the amnioserosa cells changes as in wild type embryos, but since 
there is no interaction between the amnioserosa and the germ band, the germ band 
retracts only partially. Expression of PPS integrin in the PPS mutants rescues the 
retraction defects, indicating that PPS is necessary for the process of germ band 
retraction. 
Expression of RhoA dominant negative in the amnioserosa disrupts germ band 
retraction. However, no disruption occurs when RhoA dominant negative is 
expressed in the leading edge of the germ band (Schock and Perrimon, 2002). Germ 
band retraction also fails when the amnioserosa cells undergo premature death in 
hindsight mutants (Lamka and Lipshitz, 1999). These results suggest that the 
amnioserosa is essential for the progress of the germ band retraction. 
It was proposed that the amnioserosa is needed for transmitting signals to the germ 
band tissue that induce cell migration (Lamka and Lipshitz, 1999), although the 
changes in the cells shape and the motility of the amnioserosa could also indicate 
that it contributes mechanical forces to the retraction (Schock and Perrimon, 2002). 
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The figures on the following page: 
Figure 1.5: Germ band retraction. The location of the amnioserosa (AS) and the germ band (GB) 
tissue are shown in the diagram (taken and modified from the atlas of: The Development of 
Drosophila Melanogaster (Bates and Martines-Arias, 1993). A: The process of germ band 
shortening, as observed by time-lapse photography. The germ band cells were visualised in embryos 
expressing c-catenin-GFP driven by arm-Ga14. cx-catenin-GFP is localised to the adherens junctions 
of the epidermal cells, enabling the cell shape to be revealed. The change in the orientation of the 
amnioserosa cells from the anterior-posterior to dorsal-ventral is marked by lines. B: One germ band 
cell was marked with a small dot (pointer by the arrow) and one amnioserosa cell was marked by a big 
dot. As germ band retraction progresses, the relative localisation of the two cells does not change, due 
to the attachment between the cells. Note the elongation of the germ band cells along the anterior-
posterior axis, during shortening of the tissue (Schock and Perrimon, 2002). C: view of the 
anmioserosa and the tail end of the germ band tissue, during germ band retraction. The cells in the 
amnioserosa were marked with mEGFP, which localised both in the cytoplasm and the plasma 
membrane. The expression in the amnioserosa was driven by c381-Ga14. The amnioserosa region 
overlapping the tail end of the germ band is marked by an arrowhead. The triangle marks the tail end 
of the germ band. The arrow indicates the border between the overlapping and the non-overlapping 
area of the amnioserosa. The star indicates the auotofluorescense of the yolk protein (Schock and 
Perrimon, 2002). 
Figure 1.6: Dorsal closure in a living embryo. The top diagram shows the location of the leading edge 
of the lateral epidermis and the amnioserosa (taken and modified from: The Development of 
Drosophila melanogaster (Bates and Martines-Arias, 1993). In order to observe the movement of the 
cells, the embryos express GFP targeted to actin filaments: GFP was tagged to the actin binding 
domain of moesin. A strong expression is observed at the actin cable in the leading edge (Kiehart et 
al., 2000). A: At the beginning of dorsal closure the actin cable starts to appear. B-C: As dorsal 
closure progresses the opposite edges adhere at the anterior and the posterior sides of the amnioserosa, 
and progress towards the centre of the embryo. D: Dorsal closure is completed. Actin expression is 
still observed at the dorsal midline, once closure is complete. 
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1.5.1 Myosin VI and germ band retraction 
In Myosin VI mutants jar R39 and jar R235  (Leaper and Bownes, unpublished), germ 
band retraction is incomplete and often the germ band tissue is disconnected from the 
amnioserosa. A similar phenotype was observed when Myosin VI dominant negative 
was expressed. These phenotypes are described in chapter 5. 
1.6 	Dorsal closure in Drosophila embryos 
Dorsal closure occurs after germ band retraction, during stages 14-15 of 
embryogenesis (Bownes stages (Bownes, 1975)). As germ band retraction is 
completed, a hole is left in the surface of the epidermis that contains the 
amnioserosa. During dorsal closure, the lateral epidermis that surrounds the dorsal 
hole migrates towards the dorsal midline, covering the amnioserosa (Fig. 1.6 A-D 
and Fig. 5.5 A-D in chapter 5). The migration of the lateral epidermis occurs from 
both sides of the embryo. The opposite tissues meet at the dorsal midline, the cells 
from opposite tissues adhere and the epidermis seals the dorsal opening (Martines-
Arias, 1993). Initially the edges of the lateral epidermis meet at the anterior and the 
posterior edges. As dorsal closure progresses, the sealed areas increase and move 
towards the centre of the dorsal midline, in a zipping manner. At the leading edge of 
the migrating epidermis, an acto-myosin cable is formed, composed of actin 
filaments and nonmuscle Myosin II (the presence of Myosin II in the acto-myosin 
cable is shown in figures 5.5 A-D and 5.8.1B; the actin cable is shown in figures 5.10 
A, D in chapter 5 and in figure 1.6 B-D). 
The acto-myosin cable creates a ring around the amnioserosa that contracts and pulls 
the epidermis to close the dorsal hole at the anterior and the posterior edges. The 
contraction of the acto-myosin cable changes the shape of the cells at the leading 
edge from polygonal to an elongated shape (Fig. 5. 1 O in chapter 5); therefore it was 
proposed that the contraction of the acto-myosin cable at the leading edge is like a 
purse string. The change in cell shape is gradually transferred to cells located more 
ventrally, due to the pulling of the cells at the leading edge. 
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However, the purse string model is not the only force participating during dorsal 
closure. The forces participating in dorsal closure were studied in living embryos 
expressing GFP-moesin tagged protein (which binds to actin filaments in cells), by 
creating small cuts in the tissues with ultraviolet laser beam and examining the 
structural changes and the healing process in the different tissues (Kiehart et al., 
2000). When a cut was made in the lateral epidermis near the leading edge, the tissue 
surrounding the wound moved away from the cut, causing the leading edge to move 
towards the dorsal midline. This suggests that under normal conditions, the lateral 
epidermis is put under tension that pulls the leading edge away from the dorsal 
midline, and hence retards dorsal closure. 
Close observation of living embryos expressing GFP tagged actin confirmed that the 
cells at the leading edge extend filopodia and lamellipodia during dorsal closure 
(Jacinto et al., 2000). The filopodia and lamellipodia assist initially in the recognition 
of the correct cells on the opposite edge, with which they adhere, in order to close the 
dorsal hole neatly. As the filopodia meets a cell from the opposite edges it adheres 
with the cell membrane, and pulls the opposite cells together, to promote the 
adhesion between the cells (Martin and Wood, 2002). 
The amnioserosa plays an active role in dorsal closure and it is not simply 
compressed by the migrating epidermis. Cuts in the amnioserosa release the tissue 
and the leading edge retracts away from the dorsal midline, suggesting that the 
amnioserosa tissue is under tension which contributes to dorsal closure, through the 
connection with the lateral epidermis (Kiehart et al., 2000). During dorsal closure the 
shape of the cells changes from elliptical to tubular. This change derives from an 
apical constriction of the cells and loss of cells from the tissue. The cell loss is 
established by invagination of cells and joining of the cells that remained on the top 
of them (Kiehart et al., 2000). The rupture of the amnioserosa during dorsal closure 
does not seem to prevent dorsal closure from proceeding; therefore the contraction of 
the amnioserosa might be needed to remove physical barriers during the migration of 
the epidermis. 
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1.6.1 The role of Myosin VI in dorsal closure 
Kellerman and Miller (Kellerman and Miller, 1992) used antibody staining to show 
that Myosin VI is expressed during dorsal closure in the leading edge of the lateral 
epidermis. Mutations in Myosin VI cause failure in dorsal closure, and detachment of 
the cells at the leading edge and the amnioserosa (Millo et al., 2004). Work in this 
thesis suggests that Myosin VI is necessary during dorsal closure for cell adhesion 
and the organisation of the actin cytoskeleton 
1.7 Qogenesis 
Drosophila ovaries consist of 16-20 ovarioles. Each ovariole contains a string of 
developing egg chambers of increasing age. The most immature are in the germarium 
at the anterior and the most mature eggs at the posterior, ready to enter to the oviduct 
(Fig. 1.7.1A). The egg chambers are divided into 14 developmental stages according 
to their morphology (Deng et al., 1999; King, 1970; Spradling, 1993). 
Oogenesis starts within the anterior region of the ovariole, in the germarium (Fig. 
1.7.1A-B). A germline stem cell divides asymmetrically to produce a new stem cell 
and a cystoblast. Then, the cystoblast divides four more times with incomplete 
divisions to form a cyst of 16 cells that are connected by ring canals. One of the cells 
undergoes meiosis and becomes the oocyte, while the rest of the cells become nurse 
cells. The germarium can be divided into four regions (1.7.1B). 
The stem cells and the dividing (mitotic division) cystoblasts lie within the 
germarium in region 1. Region 2a contains the newly formed 16 cell cysts. In region 
2b, the 16 cell cysts become lens shaped with the pro-oocyte positioned at the centre 
of the cyst. When the cysts occupy region 3, the oocyte is located at the posterior 
pole, where it will remain during the subsequent stages of oogenesis. Somatic stem 
cells are located at the border between regions 1 and 2 of the germarium. In region 2, 
follicle cells (made from the somatic stem cells) migrate from the wall of the 
germarium to envelop the 16 cell cysts. When they reach region 3, the cysts are 
already surrounded by a single layer (epithelium) of follicle cells and are referred as 
stage-i egg chambers. At the anterior pole of the germarium is the terminal filament, 
containing a stack of 6-9 non-dividing somatic cells. The terminal filament is closely 
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The figures in the following pages: 
Figure 1.7.1 Drosophila melanogaster ovariole and the different developmental stages of oogenesis. 
A: Drawing of an adult wild—type ovariole. The germarium is located at the anterior edge of the 
ovariole (top). Several egg chambers at different developmental stages are shown: the egg chambers 
mature along with their movement towards the posterior. B: drawing of a germarium. The 
germarium is divided into four regions: region 1 at the anterior pole, region 2a, 2b and region 3 
at the posterior pole. Region 1 contains the stem cell, the divided cystoblasts, the terminal 
filament at the anterior pole and the cap cells near the terminal filament. The somatic stem cells are 
located between region 1 and 2. Region 2a, contains the 16 cells cysts, formed after four cell 
divisions. In region 2b the 16 cell cysts become lens shaped. In region 3 the 16 cell cysts are 
surrounded by the follicle cells (their organization around the cysts started in region 2). C: A mature 
egg. The dorsal appendages and the micropyle are shown in the drawing (the operculum is marked 
with the arrowhead (Deng and Bownes, 1998). 
Figure 1.7.2 Follicle cell migrations during the mid - stages of oogenesis. A: During stage 8, the 
follicle cells are arranged in a monolayer around the germ cells. B: During stage 9 a group of anterior 
follicle cells leave the follicle cell epithelium and migrate through the nurse cells, towards the border 
between the nurse cells and the oocyte (arrowhead). These cells stop migration at stage 10. In the 
same time, most of the follicle cells that cover the nurse cells migrate to cover the oocyte at the 
posterior, forming the colunmar cells (arrows in B, Q. Only a few follicle cells remain stretched 
covering the nurse cells. C: During stage lob, the anterior columnar cells migrate centripetally along 
the nurse cell - oocyte border to cover the anterior side of the oocyte (arrows) (Deng and Bownes, 
1998). D: f3 - galactosidase staining shows chorionic appendage formation during the migration of 
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associated with another group of somatic cells called cap cells. Both the basal cells of 
the terminal filament and the cap cells lie adjacent to the germline stem cells (Fig. 
1.7.1B). In stage 2 the egg chamber leaves the germarium (Fig. 1.7.1A). As the egg 
chamber leaves the germarium, five to eight follicle cells become the stalk cells. 
These cells form stacks that separate adjacent egg chambers. Stalk cells are not part 
of the follicle epithelium. Within the epithelium, the polar cells become distinct from 
other follicle cells. These cells are important for subsequent patterning of the egg 
chamber. 
After leaving the germarium, the egg chamber grows in size. The germ cells enlarge 
due to synthesis of organelles proteins and lipids in the nurse cells, and uptake of 
yolk produced in the fat body (Spradling, 1993). The nurse cells and oocyte remain 
at approximately the same size from stage 1 to 6. In the nurse cells the nuclei divide 
several times forming polyploid cells. At stage 2, the oocyte nucleus, or germinal 
vesicle is similar in size to the nurse cell nuclei. The germinal vesicle is positioned at 
the posterior pole of the oocyte up to stage 7. When the egg chambers reaches stage 
4 they become more elongated in shape. From stage 8 to 1 Ob, the egg chambers grow 
quickly and the oocyte grows at greater rate than the nurse cells. The follicle cells 
and fat bodies produce yolk proteins, which are then transferred to the oocyte and 
allow it to grow quickly. In stage 10A egg chambers, the oocyte occupies about half 
of the egg chamber. 
From stage 1 to 8 the somatic follicle cells are distributed in a uniform layer around 
the germline cells (Fig. 1.7.2A). In stage 9 the follicle cells start to undergo several 
migrations. 
In the beginning of at stage 9, a group of 6 to 10 anterior follicle cells move through 
the nurse cell cluster towards the nurse cell - oocyte border (Fig. 1.7.213). These 
border cells participate in the formation of the micropyle in the mature egg, thus 
maintaining an opening through which the sperm enters at fertilization. 
At the same time, the majority of follicle cells (95%), which originally cover the 
nurse cells, elongate and migrate posteriorly so that by stage 10A, the oocyte is 
covered by a sheet of thick columnar follicle cells, while only a thin layer of 50 
stretched cells are left covering the nurse cells (Fig. 1.7.2B). 
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By stage lOB the anterior columnar follicle cells migrate centripetally along the 
dorsal - ventral axis to cover the anterior end of the oocyte (the centripetal cells, Fig. 
1.7.2C). These cells will secrete the anterior end of the eggshell, which, along with 
the eggshell secreted by the columnar cells, will eventually cover the entire egg. 
At stage 11, two groups of columnar follicles cells at the dorsal-anterior region 
migrate anteriorly to produce a pair of dorsal appendages (Fig. 1.7.2D, 1.7.lC) 
(Deng et al., 1999; Spradling, 1993). The formation of the dorsal appendages is 
completed at stage 14. During stages lOB to 12, the cytoplasm of the nurse cells is 
carried through the ring canals into the oocyte. The transfer is quite rapid: most of 
the cytoplasm is transported into the oocyte within 30 minutes. At stages 13 to 14, 
the remaining nurse cells and follicle cells shrink and undergo apoptosis (King, 1970; 
Spradling, 1993). The mature egg is wrapped with an eggshell (chorion), containing 
its special structures: a pair of dorsal appendages (filaments) at the anterior end of 
the egg (to facilitate embryonic respiration), micropylar apparatus (for sperm entry), 
and operculum (located between the appendages and the micropyle, used for the 
larvae to hatch, Fig. 1.7.1C). 
1.7.1 The role of Myosin VI in oogenesis 
One role of Myosin VI in oogenesis was studied by using antibodies and 
fluorescence time lapse microscopy (Bohrmann, 1997). During stages lOB-12 of 
oogenesis, Myosin VI was found in the nurse cells, attached to cytoplasmic particles, 
and at the edge of the ring canals, suggesting that Myosin VI is involved in transport 
of cytoplasmic particles from the nurse cells, through the ring canals, into the oocyte. 
Microinjection of mitochondria-specific dyes has revealed that some of the 
transported particles are mitochondria. 
Deng et al. (Deng et al., 1997) used Ga14-UAS targeted expression to detect genes 
expressed in the follicle cells at different stages of oogenesis. One of the cell lines 
had reporter gene expression in anterior follicle cells and migrating border cells, 
during stages 7-11 of oogenesis. After isolation of the gene by plasmid rescue 
techniques and sequence analysis, the gene was identified as jaguar, which encodes 
Drosophila Myosin VI (Deng et al., 1997; Kellerman and Miller, 1992). 
56 
The distribution ofjaguar mRNA transcripts during oogenesis was studied by whole 
- mount in situ hybridisation. In the follicle cells, jaguar transcripts are present in the 
anterior follicle cells during stages 7-8 (Fig. 1.7.3). During stage 9, jaguar is 
expressed in the follicle cells that move from the nurse cell cluster and cover the 
oocyte. At stage 10 jaguar is expressed in the border cells, in posterior follicle cells 
and in the centripetally migrating follicle cells. At stages 12-13 jaguar is also 
observed in the dorsal anterior follicle cells. In the nurse cells, jaguar strongly 
expressed during stages 9-13 while Myosin VI protein expression is very low. This 
may indicate that stored mRNA transcripts transfer to the oocyte and less protein is 
translated for the function of Myosin VI in the germline. 
When the expression pattern of Myosin VI during oogenesis was examined by 
antibody staining (Fig. 1.7.4, (Deng et al., 1999)), it was found that Myosin VI is 
expressed strongly in all the follicle cells that undergo migration. Myosin VI is 
expressed in the nurse cells at high levels up to stage 6 and at low levels in later 
stages. During stage 7 Myosin VI is expressed in the anterior follicle cells prior to 
their migration to the border cells (Fig. 1.7.4A). During stages 9-13 a strong staining 
appears in the follicle cells that undergo migration, including the border cells (Fig. 
1.7.413, G), the columnar cells (Fig. 1.7.413, C), the centripetal cells (Fig. 1.7.41), E) 
and the dorsal - anterior follicle cells (Fig. 1.7.417). The expression pattern of jaguar 
(mRNA) and Myosin VI (protein) are similar. These results gave the first hint about 
the role of Myosin VI in the migration of the follicle cells. 
The function of Myosin VI during oogenesis was studied by using the targeted gene 
silencing technique. This technique combines the Ga14-UAS targeted expression 
system and the antisense RNA technique (Deng et al., 1999). Thus, the expression of 
Myosin VI could be interfered with in specific somatic cells, at specific stages of 
development. One of the Ga14 lines used (C532) expressed antisense jaguar mRNA 
in all the follicle cells, except the border cells. The antisense Jaguar is expressed in 
follicle cells during stages 9 and 10 (Fig. 1.7.5). As a result, the flies had abnormal 
morphogenesis of the ovaries. The follicle cells developed shape defects and their 
migration was arrested. The integrity of the follicle cells epithelium was ruined, 
losing its organised monolayer structure (Fig. 1.7.5 B, D-F). 
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Antibody staining shows that the expression of Myosin VI is significantly reduced in 
most of the follicle cells (except of the border cells) when antisense Jaguar RNA is 
expressed (Fig. 1.7.5C). These results showed that Myosin VI is necessary for 
maintaining the integrity of the follicle cell epithelium during morphogenic changes 
and for the migration of the follicle cells. 
When the expression of Myosin VI was disrupted in the border cells, it was found 
that the cells fail to migrate, thereby showing that Myosin VI is also necessary for 
the border cells migration (Geisbrecht and Montell, 2002; Leaper, 2003). The 
expression of Myosin VI was also reduced in the border cells of flies containing a 
mutation in the slow border cells (slbo) gene, which regulates the migration of the 
border cells. This suggests that the expression of Myosin VI in the border cells is 
controlled by sibo. 
Since DE-cadherin is also necessary for border cell migration, interaction between 
the proteins was tested (Geisbrecht and Montell, 2002). In the absence of Myosin VI, 
the expression of DE-cadherin and Armadillo-which creates a complex with DE-
cadherin-was significantly reduced in the border cell, and in the columnar follicle 
cells. Additionally, the expression of Myosin VI was reduced in cells lacking DE-
cadherin or Armadillo. Co-immunoprecipitation tests show that Myosin VI interacts 
with Armadillo in ovarian cell extract. This interaction is specific since Myosin VI 
did not do-immunoprecipitate with Dig, another membrane protein expressed during 
oogenesis. When DE-cadherin was expressed at high levels by using a heat-shock 
inducible transgene in ovaries depleted of Myosin VI, the migration of the border 
cells was rescued. Therefore, it can be concluded that it was the decline in DE-
cadherin expression in the absence of Myosin VI that arrests the migration of the 
border cells. Border cell migration was also restored when UAS-Myosin VI or hs-
Myosin VI was expressed, and also over-expression of UAS-slbo. These results 
suggest that Myosin VI plays a role in the migration through the stabilisation of the 
DE-cadherin-Armadillo complex. Hence, Myosin VI might promote follicle cell 





Fig. 1.7.3. The expression of Jaguar mRNA in the Drosophila egg chambers.jaguar mRNA is expressed in 
the nurse cells throughout oogenesis, with a strong signal since stage 10 and on. In the follicle cells, jaguar is 
expressed at stage 7 in the anterior cells. At stage 9,jaguar is expressed in follicle cells that migrate to cover 
the oocyte. At stage 10 expression ofjaguar is found in the border cells and in the centripetal cells, and in 
stage 12 jaguar is expressed in the dorsal anterior cells. 
Figure 1.7.4 
Figure 1.7.4 Expression of Myosin VI protein in oogenesis. (A - F) labelling of Myosin 95F. A: During 
stage 7, Myosin VI is present in the anterior follicle cells (arrow). B: Strong staining in the border cells is 
detected at stage 1 OA (arrow). During stage 1 OA, Myosin is present in cytoplasm of all columnar cells 
covering the oocyte (B, Q. D: During stage lOB, when centripetal cells are migrating to cover the anterior 
end of the oocyte, Myosin 95F is strongly expressed in these cells (arrowhead) while staining in the columnar 
cells is fading. The staining remains in the leading centripetal cells, which form a contractile ring between the 
nurse cell cluster and the oocyte (E, arrow). F: during stages 12 - 13. Myosin VI expression is detected in 
dorsal anterior follicle cells [Deng, 1998 #17]. 
Figure 1.7.5 
Fig. 1.7.5. Targetedjaguar antisense RNA expression interrupts oogenesis. Figures A - D show 
double label with anti-spectrin (green) to visualize follicle cell shape and propidium iodide (red) 
to visualize nuclei. Figure C show labelling of anti -Myosin 95F. A: A wild - type egg chamber 
at stage 9. The arrow shows columnar cells during their migration towards the posterior. B: An 
egg chamber of line expressing antisense (C532/Am8), at stage 9. The migrating columnar cells 
have an irregular morphology (arrow), however the border cell migration is unchanged (arrowhead). 
C: The expression of Myosin VI is not detected in the degenerating egg chamber (white arrow), and 
in the columnar cells in line C532 (yellow arrow). However, expression in the border cells (arrowhead) 
and nurse cells is visible. D: Before stage 9, C532/Am8 egg chambers develop normally (arrow), while 
after stage 9 the degeneration of the egg chambers occurs (arrowhead). E: In a degenerating egg chamber, 
follicle cells have abnormal shape and the columnar follicle cells fail tomigrate. F: In extreme cases some 
of the follicle cells invade into the nurse cells cluster [Deng, 1998 #17]. 
Several experiments showed that the migration of the follicle cells by Myosin VI is 
not made through endocytosis. This possibility was tested since Myosin VI is 
involved in endocytosis in intestinal human cells (Buss et al., 2001). However, 
disruption of Myosin VI expression did not alter border cell expression of proteins 
involved in endocytosis, such as a-adaptin, or the expression of other cell membrane 
proteins. Also, reduced expression of DE-cadherin and Armadillo were not related to 
defects of endocytosis, since the expression of these proteins is not changed in egg 
chambers depleted of Dynamin, another protein necessary for endocytosis 
(Geisbrecht and Montell, 2002). 
Border cell migration is established through cell protrusions called Long Cellular 
Extensions (LCE) that are sent from one of the border cells, attached to other cells 
membrane and pull the eight border cells cluster ("grapple and pull" model, Fulga 
and Rorth, 2002). In the absence of Myosin VI, LCE are not observed in the border 
cells, indicating that Myosin VI is necessary for the creation of these extensions 
(Geisbrecht and Montell, 2002). The arrest of cell migration in the absence of DE-
cadherin indicates that the migration of the cells requires traction. The formation of 
LCE is made through actin polymerisation and membrane remodelling. These 
suggest that the connection of DE-cadherin and Armadillo to the cytoskeleton 
through Myosin VI could promote the creation of the LCE and the migration of the 
border cells (Schober and Perrimon, 2002). 
1.8 Summary 
This Introduction describes the molecular structure of Myosin VI and its functions in 
Drosophila and other species. In chapter 4 of this thesis, the function of the entire 
Myosin VI molecule and its separate domains is studied in more detail, by examining 
their localisation in organs where Myosin VI takes part in the development. The 
process of dorsal closure during embryogenesis is described and evidence is 
presented that Myosin VI is required in dorsal closure, in chapter 5. 
The stages of oogenesis, focusing on the migration of the follicle cells, and the role 
of Myosin VI in oogenesis is described and chapter 6 details the role of Myosin VI in 
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follicle cell migration, through a search for proteins that function downstream of 
myosin VI. 
The structure and function of the rest of the myosins that were found in Drosophila 
are also presented and chapter 3 describes the identification and characterisation of 
five new myosins in Drosophila melanogaster. 
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Chapter 2: 
Materials and Methods 
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2.1 	Materials 
2.1.1 	Chemicals and Radioactive isotopes 
Chemicals were purchased from Sigma, BDH, Fisher Scientific and Fluka. Some 
materials were purchased from other suppliers, and their name will be mentioned in 
the text. 
The isotope [32P]dCTP was purchased from Amersham Biosciences. 
2.1.2 	Restriction endonucleases and modifying enzymes 
Restriction endonucleases were obtained form New England Biolabs and Promega. 
Taq polymerase and accompanying buffers were supplied from Qiagen. Large 
fragments of DNA were amplified by using the Expand Long Template PCR kit of 
Roche Molecular Biochemicals. High fidelity pfu Turbo DNA polymerase was 
obtained from Stratagene. Kienow DNA polymerase was purchased from Roche 
Molecular Biochemicals. 
T4 DNA ligase was purchased form New England Biolabs. 
Reverse Transcriptase (SuperScript TM  II) was purchased from GIBCO BRL. 
2.1.3 	Buffers and Solutions 
All buffers and solutions were made with sterile double distilled water (ddH20). 
Sterilization, when was required, was made by filtering the solutions through 0.22 
tm filter (Satorious). Most of the solutions were stored at RT unless indicated 
differently. 
General solutions are listed in table 2.1.3.1. When some of the reagents had similar 
names, they were listed in separate tables, in the sections describing their use. 
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Table 2.1.3.1: 	List of general solutions and buffers 
Solution 	 I Components! Preparation 	 I Final 
concentration 
Bleaching solution 	I 100 ml bleach solution 	 I 50%- 
100 nil lx embryo wash solution 
Bromophenol Blue ' 10 mg Bromophenol Blue 0.1% 
Dissolve in 10 ml ddH20. 
CaCl2 73.5g CaC12.2H20 (Mw: 147.0) 5M 
Bring to final volume of 100 ml with ddH20. 
Carrier solution 10 mg Glycogen 10 mg/ ml 
Dissolve in I ml ddH20. Store aliquots at -20 °C. 
Denhartd's bOX ig BSA (Bovine Serum Albumin) 2% 
I  Ficoll (Mw: 400) 2% 
ig Polyvinylpyrolidone (Mw: 360) 2% 
Bring to final volume of 50 ml with ddH20. 
Store aliquots at -20°C. 
DNA Hybridisation 125 ml 20X SSPE 5X 
buffer 25 ml 10% SDS 0.5% 
25 ml 100X Denhartd's 5X 
Bring to final volume of 500 ml with ddH20. 
Prior to the use: boil 1 ml of sssDNA (10mg/ ml) for 20 tg/ ml 
10 mm, chill immediately on ice for 2 min and add to 
the solution. 
DNA 	Sample 	Buffer 3 ml 0.1% Bromophenol Blue 0.03% 
(6X) 3 ml glycerol 30% 
4mlddH2O. 
EDTA 0.5M pH 8.0 93g Na2EDTA.21-120 (Mw: 372.24) 0.5M 
Adjust to pH 8.0 with —20g NaOH, and bring to final 
volume of 500 ml with ddH20. 
Embryo wash lOX 7g NaCl 7% 
0.5 ml Triton X-100 0.5% 
Bring to final volume of 100 ml with ddH20 
Embryos 3.25 ml ddH20 
Formaldehyde mix 0.5 ml lOX PBS pH 7.4 1X 
1.25 ml 37% Formaldehyde 9.25% 
List of general solutions and buffers-continuous. 
Solution Components! Preparation Final 
concentration 
EtOH 70% 70 ml EtOH 100% 70% 
Bring to final volume of 100 ml with ddH20. 
FISH media 5 ml 1M Tris pH 8.5 100mM 
1.25gDABCO 2.5% 
45 ml glycerol 90% 
Fly buffer 5 ml 1M Tris-HC1 pH 8.5 1001TIvl 
800 p.1 NaCl 5M 80mM 
2.5g Sucrose 5% 
2.5 ml SDS 10% 0.5% 
5 ml EDTA 0.5M, pH 8.0 50niM 
Bring to final volume of 50 ml with ddH20. Store at 
4°C. 
Glucose 20g Glucose 20% 
Bring to final volume of 100 ml with ddH20. Sterilize 
and store at 4°C. 
High stringency 2.5 ml SSPE 20X 0.lX 
5 nil SDSlO% 0.1% 
Bring to final volume of 500 ml with ddH20. 
K Acetate 78.59g C113COOK (Mw: 98.14) 8M 
Bring to final volume of 100 ml with ddH2O. 
KOH 28gKOH(Mw: 56.11) 5M 
Bring to final volume of 100 ml with ddH20. 
Low stringency 50 ml SSPE 20X 2X 
5m1SDS10% 0.1% 
Bring to final volume of 500 ml with ddH20. 
Medium stringency 25 ml SSPE 20X 1X 
5 nil SDS1O% 0.1% 
Bring to final volume of 500 ml with ddH20. 
MgCl2 9.5g MgCl, (Mw: 95.21) 1M 
Bring to final volume of 100 ml with ddH20 
Mg504 24.6 gr MgSO4.7H20 (Mw: 246.5) 1M 
Bring to final volume of 100 ml with ddH2O. 
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List of general solutions and buffers- continuous. 
Solution Components! Preparation Final 
concentration 
Microinjection 	buffer 0.186g KC1 (Mw: 74.55) 50mM 
lox 5 ml PBS buffer 10mM pH 6.8 1mM 
Bring to final volume of 50 ml with ddH20. Filter and 
freeze aliquots. 
MnCl2 39.58g MnC12.4H20 (Mw: 197.9) 2M 
Bring to final volume of 100 ml with ddH20. 
Na Actetate, pH 5.2 40.8g CH3CooNa.3H20 (Mw: 136.08) 3M 
Adjust to pH 5.2 with glacial Acetic Acid SM acetate 
Bring to volume of 100 ml with ddH20. 
Na2HPO4 17.8g Na2HPO4.2H20 (Mw: 178.0) 1M 
Bring to final volume of 100 ml with ddH20. Store at 
4°C. 
NaCl 146.lg NaCl (Mw: 58.44) SM 
Bring to final volume of 500 ml with ddH20. 
NaH2PO4 15.6g NaH2P04 2H20 (Mw: 156.0) 1M 
Bring to final volume of 100 ml with ddH20. Store at 
4°C. 
NaOH 80 grNaOH (Mw: 40.0) ION 
Bring to final volume of 20 ml with ddH20. 
NGS 50.tl Normal Goat Serum 1% 
4.95 ml PBT 
Nipagin I  Nipagin 10% 
Bring to final volume of 10 ml with 95% EtOH. 
PBS pH 6.8 2.315 ml Na2HPO4.21-120 IM 46.3mM 
2.685 ml NaH2PO4.2H20 1M 53.7mM 
Bring to final volume of 50 ml with ddH20. Store at Total: 100mM 
4°C. 
PBS pH 6.8 1 ml PBS pH 6.8 100mM 10mM 
Bring to final volume of 10 ml with ddH20. Store at 
4°C. 
NO 
List of general solutions and buffers- continuous. 
Solution Components! Preparation Final 
concentration 
PBS pH 7.4 lox 40g NaCl (Mw: 58.44) 1.37M 
40 ml Na2HPO4.2H20 1M 80mM 
10 ml NaH2PO4.2H20 1M 20mM 
Adjust to pH 7.4 with 1 O NaOH 
Bring to final volume of 500 ml with ddH20 
PBT 1O nil 1OX PBS pH7.4 lx 
2.5 ml Triton X-100 0.5% 
Bring to final volume of 500 ml with ddH20. Filter 
and keep at 4°C. 
PBTA buffer 50 ml 10XPBS pH 7.4 1X 
5g BSA 1% 
0.25 ml Triton X- 100 0.05% 
0.1g Sodium azide 0.02% 
Dissolve gently in 450 ml ddH20 at 4°C. Bring to 
final volume of 500 ml with ddH20. 
p-formaldehyde 4g p-formaldehyde 4% 
1Om11OX PBS pH7.4 lx 
Bring to final volume of 100 ml with ddH20. Dissolve 
0/N at 65°C. 
Phenol/chloroform 5 ml Phenol (saturated with TE buffer, pH 8.0) 
5 ml chloroform. Shake well before use. 
Proteinase K 10 mg proteinase K 10 mg/ ml 
10 jl Tris-HCI IM, pH 7.5 10mM 
590 ii ddH20 
400 pil glycerol. 40% 
Store at -20 °C 
RbCl 12.09g RbC1 (Mw: 120.9) 1M 
Bring to final volume of 100 ml with ddH20. 
M. 
List of general solutions and buffers- continuous. 
Solution Components! Preparation Final 
concentration 
Ringer's saline pH 7.2 6.8g KC1 (Mw: 74.55) 180mM 
13.5g NaCl (Mw: 58.44) 45mM 
0. 17g CaC12.2H20 (Mw: 147) 2.3mM 
0.6g Tris-base (Mw: 121.14) 10mM 
Adjust to pH 7.2 with conc. HC1. Bring to final 
volume of 500 ml with ddH20. Filter through 0.22pm 
filter. Store at 4°C. 
RNAse (DNAse free) Dissolve 10 mg RNAse in I ml ddH20. Aliquot 250 10 mg/ ml 
il in 4 eppendorf tubes. Heat up to 110°C for 20 mm 
in a closed heating block. Leave the block to cool 
gradually to RT. Store at -20 °C, 
SDS 5OgrSDS 10% 
Bring to final volume of 500 ml with ddH20. 
Sonicated 	salmon 10mg Sonicated salmon sperm DNA in 1 ml ddH20. 10mg! ml 
sperm DNA (sssDNA) Store at -20°C. 
SSC 20X 87.65g NaCl (Mw: 58.44) 3M 
pH 7.0 44.lg Na Citrate.2H20 (Mw: 294.1) 300mM 
Adjust to pH 7.0 with ION NaOH 
Bring to final volume of 500 ml with ddH20. 
SSPE 20X 87.65g NaCl (Mw: 58.44) 3M 
pH 7.4 15.6g NaH2PO4.2H20 (Mw: 156.01) 200mM 
4.7g EDTANa2 (Mw: 372.24) 25mM 
Adjust to pH 7.4 with ION NaOH 
Bring to final volume of 500 ml with ddH20. 
Stripping solution 198 ml ddH20 0.1% SDS 
Boil and gently add 2 ml 10% SDS. 
TAE (50X) 121g Iris Base (Mw: 121.14) 2M 
28.55 ml Glacial Acetic acid 
50 ml 0.5M EDTA, pH 8.0 50mM 
Bring to final volume of 500 ml with ddH20. 
TE, pH 8.0 1 ml IM Tris, pH 8.0 10 mM 
200 .tl 0.5M EDTA, pH 8.0 1mM 
in 100 ml ddH20. 
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List of general solutions and buffers- continuous. 
Solution Components! Preparation Final 
concentration 
TFBI 1.88 ml K acetate 8M 30mM 
I ml of CaC12 SM 10mM 
12.5 ml MnC12 2M 50mM 
5O nil RbClIM 100mM 
75 nil Glycerol 15% 
Dissolve in 400 ml ddH20 (important to add the 
solution in the exact order to avoid sedimentation of 
the salts). Adjust to pH 5.8 with Glacial Acetic acid. 
Bring to final volume of 500 ml with ddH20. Sterilize 
through 0.22 mm filter, and store at 4°C. 
TFB2 0.3g Pipes (Mw: 300) 10mM 
1.5 ml CaCl2 SM 75niJV4 
I nil RbCllM 10mM 
15 ml Glycerol 15% 
Dissolve in 70 ml ddH2O (important to add the 
solution in the exact order to avoid sedimentation of 
the salts). Adjust to pH 6.5 with KOH SM. Bring to 
final volume of 100 ml with ddH20. Sterilize through 
0.22 mm filter, and store at 4°C. 
Tris Buffer pH 8.0 Dilute 1 ml of Tris buffer pH 8.0 in 90 ml ddH20. 10mM 
Check that the pH is 8.0 and bring to final volume of 
100 ml with ddH20. Store at 4°C. 
Tris-HCl 60.55g Tris Base (Mw: 121.14) 1M 
pH 7.4 Adjust to pH 7.4 with conc. HC1 (-35 ml) 
pH 7.5 Adjust to pH 7.5 with conc. HCl (32 ml) 
pH 7.6 Adjust to pH 7.6 with conc. HC1 (-30 ml) 
pH 8.0 Adjust to pH 8.0 with conc. HC1 (-.20 ml) 
pH 8.5 Adjust to pH 8.5 with conc. HC1 (-.14 ml) 
Bring to final volume of 500 ml with ddH20. Store at 
4°C. 
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2.1.4 	Media preparation 
All types of media were prepared by the Institute media staff. The media was 
sterilized by autoclaving (15 min at 15 psi) and stored at RT. 
Table 2.1.4.1: 	Media List 
Media type Components! preparation Final 
concentration 
LB (Luria Broth) lOg NaCl 1% 
log Bacto-tryptone 1% 
5g Yeast extract 0.5% 
Dissolve and bring to final volume of 1 lit, with 
ddH2O 
LB Agar lOg NaCl 1% 
lOg Bacto-tryptone 1% 
5g Yeast extract 0.5% 
l5gDifcoagar 1.5% 
Dissolve in ddH20 and bring to final volume of 
1 	lit. 
NZY+ Broth 1 O of NZ amine (casein hydrolysate) 1% 
5g of yeast extract 0.5% 
5g of NaCl (Mw: 58.44) 0.5% 
Adjust to pH 7.5 using ION NaOH. Dissolve 
and bring to final volume of 1 lit, with ddH20. 
Autoclave 
Add the following sterilized supplements prior 
to use: 
12.5 ml 1M MgC12 
12.5 ml 1M MgSO4 
20 ml of 20% (w/v) glucose 
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2.1.5 	Antibiotics preparation 
The antibiotics were prepared at the recommended concentrations and stored at - 
20°C. 
Table 21.5,1: 	Antibiotics list 
Antibiotic Stock solution Working Concentration 
Ampicillin 50 mg/ ml in ddH20, kept at 20°C 50 p.gI ml 
Kanamycin 25 mg/ ml in ddH20, kept at 20°C 50 p.g/ ml 
Tetracycline 5 mg/ ml in EtOH, kept at 20°C 
covered with aluminium foil. 
50 ig/ ml 
2.1.6 	Fly food preparation 
Fly stocks were mostly grown in bottles and vials containing Staffen food. When the 
flies were grown in cages, a different type of food was used, as described in the table 
below. 
Table 2.1.6: 	List of fly food used. 
Food name Components! Preparation Final 
concentration 
Staffen 25g corn flour 2.5% 
50g Sugar 5% 
17.5g Lyophilised yeast 1.75% 
lOgAgar 1% 
Dissolve in 1 Lit, boiling water. Add: 0.5 ml 
lO%Nipagin 0.005% 
Apple juice plates 9g agar 2.25% 
lOg sucrose 2.5% 
300 n-ilddH2O 
Dissolve until the solution becomes transparent. 
Add: 100 ml apple juice 25% 
Allow to cool to 60°C. Pour into plates. 
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List of fly food used- continuous. 
Food name Components! Preparation Final 
concentration 
Tomato juice plates 4 gr agar 1.7% 
160 ml ddH20 
Dissolve until the solution becomes transparent. 
Add: 17% 
40 ml tomato juice. Boil again 2.5% 
Allow to cool to 60°C. Add: 500 	tl nipagin 
(10%). 
Pour into plates. 
Grape juice plates 9g agar 2.25% 
lOg sucrose 2.5% 
300 mlddH2O 
Dissolve until the solution becomes transparent. 
Add: 100 ml grape juice 25% 
Allow to cool to 60°C. Add 1 ml nipagin (10%). 1.25% 
Pour into plates. 
2.2 	Bacterial strains and plasmids 
Table 2.2.1: 	List of bacterial strains 
Host strain Genotype! Source 
XL1 Blue recAl endAl gyrA96 thi-] hsdR17 supE44 relAl lac[F' 
(Stratagene) proAB 1acPZAtVIJ5 TnIO (TetR)] 
SoloPack®GoId TetR zl(mcrA)183 zi(mcrCB-hsdSMR-mrr)173 endAl supE44 
Supercompetent cells thi-] recAl gyrA96 relAl lac Hte [F' proAB lacf'ZzIMJ5 TWO 
(Stratagene) (Tef) Amy CamR]a 
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Table 2.2.2: 	List of DNA constructs 
Construct Insert Vector Cloning Selection Strain 
name enzymes 
GFP-N1 n/a pEGFP-NI n/a Kan R+ XLI Blue 
(Clontech) NeoR 
Jaguar Myosin VI pBluescript EcoRI + Amp' XL1 Blue 
(made by cDNA clone SK- XHoI 
Wu-Min (EM3) (Stratagene) 
Deng) 
PGM Myosin VI- pUAST EcoRI + Agel ArnpR SuperGold 
EGFP 
PGMH Myosin VI pUAST EcoRT + Agel AmpR SuperGold 
head- EGFP 
PGMT Myosin VI pUAST EcoRI + Agel AmpR SuperGold 
tail- EGFP 




pUAST- pEGFP-N1 pUAST EcoRI + Not I AmpR XLI Blue 
GFP 
2.2.1 	Bacteria growth and storage 
When bacteria cells were used from a stab, a glycerol stock, or from an old plate (3-4 
weeks old), they were initially streaked on plates, to obtain independent colonies. 
This is done in order to reduce the likelihood of working with a culture which has 
become contaminated or accumulated mutations. Bacteria cells were picked under 
sterile conditions and applied on agar plates, containing the appropriate selection 
antibiotic (table 2.1.5). After incubation at 37°C ON, separate colonies originated 
from single cells were obtained. 
For a small scale bacteria stock, a culture was prepared in 5 ml LB medium 
containing the appropriate antibiotic, by inoculating a single colony from a plate, 
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under sterile conditions. The culture was grown ON with shaking (150 rpm) at 
37°C. 
Larger scale cultures were prepared by expanding 1 ml of a small scale liquid culture 
in 50-500 ml LB medium containing the appropriate antibiotic and growing it ON 
with shaking (150 rpm) at 37°C. 
For a short-term storage, a single colony was streaked on a LB plate containing the 
appropriate antibiotic. The culture was grown ON at 37°C and stored at 4°C for up 
to one month. 
For a long-term storage (up to five years) bacterial stabs were prepared. A single 
colony was picked from a plate with a sterile toothpick and streaked into a LB broth 
containing 0.6% agar. The stab was incubated ON at 37°C and stored at RT in dark. 
For an indefinite storage of strains, a glycerol stock was prepared. 800 p1 of an over-
night culture were added to 200 p1 of sterile glycerol, the mixture was homogenized 
and kept at -80°C. 
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2.3 	Drosophila Methods 
23.1 	Maintenance of Drosophila stocks 
All fly stocks were maintained in cornmeal food at 18°C or 25°C. In order to prevent 
mites growth, dry filter paper strips soaked with 3% (v/v, in EtOH) Benzyl Benzoate 
were placed in the vials and bottles, on the top of the food. 
All the fly stocks used are described in table 2.3.1 
Table 3.2.1 fly stocks 
Fly line 
nickname 
Genotype Phenotype Source 
Oregon 	R 
+38B 
Wild type Red eyed wild type Roote J. 
A w-/w- White eyed 
jar R23 ja723/ TM3, Sb jaguar mutant Leaper, K. 
jar jar" -'91 TM3, Sb jaguar mutant Leaper, K. 
jar'°9 ja/ 39/ TM6, Tb jaguar mutant Leaper, K. 
jai '17°  jar' 70/ TM3, Sb jaguar mutant Leaper, K. 
janl?235  janl?235/ TM3, Sb jaguar mutant Leaper, K. 
jar'1235  jar'235/ TM6, Tb jaguar mutant Leaper, K. 
Jar n1 wI4 Jarfumflw)4/ TM3, Sb jaguar mutant Deng W.-M. 
Am8-2 w-; P{ w, UAS-jar.a}Am8.2 Myosin VI antisense Deng W.-M. 
jar/iA TP w-; P{ w, UAS-jar-/IA TP}/Cyo Myosin VI dominant negative Jan YN. 
dab st, dabM54/ TM3, Sb [Act-z] Disabled mutant Giniger, E. 
UAS 
RhoN19 2.1 
UAS RhoN19 2.1 Rho dominant negative Mlodzik, M. 
UAS 
RhoN19 4.3 
UAS RhoN19 4.3/Cyo Rho dominant negative Mlodzik, M. 
RholE3bo 
(3176) 





Fly 	line Genotype! transposon Phenotype Source 
nickname  
C865 w-,; P(w, Ga14)jarC 8ó5 Express GAL4 according to the Glover D. 
pattern ofjar gene. Kaiser K. 
e22C yl w-, P (wi, GAL4)e22c/SM5 Express GAL4 ubiquitously in Brand, A. and 
the whole embryo. Perrimon, N. 
E4 w-,,P (w, GAL4)E4 Ga14 expression during Schupbach, T. 
oogenesis in groups of follicle 
cells at the posterior region. 
en w-; P{en2.4-GAL4}eI6E Ga14 expression in a posterior Brand, A. 
strip of every segment. Located 
in chromosome 2 
T155 w;;P(w+m'GawB)T155 Express GAL4 in follicle cells Bloomington 
(5076) epithelium since stage 9. Stock Centre 
Located in chromosome 3 
C532 P {w, GAL4}C532 Express GAL4 in follicle cells 
(except of the border cells) and 
Imaginal discs 
Balancer chromosome lines 
Fly 	line Genotype Balancer/ Phenotype Source 
nickname 
TM6-GFP w1118, Ly'/TM6B, 3 	chromosome balancer. Thummel, 
p(w+m=Ub, Fluorescent during C.S. 
GFP.S65T)PAD2, Tb' embryogenesis 
TM3/TM6 w-, TM3, Sb, e/ TM6, Tb, e 3rd chromosome balancer. Cribbs, D. 
White eyed, stubble, tubby and 
ebony 
2.3.2 	Collection of embryos 
In order to create embryos with a desired phenotype, a cross was set with virgin 
females (as in section 2.3.4) and males originated from specific lines. The flies were 
left to mate and lay eggs in vials containing yeast during 2-3 days, at 25°C. 
Afterwards the flies were transferred to a cage containing grape juice, or apple juice 
plates, smeared in the centre with yeast paste (made with yeast and water). The cages 
were held at 25°C. The change of the plates and the incubation time is indicated in 
every case. The embryos were collected by rinsing the plate with embryo wash 
solution (lx), removing the embryos from the plate with a brush and collecting the 
embryos into a fine plastic sieve. 
2.3.2.1 	Collection of fluorescent or non fluorescent embryos 
Fluorescent embryos (expressing GFP) were distinguished from non-fluorescent 
embryos by examining them under dissecting GFP microscope (Leika) with the filter 
combination required for GFP observation (450-90/515). Unlike an auto-fluorescent 
objects, The fluorescent light coming from a GFP expressing tissue is observed only 
the specific GFP filter. The embryos were collected with a fine brush and used for 
further growth in a separate plate, or used for antibody staining 
2.3.3 	Collection of larvae, pupae and adults 
In order to collect larvae, flies were kept in a cage and the plate (grape juice) was 
replaced daily. First instar larvae were collected 24 hours after the replacement of the 
plate, third instar larvae were collected from the plates after 3-5 days. If fluorescent 
larvae were to be collected, they were examined under dissecting GFP microscope as 
described in section 2.3.2.1. 
Larvae at late third instar stage were selected from vials, 4 days after egg laying, by 
their ability to crawl up the bottle walls. The larvae were gently collected with 
forceps. 
Early pupae were collected 5 days after egg laying with a wet paintbrush. 
Adult flies were generally collected up to 2 weeks after their hatch. The flies were 
anaesthetized with CO2 (occasionally with diethyl ether) and collected. Male and 
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female were distinguished according to the difference in the size, abdomen shape, 
and the presence of sex combs in male. 
2.3.4 	Collection of virgin flies and crosses 
Virgin flies were collected early in the morning and during the day, at interval of 2-4 
hr. Virgin flies were identified by the bright colour of the body and the presence of a 
dark greenish spot (the meconium, the remains of their last meal before pupating) on 
the underside of the abdomen (right side). Newly hatched flies were also recognized 
by the folded wings. 
Generally, 3-5 virgin flies were mated with 1-3 males, in a vial containing fresh food 
and yeast. The flies were incubated at 25°C until larvae and pupae started to emerge. 
2.3.5 	Generation of transgenic flies 
The creation of transgenic flies was made according to Rubin and Spradling (Rubin 
and Spradling, 1982). 
2.3.5.1 	Preparation of the microinjection solution. 
The construct plasmids to be injected (PGM, PGMH, PGMT), and the helper plasmid 
pt2-3 were prepared as a plasmid midiprep (section 2.4.1.3) and purified as 
described in sections 2.4.3.1-2.4.3.3. The construct and the helper plasmids were 
brought to final concentrations of approximately 1 Vtg/ tl, and 500ng/ il respectively. 
The microinjection solutions, prepared with lox microinjection buffer, had a final 
concentration of 40OtgI ml of the transforming plasmid and 1 OOtg/ ml of the pA2-3 
plasmid, in ix injection buffer (5mM KC1, 0.1mM sodium phosphate, pH 6.8). 
2.3.5.2 	Microinjection of embryos 
3-5 days old wk flies (homozygous w, white—eyed) were incubated in apple-juice 
plates. The plates were changed every 30 min in order to collect embryos at stages 1-
2 (prior the formation of pole cells). The embryos were gently collected with a fine 
brush and transferred to a double sided sticky tape (Scotch Brand 3M No. 666). The 
embryos were manually dechorionated and transferred to a 22 X 22 mm coverslip 
(attached to a 76X26 mm slide) which had a very thin strip of double sided tape on it. 
The embryos were oriented with their posterior ends over the edge of the tape and the 
coverslip. Normally, around 30 embryos were placed on each coverslip. The 
coverslip was placed in a Petri dish containing desiccant (silica gel) for 6-10 min and 
immediately covered with K-elf oil. The slide was placed on the stage of the 
microscope with the posterior end of the embryos towards the needle. The eggs were 
injected at 1500 psi for 0.3-0.5 sec. During the injection, damaged and improperly 
aged embryos were killed. The coverslip containing the injected embryos was placed 
onto a tomato juice plate smeared in the centre with yeast paste. The embryos were 
incubated for 2-3 days at 25°C. After one day most of the larvae started to emerge, 
few emerged after 2-3 days. Every larva was transferred into a separate vial 
containing fresh Staffen food and kept at 25°C. The adult flies that eclosed from the 
pupal case were crossed with 3 wk flies from the opposite sex (using virgin females). 
Progeny of the cross were examined for red-eyed transformants. Every transgenic fly 
was crossed again with wk flies to create a separate line. In every line, the red-eyed 
flies were selected routinely every two generations, during the food change. 
2.3.5.3 	Selection of transgenic lines. 
About 100 transgenic lines were collected for every construct plasmid injected 
(PGM, PGMH, and PGMT). In order to select the lines that have the highest level of 
GFP tagged protein expression, all the flies were crossed with the Ga14 lines: T155 
(to observe expression in the follicle cells) and C865 (to observe a strong expression 
in the larvae salivary glands). Approximately 20 lines were selected from every 
construct group. The list of all the selected lines is described in chapter 4. 
2.4 	Nucleic Acid techniques 
2.4.1 	Plasmid DNA preparation 
24.1.1 	All purpose plasmid miniprep 
A 5 ml culture grown 0/N was centrifuged and the bacterial pellet was resuspended 
in 250 tl Resuspension buffer. 350 t1 of Lysis solution were added and mixed gently 
by rotating six times. After incubation for 5 min 350 jil of Neutralising solution were 
added and mixed gently by rotating six times. The mixture was centrifuged at 
22,000g for 15 mm, the supernatant was transferred to a clean eppendorf tube and the 
DNA was recovered from the solution by isopropanol precipitation (section 2.4.3.2). 
Table 2.4.1.1: 	list of solutions for plasmid miniprep 
Solution Components! preparation Final 
concentration 
Resuspension buffer 500 p.1 1M Tris-HC1 pH 7.6 50 mM 
200 p.1 0.5M EDTA pH 8.0 10 mM 
100 p.1 RNAse (DNAse free) 10 mg/ ml 100 p.g/ ml 
Bring to final volume of 10 ml with ddH20. 
Lysis solution 2 ml 1 O NaOH 0.2M 
lOmllO%SDS 1% 
Bring to final volume of 100 ml with ddH20. 
Neutralising solution 3.24g CH3CooK (Mw: 98.14) 1.32M 
Adjust the pH 4.8 with Glacial Acetic acid. 
Bring to final volume of 25 ml with ddH20. Store at 
4°C. 
	
2.4.1.2 	High purity plasmid miniprep 
High quality DNA was required for sequencing and cloning experiments. 
QlAprep®Spin Miniprep kit (Qiagen) was used to isolate and purify 20-30 .tl of 
plasmid DNA. The protocol is according to the supplier instructions. 
2.4.1.3 	High purity plasmid midiprep 
QIAfilterTM Plasmid midiprep kit (Qiagen) was used to isolate up to 150 jig of highly 
purified plasmid DNA. This kit was used for the preparation of DNA for 
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microinjection. After growing 150 ml of cell culture 0/N, the cells were pellet and 
kept at -20 for future use (up to 1 year). The purification of the plasmid DNA was 
according to the supplier instructions, using sterile water (pH 2.0). Afterwards, the 
DNA concentration was measured. When the DNA concentration was lower than the 
necessary, the plasmid DNA was precipitated and resuspended in sterile water 0/N at 
4°C. The solution was spun for 10 min at 22,000g at 4°C in order to remove DNA 
aggregates, and the DNA concentration of the collected supernatant was measured 
again. 
2.4.2 	Genomic DNA preparation 
Approximately 130 mg of flies (0.5 ml) were homogenized in 250 jil Fly buffer for 3 
mm. 750 p1 of fly buffer, was added and RNA was digested with 4 p1 RNAse 
solution one hour at 370, followed by protein digestion with 30 jil of proteinase K 
solution added to the mixture for one hour at 500.  The sample was spun for 10 min at 
15,000g at 4°C and the collected supernatant was mixed with one volume of 
phenol: chloroform solution by gentle rotation for 5 min at RT. The sample was spun 
for 3 min at l0,000g at RT and the collected supernatant was mixed with one volume 
of chloroform solution by gentle rotation for 5 min at RT. After spinning the mixture 
again the supernatant was pellet by mixing with 0.6 vol. of isopropanol for 5 min and 
centrifugation for 20 min at 15,000g at 4°C, washed in 75% EtOH, dried and 
resuspended in 70 p1 Tris buffer (10mM Tris-HCL, pH 8.0). 
The DNA concentration was measured as described in section 2.4.3.3. 
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2.4.3 	DNA purification 
2.4.3.1 	Phenol/chloroform extraction 
This protocol was generally used with plasmid DNA, and PCR amplified DNA. The 
genomic DNA was purified in a different manner, as described in section 2.4.2. 
Protein impurities were removed from nucleic acid preparations by phenol/ 
chloroform extraction. The DNA solution was brought to volume of at least 200 p1 
with ddH20. Na Acetate solution was added to final volume of 10% (22 jil) and 
mixed well. One volume of phenol/chloroform solution (220 p.1) was added; the 
mixture was shaken vigorously by hand for 3 min and spun for 3 min at 10,000g at 
RT. The supernatant was collected, one volume of chloroform (220 p.!) was added, 
and the mixture was again shaken vigorously by hand for 3 min and spun for 3 min at 
10,000g at RT. The supernatant was collected and extracted again in chloroform, in 
order to remove phenol remains. The supernatant was collected to a new tube. 
2.4.3.2 	Precipitation of nucleic acids 
One volume of DNA (200 p.1) was mixed with 2.5 volumes of ice-cold isopropanol 
(500 p.1, alternatively used 3 volumes of ice-cold 100% Ethanol) and 1 p.d of carrier 
solution (used mainly when low amount of DNA is purified). Add 10% (22p.l) of Na 
Acetate solution (no need to add if the DNA was previously extracted with 
phenol/chloroform). The sample was gently mixed and centrifuged at 15,000g at 4°C 
for 15 mm. The pellet was washed with 500 jtl of 70% EtOH and centrifuged at 
15,000g at 4 °C for 5 mm. The DNA pellet was air dried and resuspended in the 
appropriate volume of 10 mM Tris-HC1, pH 8. 0, or in sterile ddH20 (pH ). 
2.4.3.3 	Estimation of nucleic acids concentration by UV 
spectrophotometry 
The determination of DNA and RNA concentration was made by UV 
spectrophotometry. The absorbance of DNA/RNA was measured at 260nm and 
280nm using a two-beam Hitaci spectrophotometer. The concentration of the 
samples was calculated using the following formula: 
DNA! RNA concentration (ng/ il) = A260 X DF X Sc 
1000 
DF 	dilution factor 
Sc = Spectrophotometric conversion (Specific DNA! RNA absorption value): Sc=50 
for double stranded DNA, and Sc=40 for single-stranded DNA of RNA. 
The purity of DNA was estimated by assessing the ratio A260/A280: DNA and RNA 
were considered to be highly pure when the ratio was greater than 1.8 and 2.0, 
respectively. 
When a low concentration of DNA was to be detected, the amount of DNA was 
estimated by gel electrophoresis as described in section 2.4.5. 
24.4 	RNA preparation 
All the tips and tubes used for RNA preparation were DEPC treated, and all the 
solutions were made with DEPC treated water. 
30 first instar (approximately 500 tg) larvae were homogenized in 150 il Trizol® 
reagent (Invitrogen) and incubated with additional 350 pl of Trizol for 5 min at room 
temperature. The RNA was extracted by mixing with 200 Vtl chloroform (shake 
vigorously for 15 sec) and spinning for 15 min at 12,000g at 4°C. The upper phase 
was mixed with 500 j.il isopropanol and incubated at RT for 10 mm. After spinning 
the sample for 15 min at 12,000g at 4°C, the pellet was washed in 1 ml 75% EtOH, 
and air dried for 15-20 min at RT. The dried pellet was resuspended in 12 p.1 H20, 
and used for cDNA preparation, or kept at -80°C for few days. 
2.4.5 	DNA agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA molecules according to their 
size. 1% agarose gel (in 1X TAB buffer) was used for up to 10kb DNA molecules and 
0.7% gel was used for DNA molecules in the size of 10-20kb. EtBr was added to the 
gel to final concentration of 0.2 mg/ ml. Prior to the loading, the samples were mixed 
with loading buffer (Table 2.1.3.2) to a final concentration of 1X. The DNA samples 
were loaded on the gel and electrophoresed at 4-7V/cm in 1XTAE buffer, until the 
desired separation was obtained. The DNA, stained with EtBr, could be visualized on 
a long-wavelength UV transilluminator (365 run). The gel was photographed by a 
UV camera. 
In order to determine the size of DNA fragments, molecular standards were used. 
Approximately 0.5 pg of 1KB DNA ladder was applied per gel. To estimate the 
approximate amount of DNA in an unknown band, Bioline HyperLadder I was used. 
5 d of the ladder would produce a set of bands with a known amount of DNA in 
each band. The amount of DNA was estimated by comparing the intensity of the 
DNA band in the sample to the intensity of the bands in the ladder. 
2.4.6 	Purification of DNA from agarose gel 
QIEX®II Gel Extraction Kit (Qiagen) was used to extract up to 15kb DNA 
fragments from agarose gels. The supplier procedure was modified as follows: the 
DNA fragment was excised from the gel and dissolved in 3 volumes of QX1 buffer 
at 65°C for 5-10 mill. Once the whole gel was dissolved, 2 volumes of ddH20 
(according to the gel weight), 10 p1 of 3M Na Acetate and 10 p1 QIEX II resin were 
added. The sample was gently rotated during 6 min at RT, and the QIEX II particles 
were pellet at 14,000g for 1 mm. The particles were washed once with QX1 buffer 
and two times with PE buffer (Qiagen). The pellet was air-dried at 37°C for 5-10 
mm. To elute the bond DNA, 30 pJ of 10mM Tris-HC1, pH 8.0 were added to the 
pellet, the mixture was incubated for 5 min at 65°C. The sample was centrifuged at 
22,000g and the cleared supernatant was transferred into a new eppendorf tube. The 
elution was repeated and the eluted DNA solutions were combined. 
When the obtained DNA fragments were used for subsequent ligation, the DNA 
fragments were cleaned as described in section 2.4.3. 
2.4.7 	Enzymatic modifications of DNA 
2.4.7.1 	Endonuclease restriction of DNA 
The reaction was carried out in a 20-50 iii reaction mixture, according to the 
manufacturer's instructions. The reaction mixture contained: DNA sample (1 jig), 
reaction buffer (10% of the final volume), restriction enzyme (4-10U) and ddH20 to 
final volume of 20ji1 or 50jil. The reaction mixture was incubated at the 
recommended temperature (usually 37°C) for 4-20 hr, depends on the type of 
restriction enzyme used: when the restriction enzyme has a star activity (an aberrant 
restriction of DNA after a long restriction period and under abnormal conditions like 
high enzyme concentration), like Eco RI, it was incubated for a shorter time. In 
general the amount of enzyme added and the incubation time was calculated to 
restrict an amount of DNA that will be 4-20 times higher, in order to ensure a 
complete restriction, without initiation of star activity. The reaction was stopped by 
inactivation of the enzymes at 65°C for 15 min. When the sample had to be restricted 
with two enzymes or more, all the enzymes were added together with a reaction 
buffer selected for the optimal activity of all the enzymes. Alternatively, the DNA 
sample was precipitated after the first restriction (as in section 2.4.3.2), the DNA was 
resuspended in ddH20 in the appropriate volume, and the second restriction reaction 
was carried out with a new enzyme and its appropriate buffer. 
2.4.7.2 	DNA ligation 
The ligation reactions were made with DNA fragments and linearised cloning vectors 
containing cohesive ends after endonuclease restrictions. When the ligation was 
made during the formation of the GFP DNA constructs, all the DNA fragments were 
purified as described in section 2.4.3.1-2.4.3.3. 
DNA ligation was performed by incubating a DNA fragment with a linearised 
cloning vector in the presence of a 1X ligation buffer (with ATP) and 400U T4 DNA 
ligase (New England Biolabs), in 10-20 jil reaction volume. The reaction was 
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incubated at 12-18°C for 0/N and heat inactivated for 15 min at 65°C. 2p1 of the 
reaction was used to transform into competent cells (after purification), and 8tl were 
loaded on a gel in order to verify the ligation. 
2.4.8 	DNA transformation to chemically competent cells 
2.4.8.1 	Preparation of competent cells 
XL1 Blue culture was grown ON on LB plate containing tetracycline. A single 
colony was inoculated in 5 ml LB medium and incubated ON at 37°C. The whole 
culture was inoculated into 100 ml of pre-warmed (37°C) LB medium and 2 ml of 
1M MgSO4 were added (to final conc. of 20 mM). The cells were grown until the 
intensity of the cells at 0D550 reached the value of 0.4-0.6 (after 3-5 hours). The cells 
were pellet at 4500g for 10 min and kept from this stage onwards at 4°C. The cells 
were gently resuspended in 2 ml of ice-cold TFB1 solution, by using a pipette tip. 18 
ml of TFB1 were added and the cells were incubated in ice, in the cold room for 5 
mm. The cells were pellet at 4500g for 5 min at 4°C and gently resuspended in 4 ml 
ice-cold TFB2 solution. After incubation of the cells for 15-60 min in ice, in the cold 
room, aliquots of 100 p.1 were made (in the cold room) and the cells were 
immediately frozen and stored at -80°C. 
2.4.8.2 	Transformation 
100 p.1 aliquot of competent cells were thawed on ice for 5 mm. 10-50 ng of plasmid 
DNA (maximum volume of 10 p.1) was added to the aliquot and mixed gently with a 
pipette tip. The cells were incubated in ice for 45 mm. Then the cells were incubated 
for 90 seconds (not more) in 42°C pre-heated water bath. After cooling the cells for 2 
min on ice, 600 p.1 of LB medium were added and the culture was incubated for 45 
min at 37°C with agitation at 180 rpm. The cells were plated on LB plates containing 
the appropriate selective antibiotic, and incubated at 37°C for 0/N. 
When a transformation was made to GFP DNA construct after ligation, the DNA was 
purified once again as in section 2.4.3.1-2.4.3.3; and the transformation was made 
0 
with SoloPack®Gold Supercompetent cells (Stratagene), according to the 
manufacturer's instructions. 
2.4.9 	Colony lift hybridisation 
2.4.9.1 	Colony lifts 
Colony lift hybridisation was used in order to identify colonies transformed with a 
plasmid containing the desired inserts. A round HybondTM N+ nylon membrane 
(Amersham Biosciences) was marked and applied on a plate containing colonies 
after 16-24 hr incubation, allowing all the colonies to attach to the membrane. The 
position of the membrane on the plate was marked by stabbing the membrane and the 
agar and marking the pinching position on the plate. After 2 min the membrane was 
carefully removed and placed over a filter paper soaked with denaturing buffer (the 
side of the membrane without the colonies face to the paper). After 7 min of DNA 
denaturation, the membrane was aligned on a new filter paper soaked with 
neutralizing buffer for 3 mm. Then the membrane was rinsed in rinsing buffer, and 
the colonies' debris was removed with a brush. The membrane was dried on a plain 
paper and exposed to UV light for 10 mm, in order to fix the DNA to the membrane. 
Table 2.4.9.1: List of solutions used for preparing the colony lifts 
Solution Components! Preparation Final 
concentration 
Denaturing Buffer 150 ml NaCl 5M 1.5M 
25 rnlNaOH 1 O 0.5M 
Bring to final volume of 500 ml with ddH20. 
Neutralising Buffer 150 ml NaCl SM 1.5M 
250 ml 1M Tris-HC1, pH 8.0 0.5M 
Bring to final volume of 500 ml with ddH20. 
Rinse Buffer 50 ml 20X SSC 2X 
100 ml 1M Tris-HC1, pH 7.5 0.2M 
Bring to final volume of 500 ml with ddH2O. 
	
2.4.9.2 	Radio labelling of DNA probes 
The radioactive DNA probes were made by using Ready-To-GoTM DNA labelling 
Beads 
(-dCTP) (Amersham Biosciences) along with [32P]dCTP (Amersham Biosciences), 
according to the manufacturers' instructions. 200 ng of denatured DNA was used per 
labelling. Unincorporated nucleotides were removed by eluting the probe through 
NICKTM Columns (Amersham Biosciences) with TB buffer, pH 8.0. The columns 
contained Sephadex for gel filtration that allowed the high molecular weight DNA to 
pass faster through the column than the unincorporated nucleotides. The probe was 
denaturated by adding 1 j.tl ION NaOH to 100 tl of probe. 
2.4.9.3 	Hybridisation with (32PJdCTP hybridisation probes 
All the incubations were made at 65°C, with continuous rotation. The membrane was 
incubated in 50 ml DNA hybridisation buffer for 3-24 hr. The denaturated 
radioactive probe was added and the membrane was incubated for ON. The 
radioactive probe was stored for an additional use for up to 4 weeks in Perspex box. 
The membrane was washed for 15 min in low stringency solution, 20 min in medium 
stringency solution, and 15 min in high stringency solution. The membrane was 
sealed in polyethylene bag, placed in an autoradiography cassette, and exposed to a 
blue sensitive film (Kodak) at -70°C. The films were developed in an X-ograph 
compactX2 automatic film processor. 
2.4.9.4 	Use of two different probes. 
When two probes had to be used, the first probe was removed from the membrane by 
placing the membrane in boiling stripping solution and allows it to cool to RT. This 
process was repeated until no radioactive signal was detected on the membrane. If 
the signal was too strong and the probe could not be removed, a new membrane had 
to be made, using the original colony plate for the colony lift. 
2.4.10 	DNA sequencing and sequence analysis 
A typical (1X) sequencing reaction consisted of 8 p1 Labelling Mix (BigDyeTM 
Terminator for Cycle Sequencing, ABI PRISM, Applied Biosystems), 3.2pmol of the 
appropriate primer, 50-200 ng (PCR product) of 400ng (plasmid DNA) high quality 
DNA template and water to final concentration of 20 p1. The PCR program applied 
was as follows: 25 cycles, 95°C for 30 mm, 50°C for 20 sec, and 4 min extension 
step at 60°C. In order to remove unincorporated dye terminators the sequencing 
reaction was passed through a purification column (Edge Gel Filtration Cartridge, 
ver. 11 from Edge Biosystems, or genCLEAN columns from Genpack) according to 
the manufacturer's instructions. 
The amplified and labelled products were analysed on ABI PRISM 377 DNA 
sequencer (Perkin-Elmer Corporation), and on ABI PRISM 3100 DNA sequencer by 
staff from ICMB and ICAPB at Edinburgh University. 
2.4.11 	Polymerase Chain Reaction (PCR) 
2.411.1 	Standard PCR 
The standard PCR was made using the Qiagen PCR kit, and the following mixture of 
PCR reagents was made: DNA template (60-500 ng) or 2 p1 of cDNA template 
(reverse-transcribed mRNA); 1X Q solution; 1X Taq buffer; 0.2mM dNTP (dATP, 
dCTP, dGTP, dTTP); 1mM forward primer; 1mM reverse primer; 2.5U Taq 
polymerase, 0.4U pfu turbo polymerase (Stratagene) and sterile ddH20 to final vol. 
of 50 p1. 
The PCR cycle used was: 94°C for 2 mm (1 cycle); 94°C for 40 seconds, 50-62°C 
(depends on the Tm) for 40 seconds, 72°C for 2 min per every kb pair expected in 
the PCR product (35 cycles); 72°C for 10 mm (1 cycle). When the reaction was 
completed, 5-10 id of the reaction mixture was analysed by gel electrophoresis. 
Table 2.4.12 shows the sequence of all the primers that have been used. 
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2.4.11.2 	Proof-reading PCR 
A proof-reading PCR was made when the amplified DNA, as a part of a DNA 
construct, would be translated into a protein. Since the translated template has to be 
accurate, the DNA amplification should be made with a minimal number of 
mistakes. For that reason the reaction mixture was made with pfu turbo polymerase 
kit (Stratagene), as follows: 
100 ng DNA template (Myosin VI cDNA); lx pfu buffer; 0.2mM dNTP; 1mM 
foreword primer; 1mM reverse primer; 2.5 U pfu turbo polymerase (Stratagene) and 
sterile ddH20 to final vol. of 50 p1. 
The PCR cycle used was: 94°C for 2 mm (1 cycle); 94°C for 30 seconds, 45-50o 
(depends on the Tm) for 30 seconds, 72°C for 2 min and 40 sec per every kb pair 
expected in the PCR product (35 cycles); 72°C for 10 mm (1 cycle). 
	
2.4.11.3 	Long template PCR 
When PCR was undertaken for large fragments of DNA (7-15kb), the Expand Long 
Template PCR kit of Roche was used according to the manufacturer's instructions. 
Two reaction mixtures were composed separately and combined prior to the reaction 
initiation: mixture 1: 500ng genomic DNA; 0.5mM dNTP; 0.3mM foreword primer; 
0.3mM reverse primer; mixture 2: 1X buffer 3; 3U enzyme mix. 
The PCR cycle used was: 94°C for 2 mm (1 cycle); 94°C for 10 seconds, 51-59°C 
(depends on the Tm) for 40 seconds, 68°C for 2 min per every kb pair expected in 
the PCR product (10 cycles); 94°C for 10 seconds, 51-59'C for 40 seconds, 2 mm 
per every kb pair expected in the PCR product with increment of 20 seconds per 
cycle (20 cycles);68°C for 10 mm (1 cycle). 
2.4.11.4 	Single colony PCR 
A single PCR was made to select bacteria transformed with plasmids containing the 
desired insert. In the single-colony PCR, the plasmid within the bacteria served as the 
DNA template. By using a sterile toothpick, a single colony was smeared at the 
bottom of a PCR tube (the remains of the bacteria in the toothpick was used to 
inoculate in a selective plate and in 5 ml selective LB medium, in order to preserve 
the bacteria for later use), the rest of the ingredients were added to the tube and the 
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reaction was carried out in the standard way as in section 2.4.11.1. 
Table 2.4.11: 	primers used for general purposes 




529R GTC CCG ACA AGT GGA TCA G 19 60 
5k3C865 CGG GCT GAA AAG GGA AAA G 19 46-50 
C865 for GCG GAT CCA AAT CTT CTT GCT TTG CTG 27 51-55 
C865 Rev TTT GAA CAG GAA ACT GAA ACG 21 5 1-55 
EXC2For GTG CTT GTT GTT TTT CGG 18 50-52 
EXC2Rev ACA TGG AAT AGG GTG CAT GG 20 52-55 
GFPR GGT CAG CTT GCC GTA GGT 18 50 
HEC2 TAT TTA CCG GTC CCT TGC CAA TAC CCT GGT AG 32 45 
HKC865F TGT TGC TAC CCA TTG CTT TTC AAT C 25 46-50 
mmw14 
delfor 
TGC AGG TGT TGC AGA AGA GTG 21 55 
mmw14 
delrev 
TTA TCC CCT TAC CCC TAT TCC 21 55 
MYC2 ATT TAC CGG TCC TTG TTT CTG CAT TGC TGC 30 40-50 
MYN ATT TCC GAA TTC TTC GAC TCG ACT CAT CCA 
ACG 
33 45-50 
P1 GAG TTC GAC TCG ACT CAT CCA AC 23 52 
P 1027 TAG TGC GAT ATG TAA CCA CCG ACC 24 52-55 
P517-1 ATC ACG ATG ACA ACT GCG AAC 21 55 
PR491 AAG CCC AAG GGT ATC GAC AAC 21 62 
PR492 ATT GAA CTC GGC ACT GGC ACA 21 62 
pUASTF AAG CAA ATA AAC AAG CGC AG 20 50 
TAN CAT TTC CGA ATT CGG CAA GAT CAA CAA GAT 
CCG G 
34 40 
TRIF AAT CAC AGC TTC AGC CAC AC 20 60 
2.4.12 	Reverse transcription and PCR (RT-PCR) 
Reverse transcription was done using SuperscriptTM II kit (G]BCO BRL). The 
following ingredients were added: 500-2000 ng of mRNA (the whole 12 iii of 
mRNA purified as described in section 2.4.4), lj.iM oligo(dT)18 primer, 0.5mM 
dNTP (dATP, dCTP, dTTP, dGTP). After a gentle mix the sample was heated at 
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65°C for 5 min and immediately cooled on ice for 2 mm. The following ingredients 
were added to the tube: lx RT buffer, 10mM DTT, 40U RNase OUT Recombinant 
Ribonuclease Inhibitor (Roche Molecular Biochemicals). The ingredients were 
gently mixed, and pre-incubated at 42°C for 2 mm. Then 200U of SUPERSCRIPT II 
were added by pipetting up and down and the mixture was incubated for 50 min at 
42°C, followed by inactivation at 70°C for 15 mm. 
2 tl of the eDNA were used for a PCR reaction, in standard conditions, as described 
in section 2.4.11.1. 
2.4.13 	Inverse PCR 
Genomic DNA was prepared from flies containing p-element insertion(s) as 
described in section 2.4.2. 10mg of genomic DNA were restricted with Sau lilA 
(15U) during 6 hr at 37°C. The reaction was stopped by heating the sample at 65°C 
for 20 mm. The digested DNA was ligated in a 200 tl reaction containing 800U of 
T4 DNA ligase (New England Biolabs), ON at 18°C. The DNA was recovered by 
EtOH precipitation and resuspension in 150 p1 Tris buffer, 10mM, pH 8.0. 5p1 of the 
relegated genomic DNA was used as a template for subsequent PCR reaction with 
primers specific for the p element (Table 2.4.13). The PCR reaction was made in 
standard conditions as described in section 2.4.11.1. 
Table 2.4.13: 	Primers used for inverse PCR 





PGAWB 5b (5' PZ) GAA AGG TTG TGT GCG GAC GA 20 55 
Pryl (3' PZ) CCT TAG CAT GTC CGT GGG GilT TGA AT 26 58-62 
Pry4 (3' PZ) CAA TCA TAT CGC TGT CTC ACT CA 23 58-62 
SP1 (5'PZ) ACA CAA CCTTITCCTCTCA ACA A 22 55 
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2.5 	Protein Techniques 
2.5.1 	Preparation of embryos for antibody staining 
2.5.1.1 	Embryo fixation 
Embryos were collected in a plastic sieve dipped with 1X embryo wash solution, 
within a small Petri dish. The buffer was removed and the embryos were 
dechorionated in the Petri dish with 50% bleaching solution. The dechorionation 
process was observed under a dissecting microscope, the dechorionation was 
completed when the dorsal appendages were completely dissolved. The bleaching 
was stopped after 3 min or when 80% of the embryos were dechorionated (the 
shortest period); by removing the sieve from the Petri dish, rinsing it with ddH20 and 
IX embryo wash solution. The sieve was fitted on the neck of a 10 ml scintillation 
vial containing lx embryo wash solution. A screw cup closed the vial and the 
embryos were transferred into the solution by tilting the vial. The sinking embryos 
were collected into a 2 ml scintillation vial with a cut pipette tip. The remains of 
embryo solution were removed. 1 ml of Embryos formaldehyde mix (made with 
formaldehyde of Fluka, 47608) and 1 ml of heptane were added and the embryos 
were rotated at RT for 20 mm. 
2.5.1.2 	Methanol devitellination 
In most of the antibody stains the embryos were devitalinated with methanol. After 
fixing the embryos, the embryo formaldehyde mix was removed (lower phase), 1 ml 
of 100% methanol was added, and the embryos were vigorously shaken for 15 sec. 
The sinking embryos were collected into an eppendorf tube with a cut pipette tip. 
The embryos were washed twice with fresh methanol, followed by two washed in 
100% ethanol. When necessary, the embryos were stored in PBTA for 2-3 days, at 
4°C, after washing in PBT for 15 mm. 
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2.5.1.3 	Manual devitellination 
Manual devitellination was used when a stain of actin filaments was made with 
phalloidin. The fixed embryos were collected on a filter paper. After drying the 
remains of heptane and formaldehyde from the filter paper, the embryos were gently 
attach to a double sticky tape (Scotch brand, High performance coated tape 3M 
9573) attached in one side to a small Petri dish, using a paintbrush. Sticking of the 
embryos was observed in a dissecting microscope. The embryos were immediately 
covered with PBTA solution. The devitellination was made with a 23g needle fitted 
to a 2 ml syringe. The removal of the embryos from the vitelline membrane was 
made by piercing the membrane in one end of the embryo and pushing the embryo 
from the other end, through the hole. The devitalinated embryos were collected with 
a cut pipette tip. The embryos could be kept in PBTA solution for few days at 4°C. 
2.5.2 Preparation of ovaries and other tissues for antibody 
staining 
Ovaries, testes and other tissues were dissected in Ringer's saline (prepared by the 
Institute media staff) warmed to RT. The tissue was fixed for 20 min in 4% p-
formaldehyde and washed for 15 min in PBT solution. Occasionally ovarioles were 
separated with tungsten needles at this stage. When the tissues had to be stored, they 
were left in PBTA solution for up to 3 days. 
2.5.3 Whole-mount in situ antibody staining 
The tissue was washed 3 times for 15 min in PBT, in 0.2 ml eppendorf tubes. The 
blocking of the tissue was done in 1% NGS (Normal Goat Serum) for 1 hr, followed 
by incubation with a primary antibody for 0/N at 4°C, at the concentrations 
described in table 2.5.3.1. The diluted antibodies were usually kept at 4°C and re-
used for 2 more times. When two primary antibodies were used, the sample was 
washed in NGS for 10 min and incubated with the second primary antibody for 3 
hours at RT. The sample was washed 3 times for 15 min in PBT, and blocked again 
in NGS for 30 mm. The incubation with secondary antibody was done for 1.5-2 hr at 
RT, covered with aluminium foil, with the dilutions described in table 2.5.3.2. When 
two secondary antibodies were used, the sample was washed in NGS for 10 min and 
incubated with the second antibody for 1.5-2 hr at RT. The tissue was washed 2 
times for 30 min in PBT, followed with a wash in 1XPBS for 10 mm. 
Table 2.5.3.1: 	List of primary antibodies used. 
Antigen Host animal Working 
concentration 
Source 
Drosophila cx-adaptin Rabbit 1:200 Jackson A.P. 
Drosophila Ankyrin Rabbit 1:100 Dubreuil R. 
Drosophila Armadillo Mouse 1:6 Wisechaus, E. 
No. N2 7A1* 
Drosophila Bazooka Rabbit 1:500 Wodarz, A 
Drosophila E- 
Cadherin 
Rat 1:20 Uemura, T. 
Mosquito Clathrin Rabbit 1:500 Kokoza, V, Raikhel, A. 
Drosophila CLIP-190 Rabbit 1:50 Miller, K. 
Drosophila Crumbs Mouse 1:1 Knust, E. 
No. cq4* 
Drosophila Dlg Rabbit 1:250 Bryant P. J. 




Mouse 1:500 Brower D. L. 
No. CF2 C7 
Drosophila PS- 
integrin 
Mouse 1:1 Brower D. L. 
Drosophila 
Myosin VI 
Mouse 1:3 in embryos 




Nonmuscle myosin II 
Rabbit 1:50 Kiehart and Fegali 
(1986) 
No: 656 
Drosophila a-spectrin Mouse 1:6 Branton, D., Dubreuil, R. 
No: 3A9 (323 or M102)* 
Porcine Myosin VI Rabbit lojig/ ml Hasson, T. 
Iurchased trom Developmental Studies Hybndoma Bank 
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Table 2.5.3.2: 	List of secondary antibodies used. 
Antigen Host animal Labelling Working 
concentration 
Source 
Mouse IgG Goat AlexaFluor8568 1:500 Molecular 
Probes, A-i 1004 
Mouse IgG Goat FITC 1:100 Sigma F-4018 
Rat IgG Goat FITC 1:50 Sigma F-6258 
Rabbit IgG Goat AlexaFluor0568 1:500 Molecular 
Probes, A-110l1 
Rabbit IgG Goat FITC 1:100 Sigma F-9887 
	
2.5.3.1 	Actin filaments staining 
The staining of actin filaments was made with Alexa Fluor ® 568 conjugated 
phalloidin (Molecular probes, A-12380). After the staining with the secondary 
antibody, the tissue was incubated for 1 hour with phalloidin (diluted 1:50 in PBS or 
PBT), and washed in PBT and PBS as described previously. 
2.5.3.2 	Sample mounting 
In embryos, the 1XPBS solution was removed from the tube after the staining and 
40.il of VECTASHIELD® Mounting Medium (Vector Laboratories) was added. 20-
25..tl of the and medium containing the embryos was mounted on a slide, covered 
with 20 nmX20 nm coverslip and the coverslip was sealed with nail varnish. The 
slides were kept at 4°C in a dark box for up to 6 months. Imaginal discs were 
separated in a dissecting dish containing 1XPBS and mounted on a slide containing 
mounting solution. 
In ovaries the 1XPBS solution was removed from the tube after the staining and 
150d of FISH media was added. The samples were left for 15 min-O/N at 4°C. The 
tissue was mounted on a slide with 20-25p1 of mounting solution. The ovarioles were 
separated (up to two pairs of ovaries were mounted in a slide), and the slide was 
covered and sealed. Testes were mounted in a similar way. 
2.53.3 	Sample observation 
The stained samples were observed and photographed on a confocal microscope 
(Leika) or on fluorescent microscope (Zeiss Axioskopil) fitted with a digital camera. 
The pictures were processed with Adobe Photoshop program. 
2.5.4 	Preparation of slides from tissues expressing GFP 
Tissues expressing GFP were fixed as described in sections 2.5.1-2.5.2. After the 
fixation the samples were washed with 1XPBS two times for 10 min and mounted as 
described in section 2.5.3.2. 
Chapter 3: 
Identification of novel Drosophila myosins 
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This work was undertaken in collaboration with George Tzolovsky, Stephen 
Pathirana, Timothy Wood, and published in Molecular Biology and Evolution, in 
2002 (Tzolovsky et al., 2002). 
3.1 Introduction 
As described in the Introduction, eight different myosins have been found in 
Drosophila, classified into six different classes. The publication of the complete 
Drosophila melanogaster genome allowed us to screen for new potential myosins in 
Drosophila. Having the information about the new myosins enabled us to investigate 
if they function during oogenesis. 
The search for new myosins was performed using the following steps: 
Search for new potential myosins in the Drosophila genome. 
Structural analysis of the new myosins. 
Classification of the new myosins by phylogenetic analysis. 
Screening for new myosins in Drosophila was undertaken as follows (Cope et al., 
1996): proteins with high homology to the head domain of chicken skeletal Myosin 
II were searched for by using the BLAST program. Identity of 30-40% is needed for 
classification of a new myosin into a given myosin class, and identity of 25-30% is 
needed for classifying a new protein as a myosin. Five potential new myosins were 
identified: Myosin 95E (on the third chromosome), Myosin heavy chain like-PDZ 
(Mhcl-PDZ, location: 89B7, third chromosome), Myosin 28B (on the second 
chromosome), Myosin 1 OA (on the X chromosome) and Myosin 29D (on the second 
chromosome) (Tzolovsky et al., 2002). 
The borders and the conserved regions of the head domain in the four myosins found 
was determined by alignment of the four myosins with chicken skeletal myosin 
motor domain, as in early classification schemes (Cheney et al., 1993; Mooseker and 
Cheney, 1995). The motor domains of the new myosins have a similar pattern of 
conserved regions to the chicken skeletal myosin motor domain (Mooseker and 
Cheney, 1995). 
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After finding the new myosins (George Tzolovsky), I participated in the analysis of 
their molecular structure. The RT-PCR analysis described in thesis chapter was 
established by George Tzolovsky (Tzolovsky et al., 2002). 
3.2 The programs used for the structural analysis of the 
new myosins: 
The search for proteins with high homology to the head and tail domain of the newly 
found myosins was performed by using the BLAST program 
(http://www.ncbi.nlm.nih.gov/blast/).  
Alignment of similar regions in the myosins and other proteins was performed with 
CLUSTALW program in the GCG software package, version 10.1, for x-windows, 
or with the program installed on the website: http://www.ebi.ac.uk/clustalw.  
Pairwise comparison was also performed by using the program Bestfit in the GCG 
software package. 
Coiled - coils were predicted by using the Paircoil program developed by Berger et 
al. (Berger et al., 1995). The domains in the neck and tail regions were also identified 
by with Pfam program from the Sanger centre 
(http://www.sanger.ac.uk/Software/Pfam/),  
(http://www.isrec.isb-sib.ch/software/PFSCAN—form.html), 
and SMART program (http://smart.embl-heidelberg.de/ (Schultz et al., 1998). 
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3.3 	The structural analysis of the novel myosins 
The results of the protein sequence analysis are summarized in Figures 3.3.1-3.3.2. 
The analysis made for each myosin is described in a separate section. 
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Figure 3.3.1: The protein structure of the newly found myosins: Myosin 95E, Myosin 2813, Myosin 
bA, Mhcl-PDZ (8913), and Myosin 29D. 
RISELAVLIQTNFRMYHARKRFQ Myo95E IQ1 
RMRHSQNIISSAWRTWRECRFGI Myo95E IQ2A 
RNRHSQMIISSAWRTWRAREEYR Myo95E IQ2B 
LMLIKSIVTIQRGIRRVLFRRYMK Myo28B IQ1 
RYREAIITVQRYWRGRLQRRKYQ Myo28B 1Q2 
VMRQGFHRLGACIAAQQLTTKFT Myo28B 1Q3 
MVRCRTIKLQALSRGYLVRKDFQ Myo28B 1Q4 
RLRRAAVSVQRHVRGMLVPRQLA 	NyolOA IQ1 
RRQAAATRLQARWP.GQRAQQRYE NyolOA 1Q2 
RLRKGALTAQRLWRGRQARRRVQ 	MyolOA 1Q3 
LLSDRI IQLQAFCRGYLARKKMSQRR 	My08 9B IQ1 
VQELAVRCIQRNVKAFLAVRDWPWWR Myo8 9B 1Q2 
IRHKSATLMQATWRGWWWRKKMGNGG 	Myo2 9D IQ1 
AKRSKIPGLQQAPLPNNKTTPNSAAQ Myo29D 1Q2 
Figure 3.3.2: The IQ motifs identified in Myosin 95E, Myosin 28B, MyosinlOA, Myosin 8913, and 
Myosin 29D. The conserved amino acids are in colour. Myosin 95E was found to have two different 
variants in its second IQ motif, as a result of alternative splicing (Tzolovsky et al., 2002). 
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3.3.1 Mhcl 
Initial analysis revealed that Mhcl has two predicted isoforms (alti and alt2) 
composed of 1646 and 1706 amino acids (aa), respectively. The head domains of the 
two isoforms start 68 aa from the N termini. The alt2 isoform differs from the alti 
isoform by the insertion of a 60 aa transmernbrane domain just before the C terminus 
of the head domain (Fig. 3.3.1). 
Two IQ motifs were found in Mhcl (1,379-1,428 aa, figures 3.3.1-3.3.2). Two coiled 
- coil domains were predicted (1,439-1,549 and 1,616-2,121 aa) when using the 
Profilscan and Pfam programs, and these predictions were verified when using the 
Paircoil program (Tzolovsky et al., 2002), suggesting that Mhcl might form a dimer 
by attaching two myosins in the coiled - coil region. Analysis of the conservative 
head domain showed that Mhcl has high homology to mouse and human PDZ - 
containing myosin (41% and 40% identity respectively), and lower homology to 
other myosins from class II, including nonmuscle myosin (28 - 29% identity) and 
skeletal muscle (25% identity). Also the tail domain showed higher homology (32% 
identity) with myosins containing PDZ domains compared to other class II myosins 
(25% identity). 
The high homology of the Mhcl motor domain with other myosins containing a PDZ 
domain could suggest that Mhcl also contains a PDZ domain. A sequence search 
(George Tzolovsky) revealed that a PDZ sequence exists 4.8 KB upstream to the 
predicted start of Ivfhcl mRNA, and RT-PCR analysis confirmed that this PDZ 
domain is indeed part of the Mhcl gene (Tzolovsky et al., 2002). 
The initial analysis of Mhcl structure was started using the partial sequence of the 
gene as published by Biru (Biru, 1999). When the full sequence of this gene was 
published by Celera (Adams et al., 2000.), additional analysis of the sequence, in 
combination RT-PCR analysis, sequence analysis of expressed sequence tags (ESTs) 
of the Mhcl gene, and Promoter-predicting program (http://www.fruitfly.org/ 
seqptools /promoter.html) was undertaken (George Tzolovsky). The gene was found 
to be composed of 19 exons, creating seven different transcripts by the use of four 
predicted promoters (Tzolovsky et al., 2002). 
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3.3.2 Myosin 28B 
The amino acid sequence of the head domain has 61% identity with the head domain 
of crinkled - Drosophila Myosin Vila. It also showed 58% identity with the zebrafish 
Myosin Vila, suggesting that Myo2813 belongs to class VII. 
Analysis revealed that Myo28B has four IQ motifs (753-845 aa, Figures 3.3.1-3.3.2), 
the third being poorly conserved. A subsequent coiled - coil domain (849-908 aa) 
was predicted with the Profilsean, Pfam and Percoil programs. 
Two myosin tail homology 4 (MyTh4) domains (1,070-1,246 and 1,681-1,826 aa), 
were identified in Myo28B. Sequence alignment of Myo28B with other myosins 
from class VII and XV showed that the first MyTh4 domain has an insert of 61 
amino acids (Fig. 3.3.2.1). An insert of about 88 aa, in the same place, was also 
found in human class VII myosin (Chen et al., 1996), in Drosophila Myosin VITa, 
and in the hypothetical protein T10H10.1 (Caenorhabditis elegans). The two 
domains have more than 40% identity to MyTh4 domains in type VII and type XV 
myosins. The function of MyTH4 is unknown, but it appears in several motor 
proteins (including microtubule motor proteins), suggesting that it might share 
similar mechanisms of interaction with the cargo (Oliver et al., 1999). 
Two FERM domains (named for band 4.1, Ezrin, Radixin, Moesin) were identified 
(1,246-1,454 and 1,826-2,039 aa). These domains have the highest homology with 
talin and filopodin in the band 4.1 superfamily, and a high homology with the talin - 
like domains in class VII myosins. Figure 3.3.2.2 shows the percentage of identity 
between the FERM domain in myosins VII and XV with the FERM domain in C. 
elegans Talin. The FERMI motifs from Myosin VII show 12%-21% similarity to 
proteins from the FERM family and approximately 16% similarity to the band 4.1 
protein. FERM2 domains in Myosin VII show a higher similarity of 17%-18% to 
band 4.1 protein and 181/o-20% to proteins from the FERM family. When comparing 
the FERM domains in Myo28B and Drosophila Myosin VIIa, the first FERM 
domains share 42% identity (and 67% similarity) and the second FERM domain 
shares 20% identity (50% similarity). The tandem arrangement of MyTH4 and 
FERM domains (Fig. 3.3.1) is also conserved in myosins from classes VII and X, 
although it does not appear uniformly in all the myosins. Proteins from the band 4.1 
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family play a role in the stabilization of cells membrane, and the FERM domain was 
shown to mediate membrane-cytoskeleton interactions, through the binding to 
integral membrane proteins (Sun et al., 2002). In addition, the FERM domain was 
found to form interaction with other proteins from the ERM (zrin, Radixin, Moesin) 
family, by the binding with the C-terminal actin-binding domain that appears in 
ERM proteins (Sun et al., 2002). 
Unlike other myosins from class VII, none of the programs used have identified SH3 
(Src homology 3) domains in Myo28B. However, sequence alignment of SH3 
domains from Myosin VII and Myosin XV with region 1551 - 1628 in Myo2813 
revealed that this region has high homology with SH3 domains, especially in the 
conserved regions (Fig. 3.3.2.3). SH3 was found in many proteins associating with 
cytoskeleton and in membrane proteins that are involved in signal transduction 
(Parsons, 2003). This domain seems to play a role in protein-protein interactions 
through the binding to proline-rich domains (Macias et al., 2002), although SH3 
domains were also found to interact with non-proline peptides (Agrawal and Kishan, 
2002). In yeast Myosin I (Myo5p), the 5H3 domain was found to be required for 
interaction of the tail domain with actin filaments and for triggering actin 
polymerisation (Geli et al., 2000). In two types of yeast Myosin I, Myo3p and 
Myo5p, the SH3 domain interacts with Beelp and Vrplp, two adapter proteins that 
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Figure 3.3.2.1: ClustalW alignment of the MyTh4 domains in unconventional myosins. Identical 
amino acids are dark shaded and similar residues are light shaded. The sequences included in the 
alignment are: CeHp, hypothetical protein TlOHlO.l Caenorhabditis elegans (T25888); HsM7a 
human Myosin VII (Q13402); DmCk, Myosin VITa (ck) - Drosophila melanogaster (AAF44915); 
HsM15, human Myosin XV (Q9UKN7), and Myo28B (AAF52536). The first MyTh4 domain in 
HsM7a, DrnCk, CeHp, and Myo28B contain inserts of 61 - 88 AA (regions 1057 - 1144; 1048 - 
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Fig. 3.3.2.2: A diagram representing the percent of identity (left value) and similarity (right value) 
between the FERM domains in Drosophila myosins VII and XV and the talin domain from 
Caenorhabditis elegans (CE, AAA74747). The FERM domains were aligned separately with the talin 
domain of C. elegans. Multiple alignment was not made since the similarity between FERMI and 
FERM2 and the talin domain (from the Talin protein) was very low and resulted in unordered 
alignment. The comparison was preformed by using CLUSTALW (http://www2.ebi.ac.uklclustalw/). 
The FERM domains of mouse Myosin XV are also presented in the diagram. The motor domain of the 
myosins is drawn in black, the IQ motifs in grey, and the FERM domains in patterned boxes. 
Accession numbers are: C. elegans (Talin): AAA74747; D. melanogaster (Myosin VIIA):CAC05418, 
(Myo 2813): AAF52536, (Myosin 1OA-XV): AAF47980; M. musculus (Myosin XV): AAF05904. 
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Fig. 3.3.2.2. ClustalW alignment of region 1551 - 1628 in Myo28 and SH3 domains in 
unconventional myosins from class VII and XV. DrM7a, Myosin Vila (Danio rerio, CAC05418); 
MmM7a, mouse Myosin VIla (P97479); DmCk, Myosin VIla Drosophila melanogaster 
(AAF44915.1); HsM15, human Myosin XV (Q9UKN7); MmM15- mouse Myosin XV (Q9QZZ4). 
109 
Also in Dictyostelium, the SH3 domain is involved in actin dynamics in the class I 
myosins, MyoB and MyoC, however in this case the SH3 domain interacts with a 
protein called p1  16, which in turn binds to Arp 2/3 and capping protein, two proteins 
that play a role in actin dynamics (Jung et al., 2001). 
3.3.3 Myosin IOA 
A Blast search with the head and tail domains of MyolOA showed identity of 47% 
and 42%, respectively, to mouse and human Myosin XV. The motor domain of 
Myosin 10A also shares 42% identity and 58% similarity with human and mouse 
Myosin VII. 
Myosin 10A (MyolOA) has a specific N terminal domain of 149 aa, which does not 
share similarity with other N terminal domains of other myosins from class XV. 
Three IQ domains were identified in the neck domain (841-910 aa, figure 3.3.2), 
followed by a short coiled - coil domain (919-946 aa, Fig. 3.3.1). Analysis of the tail 
domain revealed one MyTh4 domain (1014-1173aa), a glutamine - rich domain 
(1611 - 1647 aa), a proline - rich domain (1937 - 1991 aa), a short transmembrane 
motif (2,194-2,214 aa) and FERM - like domain at the C terminal (2,220-2,424 aa). 
The FERM - like domain was not identified using Pfam and SMART programs, 
probably because it is shorter by 75 aa than other FERM domains, however it has 
high homology with FERM domains in mouse and human Myosin XV (in the mouse 
it shares 40% identity with the first FERM domain, and 13% identity with the second 
FERM domain) and it shares 17% identity with the FERM domain in Talin (Fig. 
3.3.2.2). 
RT-PCR analysis revealed that MyolOA has at least two transcript variants, the 
longer is composed of all the five exons and the shorter lacks the second exon 
(Tzolovsky et al., 2002). 
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3.3.4 Myosin 29D 
Analysis of the conserved head domain revealed that Myosin 29D (Myo 29D) is not 
similar to any of the known classes of myosin. It showed 29% identity (45% 
similarity) to myosin VII, X, and V from different species. This homology is not 
enough to classify Myo 29D as a class - specific myosin, suggesting that it forms a 
class of its own. 
The head domain of MyolOA has an N terminal extension of 338 aa. Two IQ motifs 
were found in the neck domain (1,089-1,136 aa,), the second is poorly conserved 
followed by a short transmembrane motif (1,144-1,279 aa, Fig. 3.3.1- 3.3.2). 
RT-PCR analysis revealed two transcripts, the first includes all the five exons 
composing the gene, and the second lacks exon 5 and produces a truncated form of 
the protein, lacking most of the motor domain (Tzolovsky et al., 2002). The two 
transcripts are present during all the stages of development; however the first 
transcript is expressed at a higher level (Tzolovsky et al., 2002). 
3.3.5 Myosin 95E 
This gene was not found in the initial searches. In the search for novel myosins, one 
of the proteins that came out with a high homology to myosins appeared to only be 
59 aa long. The detailed search for the proper size of the protein was made by 
George Tzolovsky (Tzolovsky et al., 2002). The whole gene sequence was found in 
the AEO03 746 genome scaffolding by considering the initial gene sequence, the 
published sequence of the ESTs of the gene found and the homology of the translated 
genomic DNA with other proteins. The splice sites were predicted using the 
programs: The Neural Network at http://www.fruitfly.org/seqptools/splice.html and 
GENSCAN Server at http://genes.mit.eduIGENSCAN.html. Finally, the precise 
sequence of the cDNA was identified by TRPCR. The gene is composed of 16 exons. 
The head domain of the protein reveals 33% sequence identity and 53% similarity 
with the vertebrate border class I myosins, and structural analysis showed that this 
myosin has a similar structure as class I myosins (Tzolovsky et al., 2002). Therefore 
it was termed Myosin IC (myosins IA and lB were already identified). Myosin 95F 
contains 2 IQ motifs (928-974 aa), the second being poorly conserved (fig. 3.3.2), 
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and a basic tail domain (974-1,278 aa in the first isoform, 974-1,258 aa in the 
second isoform), as described in figure 3.3.1. The basic tail domain is found to bind 
to the acidic phospholipids in the cell membrane and to actin filaments (Lee et al., 
1999; Tang et al., 2002). 
TR-PCR analysis reveals that the gene produces at least three different transcripts, 
one which is composed of all the sixteen exons of the gene, the second lacks exon 12 
and the third exon has an insert of several nucleotides in the fourth exon, causing 
shift of the open reading frame and an insert of a stop codon in exon 5 (Tzolovsky et 
al., 2002). The third transcript could hypothetically encode two types of truncated 
protein: the first composed of 464 aa encoding only a part of the head domain; and 
the second protein, composed of 864 aa, encoding a large part of the head domain, 
two IQ motifs, and the tail domain (Tzolovsky et al., 2002). 
34 Conclusions 
Eight myosins were found to exist in Drosophila melanogaster, prior to the 
publication of the Drosophila genome. These myosins belonged to class I (2 
myosins), II (2 myosins), III, V, VI and VII. Five novel myosins have been 
identified, four of them belong to classes I, VII, XV, XVIII and one creates a new 
class. 
By the time that our article was prepared, a paper was published by Yamashita et al. 
(Yamashita et al., 2000) showing the identified novel myosins in Drosophila after a 
blast search, classifying myo28B in class VII, myolOA in class XV and Mhcl in 
class XVIII. Our work complements this publication, by describing the domain 
composition of all the novel myosins and by classifying Myo95E as Myosin I and 
Myo29D in a unique class (class XIX). In addition, a transcription analysis that was 
made for the myosins Myo95E, MyolOA, Mhcl, and Myo 29D (Tzolovsky et al., 
2002). The analysis of the transcripts for these myosins confirmed the expression of 
these genes in Drosophila (along with the identification of ESTs for every gene), 
showed the various splicing forms in which each myosin is expressed and served as a 
useful tool for verifying the sequence of the genes. 
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The Drosophila myosins are classified in nine different classes, which share different 
structures of the tail domain and participate in a variety of cell functions, including 
membrane and mRNA transport, cell adhesion, and actin dynamics (the function of 
the known myosins is described in chapter 1). It would be interesting to examine the 
function of the new myosins in Drosophila, especially the function of myo29D 
which has a unique structure which could be needed for a new purpose. RTPCR 
analysis revealed that Myo95E is expressed during oogenesis; MyolOA is expressed 
from the larval stage onwards, while Mhcl and Myo 29D are expressed throughout 
the life cycle (Tzolovsky et al., 2002). In situ hybridisation to ovaries undertaken in 
our lab by the honour student, Holy Jones, revealed that MyolOA is expressed during 
stages 1-13 in the nurse cells and the follicle cells, and the transcripts from the nurse 
cells are transferred to the oocyte. Myo29 transcripts are present in the nurse cells in 
stages 1-3 and weakly expressed in the follicle cells from stage 6. Mhcl transcripts 
are expressed in the nurse cells from stage 3 and transported to the oocyte at stage 
12. Myo95E is strongly expressed in the nurse cells from stage 8 and has a moderate 
expression in the follicle cells from stage 7. Now that the mRNA expression pattern 
is established, it would be interesting to test the protein expression pattern of these 
myosins. Generally, the function of these myosins during oogenesis could be verified 
by disrupting their expression using a targeted silencing technique or by creating 
mutants of the myosins observing the phenotype of clones of mutant cells, or by 
over-expression of the proteins. 
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Chapter 4: 
The function of Myosin VI in Drosophila: 
functional analysis by expression of Myosin VI-
GFP fusion proteins 
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4.1 Introduction: 
Myosin VI participates in the organization and patterning of many epithelial tissues 
as they develop, and for building membrane constructs through membrane trafficking 
(Deng et al., 1999; Hicks et al., 1999; Kellerman and Miller, 1992; Lantz and Miller, 
1998). The function of Myosin VI was studied by observing Myosin VI within the 
tissue, using Myosin VI antibody, and by comparing the morphology of cells and 
tissues in wild-type flies and in mutant flies or flies in which the expression of 
Myosin VI was disrupted. In all these experiments, the function of Myosin VI was 
studied as a whole molecule. The function of Myosin VI and its separate domains 
was studied in mammalian epithelial cells (normal rat kidney cells), during 
endocytosis (Buss et al., 2001). However, very little is known about the way Myosin 
VI molecule and its separate domains function during Drosophila development. 
Myosin VI is composed of three domains: the head which is the motor domain and 
moves along actin filaments, the neck which regulates the movement of Myosin VT, 
and the tail domain which serves as a cargo for other molecules. Myosin VI is 
involved in dynamic processes, such as the migration of follicle cells, where it might 
be needed for asymmetric localization of molecules within the cells. Information 
about the localization of the tail and the head domains, and the whole myosin during 
the migration of the follicle cells, and in other processes, will give us a better 
understanding of the way Myosin VI and its separate domains work in the cell. 
To do this Myosin VI and its domains, tagged to Green Fluorescent Protein (GFP) 
were produced. The expression of the GFP-tagged proteins in flies allows us to 
observe the expressed proteins in real time in living tissues, as well as in fixed 
tissues. 
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4.1.1 Design of the fusion proteins 
Three different tagged proteins were expressed: full length Myosin VI, the head + 
neck domain and the tail domain, each tagged in-frame with GFP, at its N terminus 
(Fig 4.1.1). 
	
Myosin Vi head+ neck + tail 	GFP 
PGM 
Myosin VI haed + neck 	GFP 
:-. _T PGMH 
Myosin VI tail 	GFP 
_:: PGMT 
Figure 4.1.1: The three fusion proteins expressed in Drosophila: whole Myosin VI (PGM), the head 
and neck domains (PGM1H) and the tail domain (PGMT), tagged to GFP. The head + neck domain is 
coloured in purple; the tail domain is coloured in yellow. 
4.2 	Expression of the fusion proteins using the Ga14/ UAS 
system 
The expression of the fusion protein is achieved by using the Ga14/ UAS system 
(Brand and Perrimon, 1993). The DNA construct contains the eDNA corresponding 
to the jaguar gene (encoding Myosin VI) fused in - frame to EGFF DNA sequence 
(expressing GFP), cloned within the 
pUAST plasmid, which contains two P 
elements and an UAS (upstream activation 	 -- 
sequence) target sequence (Fig. 4.2.1). 
Figure 4.2.1: The structure of the pUAST plasmid: 
The plasmid contains the UAS (Upstream 
Activation Sequence) target sequence, adjacent 
to the hsp 70 promoter containing a TATA box; 
a multiple cloning site is followed by the SV40 
termination domain, that includes a stop codon 
and a polyadenylation site; mini - white marker, 
two P - elements (5' and 3'), and pUCB 




The UAS target sequence and the genes are incorporated into the chromosomes by its 
two p-element ends catalysed by a transposase from another insertion (using the 
PA2-3 plasmid), which cannot transpose by itself The transgenic flies are crossed 
with flies that express Ga14 in specific tissues (Fig. 4.2.2). The Ga14 gene encodes a 
specific transcriptional activator (Ga14) which binds to the UAS target sequence. The 
binding of Ga14 to the UAS sequence triggers the expression of the jaguar - EGFP 
fusion gene, which is translated into a Myosin VI - GFP fusion protein 
0 GAL4 
ga14 white I+LjIjjjh x 41 UAS I jaguar - FfFP Iwhite14 
Tissue specific 	 x 	UAS jaguar -EGFP 
GAL4 line line 
Figure 4.2.2: Activation of jaguar - EGFP expression by the Ga14/UAS system. The P[Ga141 
element, which contains a reporter gene Ga14 , a marker gene white and sequence from pBluescript 
plasmid, was inserted into a fly genome. The expression of the 0a14 gene is regulated by the enhancer 
of the gene, X, close to the P insertion. In a different fly line, the UAS - jaguar - EGFP construct is 
incorporated into the Drosophila genome. When the two lines are crossed, the expressed GAL4 
transcriptional factor interacts with the UAS sequence and triggers the expression of jaguar - EGFP 
sequence. 
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4.3 	Creation of the DNA constructs 
Three different DNA constructs were created: PGM (PUAST-GFP-Myosin _Vi), 
containing the whole jaguar cDNA; PGMH (PUAST-GFP-Myosin VI Head), 
containing the jaguar cDNA encoding the head and neck domains of Myosin VI, and 
PGMT (PUAST-GFP-Myosin VI Tail), containing the jaguar cDNA encoding the 
tail domain of Myosin VT. In all the constructs, jaguar cDNA was fused in-frame 
with the EGFP gene, and cloned within the pUAST gene. 
All the constructs were made by two cloning steps (described in Fig. 4.3.1). In the 
first cloning step EGFP DNA sequence was isolated from the pEGFP -Ni plasmid 
by restriction with the enzymes EcoRl and Noil (section 2.4.7.1) and gel purification 
(section 2.4.6). The purified EGFP DNA was cloned into the pUAST plasmid 
(restricted with the same enzymes and gel purified) to form the PUAST - GFP 
plasmid (section 2.4.7.2). After transformation (section 2.4.8) the colonies containing 
the PUAST - GFP plasmid were selected by restriction analysis with EcoRl and Nod. 
jaguar cDNA was amplified by proof-reading PCR (section 2.4.11.2), using primers 
that were designed to contain the restriction sites for the enzymes EcoI?J in the 5' end 
and Agel in the 3' end. In order to connect in-frame of jaguar and EGFP genes, the 
primers at the 3' end (HEC2, MYC2) contained two C nucleotides inserted between 
the Agel restriction site and the 3' end of the jaguar gene, to encode the amino acid 
glycine. 	The coding region of the whole Myosin VI was amplified using the 
primers: MYN and MYC2; for the head domain the primers used were MYN and 
HEC2, and for the tail domain the primers used were TAN and MYC2. The 
amplified cDNA fragments and the pUAST - GFP plasmid were restricted with 
EcoRl and Age] enzymes, gel purified, and cleaned (section 2.4.3). Then the plasmid 
and the cDNA fragments were ligated, cleaned again and transformed into competent 
cells. In parallel the DNA was analysed on gel to verify ligation. 
Figure 4.3.1: The cloning steps used to build the pUAST -jaguar - EGFP DNA construct. (A) In the 
first stage pEGFPN1 and pUAST plasmids were restricted with EcoRl and Noti restriction enzymes. 
EGFP DNA was isolated and cloned into pUAST plasmid to form PUAST - GFP plasmid. (B) In the 
second stage jaguar cDNA was amplified by PCR, forming specific restriction sites (EcoRI, Age]) at 
the two edges. The PCR product and the pUAST - GFP plasmids were restricted with EcoRl and Agel 





EcoRl 	 AeeI 	 Not! 
pEGFP-N1 
TATA Kanr I Stop/polyA 
EcoRl 	Not! 
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pUAST 
ATAI 5xUAS I'I DUCB 1P5'1 Mini-white I Stop/polyA 
EcoRl 	Age! 	 Not! 
p UAST-EGFP 
TATA5xUASP3' pUCB s'j Mini-white I Stop/polyA 
EcoRl 	 Age! 	 Not! 	 EcoRl 	 Age! 
jaguar 
p UAST-EGFP 
TATA5xUASP3' nUCB P5'1 Mini-white I Stop/polyA 




TATA 5xUAS 	pUCB 	Mini-white I Stop/polyA 
The colonies containing the insert of the jaguar and EGFP were selected by colony 
lift hybridisation (section 2.4.9) and single colony PCR (section 2.4.11.4). The 
cloning steps are described in figure 4.3.1. 
The plasmids from the selected colonies were restriction-analysed with the enzymes 
EcoRI, NotI, and Agel in order to verify the presence of EGFP and jaguar cDNA 
within the PGM, PGMH and PGMT plasmids (Fig. 4.3.2). 






Figure 4.3.2: Restriction analysis for the three DNA constructs made: PGM (M), PGMH (H), and 
PGMT (T) with EcoRl, NotI and Agel restriction enzymes. All the constructs contain the pUAST 
plasmid with the size of 8.9 kb, and the EGFP gene (0.8 kb). PGM contains the whole jaguar cDNA 
(4.2 kb), PGMH contains the coding region of the head and neck domains (2.85 kb) and PGMT 
contains the coding region of the tail domain (1.35 kb). 
Finally, the connection in-frame of jaguar cDNA with EGFP sequence was verified 
by sequencing the region between the two genes in all the three constructs, using the 
GFPR primer. In order to ensure the accurate amplification of jaguar cDNA in the 
three constructs, various fragments in jaguar cDNA were sequenced, using the 
primers MYC2, MYN, TAN, HEC2, and pUASTF (thus sequenced the region 
connecting the pUAST plasmid and jaguar cDNA). In all the DNA constructs, 
jaguar cDNA was fused in-frame with EGFP, and the sequence of jaguar cDNA in 
all the three constructs was amplified accurately, without mistakes. 
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4.4 	Creation of transgenic flies 
The creation of transgenic flies was as described in section 2.3.5. The number of flies 
injected and the number of transgenic flies created for the constructs: PGM, PGMH 
and PGMT are described in table 4.4.1 
Table 4.4.1: Microinjection summary 
The injected No. of No. of larvae No. of No. of No. of 
construct embryos survived hatching flies crosses that injected flies 
injected (crossed) gave producing 
progeny transgenic 
flies 
PGM 1077 279 205 134 
541109B 
26%A 19%A 124%A 66%A 
(495%C) 
PGMH 1055 276 192 134 54/134's 
35•6%A 18.2 127o,iA 12.7 5A (40.3%c) 
PGMT 1068 322 217 165 401138B 
203%A 155%A 45%A(30%1) 
A  The percentages in the table indicate the recovery out of the number of the embryos injected 
B  The number of crosses that were examined. 
C  The recovery is number of injected flies creating transgenic progeny/ number of crosses that were 
examined. 
The main decline in the survival rate was after the microinj ection. About 6-10% of 
the animals died during the larval and pupal stages. Among the injected flies that 
hatched, 65-76% were fertile. The loss of fertility in the rest of the flies could have 
been caused by the loss of the pole cells from the embryos during the microinjection. 
In spite of the low recovery of flies after the injection, the percentage of transgenic 
flies generated was high. 
The expression level of the GFP tagged proteins depends on the location of the 
insert. Transgenic flies that came from the same injected embryo can have the 
insertion in the same place within the chromosome, if all the flies are originated from 
the same stem cell. However, if the transgenic flies collected are originated from 
different injected flies, the variability in the location of the inserts in the 
chromosomes increase and therefore the chance of getting flies with a good 
expression of the tagged proteins increases as well. 
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Insertion genotype ChrA Fly line 
nickname 
Insertion genotype ChrA 
PGMI7-1 P{w, UAS-PGM}17.1  PGM75-5-2 P(w, UAS-PGM)75.5.2  
PGMI7-2 P(w, UAS-PGM}17.2  PGM75-10 P{w, UAS-PGM}75.10 3 
PGM22-1 P(w, UAS-PGM)22.1 2 PGM109-1 P{w, UAS.-PGM}109.1  
PGM22-3 P( w, UAS-PGM)22.3 4 PGM125-2 P{ w, UAS-PGM} 125.2 2 
PGM25-3 P{ w, UAS-PGM}25.3  PGMI28-4 P(w, UAS-PGM}128.4 2 
PGM38-2 P( w' , UAS-PGM)38.2 PGMI67-2 P{ w, UAS-PGM} 167.2  
PGM4 1-1 P( w, UAS-PGM)41. 1 PGMJ 72-2 P( w, UAS-PGM) 172.2  
PGM41-2 P{w, UAS-PGM}41.2  PGMI96-2 P{w, UAS-PGM}196.2 X 
PGM43-2 P{w, UAS-PGM}43.2 2 PGM214-1 P(w, UAS-PGM)214.1  
PGM45-1 P{ w, UAS-PGM}45. I  PGM226-9 P{w, UAS-PGM}226.9 3 
PGM45-2 P( w, UAS-PGM)45.2 PGM228-1 P1  w, UAS-PGM}228. 1 2 
PGM58-1 P{w, UAS-PGM}58.1 2 PGM238-2 P(w, UAS-PGM)238.2  
PGM75-5-1 P{ w, UAS-PGM}75.5.1 3 PGM238-5 P{w, UAS-PGM}238.5  
'The chromosome location of some of the inserts is indicated. 
PGMH lines  
Fly line 
nickname 
Insertion genotype ChrA Fly line 
nickname 
Insertion genotype ChrA 
PGMH8-2 PI w+, UAS-PGMH)8.2  PGMHI14-2 P{ w, UAS-PGMH}//4.2 3 
PGMH56-1 P{ w, UAS-PGMH}56. 1 2 PGMJ-I1 19-1 P( w, UAS-PGMH)119. 1 
PGMH57-1 P{w, UAS-PGMH}57.1 2 PGMH130-2 P(w, UAS-PGMH)130.2 2 
PGMH90-1 P1  w, UAS-PGMH}90. 1 3 PGMH156-1 P1 w, UAS-PGMH,?156. I 
PGMH90-2 P( w, UAS-PGMH)90.2 PGMH18I-3 P1 w, UAS-PGMH} 181.3 3 
PGMH94-1 P{w, UAS-PGMH)94.1 3 PGMH197-2 P(w, UAS-PGMH)197.2 
PGMH94-2 P( w, UAS-PGMH)94.2 PGMH224-I P( w, UAS-PGMH)224. 1 
PGMHJO6-2 P( w, UAS-PGMH) 106.2 PGMH235-2 P1 w, UAS-PGMH)235.2 
PGMH1I4-1 P(w, UAS-PGMH)114.1 1 
A  The chromosome location of some of the inserts is indicated. 
PGMT lines  
Fly line 
nickname 
Insertion genotype Chr' Fly line 
nickname 
Insertion genotype ChrA 
PGMT 33-2 P{w, UAS-PGMT}33.2  PGMT84-1 P(w, UAS-PGMT)84.1  
PGMT 41-1 P( w, UAS-PGMT)41. 1  PGMT 84-3 P( w, UAS-PGMT)84. 3  
PGMT 59-2 P{ w, UAS-PGMT}59.2  PGMT 85-1 P( w, UAS-PGMT)85. I  
PGMT 59-3 P{w, UAS-PGMT}59.3 PGMT 85-2 P1w,  UAS-PGMT)85.2  
PGMT 59-5 P{ w, UAS-PGMT}59. 5 PGMT 106-1 P( w, UAS-PGMT)1 06.1 
PGMT 61-1 P{w, UAS-PGMT}61.1  PGMT I27-2 P(w,  UAS-PGMT)127.2 
PGMT 61-2 P( w, UAS-PGMT)61 .2 PGMT 23 1-2 P( w, UAS-PGMT)231 .2 
PGMT 61-3P{w, UAS-PGMT}61.3 X PGMT236-1 P(w, UAS-PGMT)236.1  
PGMT 69-1 P(w, UAS-PGMT)69.1 PGMT239-1 P{w, UAS-PGMT}239.1 
PGMT 69-2 P1w, UAS-PGMT}69.2 PGMT29I-1 P1 w, UAS-PGMT}291.1 
PGMT 69-3 P( w, UAS-PGMT)69. 3 PGMT 291-2 P1 w, UAS-PGMT)291 .2 
PGMT 79-1 P( w, UAS-PGMT) 79.1 PGMT 315-2 P( w, UAS-PGMT)3 15.2 
PGMT 83-1 P1 w, UAS-PGMT}83. I  
"The chromosome location of some of the inserts is indicated. 
p4I 
For that reason, from every injected fly that produced transgenic flies, only 2-3 lines 
were selected. After collecting 100 transgenic flies for every injected construct, the 
flies having the highest expression level of GFP were selected as described in section 
2.3.5.3, and the selected lines are described in table 4.4.2. Some of the fly lines we 
purposed to use in subsequent experiments were balanced and the chromosome 
location of the transposon is indicated. The expression of 
PGM, PGMH and PGMT did not affect the normal function of native Myosin VI and 
viability. All the flies expressing the fusion proteins had progeny. 
There was no correlation between the eye colour and the expression level of the 
fusion proteins: fly lines having bright orange eyes showed a strong expression of 
PGM when crossed with Ga14 lines, while several lines having dark red eyes had a 
weak expression of PGM. Probably the reason for the differences is that the mini-
white gene is activated by certain activators, near the insertion site, whilst PGM 
expression is activated by Gal4, but which is still manipulated by different 
enhancers. However, it seems that there are other factors affecting the expression of 
PGM since the transgenic flies have different levels of PGM expression. 
4.5 	Expression pattern of Myosin VI during the whole fly life 
cycle 
The fly line C865 contains the Ga14 gene inserted within the jaguar gene, in its 
5'UTR region, at bp 306 in the first exon (Millo et al., 2004). In this line, Ga14 is 
expressed according to the expression pattern of Myosin VI. By crossing line C865 
with PGM and PGMH fly lines, it was possible to detect in which tissues and at 
which stages Myosin VI is expressed during the entire fly life cycle. Because PGM 
and PGMH expression is controlled by Ga14, the two fusion proteins showed 
expression in all the tissues described. 
Figure 4.5.1 shows various tissues expressing PGM (the whole Myosin VI tagged to 
GFP) and PGMH (Myosin VI head and neck domains tagged to Myosin VI) during 
embryogenesis. In late embryogenesis (stages 13-15) PGM is expressed during 
dorsal closure, mainly at the leading edge and in the amnioserosa (A, B). PGM and 
PGMH are observed in the neurons of the central nervous system (F) and the 
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peripheral nervous system (C, D) in stages 13-15, according to Bownes stages, 
(Bownes, 1975; Campos-Ortega, 1985). 
In Drosophila embryos at stage 16, Myosin VI has a physical interaction with 
Miranda, and is necessary for the localization of Miranda in the basal cell membrane 
of metaphase neuroblasts. In addition, Myosin VI is necessary for rotating the 
spindle in the neuroblasts by 90°C (Petritsch et al., 2003): in the Myosin VI mutant, 
jar322, the neuroblasts spindles were disorientated and Miranda was mislocalised to 
the cytoplasm. Similar results were obtained when the expression and the function of 
Myosin VI in the neurons were disrupted by different approaches (Petritsch et al., 
2003). The expression of PGM or PGMH in the neurons is consistent with the 
expression of Myosin VI, which is necessary for their asymmetric cell divisions, and 
for the proper development of the nervous system. 
At stages 13-15 PGM and PGMH were also observed in the developing trachea (E), 
having expression at the posterior spiracle (Fig. 4.5.1 B, D). In the final stages of 
embryogenesis, the expression of PGM and PGMH is found in the developed 
salivary glands (F, G) and in the midgut mesoderm (marked MG in G and H), after 
the fusion of the anterior and posterior midgut. 
In the third instar larvae (Fig. 4.5.2), PGM continues to be expressed in the trachea 
and in the epithelial cells at the dorsal trunk (Fig. 4.5.2 A, B). In the cuticle, PGM is 
expressed in epidermal cells appearing at the posterior part of each segment (Fig. 
4.5.2 C, D). In the salivary gland PGM show a strong expression (Fig. 4.5.2 E): the 
strongest expression of PGM appeared within the salivary gland main duct (Fig. 
4.5.2 F). PGM appears to be concentrated in groups in the salivary duct. Perhaps 
PGM forms a complex with proteins that have been transferred from the secretory 
cells to the duct. The expression of PGM and PGMH in the neurons continues to 
appear from embryogenesis to the moult stage, in the larval brain hemispheres and 
the ventral ganglion (Fig. 4.5.2 G, H). 
Figure 4.5.3 shows the expression of PGM in the leg, halter and wing discs. In the 
leg wing and halter discs, PGM expression appears in a punctate form (A). However 
in some flies, PGM expression appeared all over the leg and wing discs (B). As the 
leg disc evaginates, PGM is expressed in the entire leg (C), suggesting that Myosin 
VI is necessary for the migration of the epithelial cell as the leg spreads. 
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The figures in the following pages: 
Figure 4.5.1: Expression of PGM during embryogenesis. A: During dorsal closure PGM is expressed 
in the amnioserosa (AS) and at the leading edge (LE). The embryos were stained with phalloidin to 
visualise the actin filaments. In the amnioserosa Myosin VI is localized mainly in the cytoplasm and is 
excluded from the nuclei. B: A picture showing PGM expression as dorsal closure progress. The cells 
expressing PGM, at the leading edge are more elongated. C-E: Expression of PGM and PGMH in the 
neurons (NEU) of the peripheral nervous system and the trachea. The strong expression of PGM and 
PGMH in the posterior spiracle (PS) is marked. Figure F shows expression of PGMH in the neurons 
of the central nervous system (CNS). In the late stages of embryogenesis (stage 15 onwards) PGM is 
expressed in the salivary glands (SG) and in the midgut endoderm. G-H: expression of Myosin VI in 
the midgut (MG). 
Figure 4.5.2: Expression of PGM in third instar larvae. PGM expression appeared in the first and 
second instar larvae, but it was more obvious at the third larval instar stage. PGM is expressed in the 
dorsal trunk of the larval trachea (A, B); in the cytoplasm of the epidermal cells producing the cuticle 
(C, D); strong expression of PGM (E) appears in the salivary glands, where PGM is localized at the 
cell membrane and in the cell cytoplasm. F: A strong concentration of PGM is observed in the 
salivary gland duct, some of it is appears as in aggregates, probably connected to vesicles. PGM is 
also expressed in the brain neurons, in the brain hemispheres (BH) and the ventral ganglion (VG, 
figures G-H). 
Figure 4.5.3: Expression of PGM in the imaginal discs of the larvae (third instar) and pupae. A, B: leg 
wing and halter imaginal discs of third instar larvae. Figure A was taken through red and green filters 
in order to produce a clearer image of the cells expressing PGM. C: An evaginating leg disc. D and E 
are legs at the pupal stage. PGM is expressed in the nerve cells (microcheates) in the femur and the 
tibia. F, G: Evaginating wing discs. PGM is expressed in the wing epithelial sheet prior to the 
spreading of the wing, and at the basal side of the epithelial cells, where the two epithelial sheets face 
to each other (arrow). H: A wing of a en/AM8-2 pupae, showing malformation and blistering of the 
wing in the posterior part of the wing (PST), where Myosin VI is disrupted (see asterisk). The anterior 
remains normal (ANT) I: Expression of PGM in the wings (arrow) and legs (asterisk) during 
metamorphosis within the pupal case. 
Figure 4.5.4: Expression of PGM in the eye-antennal imaginal discs and in the testes of the adult fly. 
PGM is expressed throughout the eye-antenna disc during the third larval instar (A). In the pupae 
PGM is expressed in the onmiatidia of the developing eye (B, C), in the evaginating antenna disc (E), 
and in the antenna (F). D: when Myosin VI is disrupted in the posterior part, the hairs are slightly 
thinner. In the adult fly, during spermatogenesis PGM is expressed in the individualization complexes, 
showing a strong expression mainly at the base of the cone (G). Myosin VI is also expressed in cells 
within the accessory gland (H). 
Figure 4.5.5: PGM is expressed during oogenesis in all the migrating follicle cells. A: During stage 7 
PGM is expressed in the anterior follicle cells and in the border cells as they start to migrate towards 
the oocytes. B: At stage 9 PGM is expressed in the columnar follicle cells as they migrate, note the 
strong expression at the apical side of the cells; C: A view of the expression in the columnar follicle 
cells as they cover the oocyte. D: During stage lOB, PGM expression is observed in the centripetal 
follicle cells as they migrate to cover the anterior part of the oocyte. E: Expression of PGM in the 
border cells as they reach the oocyte-nurse cell border, and in the contractile ring formed at the 
anterior of the oocyte. F: Expression of PGM in the columnar cells, PGM is expressed in the 
cytoplasm and excluded from the nucleus. G: Expression of PGM in the dorsal-anterior follicle cells 
at stages 12-13. The dorsal appendages start to develop (arrow). The border cells still show strong 
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When the leg reaches its full extension, PGM is expressed in the neurons 
(microcheates) within the leg. Figures 4.5.3 D and E show expression of PGM in the 
microcheate neurons within the tibia and femur, respectively. 
Disruption in Myosin VI expression by induction of Myosin VI antisense driven by 
the Ga14 line C532 caused malformed legs to form (Deng et al., 1999). The 
malformation seems to be caused due to abnormal organization of the epithelial 
tissue in the evaginating disc. The expression of PGM in the leg disc during the 
larval and pupal stages is consistent with these results. 
In the evaginating wing disc, PGM is expressed in the cells of the epithelial sheets, 
prior to their evagination (Fig. 4.5.3 F). The induction of Myosin VI antisense by the 
C532 Ga14 line caused malformations in the wings of the adult fly (Deng et al., 
1999). In many cases the wings remain folded after hatching from the pupa, and were 
not able to form properly. This suggests that the expression of Myosin VI in the 
wings is necessary for spreading the wing as the fly hatches, however, the inability of 
the wings to spread could be due to an abnormal organization of the wing epithelium 
at the pupal stage. PGM is also seen in the basal side of the epithelial cells, at the 
connection area of the two epithelium sheets in the wings (Fig. 4.5.3 G). In another 
approach for understanding the specific role of Myosin VI in the imaginal discs, we 
crossed the fly line Am8-2 with an engrailed Ga14 line to generate a progeny with 
disrupted expression of Myosin VI only in the posterior compartment of the imaginal 
discs. In the pupa, the posterior of the wing lost its organized, folded form, forming 
blisters (Fig. 4.5.3 H). These results suggest that Myosin VI is necessary for 
patterning the organized, compact folded form of the wing as it appears in the pupae, 
and for keeping the epithelial sheets attached, during the wing morphogenesis. All 
these results suggest that Myosin VI plays a role in the migration and patterning of 
the epithelial sheet of the wing as it develops. 
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In the eye-antenna disc PGM expression appeared in the whole disc (Fig. 4.5.4 A). 
In later stages PGM is expressed in the eye ommatidia (Fig. 4.5.4 B, C) and in the 
evaginating antenna (Fig. 4.5.4 F, G). It is not clear what role Myosin VI plays in the 
development of the eye and the antenna. When the expression of Myosin VI is 
disrupted in en/A m8-2 flies, the hairs in the posterior part of the eye seem to be 
slightly thinner (Fig. 4.5.4 D). 
In the adult testes, PGM is expressed in the individualization complexes (Fig. 4.5.4 
G). Myosin VI has been shown previously to be necessary for the creation of the 
individualization complex during sperm individualization (Hicks et al., 1999; Rogat 
and Miller, 2002) this is also mentioned in the mutant rescue test, in the following 
section). In the mutation jar. mw4,  Myosin VI is not expressed in the testes, the 
individualization complex is not formed and as a result the male flies are sterile. 
Antibody staining showed the expression of Myosin VI in the individualization 
complex (Hicks et al., 1999; Rogat and Miller, 2002), and the expression of PGM, in 
the individualization complex is consistent with these results. PGM is located in the 
whole individualization complex, with a strong expression at the base of the cone 
where Myosin VI creates a ring around every maturating spermatid. Myosin VI 
showed a strong expression in cells within the accessory gland as well (Fig. 4.5.4 G). 
During oogenesis, PGM is expressed in all the follicle cells as they undergo 
migration (Fig. 4.5.5). During stage 7, PGM is expressed in the anterior follicle cells 
and in the border cells as they start their migration (Fig. 4.5.5 A). At stages 9-10 
PGM is expressed in the migrating columnar cells (Fig. 4.5.5 B,C). At stage lOb, 
PGM is expressed in the centripetal follicle cells as they migrate towards the 
anterior part of the oocyte (Fig. 4.5.5, D-F), and in the contractile ring connecting the 
centripetal cells (Fig. 4.5.5 E). In figure D the stronger expression of PGM in the 
centripetal cells compared with the columnar cells, indicates a specific expression in 
the follicle cells that undergo migration. At stages 12-13 PGM is expressed in the 
dorsal-anterior follicle cells as they create the dorsal appendages (Fig. 4.5.5 G-H). 
Figure H shows a specific strong expression of PGM in the region of the developing 
dorsal appendages. 
Because gene expression induced by Ga14 appears only in somatic cells (Gustafson 
and Bouliarme, 1996), PGM is not expressed in the germ line. Therefore in spite of 
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the presence of Myosin VI in the nurse cells (Bohrmann, 1997; Deng et al., 1999), 
PGM is not expressed as this technique does not permit analysis of the location of 
Myosin VI in the nurse cells. However, in the follicle cells, the expression is similar 
to this observed in egg chambers stained with Myosin VI antibody. The antibody 
staining of the columnar cells showed a uniform expression of Myosin VI while 
PGM expression showed various levels of expression in different groups of cells. It 
is possible that the expression of PGM shows a more realistic picture of the 
expression pattern of Myosin VI in the follicle cells than antibody staining, since 
PGM expression is triggered by a Myosin VI Ga14 line (C865), according the 
expression pattern Myosin VI. It is also possible that a different turnover of jaguar-
EGFP mRNA and PGM protein would cause different levels of expression in 
different cells. 
Expression of Myosin VI antisense RNA in the follicle cells disrupts Myosin VI 
expression, the follicle cells have an abnormal shape and the migration of the cells is 
arrested, causing a creation of an abnormal cell epithelium (Deng et al., 1999). The 
expression of PGM, driven by Myosin VI-Ga14, in the migrating follicle cells, gives 
a clear picture of the expression of Myosin VI in the follicle cells, which is needed 
for their migration, and for the creation of the organized follicle cell epithelium 
around the oocyte, and it maintains the shape of cells shape as they move. 
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4.6 	The rescue of Myosin VI mutants by the expression of 
PGM 
In order to use the fusion proteins in further experiments, it was necessary to verify 
that PGM functions in a similar way to the native Myosin VI, and that the tagging of 
GFP to the C terminus of Myosin VI did not interfere with its function. To test this 
possibility, I made two mutant rescue studies. The first study examined the ability of 
PGM to rescue the embryonic lethal phenotype observed in the homozygous 
mutants: janI?23, janI?39, jarR7O and jarR235. The second study examined the ability of 
PGM to rescue the male sterility phenotype of the mutants: jarR39/jarmlfh4,  and 
jarR235 /jarmm 4.  
4.6.1 	Study 1: examination of embryonic lethal phenotype 
rescue by PGM expression, in jar"', jarR39,  jar R70  and jarR235 
In the homozygous mutant flies jar R23,  jar R39,  JarR7O and jarR235 Myosin VI 
expression is disrupted (Millo et al., 2004, and chapter 5). Maternal Myosin VI is 
used for early embryogenesis, however the lack of new Myosin VI production in 
later stages (stage 12 onwards), in Myosin VI mutants causes failure in germ band 
retraction and dorsal closure. Many embryos died though some survived to the first 
larval instar using maternal Myosin VI. The purpose of this study was to examine 
whether or not the expression of PGM in the embryos would increase the survival 
rate of the homozygous mutant embryos, by increasing the number of larvae hatching 
from eggs. 
4.6.1.1 	Creation of fluorescent heterozygous mutants 
In order to express PGM in mutant embryos, heterozygous mutant flies (janI?23, 
janJ?39, jar"' or jarR235) were created, containing the jaguar-EGFP gene expressing 
PGM on the X chromosome, the e22C-Ga14 gene on the second chromosome, and 
the mutant gene jar R23, jan?39, janl?7O or jarR235 on the third chromosome, balanced 
with the chromosome TM3. e22C-Ga14 expresses the Ga14 protein ubiquitously 
during embryogenesis, and hence triggers the expression of PGM throughout the 
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embryo during the late stages of embryogenesis. The crosses undertaken using jarR23 
as an example, is described as follows: 
1. 	In the first cross, flies from lines expressing Ga14 ubiquitously in the embryo 
were crossed with PGM flies, to create embryos which are ubiquitously fluorescent. 
They were fluorescent in the brain region at the larval stage, and had straight wing 
due to the loss of the balancer of the second chromosome, SM5, in the cross. In all 
the stages a reciprocal cross was made. 
P[Wf(GAL4)r22L x 	UAS-PGM, ± 
SM5 	 + 	+ 
Curly colour eyed male/female, 	colour eyed male/female 
F]: 1GM; P1W (GAL4)11,2  
-4- 
Male/female larvae, fluorescent in the brain region, adults with straight wings. 
2. In the second cross, the fluorescent flies UAS-PGM; e22C were crossed with 
the balancer fly line TM3/ TM6. The selected progeny were fluorescent, and 
contained the balancer chromosome TM3 (Stubble phenotype), or TM6 (Tubby 
phenotype). 
UAS-PGM: P[W (GAL4)e I V J 2  X ±; ±, TM3, Sb, e 
+ 	 + 	+ TM6, The 
Fluorescent larvae male/female 	Stubble, Tubby and 
ebony adult male/female 
Fl: 
U4S-PGM: PfW(GAL4)7 22  : TM3. Sb. e 
-w 
Fluorescent (brain) larvae, Stubble adult male/female 
UAS-PGM; P[W (GAL4)f 22c 	+ 
- 	 TM6. Tb. e 
Fluorescent (brain) larvae, Tubby adult male/female 
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3. 	In the third cross the fluorescent flies UAS-PGM; e22C; TM3 and 
UAS-PGM; e22C; TM6 were crossed again with the fly line TM3/ TM6. The 
selected progeny were fluorescent, and contained the two balancer chromosomes 
TM3 and TM6, having the phenotype: Stubble, Tubby and ebony (a recessive 
phenotype that appears in the presence of the two balancer chromosomes). 
UAS-I'GM: P/ W'- (GAL4)1e ; TM3, Sb. e 	X ±, ±; TM3, Sb, e 
+ 	 + + + TM6, Tb, e 
Fluorescent larvae, 	 Stubble, Tubby and 
Stubble adult male/female 	 ebony male/female adult 
UAS-PGM; P[frl (GAL4)/e22 	+ 	X ±; ±J TM3. Sb, e+ 
+/y 	 + 	TM6.Th.e 4 	+ + TM6, Tb, e± 
Fluorescent larvae, 	 Stubble, Tubby and 
Tubby adult male/female 	 ebony adult male/female 
Fl: 
UAS-PGM; P1W ('GAL4)f 22 ; TM3, Sb. e 
+/y 	+ 	TM6. Th, e 
Fluorescent (brain) larvae, Tubby. Stubble, and ebony adult male! female 
4. In the fourth cross the selected flies were crossed with the heterozygous 
mutant jar823/  TM3. The progeny had four possible combinations of third 
chromosomes, as described in the diagram below. The homozygotes carrying 
the balancer chromosome TM3 are lethal therefore all the flies that are 
stubble will be heterozygous for the mutant jar' 23 (marked in box). Since the 
homozygous mutant flies had a Ga14 gene inserted on the third chromosome, 
an additional expression pattern of PGM appeared the salivary glands (and in 
132 
the ovaries and the testes in later stages). Therefore the selected larvae were 
fluorescent in the brain region and in the salivary glands. 
UAS-PGM P[W((AL4)r22 ; TM3. Sb. C X 
+/v 	+ 	 TM6. Tb, e 
Fluorescent larvae, 
Tubby, Stubble, and ebony 
adult male! female 
± ±; pfV (GA  L4)/fl21u3 
+ + 	TM3, Sb, e 
Stubble, mutant 
adult male/ female 
F]: UAS-PGM; P[W(GAL4)7e22(  P1W  (GAL4)1Ja1R23 
+/y 	+ 	 TM3, Sb, e 
selected: Fluorescent larvae (brain and/or s.gland), Stubble, but not Tubby adult male! female 
The cross combinations that appeared in the third chromosome were (in adults): 
TM3, Sb, e 
TM3, Sb, e 
Homozygous 
lethal 
TM3, Sb, e 
P[W (GAL4)] jarR23 
heterozygous 
mutant, Stubble 
TM6, Tb, e 	TM6, Tb, e 
TM3, Sb, e 
heterozygous 	Stubble 
mutant, Tubby Tubby 
ebony 
R23 	R39 . R70 After creating heterozygous flies, jar ,jar ,Jar and jar 35 that express PGM 
ubiquitously in the embryo, the fluorescent heterozygous flies (selected in the larval 
stage) were crossed with the non-fluorescent heterozygous flies. 
UAS-PGM; P[W*  (GAL4) J"--"' 
e22( P[W (GAL 4) 
/1W?2 	X ±; ± ; PflGAL4) jjarR23 
+ 	TM3, Sb e 	 y/+ + TM3, Sb e + 
In fluorescent heterozygous female, it was found that PGM was expressed in the 
follicle cells during oogenesis (data not shown). In order to test if maternal PGM 
affected embryonic survival , the survival rates of the embryos were examined when 
crossing fluorescent males and females separately. The fluorescent and non- 
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fluorescent embryos obtained from every cross were selected separately (100 eggs 
from each group) and the survival rates of embryos was calculated as the number of 
larvae hatching from the eggs during the following the following two days. 
This cross created fluorescent and non-fluorescent progeny; each group contained 
the same genotype composition of the third chromosome (for simplicity 
P[W (GAL4)] jarR23  was written as Jar I?23): 
jar R23 
















In the non-fluorescent flies, most of the homozygous mutant embryos die, and the 
TM3 homozygous embryos die as well. Since only the heterozygous embryos 
survive, at least 50% of all the eggs are expected to hatch (the percentage is 
approximate since some of the homozygous mutant embryos survive until first instar 
larvae). In the fluorescent flies, the survival rate of the heterozygous flies and the 
lethality of the homozygous TM3 flies should not be affected by the expression of 
PGM. However, if the PGM does function like a native Myosin VI, it would then 
rescue the embryonic lethal phenotype, and the number of fluorescent larvae 
hatching from the eggs would be significantly higher than with non-fluorescent 
embryos. Therefore the increase in the survival rate will be due to the rescue of the 
homozygous mutant group only. 
As a control the effect of PGM expression on the survival of non-homozygous 
mutant embryos was examined by setting the following cross (described for jar?23): 
UAS-PGM; P[W GAL4)f 22L P1W (GAL4)/' 	X - 	± ; TM6, Tb, e 
+ 	TM3, Sb e + TM3, Sb e 
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This cross created fluorescent and non-fluorescent flies; each group is expected to 
produce 75% viable embryos, heterozygous and non-mutant (for simplicity 
P[w(GAL4)]' 23 was written as jar R23): 
jar R23 jar R23 TM3,Sb e 
TM6, Tb, e TM3,Sb e TM6, Tb, e 
25% 25% 25% 
homozygous heterozygous non-mutant 
mutant mutant Stubble 





In the majority of the cases fluorescent and non-fluorescent embryos were clearly 
distinguishable; however, in the few cases where fluorescent larvae hatched from 
eggs considered to be non-fluorescent, the number of non-fluorescent eggs collected 
was multiplied with the correcting factor: 
No. of non-fluorescent eggs collected = 
No. of eggs collected X 
	
No. of non-fluorescent larvae 
(No. of fluorescent larvae + No. of non-fluorescent 
larvae) 
The percentage of larvae hatched from the eggs was calculated as follows: 
% of larvae hatched = No. of larvae hatched X 100 
No. of eggs collected 
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4.6.1.2 	The different groups in the experiment: 
For every mutant, there were four test groups and four control groups according to 
the following table (the mutant selected as an example is R23, for simplicity 
P[W (GAL4)] jaR23  was written as jar R23): 
Table 4.6.1.2: the crosses for mutant rescue test I 
Test groups 
ja 23/ TM3 d X 
U4S-PGM; e22G;ja 23/ TM3 Y 
UAS-PGM; 	e22C; ja 23/ TM3d 	X 
ja 23/ TAB 
test group I fluorescent progeny test group 3 fluorescent progeny 
test group 2 non- fluorescent progeny test group 4 non- fluorescent progeny 
Control groups 
TM3/ TM6 6 X UAS-PGM; e22C;ja 23/ TM3c' X 
U-1S-PGM; e22C;jar'23/ TM3 Y TM3/ TM6 ? 
control group A fluorescent progeny control group C fluorescent progeny 
control group B non- fluorescent control group D non- fluorescent 
progeny progeny 
The survival rates of test groups 1 and 2 were compared with the rates in the control 
groups A and B. The survival rates of test groups 3 and 4 were compared with the 
rates in control groups C and D. 
4.6.1.3 	Chi square test: 
If there is no rescue of the mutants by the fusion protein, it would be expected that 
similar survival rates would appear in the fluorescent and the non-fluorescent test 
groups, and that the difference in the survival rates between fluorescent and non 
fluorescent groups would be similar to that of the control group. For example, if in 
the control group A 57% of the larvae hatched, and in group B 50% of the larvae 
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hatched, the survival rate in group A is higher by 7% from group B. In this case, the 
null assumption (Ho) will be that in the test group the survival rate of group 1 will be 
higher by not more than 7% than group 2. H0 will be rejected if the difference 
between survival rate of groups 1 and 2 is significantly higher compared to the 
difference in the control groups A and B. H0 was rejected when the p values were 
lower than 0.05 (5%). 
4.6.1.4 	Results 
The survival rate of the fluorescent and non-fluorescent flies in the test and the 
control groups is described for the four mutants in the following chart: 
70.00 
Larvae hatched from eggs (%) 
* 
. 	60.00 
C U 1 fluorescent 
o * 
50.00 1 non-fluorescent 
0) 
(A




d 2 non-fluorescent 
30.00 	- 
3 fluorescent G) 
.. 
20.00 : 3 non-fluorescent 
W E3 4 fluorescent woo 
 - .. .. : 4 non-fluorescent 
9.00 
o 
Test 	Control 	Test 	Control 	Test 	Control 	Test 	Control 
jar' 23 	jar' 39 	jar' 70 	jarR235  
Figure 4.6.1.4: The survival rate of fluorescent and non-fluorescent embryos in the test and the 
control group, as made for the mutants: jar R21,  jar"', jar"' and jari?2S5.  Crosses I and 2 were made in 
the test group and crosses 3 and 4 were made in the control group. Crosses 1 and 3 (the first two 
columns) were made with heterozygous female expressing PGM protein (fluorescent) and non-
fluorescent male. Crosses 2 and 4 were created with fluorescent heterozygous male and non-
fluorescent female. The difference between the survival of fluorescent and non-fluorescent embryos 
was compared between groups 1 and 3, and between groups 2 and 4 and examined statistically with 
chi-square test. The asterisks indicates significant increase in the survival rate of fluorescent embryos 
(p<O.005). 
137 
For an unknown reason, fluorescent embryos had a higher survival rate than the non-
fluorescent embryos in both the control and the test groups. However, the difference 
between the survival of fluorescent and non-fluorescent embryos (larvae) in the test 
group was significantly higher, compared to the control group, for the three mutants: 
jar"', jar"' and JanJ?235.  When a cross was set with female fluorescent heterozygous 
flies (groupi), the embryos survival rate was slightly higher than in the reciprocal 
cross, suggesting that maternal GFP protein could contribute to the survival of the 
embryos. The survival rate of all the embryos was lower than the expected. This 
could be related to the decrease in viability due to the manual collection of the 
embryos and extensive handing to check fluorescence. The survival rate of OrR flies 
collected was 74% (data not shown), indicating that at least 25% of the flies die due 
experimental procedures. 
In jar 235 the increase in the survival rate of the fluorescent flies in cross 1 at the test 
group was not significantly higher than in control group 3. This could be related to 
the increase in the survival rate of fluorescent embryos in control group, 3. 
In the mutant jar R23  the expression of PGM in the test groups did not increase 
significantly the survival rate of the fluorescent embryos. A Western blot analysis 
that was made for all the four mutants, at late stages of embryogenesis showed that 
the homozygous mutant embryos jarR23/JarR23  and jarR7O/JanI?70  had reduced level of 
Myosin VI compared to wild-type embryos, while in the embryos Jar?39/JanI?39  and 
JarI?235/JanJ?235, no Myosin VI was detected (Millo et al., 2004). In addition, the 
survival rate of the janJ?23  non fluorescent mutants was higher than the one in the rest 
of the mutants. It seems that the reduced level of Myosin VI in jar 23 homozygous 
mutant embryos is sufficient for them to survive, and the expression of PGM does 
not make a significant contribution their survival, while in the mutants lacking 
Myosin VI, (jar R39  and jar 235) the expression of PGM is vital for their survival. 
InJanI?70, the increase in the survival rate changed significantly only in test cross 1. It 
is possible that the maternal contribution of PGM helped the survival of the mutant 
embryos in this cross. 
Taken together, these results show that the expression of PGM rescues the embryonic 
lethal phenotype in at least one of the test groups ofjanl?39,janl?70  and  janR23S  mutants. 
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4.62 Study 2: PGM rescues male sterility phenotype in the 
	
heteroallelic mutants: 	 , and jar235/jarF7m4 
Myosin VI is necessary during sperm individualization for the creation of the 
individualization complex. In the mutant jarmm4, Myosin VI is not expressed in the 
testes, as a result, the individualization complexes are not created properly and the 
male flies are sterile (Hicks et al., 1999). The homozygous mutants: JanJ?39  and jar?235 
are embryonic lethal, however, when crossed with jar'"'" 4 , these heteroallelic lines 
survive until adulthood. Because the mutations in the three mutants are located in the 
same region of the Myosin VI molecule, jar R39  and jar R235  cannot complement the 







m,nw  males are sterile (Millo et al., 2004), and chapter 5). Previous 
experiment showed that the expression of Myosin VI cDNA restores the fertility 
phenotype of jarmflm14  homozygous males (Hicks et al., 1999). In this experiment I 
tested whether the expression of PGM could also rescue the sterility phenotype of the 
heteroallelic mutants. 
The rescue of the embryonic lethal phenotype described in the previous section 
proved statistically that PGM rescues the embryonic lethal phenotype. In this test, 
because none of the heteroallelic flies are fertile, if PGM restores fertility, it will 
show clearly that PGM functions as a native Myosin VI. 
The creation of heteroallelic flies, which will express PGM in the testes, is described 
as follows (described for jar 39): 
Fluorescent heterozygous female flies jar?39  and jar R235 (created in the previous test, 
in the last cross), were crossed with the male heterozygous mutant: jarmmw4.  As 
mentioned previously, jar R39  and jar R235  have a Ga14 gene expressed in the testes 
individualization complex. All the mutants are balanced over the TM3 chromosome, 
having the dominant phenotype Stubble. 
± 	_________ 	X 	U4S-PGM.; P1W (GL4)7'" 
y TM3, Sb, e + 	TM3, Sb, e* 
Heterozygous mutant 	Heterozygous mutant 
White - eyed, 	 fluorescent in testes 
Stubble, adult male 	 Stubble, adult female 
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In the progeny, male and female flies were created, having four different 
combinations in the third chromosome from this cross (for simplicity P[W(GAL4)] 
jarR39 was written as Jar k39): 
jar 
R39 /armmu14 jar 
R39 TM3, Sb 
jarm4 TM3, Sb, e 4 TM3, Sb, e e 
heteroallelic heterozygous heterozygous homozygous 
mutant mutant mutant lethal 
non-Stubble Stubble Stubble 
adult adult adult 
The heteroallelic mutant differs from the heterozygous mutants by having non- 
Stubble bristles in the adult fly. 
Therefore two groups of heteroallelic male were selected: 




Adult male, non-stubble, fluorescent in testes 
2. 	±;; P[V(GAL4)]' 39  
tnmw /4 
Y 	jar 
Adult male, non-stubble, non-fluorescent 
The fluorescent and non-fluorescent heteroallelic males were tested for fertility by 
crossing them with OrR virgin females. The following table summaries the No. of 
crosses made with each heteroallelic fly and the Number of fertile males in every 
group (for simplicity P[ (GAL4)]" 39235 was written as jar R39/?3S). 
Table 46.2: results of mutant rescue test 2 






No. of crosses 11 1 20 14 
Fertile 9 0 18 0 
Sterile 2 1 	1 2 1 	
14 
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The non-fluorescent heteroallelic male were sterile as expected, while the majority of 
the fluorescent males were fertile: 9 males out of 11 were fertile in jarR39 Ijar ,nmwl4 
mutants, and 18 out of 20 males were fertile in jarI?235/jarmI4.  These results show 
that the expression of PGM in the heteroallelic flies rescued their male sterility 
phenotype. 
When the testes of heterozygous male jari?39/TM3  were stained with Myosin VI 
antibody and phalloidin, the expression of Myosin VI in the individualization 
complexes was obvious (Fig. 4.6.2.1 A-C); however Myosin VI or phalloidin were 
not detected in antibody stain in the heteroallelic mutant males (Fig. 4.6.2.1 D-I). 
Myosin VI is necessary for the proper formation of the individualization complex 
(Fig. 1.3.I13 in Introduction). Previous studies showed that in the mutant 
the actin filaments are present, however the actin cone is not organized properly 
(Hicks et al., 1999). A very weak stain of the actin filaments appeared also in the 
individualization complexes of the double mutant Myosin VI-Dynamin (shi 1 /Y; 
jar'/jar) (Rogat and Miller, 2002). Perhaps the stability of the actin filaments is 
dramatically reduced when the two jar alleles are present. 
In the fluorescent heteroallelic flies, PGM was expressed in the individualization 
complex (Fig. 4.6.2.2). The localization of PGM in the individualization complex of 
heteroallelic flies was similar to that of PGM and native Myosin VI, in the 
individualization complex of the fertile heterozygous flies jar?39/TM3  (Fig. 4.6.2.3): 
PGM appeared in the all the individualization complexes, concentrated mainly at the 
base of the cone. In addition, the actin filaments appeared in the individualization 
cones of the heteroallelic flies, although their staining was weaker than the one in 
jar?39/TM3. We conclude that the expression of PGM in the testes of the heteroallelic 
flies allowed the creation of the individualization complexes in their proper form, the 
maturation of the spermatides and the recovery of the sterility in the heteroallelic 
males. These results show that PGM functions like the native Myosin VI, therefore 
the tagging of Myosin VI in its C terminus with GFP does not disturb its function. 
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In figures 4.6.2.1-4.6.2.3, P[W(GAL4)] jorR39  and P[W(GAL4)] ja235  are written 
asja 39 and jar"'  for simplicity. 
Figure 4.6.2.1: The expression of Myosin VI and actin in the individualization complexes of the 
testes. In the heterozygous males jar R31 /TM3, Myosin VI and actin co-localise in the individualization 
complexes (IC, arrows in A-C), however no expression of Myosin VI nor actin are observed in the 
heteroallelic flies jar'3' /jarmm%4  (D-F,) and jar 235/jar1P1wZ 4  (G-I). 
Figure 4.6.2.2: PGM expression in the individualization complexes of the fluorescent heteroallelic 
males 	 R235 and UASPGM;,jarR39/ja,1?7m?4(DF). 
Figure 4.6.2.3: A similar pattern of antibody stained Myosin VI (A-C) and PGM (D-F) was observed 
in the fertile heterozygous male: jarl?39/TM3.  Myosin VI and PGM are expressed mainly at the base of 
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47 Comparison of PGM, PGMH and PGMT expression 
patterns 
The expression of the head, the tail and the whole Myosin VI, tagged to GFP was 
made in order to have a better understanding of how Myosin VI and its domains 
function in different tissues during development. After expressing the three proteins, 
tissues that showed obvious differences in the expression pattern of the three 
constructs were examined further. By comparing the location of the separate domains 
with the location of the whole myosin it became possible to conclude about the 
location of the region in which the tail domain binds to the cargo, the region where 
the head domain binds to the actin filaments, and which domain determines the final 
localization of Myosin VI within the cells. This can also give us a clue to how 
Myosin VI functions in the cells. 
4.7.1 The location of the PGM, PGMH and PGMT in the salivary 
glands. 
One of the epithelial tissues that showed the most striking differences in the 
expression pattern of the head, the tail, and the whole Myosin VI, was the salivary 
gland. This tissue had the highest expression intensity of Myosin VI, and since it 
contains big cells, it was relatively easy to observe the differences between 
constructs. 
The whole Myosin VI is present in the cytoplasm and in the cell membrane (Fig. 
4.7.1.1 A-C). PGM was excluded from the cell nucleus. In contrast, the head domain 
was present in the nucleus, but excluded from the nucleolus. PGMR has also a strong 
expression in the cell membrane (Fig. 4.7.1.1 D-F). The tail domain had a similar 
localization in the cell to the whole Myosin VI, although its expression was weaker: 
it was found in the cytoplasm and the cell membrane, but not in the nucleus (Fig. 
4.7.1.2 A-C). 
Because the head domain contains the motor domain that moves along actin 
filaments, PGMH is expected to co-localize with actin filaments. Therefore the 
salivary gland expressing PGM, PGM and PGMT were stained with phalloidin. 
Surprisingly, in the early stages of the third larval instar, the actin filaments showed 
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a complete co-localization with the expression pattern of the three different proteins, 
and the expression intensity of actin was proportional to the expression intensity of 
the fusion proteins: in salivary glands expressing the whole Myosin VI (PGM), the 
actin filaments were present mainly in the cell membrane and at lower levels in the 
cytoplasm, but excluded from the nucleus. When the head domain was expressed, a 
strong expression of the actin filaments appeared in the cell membrane and the cell 
nucleus surrounding the nucleolus (Fig. 4.7.1.1 D-F). At a later stage, the actin 
filaments surrounded the nucleus, which still contained the PGMH protein (Fig. 
4.7.1.1G-I). When the tail domain was expressed, a net of actin and tail domain was 
created in the cytoplasm, surrounding the nucleus (Fig. 4.7.1.2 D-F, arrows). The 
actin filaments also had a strong expression at the cell membrane, where the tail 
domain was also present. These results were surprising. Not only that the head 
domain was localised in the cell nucleus, but that the actin filaments organization 
was also affected and followed the localization of the head domain. 
When the entire Myosin VI is expressed on its own, the filaments are not created 
within the nucleus. This fact may indicate that the head domain plays a part in the 
creation of the actin filaments. Similarly, the ring created around the nucleus when 
PGMT was expressed, was absent when the whole Myosin VI was expressed (PGM), 
suggesting that in the salivary gland cells, Myosin VI plays a role in directing actin 
filament polarization. 
Figure 4.7.1.1: The expression of the whole myosin (PGM) and the head domain (PGMH) in the 
salivary gland cells during third instar larvae. PGM has a strong expression in the cell membrane and 
a weaker expression in the cell cytoplasm (A, Q. PGM also is located at the periphery of the. nucleus. 
The actin filaments co-localised with PGM in the cell membrane and the cytoplasm, although at the 
ring of PGM surrounding the nucleus, the co-localization is weaker (B, Q. In the early third larval 
instar, the head domain, expressed by PGMH, is localized within the cell nucleus, but not in the 
nucleolus, and the actin filaments are also located in the nucleus, and co-localise with PGMH in the 
entire cell (D-F, arrowhead). In later stages, prior to pupariation, actin filaments surround the nucleus 
while the head domain remains in it (G-I). 
Figure 4.7.1.2: The expression of the tail domain (PGMT) in the salivary gland cells during the third 
larval instar. Like PGM, PGMT has a strong expression in the cell membrane and a weaker expression 
in the cytoplasm, with no expression in the nucleus (A, C, arrows). The actin filaments co-localise 
with PGMT at the cell membrane (B). In the cytoplasm there is an area circling the nucleolus, where 
PGMT is localised at higher concentration (D-F, arrows), and the actin filaments co-localise with 
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PGMH is bigger than PGMT (130kd compared to 75kd approximately), therefore if 
PGMH could enter the nucleus through diffusion, HGMT would also be able to enter 
the nucleus. This suggests that the entry of PGMH into the nucleus is directed by the 
movement of the head domain to the minus end, of the actin filaments, which face 
towards the inner part of the cells (see discussion). Perhaps the tail domain interacts 
with other proteins and the whole protein complex anchors the tail away from the 
nucleus. 
The different locations of the head domain and the tail domain in the cytoplasm can 
represent two different forces that are applied to the Myosin VI molecule in the 
salivary gland cells: the head domain pulls the molecule to the cell nucleus and the 
tail domain is concentrated in the cytoplasm mainly in a sphere surrounding the 
nucleus but slightly distant to it. The whole Myosin VI has a uniform expression in 
the cytoplasm, without clustering like the tail domain. This could suggest that the 
location of Myosin VI in the cytoplasm is dynamic and in equilibrium between the 
two different forces applied. 
It is not clear why the clustering of PGMT around the nucleus is created. It is 
possible that this is the region where the cargo is located. In the cell cortex, the 
whole Myosin VI and its separate domains were localised, the head domain attached 
to the cortical actin, and the tail domain to the cargo. The similar localization of the 
different domains shows that in this region there are no forces that attract the 
domains in separate directions. Perhaps this is the last destination of the cargo 
molecules. Alternatively, Myosin VI could be playing a different role in this region, 
keeping the cargo attached to the cell membrane rather than dragging the cargo 
through the cell. 
The exclusion of PGM and PGMT from the nucleus suggests that the tail domain is 
the part that anchors the whole myosin away from the nucleus. This phenomenon is 
also observed in other tissues such as: in the follicle cell epithelium and the 
embryonic epidermis. 
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4.7.2 The location of PGM, PGMH and PGMT in the follicle cells 
during oogenesis. 
During oogenesis, the whole Myosin VI and the tail domain are expressed in the cell 
membrane and the cytoplasm, but not in the nucleus (Fig. 4.5.5, F., 4.7.2.1). In the 
columnar and centripetal follicle cells, PGMH is strongly expressed in the cell 
nucleus. In order to test whether or not the different localization of the head, the tail 
and the whole Myosin VI affect the organization of actin filaments within cells, 
ovaries expressing the three different fusion proteins were stained with phalloidin 
(Fig. 4.7.2.1 F-H). In columnar cells expressing PGM (F), PGMT (G), or PGMH (H) 
the actin filaments appeared at the cell membranes, without any significant change in 
their organization, suggesting that unlike the salivary gland cells, the expression of 
the head and the tail domain did not affect the normal organization of the actin 
filaments. Possibly the changes in actin organization are more difficult to observe in 
the follicle cells, which are much smaller. 
Figure 4.7.2.1: A-C: The expression of the head domain (PGMH) in the columnar and centripetal 
follicle cells. The head domain is strongly expressed in the nucleus, but not in the nucleolus (arrow), 
and a weaker expression is seen in the cell membrane and the cytoplasm. In the centripetal cells at the 
anterior of the oocyte, the strong expression of PGMH in the nucleus is not obvious, possibly due to 
the strong expression of PGMH over the entire cell. D-E: The tail domain (PGMT) is localised in the 
cell membrane and the cell cytoplasm and excluded from the nucleus. PGMT had weaker expression 
than PGMH and PGM, and the protein appeared in punctate form. In figures A-E PGMH and PGMT 
were crossed with the Ga14 line T155 that had a stronger expression in the follicle cells. Figures F-H, 
show columnar follicle cells of ovaries expressing PGM (F), PGMT (G) and PGMH (H), stained with 
phalloidin to view the actin cytoskeleton. The whole Myosin VI (F) and the tail domain (G) show a 
similar pattern of expression in the cell cytoplasm and the cell membrane, while the head domain (H) 
has a strong expression in the nucleus. The different pattern of expression did not significantly change 
the organization of the actin filaments: the actin filaments appeared in the cell membrane, and the 
expression of the head domain did not trigger actin polymerisation in the nucleus. The head domain 
had the strongest co-localization with actin filaments (H) 
Figure 4.7.2.2: The expression of PGM, PGMH and PGMT at the leading edge of the border cells. 
Figure A shows the border cells with a strong expression of PGM at the leading edge, as they arrive at 
the nurse-cell-oocyte border. Figures B, E, and H show the expression of the whole Myosin VI 
(PGM), the head domain (PGMH), and the tail domain (PGMT), respectively. Figures C, F and I 
show the location of the actin filaments in the respective cells and the overlay images are shown in D, 
G and J. B-D: When the whole Myosin VI is expressed, it has a strong expression in the leading edge 
and some expression in the cell cytoplasm. F-G: The head domain shows a weaker expression in the 
leading edge and more expression in the cell cytoplasm. H-J: At some levels of focus the tail domain 
has a strong expression in the leading edge only. The actin filaments co-localise with the leading edge 
of all the proteins, but the tail domain and the whole Myosin VI were more concentrated in the region 
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Expression of PGM/H/T in Collumnar follicle cells 
PGM 22-3 X C865 	PGMT 33-2 X C865 PGMH 181-3XC865 

PGMT had a weaker expression and appeared in a punctate form. This pattern also 
appeared in other tissues. Initially it seems that PGMT forms random aggregates, but 
as discussed in section 4.8, the tail domain co-localised with cargo molecules that 
genetically interact with Myosin VI within the cell. 
As the border cells migrate, the expression pattern of PGM, PGMH and PGMT 
within the cells was similar: the proteins were localised in the cell cytoplasm. 
Antibody staining and PGM expression showed that when the border cells arrive at 
the nurse cell-oocyte border, a stronger expression of Myosin VI is observed at the 
leading edge, and the protein at the leading edge co-localises with the actin filaments 
at the border. Figure 4.7.2.2 shows border cells arriving to the nurse cell-oocyte 
border. The three proteins were expressed in the cell cytoplasm; however PGM and 
PGMT had a stronger expression at the leading edge. 
The photographs presented are taken from sections showing the strong expression of 
the proteins at the leading edge, and are compared with the localization of the actin 
filaments. PGM has a strong expression at the leading edge and it co-localises with 
the actin filaments (Fig. 4.7.2.2 A-D). PGMH is spread throughout the cell 
cytoplasm, but also shows expression at the leading edge (Fig. 4.7.2.2 E-G). In 
contrast, the tail domain (PGMT) is localized in an organized area at the leading 
edge, which co-localises with the actin filaments (Fig. 4.7.2.2 H-J). 
Myosin VI is necessary for the migration of the border cells: disruption in its 
expression significantly inhibits cell migration (Geisbrecht and Montell, 2002). 
However, the strong expression of Myosin VI at the leading edge of the border cells 
appeared mostly as the migration was ending. This suggests that the strong 
expression of Myosin VI in the leading edge may be connected the borders cells 
ceasing migration. 
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The expression of the tail domain at the leading edge, where the actin filaments are 
localised, is probably the region where Myosin VI binds to its cargo. It seems that 
when the border cells migrate, Myosin VI is spread though the cell cytoplasm, and as 
the migration stops, Myosin VI is blocked by attachment of the tail domain at the 
leading edge to a specific cargo at the nurse cell-oocyte border. DE-cadherin and 
Armadillo are necessary for the migration of the border cells, but not for the 
recruitment of the cells to the nurse cell-oocyte border (mutations in the genes 
encoding these proteins have reduced border-cell migration, but not invasion into the 
oocyte (Montell, 2003). Perhaps there are other proteins that anchor of the border 
cells to the oocyte-nurse cell border, and these affect the concentration of Myosin VI 
at the leading edge. 
4.7.3 The location PGM, PGMH and PGMT in the epidermal cells at 
the leading edge during dorsal closure 
During embryogenesis Myosin VI is expressed and necessary for the process of 
dorsal closure (Kellerman and Miller, 1992; Millo et al., 2004) and see chapter 5). 
Throughout dorsal closure, PGM expression shows that the whole Myosin VI is 
located in the cells at the leading edge and in the anmioserosa (Fig. 4.5.1A and 
4.7.3A). Within the cells at the leading edge, PGM is localised in the cytoplasm and 
the cell membrane and excluded from the nucleus (4.7.3 A see magnification). 
PGMH shows a strong expression of the head domain in the cell membrane and co-
localization with the actin filaments (Fig. 4.7.3 B-C, see magnifications). 
Figure 4.7.3: The pattern expression of the head, the tail and the whole Myosin VI in the embryos, 
during dorsal closure. All the embryos were stained with phalloidin to visualize the actin filaments. A: 
In the leading edge cells, the whole Myosin VI (PGM) is expressed in the cell cytoplasm and the cell 
membrane and excluded from the nucleus. B-C: The head domain is strongly expressed in the cell 
membrane of the epidermal cells, where it co-localise with the actin filaments (see magnifications). 
The expression of PGMH in the cell is observed in the cytoplasm and the nucleus, although it does not 
seem to be concentrated in the nucleus. The tail domain (D, PGMT) localizes to the cell membrane 






The head domain is also located in the cytoplasm, but it is not excluded from the 
nucleus. PGMT was localised in the leading edge cells, in the membrane and 
cytoplasm and excluded from the nucleus. When looking at the apical surface of the 
cells, PGMT has a strong expression at the cell surface, mainly in the area closer to 
the leading edge. Thus we assume that the cargo of Myosin VI is located in high 
concentration at the apical surface of the cells. Antibody staining of Myosin VI 
showed a strong expression of Myosin VI at the apical surface of the cells at the 
leading edge, suggesting a possible role in maintaining the rigidity of the cells as 
they move and cover the amnioserosa. Because PGMT is expressed in cells that also 
have normal Myosin VI, PGMT can bind to the cargo as the cargo migrates or at its 
final destination. If Myosin VI is necessary for the localisation of its cargo to a 
specific place, it could be assumed that if would have a strong expression at its final 
destination, therefore, the strong expression of Myosin VI and PGMT at the apical 
surface of the cells could indicate that this it the one of the destinations to which 
Myosin VI brings its cargo. 
In the amnioserosa PGM and PGMH had a similar expression pattern although the 
exclusion from the nucleus was slightly stronger in PGM (Fig. 4.7.3 A and Q. 
PGMT had a very weak expression in the amnioserosa (Fig. 4.7.3 D). 
As in other tissues, PGM and PGMT are excluded from the cell nucleus. This 
indicates that it is the tail domain that anchors Myosin VI away from the nucleus. 
The expression of PGMH is not localisaed at the cell nucleus but rather at the cell 
membrane. When Myosin VI function is disrupted, the cells at the leading edge and 
the amnioserosa start to detach. This suggests that the direction of Myosin VI to the 
cell surface by the head domain could be necessary for the role of Myosin VI in cell-
cell adhesion. 
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4.7.4 The location of the head, the tail and the whole Myosin VI in 
the individualization complex of the testes. 
During sperm individualization, Myosin VI is expressed in the individualization 
complex and is necessary for the building of an individual membrane every created 
spermatid (Hicks et al., 1999; Rogat and Miller, 2002). In order to compare the 
localization of the head, the tail and the whole Myosin VI in the individualization 
complex, I have compared their expression to that of Dynamin. Dynamin functions 
along with Myosin VI in the regulation of actin dynamics in the individualization 
complex. Dynamin is localised along the length of actin cones, and a double staining 
of Myosin VI and Dynamin showed localization of Myosin VI at the front of the 
Dynamin-stained cones (Rogat and Miller, 2002). The Dynamin - stained cone allow 
us to compare the localization of the head and the tail domain. When PGM was 
expressed (Fig. 4.7.4 A-C), it was localised at the front of the Dynamin-stained cone, 
and several pictures showed that there is also some expression of PGM along the 
actin cone (Fig. 4.5.4. G), like the native Myosin VI. The head domain (PGMH) was 
localised along the Dynamin-stained cone, and in front of the cone. This suggests 
that the head domain is attached to actin filaments along the cone (Fig. 4.7.4 D-F). 
The tail domain was localised at the front part of the cone, some of it localised at the 
base of the cone and some localised on the cone itself (Fig. 4.7.4 G-I). Taken 
together it seems that the tail domain, attached to its cargo, anchors the whole 
Myosin VI to the base of the cone, while the head domain is attached to the actin 
filaments and pulls the whole molecule towards the base of the cone, where Myosin 
VI would interact with the actin polymerisation regulatory proteins: Arp2/3 and 
Cortactin (Rogat and Miller, 2002). 
Figure 4.7.4: The expression of Myosin VI, the head and the tail domain in the individualization 
complexes during spermatogenesis. Testes expressing PGM (A-C), PGMH (D-F) and PGMT (G-I) 
were stained with Dynamin, which is located along the actin cone, in order to compare the localization 
of each protein. A-C: The whole Myosin VI is localised at the base of the cone. D-F: The head 
domain is localised along the actin cone. G-I: The tail domain is localised mainly at the base of the 
actin cone, with some expression along the lower part of the cone. 
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Myosin VI was found to co-localise with Capping Protein, at the base of the cone 
(Rogat and Miller, 2002). Capping Protein is localised at the growing plus, barbed-
end of the actin filaments, where it regulates actin polymerisation. Therefore the plus 
end of the actin filaments is located at the base of the cone. It was surprising to find 
that Myosin VI was located at the barbed end and not at the pointed end. However, 
the anchoring of the tail domain to the base of the cone as it is observed here can 
explain the orientation of Myosin VI at the base of the actin cone, at the barbed end 
of the actin filaments. 
4.8 The tail domain co-localizes with proteins interacting 
with Myosin VI during oo genesis. 
When looking at the expression of the tail domain (PGMT) in the egg chambers and 
in other tissues it is punctate, suggesting the presence of aggregates in the cell 
cytoplasm. The specific localization of the tail domain in the testes and the epithelial 
cells suggest that the tail in PGMT functions in a similar way to the regular tail 
domain. Why does the tail domain form aggregates in the cell cytoplasm? It seems 
possible that the aggregates of PGMT were created by vesicles and particles 
containing the cargo. Since the head domain which pulls Myosin VI to the actin 
filaments was missing, the tail domain could gather freely around the cargo and 
create aggregates around it. 
To test this assumption we stained egg chambers expressing PGMT with antibodies 
for proteins that genetically interact with Myosin VI, as described in chapter 6. 
All the proteins that were located in vesicles within the cytoplasm, had few vesicles 
that co-localised with PGMT aggregates: In the columnar cells, Ankyrin vesicles at 
the basal side co-localise with PGMT (Fig. 4.8.1 A-F, see arrows), while Armadillo 
vesicles co-localise at the apical side of the columnar cells (Fig. 4.8.1 G-L, arrows). 
PGMT protein seems to be associated with Bazooka vesicles, at the basal side of the 
columnar cells (Fig. 4.8.2 A-G, arrows). Unlike the results observed here, an 
antibody staining that was previously made in egg chambers revealed a strong 
expression of Bazooka in the apical side of the follicle cells, however the stain was 
made to egg chambers at early stages (6-8) and it could be that the staining pattern 
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changes during oogenesis. PS2a-integrin showed co-localization with PGMT all 
over the columnar cells (Fig. 4.8.2. H-J, arrows). Myosin VI genetically interacts 
with PS3-integrin, and with Discs large (Dig). PS3-integrin is weakly expressed in 
vesicles (Fig. 4.8.3 B) and Dlg is not expressed in vesicles at all (Fig. 4.8.3 E), 
therefore we did not expect to see co-localization of PGMT aggregates with vesicles 
containing those proteins (Fig. 4.8.3 A-F). 
a-spectrin, which does not interact with Myosin VI, did not show a co-localization 
with PGMT aggregates (Fig. 4.8.3 H-J). These results support the assumption that 
the clustering of PGMT in the cell cytoplasm is not a random aggregation but an 
assembly with vesicles containing proteins that seem to interact with Myosin VI. The 
co-localization of the tail domain with vesicles containing Ankyrin, Armadillo, 
Bazooka and PS2a-integrin could suggest that Myosin VI physically interacts with 
these proteins. It must be stressed that direct physical interactions should be tested in 
vivo. In order to verify that the tail domain does not accelerate creation of vesicles in 
the follicle cells, the existence of vesicles expressing Ankyrin, Armadillo, Bazooka 
and PS2a-integrin was tested in OrR egg chambers (Fig. 4.8.4). 
Figure 4.8.1: Antibody staining of Ankyrin and Armadillo in columnar follicle cells expressing the 
tail domain (PGMT).(A-F) Images of PGMT (A, D) Ankyrin (B, E) and their co-localization (C, F). 
(G-L) Images of PGMT (G, J), Armadillo (H, K) and their co-localization (I, L). Arrows indicate co-
localizing vesicles. 
Figure 4.8.2: Antibody staining of Bazooka and PS2a-integrin in columnar follicle cells expressing 
the tail domain (PGMT). (A-G) Images of PGMT (A, D) Bazooka (B, E) and their co-localization (C, 
F, and G). (H-J) Images of PGMT (H), PS2a-integrin (I) and their co-localization (J). Arrows 
indicate co-localizing vesicles. 
Figure 4.8.3: Antibody staining of PS3-integrin, Dlg and a-spectrin in columnar follicle cells 
expressing the tail domain (PGMT). (A-C) Images of PGMT (A) PSf3-integrin (B) and their co-
localization (C). The tail domain weakly co-localizes with PS-integrin, probably due to the low 
number of vesicles containing this protein (D-F) Images of PGMT (D), Dlg (E) and their co-
localization (F). Dlg does not seem to have vesicles, therefore no co-localization is observed with 
PGMT aggregates. (C-I) Images of PGMT (G), cc-spectrin (H) and their co-localization (F). a-
spectrin does not interact with Myosin VI, and no vesicles were found to co-localization with PGMT. 
Arrows indicate co-localizing vesicles. 
Figure 4.8.4: Antibody staining of Ankyrin (A-B), PS2a-integrin (C-D), Armadillo (C-H), and 
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All these proteins appeared in vesicles at a similar concentration in follicle cells of 
wild-type egg chambers, therefore the expression of the tail domain does not 
accelerate the creation of vesicles bearing these proteins. 
4.9 Conclusions 
This chapter describes the expression of Myosin VI and its domains, tagged to GFP. 
In the first stage the DNA constructs expressing the fusion proteins were created, 
followed by the creation of the transgenic flies. The expression of Myosin VI-GFP 
(PGM), driven by Myosin VI-Gal4 allowed us to detect all the epithelial tissues 
expressing Myosin VI during Drosophila development. PGM expression rescued the 
homozygous lethality of the mutants: jarI?39,jarJ?70  and jar?235,  and the male sterility 
phenotype of the heteroallelic mutants: jar1'?39/jarm4,  and jar?235/jaru14.  This 
proved that PGM functions in a similar way to the native Myosin VI. Finally, the 
molecular function of the whole Myosin VI was examined by testing the localization 
of the head, the tail and the whole Myosin VI in the salivary gland excitatory cells, in 
the columnar follicle cells, in the leading edge during dorsal closure and in the 
individualization complexes during spermatogenesis. In all epithelial tissues, PGM, 
PGMH and PGMT were concentrated at the cell membrane. PGM and PGMT were 
concentrated in the cell cytoplasm and excluded from the nucleus. PGMH was not 
excluded from the nucleus, and in the columnar follicle cells and the salivary gland 
cells PGMH was concentrated in the nucleus. In the salivary gland cells, the 
concentration of PGMH in the nucleus triggered actin polymerisation in the nucleus. 
Finally, in the individualization complex of the testes, the tail domain was found to 
anchor the whole molecule to the base of the actin cone. 
Driving PGM expression by a Myosin VI-Ga14 line revealed various tissues where 
Myosin VI is expressed during morphogenesis. PGM was expressed in tissues that 
Myosin VI was shown to be expressed in and necessary for their correct 
morphogenesis (Deng et al., 1999; Hicks et al., 1999; Kellerman and Miller, 1992; 
Petritsch et al., 2003). However, PGM was also expressed in tissues, in which the 
expression of Myosin VI had not being previously described, including: the trachea, 
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the midgut, the salivary glands, the larval epidermis, the halter and eye-antenna 
imaginal discs, and the brain. 
PGM was also expressed in tissues undergoing different processes of epithelial 
morphogenesis and membrane remodelling. For example, in the trachea and the 
salivary glands, PGM was expressed as the tissues undergo tubular morphogenesis 
(Nelson, 2003). During oogenesis, the follicle cells interconnect between themselves 
as they migrate. The position of the cells between themselves does not change during 
the migration (Spradling, 1993). Also during dorsal closure the whole epidermal 
tissue moves together to cover the amnioserosa (Martin and Wood, 2002) and during 
the evagination of the imaginal discs the epithelial cells migrate as the organs stretch 
to obtain their final shape (Fristrom and Fristrom, 1993). Although Myosin VI 
seems to be expressed in epithelial tissues seem to be shaped by various mechanisms 
of cells migration, perhaps Myosin VI plays a common role during their 
morphogenesis. 
Myosin VI is not only necessary for the migration of the cells in epithelial tissues, 
but also for the attachment of tissues during their morphogenesis. In the evaginating 
wing disc, PGM was found to be expressed at the basal side of the epithelial cells, 
where the two epithelial sheets creating the wing connect, and when the expression 
of Myosin VI was disrupted, in the posterior compartment, the wing developed 
blisters. This suggest that Myosin VI is necessary for interactions with the 
extracellular matrix, and this is consistent with the need for Myosin VI for the 
attachment of the germ band to the amnioserosa during germ band retraction and the 
attachment of the leading edge to the amnioserosa during dorsal closure (this is 
discussed in chapter 5). When Myosin VI antisense was induced by C532-Ga14 line, 
the wings in the adult flies were unfolded and malformed although no blistering was 
observed. It seems that in this case Myosin VI antisense was induced after the 
adhesion of the wing sheets was completed (30 hours after pupariation (Brabant et 
al., 1996). 
PGM had a very strong expression in the salivary gland ducts, with some of the 
protein appearing in clustering (Fig. 4.5.2 F). The salivary gland is largest secretory 
tissue in the larvae, and many genes involved in the secretory pathway such as 
vesicular transport from the ER to the Golgi, are highly expressed. In mammalian 
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cells, Myosin VI is localised in the Golgi complex as a peripheral membrane protein 
and is necessary for secretion from the Golgi complex, and for preserving its proper 
morphology (Buss et al., 1998; Warner et al., 2003). The strong expression of PGM 
in the salivary gland, mainly in the salivary duct could suggest a role of Myosin VI in 
secretion from the salivary glands, and the clustering of PGM in the duct could be 
related to particles secreted into the duct by a mechanism including Myosin VI. 
However the necessity of Myosin VI for proteins secretion should be verified. 
The concentration of PGMH in the cell nucleus is a phenomenon that appeared in the 
columnar follicle cells and the salivary glands secretory cells. The salivary glands 
cells contain microvilli in the membrane facing to the lumen (Riparbelli et al., 1993). 
Therefore, the organization of the actin filaments should be similar to those observed 
in other epithelial cells having a microvillar structure at the cell membrane: in these 
cells the plus-end of the actin filaments face the cell membrane and the minus ends 
face the cell interior (Mooseker, 1985). The concentration of PGMH in the cell 
nucleus is therefore consistent with the tendency of Myosin VI to move to the minus 
end of the actin filaments, especially when the head and the neck domains of Myosin 
VI are sufficient for a movement directed to the minus end of the actin filament 
(Homma et al., 2001; Wells et al., 1999). The concentration of PGMH in the cell 
nucleus of the columnar follicle cells, and the similar distribution of the actin 
filaments (a high concentration of actin filaments in the cell cortex and a net of actin 
filaments spread within the cells) suggest that in these cells the minus-end of the 
actin filaments is oriented was to the cell interior. 
The change in the actin cytoskeleton can be related to the change in the cell shape as 
they become immobile: PGMH was concentrated at the nucleus of the columnar 
follicle cells, as they completed migration, but not in the migrating centripetal cells. 
The organization of the actin filaments in the basal part of in immobile follicle cells 
was shown to have a different pattern from the one of migrating follicle cells 
(Gutzeit, 1990). Change in the organization of the filaments in the migrating cells 
would change the localisation of PGMH since it binds to the filaments. 
In the individualization complex, the head domain was localised throughout the actin 
cone and did not concentrate at the top of the actin cone, where the minus ends of 
actin are located. Thus PGMH does not move to the regions of the minus-end actin 
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filaments in all the organs. The orientation of PGMH and actin filaments in the cell 
nucleus suggest that the head and neck domains affect the polymerisation of actin 
filaments, either by triggering actin polymerisation or inhibiting de-polymerisation. 
If the orientation of the head domain triggers actin polymerisation or stabilizes actin 
filaments at their ends, then the recruitment of the head domain to the base of the 
actin cone in the individualization complex could be necessary for stabilizing the 
actin cone and for actin dynamics (Rogat and Miller, 2002). 
In the border cells at the leading edge and in the individualization complex, the 
concentration of the head and the tail domains is different, and in both cases the tail 
domain seems to be most similar to the localisation of the whole Myosin VI 
molecule. It seems likely that in systems there are proteins that interact with the tail 
domain and thus recruit the whole myosin to a specific location. 
In the columnar follicle cells and during dorsal closure the tail domain was 
expressed in the cell cytoplasm in aggregates. When comparing the tail expression 
with proteins that were found to interact genetically with Myosin VI, the tail 
aggregates co-localised with vesicles containing Ankyrin, Armadillo, Bazooka and 
PS2a-integrin, suggesting that the aggregates of the tail domain are formed by 
attaching to molecules that interact with Myosin VI. These aggregates are not 
formed when PGM is expressed and this is probably because the head domain pulls 
the tail to the actin filaments. This shows that both the head and the tail domains 
affect the localization of Myosin VI, and in different cells and tissues the relative 
importance of the two domains could change. 
In the columnar follicle cells, the movement of the head domains towards the minus-
end directed actin filaments, and the co-localization of the tail domain with 
genetically interacting membrane proteins produces evidence for the role of Myosin 
VI as a connector between the actin cytoskeleton and membrane proteins during 
oogenesis. 
The localisation of the whole Myosin VI molecule and its separate domains was also 
studied in normal rat kidney cells, expressing the chicken brush border Myosin VI 
(Buss et al., 2001). The whole Myosin VI-GFP tagged molecule was concentrated in 
the Golgi complex, in the ruffles at the leading edge and in a punctate pattern at the 
plasma membrane, with a partial do-localisation with Clathrin coated pits/vesicles. 
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The globular tail domain was necessary for targeting the molecule to the Golgi 
complex and to Clathrin coated pits and the motor domain was found to be necessary 
for targeting the molecule to the membrane ruffles. In the absence of the globular tail 
domain (leaving only the coiled-coil region in the tail) the tagged protein was 
localised in the cytosol and concentrated in the membrane ruffles, but excluded from 
the nucleus. It would be interesting to investigate the location of the head and the 
neck in these cells. If the head and neck domains tend to move towards the cell 
interior, as it was observed in our experiments, then the anchoring of the whole 
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This work was undertaken in collaboration with Kevin Leaper and Vasiliki Lazou. 
5.1 Introduction 
This chapter describes recent studies on the function of Myosin VI in dorsal closure 
and germ band retraction. 
Kevin Leaper created four Myosin VI mutant fly lines which fail to complete dorsal 
closure: jar R23, jar R39 jarI?7O and Jan8235.  Many of the mutant embryos die during 
embryogenesis and a few die in first larval instar. Close inspection reveals that the 
mutants have loose cells in the amnioserosa and the haemolymph. In several cases 
the embryos fail to complete germ band retraction, prior to dorsal closure. Protein 
analysis of the mutants at late stages of embryogenesis revealed that the Myosin VI 
level is significantly reduced, in the mutantsJanl?39andJanl?235.  
In this chapter I describe the molecular analysis of the mutations in the fly lines: 
jar 	and JanI?235.  I also mention the mutant rescue tests described in chapter four- 
these tests prove that the embryonic lethal phenotype observed in the homozygous 
mutant embryos is connected to the lack of Myosin VI. 
The mechanism by which Myosin VI functions during dorsal closure is tested in the 
Myosin VI mutants and in embryos expressing a Myosin VI dominant negative 
molecule. In these embryos I examined the expression of myosin II, which is needed 
for the migration of the cells during dorsal closure; DE-cadherin and Armadillo, 
which are needed for cell adhesion; and the expression of Dlg and Crumbs, two 
proteins which play a role in epithelial cells polarity. I also examined the shape of the 
actin filaments at the cell membrane in order to determine if Myosin VI plays a role 
in the organisation of actin cytoskeleton during dorsal closure. In a search for factors 
that control the expression of Myosin VI during dorsal closure, I examined the effect 
of RhoA on the expression of Myosin VI. 
In the final section, I test the effect of Myosin VI on the expression of CLIP- 190 in 
the development of the central nervous system. 
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5.2 Description of the genetic analysis made previously to 
mutants: jar' 23, jalfl39 Y jar' 70 and jar' 235 
Two mutants for Myosin VI had been generated previously: jar' (Castrillon et al., 
1993), and jarmm4  mutant, which was created in our laboratory by Wu-Min Deng 
(Hicks et al., 1999). jar' was created by insertion of a P element, P[lacZ, rylJ, into 
exon 2 of jaguar, 4.5 kb from the initiator methionine , and the phenotype of the 
homozygous mutant jar'/ jar' is male sterility (Hicks et al., 1999). jar mmw/4  was 
created by a deletion of the non-coding exon 1 (See Fig. 5.2C). Genetic analysis 
showed that the two mutants fail to complement each other, and the heterozygous 
mutant jar'l jar mmw4  is also male sterile. When jarmmw4  is crossed with DJ87-5, a 
deficiency line for the jar region, the heterozygous line Df875/jarmm4  is male 
sterile, and Western analysis shows that there is no expression of Myosin VI in the 
testes, however, Myosin VI is still expressed in the fly carcass (Hicks et al., 1999). 
Figure 5.2: The organisation of the wild type and mutatedjar genes. 
A: 	The transcript which encodes the EM3 isoform of jar (the isoform that contains all the exons 
(Kellerman and Miller, 1992). B C865 contains a single P[GawB] element inserted at bp 306 in exon 
1. It is located in the 5' UTR and causes no observable phenotype. The number of P[GawB] 
elements was determined by Southern blots, and the position of the insertion by plasmid rescue (made 
by Kevin Leaper). C jar""  was created by imprecise excision of P[GawB], removing the whole 
first exon along with 485 bp flanking the 5' end and 47 bp flanking the 3' end (total deletion of 862 
bp). This allele is homozygous viable but male sterile due to absence of a male specific transcript 
(Hicks et al., 1999). The location of the primers used for the identification and sequencing of the 
deletion (C865For, C865 Rev, EXC2For and EXC2Rev) are shown. The gel shows PCR products 
generated fromjar genomic DNA from jar"' 4/TM3 heterozygous flies: 1) when the PCR was made 
with the primers C865 For + Exc2Rev, two bands appeared, one corresponding to the predicted size 
obtained from amplification of jar genomic DNA from the balancer chromosome, TM3 (1.5 kb), and 
one smaller band (-0.7 kb), corresponding to the size obtained by amplification of the deleted jar 
genomic DNA from jar" 14 chromosome (see arrow). This band was sequenced and the precise 
location of the deletion was found. 2) When PCR was made with the primers: Exc2For + C865Rev, 
only one band appeared, which correspond to the predicted size obtained by amplification of jar 
genomic DNA from the balancer chromosome, TM3 (2.3 kb). The other band was not amplified since 
the primer Exc2For is located within the deletion region of jarnmwl4  mutant. D After finding the 
precise location of the deletion in ja/lm14,  a pair of primers was designed to replicate the whole 
deletion region. In that way, only the mutant genomic DNA was amplified by PCR, and the specific 
mutation (marked by a red asterisk) was located in this region by sequencing. E The mutation found 
the sequence marked by a dashed line was deleted and the sequence marked in the 
box was duplicated. F The mutation found 	 the sequence GTATAC was changed 
to GTTTTC, the nucleotide A, 438 bp upstream to the first exon was deleted, and the nucleotide G (38 
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In previous antisense experiments it was shown that Myosin VI is necessary in many 
other organs as well, like the ovaries and the imaginal discs (Deng et al., 1999), 
therefore it was necessary to generate more mutants with additional phenotypes. 
The mutants were generated by Kevin Leaper, by remobilising a Ga14 insertion in 
the jar gene. 
Figure 5.2A shows the intron-exon organisation ofjar, which was determined in our 
lab by sequence analysis and by using the published Drosophila genorne sequence 
(Adams et al., 2000.). Figure 5.2.13 describes the location of the P[GawB] insertion 
containing the Ga14 gene in line C865, as it was found by Kevin Leaper through 
plasmid rescue of the P[GawB] insertion and sequencing. The insert was found to be 
located at bp 306 in the first exon (Millo et al., 2004). This is in an untranslated 5' 
UTR and the insertion causes no observable abnormal phenotype and produces 
normal levels of Myosin VI transcripts and proteins. Four Myosin VI mutants have 
been established by Kevin Leaper: jarR23, jan/?39, janl??O and jar?235.  All of them are 
homozygous lethal during embryogenesis. When crossed to each other and with 
DJ87-5 and janm1I4  lines, they fell into two complementation groups: jar R23,  jar  R70 
and DJ87-5 were in one group; jar R39, JanI?235 and jar"' 4 were in another group. 
jar R23  and jarR7O  failed to complement the Df line (which is deficient for jar region), 
and the crosses led to lethality in the following progeny; janR39  and janJ?235  did not 
complement with jarmm4  (which disrupts a specific transcript of jar in the testes), 
and the cross produced male sterile progeny. Therefore the mutants were suggested 
to be in thejar gene. 
When a Western blot analysis was made in embryos in late stages of embryogenesis, 
it was shown that wild type OrR and jar mm4 embryos have high levels of several 
isoforms of Myosin VI. jar R23  has slightly reduced Myosin VI, jar ° has much 
reduced Myosin VI and injar 39 and jarR235  no Myosin VI could be detected (Millo 
et al., 2004). In situ antibody staining revealed that by the time dorsal closure starts 
there is no detectable Myosin VI and this loss of Myosin VI continues into the fully 
formed larvae (Millo et al., 2004). 
53 	Molecular analysis of jar" and janF?235  mutants 
In order to have a better characterisation of the mutants it was necessary locate the 
mutations in jar gene and to further investigate the effects of Myosin VI depletion in 
the mutants. 
The P element in the C865 line which was used for the P hop mutagenesis is located 
in the 5' UTR of jar mRNA (Fig. 5.2B). When we undertook PCR with primers 
flanking the location of the original P element location, we found that the P element 
was excised from the 5' UTR region in all the mutants, jar J?23, janJ?39,  jari?7O and 
jar1235 (Fig. 5.3). janJ?39  and jarR235  were the mutants that showed the most severe 
phenotypes, therefore we decided to determine the molecular basis of the mutations 
in these lines. The RTPCR results (see following section) suggest the mutations 
should be in the 5' region. Since these lines fail to complement jar mmw4 
(iarmmw4/jarR39 and jar mnm4/jarR235  heterozygotes are male sterile) the mutations 
should affect some of the same transcripts that are affected in jarmm14. 1n jarmmfh 4,  
imprecise excision of the P element caused a deletion of about 1 kb around the 5' 
UTR (Hicks et al., 1999). It is therefore possible that in the ja/39 and jar R235 lines 
the mutation could have been caused by an imprecise excision event, as injarmmi4. 
A restriction analysis was made of the amplified PCR products, however, unlike 
nrnwI4 
jar 	, any potential deletions in the mutants jarR39  and jarR235  were not big 
enough to be visualised on a gel (data not shown). 
Figure 5.3: A search for the p element in the 5 ' UTR region in the mutant genomic DNA. 
The genomic region where the p element was originally located in line C865 (5' UTR) was 
amplified by PCR, in the heterozygous mutant lines: jari?23/TM3,  jar ' 39/TM3 , ja/70/TM3 , jar' 235/TM3, 
in C865 and in OrR, using primers flanking the insert region: C86517or and C865Rev. In C865 two 
bands appeared: the upper band (arrow) corresponds to the p element, 14 kb, and the lower band 
corresponds to the same region in the chromosome that does not contain the p element (as in OrR). In 




The mutant flies jar R39, jarR235 and jar'" 14 are homozygous lethal, therefore they 
are balanced over a chromosome TM3, which contains the marker stubble (Sb). 
When jarR39/TM3  and jar?235/TM3  are crossed with jarmmw4/TM3,  the heterozygous 
mutants jarR39/jarmhulwl4  and 	 can be visualised since they do not 
contain the balancer chromosome TM3, therefore they are not Stubble. These 
heterozygous flies are male sterile. In these heteroallelic lines, one chromosome will 
contain the genomic DNA ofjarm14,  with the 1 kb deletion in the 5' UTR, and the 
other chromosome will contain the genomic DNA of either mutant with its specific 
mutation. We know any changes at this location are too small to be detected on gels, 
but any new mutations could well be located within the 1 kb deletion created in 
jarmF4 (Fig. 5.21)). Therefore, heterozygous flies will have only one copy of the 
jarR235 or jar?39  mutant genomic DNA in this region. To establish if there was a 
mutation caused by excision we needed to sequence this single copy of the DNA. To 
do this the precise location of the deletion injar"'4  had to be established. When a 
PCR was made using DNA from jarm11)4/TM3  heterozygous flies with primers 
located 593 bp upstream and 921 bp downstream of the beginning of the first exon, 
two bands appeared, one corresponding to the product resulting from amplification 
of TM3 genomic DNA, and one smaller band, corresponding to the amplification of 
the jarfhmhtJ4  chromosome (Fig. 5.2C on gel, lane 1). Sequencing of the lower band 
revealed that the deletion injar'" 14 was from 485 bp upstream of the first exon to 
47 bp downstream of the first exon (Fig. 5.2C) making an excision of 862 bp, which 
includes the whole first exon. When this region was amplified and sequenced in the 
jar '39/jar'"'4  heterozygotes and jar?235/jarmml4  it was found that indeed mutations 
were detected. 
In the jari?39/jarmmw4 heterozygotes the sequence: GTATACTG (347-340 bp 
upstream of the first exon) was deleted, while the sequence: 
TTTATATATACTGATATG (341-322 bp upstream of the first exon) was duplicated 
(Fig. 5.2E). Injar?235/jarmmwI4 the sequence: GTATAC (347-342 bp upstream to the 
first exon) was changed to: GTTTTC, possibly by deletion of the sequence: ATA and 
duplication of the sequence: TTT (341-339 bp upstream of the first exon, see Figure 
5.2F). This mutation is located in the same region as the mutation injar?39  and this 
explains the similar truncation of the mRNA transcripts that was found at the 5' end 
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in both mutants. 
Both mutations have disrupted the sequence: AGTATACT. InjarR235  this sequence 
has been changed and in JanI?39  the sequence is deleted. This is a palindromic 
sequence and as such could potentially regulate the transcription of jar. In 
Drosophila palindromic sequences located within the promoter region are often 
necessary for accurate transcription (Cho et al., 1998; Oh et al., 1999). DNA 
replication elements are composed of the common palindromic sequence: 
TATCGATA (Hirose et al., 1993) The transcription of the gene Timeless requires 
the palindromic sequence CACGTG for correct transcription (Okada et al., 2001), 
and the palindromic sequence: CTTTT-GAAAAG is necessary for proper function of 
the promoter in the transcription binding protein (TBP) gene (Oh et al., 1999). The 
palindromic region might be a specific binding site for transcription factors (Hirose 
et al., 1993). 
jar R235  also has a missing nucleotide, A, 438 bp upstream of the first exon (Fig. 
5.217), and the nucleotide G (38 bp upstream of the first exon) was replaced by A 
(Fig. 5.217). In spite of the excision of the P element from the 5' UTR in the two 
mutants, the flies are red-eyed, therefore a P element must have been inserted into a 
different region of the genome. Inverse PCR revealed that in Janh'?39  a P element has 
inserted into the third chromosome, within the region of the hypothetical gene 
CG5991, which is located upstream of the jar gene. The P element in janJ?235  was 
also re-inserted into the third chromosome, upstream of the jar gene, in a region 
between the hypothetical genes: CG6 164 and CG 6173. 
There was therefore a mobilisation of the P element to different genes in each case. 
The two new jar mutants fail to complement each other and the deletion mutant 
Jarmmw4 , but we needed to be sure that the lethality associated with jar'?39/jarR235 
transheterozygous embryos and larvae are due to the mutations in Myosin VI and not 
in the other genes where the P element has inserted. We investigated the expression 
of Myosin VT and analysed the phenotype of the transheterozygous mutant 
janl?39/janl?235. Because the insertion sites of the P element in janI?39  and janh'?235  are 
different, the cross of the two mutants will complement the mutations caused as a 
result of the P element insertion in different genes, allowing us to test the phenotype 
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of the mutations within jaguar only. The transheterozygous mutants had a similar 
phenotype to the homozygous mutants: i.e. Myosin VI was absent late in 
embryogenesis and many embryos failed to complete dorsal closure (Fig. 5.5E, 5.8.3 
D-E). Those which completed dorsal closure died during the first larval instar. 
Thus we can relate the phenotype to a deficiency in Myosin VI late in 
embryogenesis. 
5.4 The transcription of the 5' end mRNA is disrupted in 
homozygous mutants 
Previously it was shown that jar"' 4 mRNA is disrupted at its 5' region: up to 517 
nucleotides are not transcribed at the 5' end of the mRNA (Hicks et al., 1999). 
Since jar""""' does not complement with jarR39  and jan8235  we wanted to test if the 
transcription at the 5' end of jar mRNA is also disrupted in these mutants. RTPCR 
was undertaken, using RNA templates from homozygous mutant and OrR larvae (1 st 
instar), for two regions at the 5' end of the jar mRNA: the first 1027 nucleotides and 
the region between nucleotides 517 and 1027 were investigated (Fig. 3A). An 
additional RTPCR was made for a region located further downstream, 2850-4100 
bp from the 5' end. The RTPCR of the two 5' regions was very weak in the 
homozygous mutant larvae, compared to OrR larvae (Fig. 313). It seems that as in 
jarmnm'4, there is reduced transcription of jar mRNA at the 5' end in jar 	and 
jar R235 
mutants. When RTPCR was made to transcripts at the 3' end (Fig. 3C), a 
high level of product was observed, although not to the same extent as in OrR. This 
is to be expected since transcripts initiated at the 5' end of the gene are absent. This 
suggests that only some of the transcripts are affected. When RTPCR was made for 
mRNA of ribosomal protein (Fig. 3D) and myosin 29D (Fig. 3E) as a control, the 
expression level in the homozygous mutants was similar to the expression in OrR, 
therefore the disruption in mRNA expression is unique to jar. 
When RTPCR was made with homozygous young mutant embryos of jar R39  and 
jar ?235,  all the RNA transcripts appeared at a similar intensity to OrR embryos (data 
not shown). The 5' transcripts in homozygous mutant embryos are from maternal 
jar mRNA, these maternal transcripts allow the embryos to survive until late stages 
of embryogenesis and a few even survive to become first instar larvae. 
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Given that there are at least some transcripts present in larvae in the JanI?39  and JarR23S 
it seems unlikely either are nulls. 
The disruption in the transcription of Myosin VI is consistent with the depletion of 
Myosin VI protein in the mutants, during late stages of embryogenesis. 
5.5 Myosin VI is necessary for dorsal closure and germ 
band retraction 
Most homozygous mutant embryos developed into late embryos which failed to 
hatch. A few hatched into larvae, but soon died. The anterior/posterior and 
dorsal/ventral polarity and segment number was normal. A number of embryos 
failed to complete dorsal closure and thus there was exposed yolk and free floating 
yolk between the cuticle and the vitelline membrane and many embryos had loose 
cells inside the vitelline membrane. The cells in the amnioserosa were detached. The 
leading edge of the epithelial sheets loose their tight and organised shape (Fig. 5.5E 
compared to 5.5 A-D in wild type embryos, and Fig. 8E), and the tissue was folded 
inside. Some of the mutant embryos also failed to complete germ band retraction 
(Fig. 5.8.313, B), having the tissue folded in and separated from the amnioserosa. 
Many of the mutant embryos that died and larvae that hatched had completed dorsal 
closure but had loose cells floating in the haemolymph in the dorsal aorta (Millo et 
al., 2004). 
Figure 5.4: RTPCR analysis ofjar' 39, jar R23S  homozygous mutant and OrR larvae. A: A diagram of 
the primers used for the RTPCR analysis of jar mRNA. B RTPCR for the 5' region of jar mRNA, 
using the primers p1 + p1027, and p517 + p1027. In jarR39  andjarl?235 the PCR gave a signal which is 
much weaker compared to OrR, suggesting that these transcripts are not synthesized in the larvae and 
the weak signal obtained was probably from remaining maternal transcripts. C RTPCR of the jar tail 
encoding domain (located downstream, see 3A). The 3' transcripts in the mutants exist, although not 
to the same extent as in OrR. The transcription of a fragment in ribosomal protein, L32 (D) and of 
Myosin 29D mRNA (E) was used as a control. 
Figure 5.5: Phenotypes of mutant embryos. A-D: Dorsal closure in OrR flies (the embryos are 
stained with antibodies raised against nomnuscie Myosin II). The leading edges of the lateral 
epidermis are connected along the anterior and the posterior sides, towards the centre (arrows), to 
cover the amnioserosa. E: Failure of dorsal closure in jar R39  mutant embryos, the cells in the 
amnioserosa are detached (arrows), leaving loose yolk. Note that the cells in the leading edge of the 
epithelium are loose or abnormally shaped. AS = amnioserosa LE = leading edge 
Figure 54 
A . P517 P1027 TAN MYC2 
1 517 1027 2850 4100 
B 	 C 







P1 + P1 027 P517 + P1027 
	




R39 R235 OrR 
	







Ribosomal protein 	 myosin 29D 
L32 







5.6 	Myosin VI cDNA rescues the lethal phenotype of 
jarR39 and JanI?235  mutant embryos. 
As described in the two mutant rescue experiments in chapter 4, the expression of 
Myosin VI-GFP tagged protein (PGM) rescued the embryonic lethal phenotype of 
the homozygous mutants: janI?39  and jarR235  by increasing the viability of the mutant 
embryos. These results prove that the embryonic lethal phenotype results from to the 
disruption in Myosin VI expression. 
In the adult flies, PGM expression also rescued the male sterile phenotype of the 
heteroallelic mutants: jar R391 jarrn!nwI4 and jarR235/ jarFlm4 by recovering their 
fertility, showing that the male sterility phenotype of the transheterozygous mutants 
is also caused by the disruption of Myosin VI expression in the testes. 
5.7 	Dominant negative expression of Myosin VI leads to cell 
adhesion defects and failure in germ band retraction 
An alternative way to interfere with the function of Myosin VI during dorsal closure 
is to express a truncated form of Myosin VI, which lacks the ATP binding domain 
(AATP-jar, Petritsch et al. 2003). This dominant-negative Myosin VI was driven by 
engrailed-Ga14 (en-Ga14). This causes alternating stripes of cells to misexpress 
Myosin VI so normal cells and potential cell defects can be observed in the same 
embryo. This caused rupture of the tissue at the leading edge and the amnioserosa 
(Fig. 5.7 A, 5.9B), leaving loose cells. Furthermore, the detachment of the cells 
appears only in the stripes of cells expressing AATP-jar. The cells at the leading edge 
tend to separate from the amnioserosa (Fig. 5.7A, 5.913). 
These results suggest that Myosin VI is necessary for cell adhesion during dorsal 
closure. Embryos that reached the final stages of dorsal closure had holes at the 
dorsal midline, suggesting that Myosin VI is also necessary for the adhesion of the 
two edges of the leading edge along the dorsal midline, during the final "zipping" of 
the epidermis (Fig. 5.7C). As observed in the homozygous mutant embryos, apart 
from the change in the adhesion properties, the cells also loose their normal 
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morphology. In many cases, cells expressing AATP-jar tend to fold inside, at the 
lateral epidermis and the leading edge (Fig. 5.7E). Figure 5.71) shows an embryo 
expressing AATP-jar, stained with Myosin VI antibody. The stripes expressing 
AATP-jar have a stronger antibody stain. These are also the specific regions where 
the tissue is folding in, indicating that it is the AATP-jar that causes the folding of the 
tissue. It could be that the strong expression of Myosin VI in the band of 4-5 cells at 
the leading edge and the amnioserosa, along with the low expression in the lateral 
epidermis are necessary for keeping the cells rigid as they migrate. The change in the 
shape of the actin filaments in stripes expressing the dominant-negative Myosin VI 
indicates a change in the actin cytoskeleton in these cells, and this could reduce the 
cells rigidity. However, the loose tissue at the leading edge could also appear as a 
result of the detachment from the amnioserosa, as appeared when germ band 
retraction failed. 
Embryos expressing AATP-jar failed to complete germ band retraction. The germ 
band tissue appeared loose and separated from the amnioserosa (Fig. 5.717), and in 
severe cases germ band retraction did not occur at all (Fig. 5.7G). These results along 
with the strong expression of Myosin VI observed at the inner edge of the posterior 
segments during germ band extension (results of Kevin Leaper, (Millo et al., 2004) 
suggests that Myosin VI is necessary for germ band retraction, either for the 
migration of the tissue or for the connection with the amnioserosa. 
Figure 5.7: The effect of dominant-negative Myosin VI expression. AATP-jar was controlled by en-
Ga14, at the posterior of every segment. Figures A-C and E are stained with phalloidin to view the 
actin filaments and the cell shape. A: The disruption of Myosin VI function caused detachment of the 
cells at the leading edge and the amnioserosa. The actin cable at the leading edge is disrupted in all the 
areas where AATP-jar was expressed. B: In some embryos, cells expressing AATP-jar in the lateral 
epidermis changed their shape and the actin filaments lost their tight organization at the cells cortex. 
C: In the final stage of dorsal closure, when Myosin VI is disrupted, dorsal closure is not completed, 
and holes are left. D-E: Some embryos show "folding-in" of the lateral epidermis in the stripes 
expressing the dominant-negative. D: staining with Myosin VI antibody: the stripes expressing the 
dominant negative Myosin VI have stronger stain of Myosin VI (arrows), and tend to fold inside the 
embryo. E: In severe cases the actin cable disappears and filament aggregates are formed (see arrows). 
A milder version of this phenotype appeared in the mutants (see figure 5,11). F-G: In many cases 
germ band retraction is not completed, the germ band tissue is loose and folded, and the posterior 
spiracles are not formed. In F, the process of dorsal closure was progressed in spite of the incomplete 
process of germ band retraction (DE-cadherin stain). In G germ band retraction ceased in very early 
stage: the embryo is totally folded, and the germ band tissue is disconnected from the amnioserosa. 
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Figure 5.7 
AA TP-jar/ en-ga!4 
5.8 	The affect of Myosin VI depletion on nonmuscie 
Myosin II expression 
Nonmuscle Myosin II is also essential for dorsal closure. Myosin II creates the acto-
myosin contractile ring, termed the purse string, at the leading edge. The purse string 
provides the force to promote dorsal closure. Myosin II also preserves cell shape 
during the morphogenic changes of the tissue (Young et al., 1993). Previous studies 
showed expression of Myosin VI (Kellerman and Miller, 1992) and nonmuscie 
Myosin II (Young et al., 1993) in the amnioserosa and in the surrounding epithelial 
sheet, but co-localisation of the two proteins during dorsal closure has not been 
investigated. We were interested to compare the expression of the two myosins in 
the embryo and to investigate the effect of Myosin VI depletion on Myosin II 
localisation. For this purpose we used jar4'?39  and jar R215  mutant embryos, which 
lacked any expression of Myosin VI protein during the late stages of embryogenesis. 
We also used the transheterozygous mut  ant jarJ?39/jarI?235  to ensure that the results are 
caused by the mutations in jaguar gene and not due to the insertion of the P elements 
on the third chromosome. 
In OrR flies, we found that Myosin VI and nonmuscle Myosin II show similar 
localisation in the amnioserosa, and the lateral epidermis (Fig. 5.8.1 A-D), however, 
Myosin VI shows a stronger expression in the cells surrounding the leading edge 
compared to Myosin II which is strongly concentrated at the acto-myosin cable. This 
might suggest that Myosin VI plays a role in keeping the cells connected as dorsal 
closure progresses. Figure 5.8.11) shows Myosin VI is strongly expressed all over 
the apical surface of the cells. In the jar R39  and janI?235  mutants, Myosin VI 
expression was very weak, while the expression and organisation of nonmuscle 
Myosin II was similar to that observed in OrR (Fig. 5.8.2). In the transheterozygous 
mutant jar?39/jar?235  Myosin II is expressed in the leading edge, the "zipper"  region 
and in the plasma membrane of the cells in the lateral epidermis, although when the 
embryos fail to complete dorsal closure - the uniform structure of the purse string 
and the cable at the leading edge disappear and so does the strong expression of 
Myosin II at the leading edge (Fig. 5.5E, 5.8.31), E). 
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The figures in the following pages: 
Figure 5.8.1: Expression of Myosin VI and Myosin II in OrR embryos during dorsal closure. 
A-C show an embryo as the process of dorsal closure is progressing. Myosin VI (A) has a strong 
expression in a layer of four to five cells surrounding the leading edge, while Myosin 11(B) has a 
strong expression at the acto-myosin cable, at the leading edge (see magnification). Note the strong 
expression of Myosin II at the "purse string" and the expression of Myosin VI in the cells surrounding 
the purse string in the overlay figure (C). D: observation of the apical surface of the cells at the 
leading edge shows that Myosin VI is spread all over the cell surface with a very strong intensity. 
When checking the inner layers Myosin VI appears to be localised in the cytoplasm. 
Figure 5.8.2: Expression of Myosin VI and Myosin II in jar)?39 andjari?255  homozygous mutants. 
Myosin VI expression is absent in jar"' and jarR2SS  mutants (A and D respectively). The expression 
and localisation of Myosin II in these mutant embryos and larvae is not effected (B and E 
respectively, and overlay in C and F). 
Figure 5.8.3: Expression of Myosin VI and Myosin II in the heteroallelic mutant jar"' ljar 235 and in 
AA TP-jar/ en-Ga14 embryos. Figures A-C show embryos in the process of dorsal closure. Myosin II 
is present in the leading edge, in the "zipper" region, and in the plasma membrane of the cells of the 
lateral epidermis suggesting that the localisation of Myosin II in the heteroallelic mutant is not 
affected. However, Myosin VI is absent in the cells adjacent to the leading edge (see as comparison 
the expression in OrR flies). When a heteroallelic mutant embryos fail to complete dorsal closure (D, 
E), the 'purse string' around the amnioserosa is absent and the expression of Myosin II at the leading 
edge is absent as well, although Myosin II is present in the cells at the lateral epidermis and the 
amnioserosa. The amnioserosa sheet has lost its organised uniform sheet, having loose cells with a 
changed shape and holes (arrow). The holes appear also in the area connecting the epidermis and the 
amnioserosa (E, arrow). It seems that the cells at the leading edge have been folded inside so it is 
impossible to observe the actin-myosin cable. F: Myosin II expression is not reduced when iATP-jar 
is expressed in the posterior compartment of the segments, however in some regions myosin II is 
mislocalised from the membrane (asterisks). The concentration of myosin II is also reduced in the 
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In these embryos the tissue is folded inside the leading edge and is not visible. 
Considering the strong expression of Myosin VI at the leading edge (Fig. 5.8.1 D) we 
suggest that Myosin VI might be necessary for maintaining the structure of the tissue 
at the leading edge and preventing it from folding inside during dorsal closure. 
To verify these results, the expression of myosin II was also tested when the function 
of Myosin VI was disrupted by expressing the dominant negative AATP-jar (a 
Myosin VI molecule that lacks the ATP binding domain). This experiment was 
undertaken my Vasiliki Lazou. At the posterior part of every segment, driven by an 
en-Ga14 construct. When looking at the lateral epidermis, the expression of myosin II 
was not reduced in the posterior stripes and myosin II is localised to the cell 
membrane, although in some areas localisation was slightly reduced (Fig. 5.8.3, F, 
asterisks). The mislocalisation of myosin II appeared in isolated groups of cells, 
therefore it is not clear whether or not it is directly related to the disruption in 
Myosin VI function. In the leading edge, the expression of myosin II was reduced at 
the acto-myosin cable, probably due to the rupture of the cable (arrows). Possibly, 
the mislocalisation of myosin II at the cell membrane could be related to the changes 
in the actin cytoskeleton in the cell cortex. Previous evidence showed that Myosin II 
does not co-immunoprecipitate with Myosin VI in embryo extracts (Petritsch et al., 
2003). The change in the localisation of myosin II does not seem to be directly 
related to the function of Myosin VI. 
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5.9 Disruption of Myosin VI function affects epidermal cell 
adhesion molecules 
Epidermal cells expressing of AATP-jar had altered cell adhesion properties. Cell-
cell adhesion in the Drosophila embryonic epidermis is mediated by DE-cadherin. 
Myosin VI was found to interact with DE-cadherin during the migration of border 
cells during oogenesis (Geisbrecht and Montell, 2002). This raises the possibility that 
Myosin VI interacts with cadherin during embryogenesis and that the loss of cell-cell 
adhesion in the disruption of Myosin VI function could lead to changes in DE-
cadherin expression or localisation. 
To test this hypothesis, embryos expressing AATP-jar via en-Ga14 expression during 
dorsal closure were stained with DE-cadherin antibody (Fig. 5.9 A- Q. In some of 
the embryos, DE-cadherin levels were significantly reduced in cells expressing 
AATP-jar (Fig. 5.9 A). In other embryos the localisation of DE-cadherin was 
disrupted and the protein appeared in the cell cytoplasm and not in the cell 
membrane as in the wild-type cells (Fig. 5.9B). 
In the mutant embryos, the localisation of DE-cadherin in the lateral epidermis, the 
leading edge and the amnioserosa cells was not altered (Fig. 5.9C). It is possible that 
the maternal Myosin VI leads to the correct localisation of cadherin. Similar results 
were observed when the expression of DE-cadherin was examined in RhoA 
homozygous mutant embryos and in embryos expressing the dominant-negative of 
RhoA, RhoN19: In the homozygous mutant RhoA embryos, no defect was observed 
in the localisation of DE-cadherin, while the in cells expressing RhoN19 the 
expression of DE-cadherin was significantly reduced (Bloor and Kiehart, 2002). 
Figure 5.9: Expression of jar dominant negative molecules disrupts the expression and localization of 
DE-cadherin and Armadillo within the cells. A: some of the areas expressing AATP-jar, DE-cadherin 
is absent from the cell membrane (see arrow in the magnified picture in A), in other areas the 
localisation of DE-cadherin to the cell membrane is disrupted and DE-cadherin is present in the cell 
cytoplasm (B, arrow). In some areas of the lateral epidermis the tissue is "folding in" (A, asterisk). C: 
In homozygous jar R235  embryos, no disruption in DE-cadherin expression was observed. D: The 
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In addition, in embryos expressing AATP-jar, the defects observed in the epidennal 
cells were more severe than the ones observed in the homozygous mutants (possibly 
due to the maternal contribution of Myosin VI in the mutant embryos). 
In Drosophila embryogenesis, DE-cadherin interacts with Armadillo, the Drosophila 
homologue of -catenin. Armadillo binds to Cadherin in cell-cell adhesion 
complexes, which are necessary for actin co-ordinated movement of cells during 
epithelial morphogenesis (McCrea et al., 1991; Oda et al., 1994). In the ovary, 
Drosophila Myosin VI interacts with 
DE-cadherin and Armadillo (Geisbrecht and Montell, 2002). Since AATP-jar 
expression affects the localisation of DE-cadherin it might also affect the localisation 
of Armadillo. To test this possibility, AA TP-jar/ en-Gal4 embryos were stained with 
an antibody specific for Armadillo. However, because of the folding- in of the tissue 
in the stripes expressing AATP-jar it was difficult to observe the effects on 
Armadillo. 
In some segments it was possible to see a reduction in Armadillo expression at the 
lateral epidermis (Fig. 5.91), arrows), therefore the expression pattern of Armadillo is 
also changed when Myosin VI function is interfered with. 
510 	The effect of Myosin VI depletion on actin 
organisation in the amnioserosa and in the leading edge cells 
Mutations in the nonmuscie Myosin II gene (zipper) have been shown to disrupt 
actin filaments organisation, causing aberrations of cell shape in the amnioserosa and 
in the leading edge cells during dorsal closure (Young et al., 1993). Since Myosin 
VI and nonmuscie Myosin II have a similar pattern of expression, we wanted to 
check if the depletion of Myosin VI would effect the organisation of actin filaments 
in the amnioserosa cells in the actin cable and the cells at the leading edge. 
In OrR flies, Myosin VI and actin have a similar localisation; however, in the leading 
edge the actin cable is concentrated mainly around the amnioserosa, where Myosin 
VI is concentrated in a layer of cells between the actin cable and the epithelial sheet 
(Fig. 5.10A-C). In the leading edge the cells are elongated (Fig. 5.101)), and 
connected to the actin cable, surrounding the amnioserosa at a uniform width. Not 
all the mutant embryos showed defects in actin organisation within the cells, 
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however in some of the mutant embryos that failed to complete dorsal closure, the 
actin filaments in the amnioserosa are disassociated (Fig. 5.10E). In the leading 
edge, some of the regions in the actin cable are destroyed, many of the cells are not 
elongated and the organisation of the cells as a row at the front is disrupted (Fig. 
5.10E, increased frame). An aberrant shape is also observed in the border regions 
between the segments, suggesting that the disruption in the cell shape and movement 
occurs in other epithelial cells in the lateral epidermis. 
When AATP-jar was expressed, the loss in cell shape and actin cable organisation 
was even more dramatic (Fig. 5.7 A-C, E). In severe cases the actin cable disappears, 
and the cells at the leading edge connect remnants of actin cables that appear as 
aggregates of filaments (Fig. 7E, arrows). It appears that cell shape in the leading 
edge and in the amnioserosa changed significantly as a consequence of loss of cell 
adhesion. In some embryos the cells changed their shape and the tight organisation of 
the actin filaments at the cell membrane was disrupted (Fig. 5.7 B). The change in 
the cytoskeletal organisation could be the reason why the cells expressing AATP-jar 
lose their rigidity and fold in. These results suggest that during dorsal closure Myosin 
VI plays a role not only in the adhesion of the cells, but also in the arrangement of 
the actin cytoskeleton. 
Figure 5.10: Cell shape and actin organisation in the amnioserosa and the leading edge of OrR and 
jar R39  mutants. A-C: Localisation of actin (A) and Myosin VI (B) in the embryo prior to dorsal 
closure. Actin is localised at the leading edge of the migrating epithelial sheet (C, white arrowhead), 
while Myosin VI is localised in a basal layer of cells surrounding actin cables (C, yellow arrowhead). 
Note the strong expression of actin and Myosin VI in the posterior spiracle (arrow). D In OrR, the 
cells in the leading edge are elongated, the actin cable is intact and the cells in the amnioserosa are 
intact and form a uniform layer. E a mutant embryo Jani?39.  The cells in the amnioserosa lose their 
organised shape, in the leading edge the actin cable is broken in several places (asterisk), and some of 
the cells still have a polygonal shape and do not elongate. Note the abnormalities in segment 
organisation, near the asterisk. 
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5. 11 The expression of Dig and Crumbs during dorsal 
closure 
In a search for additional proteins that might interact with Myosin VI, Dig was 
selected since the mammalian homologue (SAP97) was found to interact with 
Myosin VI in rat nerve cells. In addition, like Myosin VI, Dlg is necessary for 
epithelial morphogenesis of the follicle cells during oogenesis, and the epidermis 
during dorsal closure (Goode and Perrimon, 1997; Perrimon, 1988). 
The expression of Dig was examined in embryos expressing AATP-jar in the 
posterior compartment of every stripe by en-Ga14. In cells expressing tATP-jar, the 
expression of Dlg was not changed, and Dig was localised to the cell membrane, as 
in wild-type cells (Figs. 5.11 A-C). 
Crumbs is another protein that is necessary both for the process of dorsal closure and 
the formation and maintenance of the follicular cells epithelium (Harden et al., 2002; 
Tanentzapf et al., 2000; Tanentzapf et al., 2003). Crumbs is an integral membrane 
protein which determines the basal-apical polarity in epithelia (Wodarz et al., 1993). 
Hypomorphic mutations in the crumbs gene cause a failure in gerin band retraction, 
and rupture of the amnioserosa, similar characteristics are observed when the 
function of Myosin VI is disrupted (Harden et al., 2002). In embryos homozygous 
for amorphic alleles of crumbs, the epidermal cells are disorganised and die (Tepass 
et al., 1990). 
In spite of the similarity in the phenotype of Crumbs mutants and Myosin VI 
mutants, the expression of Crumbs was hardly changed in cells expressing AATP-jar 
(Fig. 5.1 1D-E). In several placed the localisation of Crumbs was slightly reduced in 
the cell membrane however, these areas are relatively small. 
Taken together, the disruption in Myosin VI function does not seem to affect the 
localisation of Dig and Crumbs during dorsal closure. These proteins are necessary 
for regulating cell polarity in epithelial cells (Bilder et al., 2000; Wodarz et al., 
1993). Perhaps there results indicate that Myosin VI does not play a role in 
maintaining cell polarity during dorsal closure. 
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Figure 5.11: The expression of Dig and Crumbs in zIATP-jar/en-Ga14 embryos.A-C: Dig is localised 
at the cell membrane in wild type cells as well as in cells expressing AATP-jar (in the magnification of 
figure C, the stripes of cells expressing AATP-jar are marked). D-E: The localisation of Crumbs to the 
cell membrane is found in most of the tissue. Only in several points Crumbs was absent from the cell 
membrane (marked in asterisks). 
5.12 The effect of RhoA on Myosin VI expression during 
dorsal closure 
As shown in this chapter and in previous experiments, Myosin VI and myosin II have 
a similar pattern of expression during dorsal closure and oogenesis (Deng et al., 
1999). The two myosins appear to be necessary in other epithelial tissues: Mutation 
of the myosin II regulatory light chain, spaghetti squash (sqh), causes malformations 
of the legs during imaginal disc evagination (Jordan and Karess, 1997). Similar 
phenotypes appear when the expression of Myosin VI is disrupted, suggesting that 
the two myosins have similar roles in the evagination of the leg discs (Deng et al., 
1999; Edwards and Kiehart, 1996). It is interesting to note that mutations in the 
signal protein RhoA, cause similar malformations in the legs (Halsell et al., 2000). 
Genetic studies showed that RhoA signal transduction regulates the activity of 
Myosin II (Halsell et al., 2000). It is possible that also Myosin VI is also regulated 
by RhoA, since disruption in the expression of RhoA by using dominant-negative 
techniques causes similar, but more severe, phenotypes in the embryos, to those we 
found in Myosin VI mutants (Bloor and Kiehart, 2002). 
Previously, the expression of RhoA dominant negative, RhoAN19, interfered with 
actin filaments organisation, disrupted the localisation of myosin II and reduced the 
expression of DE-cadherin in the leading edge and the lateral epidermis (Bloor and 
Kiehart, 2002). To test if Myosin VI expression is controlled by RhoA, the 
expression pattern of Myosin VI was tested in UAS-RhoAN19/en-Ga14 embryos. 
These embryos express RhoA dominant negative protein in a posterior stripe in every 
segment (Fig. 5.12). The cell shape and the actin filaments were stained with 
phalloidin. The cells expressing RhoAN19 change their shape and appear larger and 
rounder than the wild type cells. In addition, the actin cable in the leading edge is 
present but loses its uniform shape, since the organisation of the actin filaments is 
disrupted (Fig. 5.12 B, E in the marked stripes). These -results are similar to these 
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observed previously (Bloor and Kiehart, 2002). When looking at the expression of 
Myosin VI in wild-type cells, the expression is spread equally in a layer of 4-5 cells 
at the leading edge, while in 
the stripes of cells expressing RhoAN19 Myosin VI is concentrated at the very front 
line of cells at the leading edge (Fig. 5.12 A, D, arrows). The changes in the 
localisation could be related to the change in cell size and shape; nevertheless, the 
results might indicate that RhoA regulates the expression level and the localisation of 
Myosin VI in the leading edge. 
As mentioned previously, the disruption of Myosin VI, myosin II and RhoA lead to 
abnormal leg morphogenesis. In a genetic screen for genes interacting with myosin 
II, it was found that the RhoA mutant Rh0AE'310  fails to complement the myosin II 
mutant zipEl  (Halsell et al., 2000). In this double heterozygous mutant (RhoA' 310  
+/+ Zlp '), the adult flies had malformed legs, having a twisted femur and shortened 
tibia. These results show a genetic interaction between myosin II and RhoA. To test a 
genetic interaction between Myosin VI and RhoA, a cross was made to create the 
double mutants: Rh0AE310  . +/+,.jar?39 and RhoA'-'O; +/+,.jarl?235.  These flies were 
originally created from the balanced lines: RhoAL'3b0  /Cyo (balanced at the second 
chromosome) having curly wings phenotype, jarl?39/TM3,  Sb and jarl?235/TM3,  Sb 
(balanced on the third chromosome) having stubble bristles on the back. 
When crossed together, the double mutant flies lose their balanced chromosomes, 
and they have straight wings and non-stubble bristles. When the legs were examined 
in those flies, some of them had malformed legs, however this phenotype was also 
observed in heterozygous flies that were not double mutants (i.e. RhoAL'3o  +/+ 
TM3). In addition, no reduced viability was observed in the double mutant flies. 
Therefore, unlike myosin II, Myosin VI and RhoA do complement each other in the 
double mutant. Perhaps RhoA affects the localisation of Myosin VI during dorsal 
closure but not during the morphogenesis of imaginal discs. 
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Figure 5.12: The effect of the disruption in RhoA function on the expression of Myosin VI. Figures 
D-F are magnifications of figures A-C. A, D: Myosin VI staining. In stripes expressing RhoAN19 
(marked in lines) Myosin VI is concentrated at the very front line of cells in the leading edge, while in 
the wild type cells the increase in the expression of Myosin VI at the leading edge is less obvious. B, 
B: Stain of the actin filaments with phalloidin. The cells expressing RhoAN 19 are bigger and lost the 
tight organized shape. Although the actin cable still exists, it lost its uniform shape. 
The genetic interactions between Myosin VI and RhoA should be further tested. The 
two mutations are homozygous lethal at the embryonic stage. The creation of double 
mutant homozygous mutants for one of the genes could aggravate the phenotype of 
the embryos. However it might be difficult to observe it since the severity of the 
phenotypes during embryogenesis is also dependent in the amount of maternal 
proteins that remain at the late stages of embryogenesis. A double mutant could be 
created with homozygous alleles that have a weaker phenotype, and survive beyond 
embryogenesis. For example, the homozygous mutant jar 322  lives until early stages 
of the second larval instar. If the double homozygous mutant: RhoAE'3 o +/ jar322  
jar322 died during embryogenesis, then it could be concluded that RhoA and Myosin 
VI genetically interact. 
5.13 The effect of Myosin VI on the localisation of CLIP-190 
in the central nervous cells. 
Although this chapter discusses the role of Myosin VI in dorsal closure, I add this 
section that deals with the affect of Myosin VI in the localisation of CLIP- 190 
(cytoplasmic linker protein 190) in the central nervous system, since the two 
processes occur during embryogenesis. 
Previous studies showed that Myosin VI co-immunoprecipitate with CLIP-190, and 
that the two proteins co-localise in the connectives and the commissures fibres, 
which compose the ventral nerve cord (Lantz and Miller, 1998). We were interested 
to test if reduced expression or disrupted function of Myosin VI would change the 
localisation of CLIP- 190 in the central nerve system. 
Figure 5.13: The effect of Myosin VI on the localisation of CLIP-l90 in the central nervous cells. 
A-C: In OrR embryos, Myosin VI and CLIP-190 are expressed in the connectives (CN), the 
commissures (CO) fibres, and the midline glial cells (MGC). D-F: Expression of Myosin VI and 
CLIP- 190 in the heteroallelic mutant embryos jar' 39/jar' 235. G-L: Expression of Myosin VI and CLIP- 
190 in jathATP/en-Gal4 embryos. Figures J-L are magnifications of figures G-I. 
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The expression of Myosin VI and CLIP-190 was examined in heteroallelic mutant 
jarR39/jarR235 that has a reduced expression of Myosin VI (Fig. 5.14 D-F), and 
compared to OrR flies (Fig. 5.14 A-C). In the wild-type embryos, Myosin VI and 
CLIP-190 were co-localised in the connective (CN) and the commissure (CO) fibres. 
Co-localisation of the two proteins was also observed in and midline glial cells 
(MGC), previously Myosin VI was shown to be expressed in the MGC, but CLIP-
190 was not observed (Lantz and Miller, 1998). The difference in the expression 
pattern could be related to the fact that in our experiment the embryos stained were at 
stage 15, while in the previous experiment the embryos were at stage 16. 
In the mutant embryos jar?39/jarl?235,  the expression of Myosin VI was significantly 
reduced (Fig. 5.14 D). CLIP-190 was still present in the connective and the 
commissure fibres, although its expression was slightly reduced. In the midline glial 
cells, the expression of CLIP-190 was absent. 
The expression pattern of CLIP- 190 and Myosin VI was also examined when the 
function of Myosin VI was disrupted at the posterior compartment of every segment 
by using in jarzi4TP/en-Ga14. Engrailed was found to be expressed in the central 
nervous system, during stage 16, in a posterior stripe within every segment (Menne 
et al., 1997). Although the dominant negative Myosin VI was expressed in the 
posterior compartments, the expression of Myosin VI was significantly reduced in 
the entire central nervous system (Fig. 5.14 G, J). Nevertheless, 
CLIP-190 was still expressed in the connective and the commissure fibres. The 
central nerve cord seems to be torn at the anterior (Fig. 5.14 H, I arrow). Presumably, 
it is related to the destruction of the tissues due to the detachment of the cells, due to 
the expression of dominant negative Myosin VI. 
Taken together, these results show that in spite of the physical interaction between 
Myosin VI and CLIP-190 in embryos, Myosin VI does not affect the expression or 
the localisation of CLIP- 190 in the central nervous system. 
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5.14 	Conclusions 
In this study we provide evidence that Myosin VI is necessary for cell-cell adhesion 
and maintaining cell rigidity during dorsal closure. Disruption in Myosin VI function 
caused folding-in of the migrating epithelial tissue and rupture of the tissue, which 
suggests that Myosin VI is necessary not only for the cell-cell adhesion but also for 
keeping the cells rigid as they migrate. 
5.14.1 	Identification of novel Myosin VI mutants 
Kevin Leaper has isolated lethal mutants in the jar gene of Drosophila which 
encodes Myosin VI (Leaper, 2003). The resulting embryos die late in embryogenesis 
failing to complete dorsal closure or as early larvae. The expression of fluorescent 
tagged Myosin VI in the mutant embryos rescued the lethal phenotype of embryos. 
This indicates that the lethality of the embryos is caused by the mutation within the 
Myosin VI gene, jaguar. 
Not all the embryos failed to complete dorsal closure and some hatched as larvae. 
RTPCR results show that in homozygous mutant embryos (stage 14 onwards) 
Myosin VI transcripts are still observed. However, in the homozygous mutant 
larvae, the expression level of Myosin VI transcripts is lower than OrR (these results 
are consistent with the Western Blot and antibody localization results). These results 
suggest that survival throughout embryogenesis is due largely to the use of maternal 
Myosin VI. 
Genetic and molecular analysis revealed that the two mutants have disruptions in a 
palindromic sequence 339 - 348 bp upstream ofjar mRNA. The two mutants jar?39 
and jar R235  had imprecise excision of the P element and a new insertion on the third 
chromosome. Analysis of the transheterozygous mutant jar?39/jar?235  revealed that it 
is the imprecise excision of the P elements from the jar gene and not the re-insertion 
of the P element elsewhere in the chromosome that caused the observed phenotypes 
and the disruption in Myosin VI expression. Since there is no disruption in the 
coding sequence, but there is interference with the expression of jar transcripts that 
initiate at the 5' end of Myosin VI, it seems likely that the jar gene has been 
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disrupted in its promoter/enhancer sequences. It is surprising to find that the deletion 
of this palindromic region and the whole first exon in jarmu14  does not disturb the 
development of the flies until adolescence, causing only a disruption in the 
expression ofjar transcripts and protein in the testes, while the smaller deletions and 
duplications in janI?39  and jarR235  disrupt significantly the expression ofjar transcripts 
and protein from embryogenesis, causing late embryonic and early larval lethality. It 
is possible that the mutations in jar R39  and jarR235  not only interfere in the 
transcription initiation of specific transcripts in this region, but also interfere with the 
synthesis of other transcripts, driven by other upstream enhancers, while in jar'' 4  
this interference does not exist. 
In the three mutants: jar mm 4, jarR39 and JanI?235  the 5' end of the mRNA was 
truncated, however the truncated region in jarR39  and jar R235  is bigger than that 
observed in jarm114  (1027 bp compared with 517 bp). When comparing with the 
results of the protein expression in late embryos, it seems possible that the truncation 
of mRNA in jar nm,14  disrupts the expression of a specific isoform of Myosin VI in 
the testes, allowing the rest of the isoforms to be expressed and survive until 
adolescence, while in the mutants JarR39  and jarR235  the bigger truncation disrupts the 
translation of all the protein isoforms in the larvae, causing lethality in the late 
embryonic and early larval stages. In contrast to the disruption in the protein 
expression, some transcripts covering 3' end of the gene in jarR39  and jar R235  were 
detected. The antibody used for the testing the expression of Myosin VI was raised 
against the whole tail domain, so if the transcripts covering the 3' region were 
translated, the resulting proteins should be detected. It is possible therefore that 
these mRNAs are not translated. 
Analysis of the null mutant jar322 , published after completion of our experiments 
(Petritsch et al., 2003), showed that it affected the embryonic neuroblasts and there 
is no mention of any defects in cell shape in the lateral epidermis, or of some 
embryos failing in dorsal closure. However, we have shown that the same dominant 
negative Myosin VI that caused mislocalisation of Miranda and misorientation of the 
spindle in neuroblasts is shown to disrupt cell attachment in the amnioserosa and the 
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leading edge epidermis during dorsal closure. Therefore, Myosin VI is necessary for 
both neuroblast morphogenesis and dorsal closure during embryogenesis. It is 
surprising to find that the null mutant jar322 lives until the early stages of second 
instar, while the homozygous mutants jar?39  and jarR235  die during embryogenesis 
and during first instar. Since no protein was observed in the mutants janI?39  and 
jar R235, the severe effect of the mutants might be expected to be the same as in a null 
mutant. 
5.14.2 	The function of Myosin VI during dorsal closure 
Depletion and disruption in Myosin VI function caused detachment of cells and 
folding-in of the migrating epidermis, during dorsal closure. In en/AATP-jar embryos 
these affects were dramatic; if the cells expressing AATP-jar are not as robust as the 
wild type cells, they might not be able to bear the multiple forces applied on them 
during dorsal closure, and as a result the cells will detach from each other, causing a 
rupture of the tissue. 
The rupture of the tissue in the amnioserosa and the epidermis seem to be related to 
the changes in the adhesion properties of the cells in the absence of Myosin VI 
function. This assumption is supported by the reduced expression and disruption in 
the localisation of DE-cadherin and Armadillo in the expression of AATP-jar. During 
oogenesis, DE-cadherin, as well as Myosin VI is necessary for border cell migration 
and the proteins are co-expressed in the columnar follicle cells, as the epithelium 
forms around the oocyte (Geisbrecht and Montell, 2002). Indeed, egg chambers 
expressing Myosin VI antisense RNA show a similar phenotype when comparing 
them embryos failing to complete dorsal closure: the follicle cells fail to migrate; the 
cells loose their shape and separate from the epithelium (Deng et al., 1999). In both 
cases Myosin VI is needed for the correct movement of a sheet or tight cluster of 
follicle cells. 
The reduction of Armadillo expression observed in \ATP-jar expressing cells 
suggests that Myosin VI is necessary for the localization of Armadillo, as well as 
DE-cadherin, to the cell membrane. Interestingly, as in Myosin VI mutants, 
mutations in Armadillo (arm 33) cause detachment of cells in the amnioserosa. The 
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amnioserosa rips from the leading edge and as a result the cells at the leading edge 
remain polygonal in shape (McEwen et al., 2000). This could suggest the two 
proteins interact to maintain cell-cell interactions during dorsal closure. 
In many mutant embryos that failed to complete dorsal closure the leading edge 
folded inwards. We suggest that the strong expression of Myosin VI at the apical 
surface of the leading edge cells might be necessary as a physical support for the 
leading edge during its migration over the amnioserosa. The reduction in the rigidity 
of the cells could also be related to the change in the organisation of the actin 
cytoskeleton. In several cases, cells that express AATP-jar and mutant cells had an 
aberrant organisation of the actin filaments in the cell cortex at the leading edge, and 
the cells lost their elongated shape. This is the area that was found to fold-in in many 
embryos. The connection between the change in cell shape and the disorganization of 
the cytoskeleton could suggest that the cytoskeleton is necessary for maintaining cell 
rigidity. This suggests that Myosin VI preserves cell shape by participating in the 
synthesis or the patterning of the actin filaments during the migration of the epithelial 
cells. This is consistent with previous studies showing the role of Myosin VI in actin 
dynamics in the individualization complex in the testes, via interactions Cortactin, 
Arp 2/3 and Dynamin (Rogat and Miller, 2002). 
Kiehart et al. (Kiehart et al., 2000) showed that the leading edge created a purse-
string—like structure that promotes forces required for dorsal closure. As dorsal 
closure progresses, these cells become elongated and robust. The cells change their 
shape by the contraction of the acto-myosin cable; however their shape is dependent 
upon other factors including the adhesion between the cells in the leading edge and 
in the aninioserosa, and the connection between the leading edge and the 
amnioserosa. All these properties could contribute to the forces on a cell at the 
leading edge during dorsal closure and all these parameters change when the function 
of Myosin VI is disrupted. 
The creation of multiple wounds by laser beams in embryos did not prevent their 
quick recovery (Kiehart et al., 2000). Disruption caused by Myosin VI prevents or 
does not enable recovery of the ripped tissues, probably due to the loss of cell 
adhesion properties. This suggests a potentially important role for Myosin VI in 
wound healing. Myosin VI and myosin II localise at the leading edge during dorsal 
closure although Myosin VI seems to have a very little affect on the localisation of 
myosin II at the cell membrane. Myosin II was found previously to be expressed at 
the leading edge of wounds in chick embryos and at the wound borders in Xenopus 
oocytes, creating the purse string during the wound closure (Bement et al., 1999; 
Brock et al., 1996). In the chick bud wounds, antibody staining revealed localisation 
of cadherins in cell junction clusters at the wound margins. It would be interesting to 
test whether or not Myosin VI is expressed and necessary for wound healing in 
mammals. 
Many mutant and dominant-negative embryos failed to complete germ band 
retraction during stages 12-13. The direction of movement of the germ band is 
opposite to the leading edge in which the germ band moves away from the 
amnioserosa, leaving it exposed, while the leading edge covers the amnioserosa, 
therefore the forces applied on every tissue would be different. In spite of the 
different directions of migration both tissues fail to migrate properly following the 
disruption of Myosin VI and in both cases the tissues become detached from the 
amnioserosa, and was loose and disorganized. Myosin VI could maintain the contacts 
between cells and the extracellular matrix. Mutation in the genes encoding PPS-
integrin and aPS3-integrin, which compose PS3, a member of the position-specific 
integrin family that are necessary for the connection of cells to the extracellular 
matrix during the Drosophila development, caused failure in dorsal closure and 
germ band retraction (Brown et al., 2000; Narasimha and Brown, 2004). 
Interestingly, mutations in ctPS3-integrin cause the same u-shaped phenotype 
observed in jar mutants that failed to complete germ band retraction (Schock and 
Perrirnon, 2003). Mutations in PPS aPS1 and aPS2-integrins also cause rupture in 
the amnioserosa (Roote and Zusman, 1995). In wild type embryos, PS- integrin is 
expressed in many areas at the interface between the yolk and the surrounding 
mesoderm (Leptin et al., 1989), and aPS2-integrin is expressed in the mesoderm 
which composes the germ band (Bogaert et al., 1987), however PS integrins are not 
expressed at the leading edge or the amnioserosa. As described in chapter 6, Myosin 
VI affects the expression of PPS and aPS2-integrins in the follicle cells. It would be 
interesting to test the expression of these proteins in the mesoderm in Myosin VI 
mutants during germ band retraction. 
In spite of the necessity for Myosin VI in cell shape organisation and cell movement, 
depletion of Myosin VI did not significantly change the expression of Myosin II. 
However, when the function of Myosin VI was disrupted by AATP-jar, the 
localisation of myosin II to the cell membrane was slightly reduced in several regions 
at the lateral epidermis. Myosin VI and Myosin II also showed similar patterns of 
expression in the egg chambers during mid and late stages of oogenesis (Deng et al., 
1999), however, disruption of Myosin VI expression did not reduce the expression of 
nonmuscle Myosin II. 
5.14.3 Results obtained recently by Vasiliki Lazou: Myosin VI is 
present at the filopodia and lamellipodia during dorsal closure 
As the epidermis covers the amnioserosa during dorsal closure, the epithelial cells at 
the leading edge shows an extensive activity of filopodia and lamellipodia, which are 
crucial for zipping together the epithelial sheets and for the precise matching of the 
cells in the zipping process (Jacinto et al., 2000). The filopodia (and subsequently the 
lamellipodia) are necessary for bringing together the epithelial cells from opposing 
edges. Initially, filopodia sent from both edges meet and create a weak adhesion. A 
regression of the filopodia brings the cells closer and allows a stronger adhesion 
between the cells along the attached cell membranes (Martin and Wood, 2002). In 
order to observe the location of Myosin VI during the closure of the dorsal midline, 
PGM was expressed during dorsal closure, using an en-Ga14 line, and filopodia and 
lamellipodia were observed in live embryos. There is strong expression of PGM in 
the cell membrane at the edge of epithelial cells facing the opposite edge (Millo et 
al., 2004). PGM was also present in filopodia and lamellipodia. As the cells from 
opposite tissues meet, PGM expression increased in the adhesion area. When the 
adhesion between the cells is completed, the expression of PGM between the joined 
cells is reduced. The expression of PGM in the filopodia and lamellipodia suggests 
that Myosin VI is necessary for the migration of the cells as well as for cell adhesion; 
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however the expression in lamellipodia could be necessary for the initial attachment 
of the cells. 
SEM images of embryos expressing of Myosin VI dominant negative revealed that 
the filopodia was loose and did not connect the two leading edges. The tight 
organisation of the leading edge was lost and contained membrane protrusions that 
were not observed in previous studies. These results should be verified with images 
of wild-type embryos produced in Edinburgh (in order to ensure that there are no 
artefacts in the way the embryos were treated in this experiment). However if the 
results are genuine then it is possible the expression of Myosin VI in the lamellipodia 
is necessary for the attachment of the opposite cells, and that Myosin VI plays a role 
in membrane ruffling during dorsal closure. 
During spermatogenesis in Drosophila male sterile jar mutants fail in sperm 
individualization, (Hicks et al., 1999) an event which requires separation of sperm by 
membranes. It is possible that Myosin VI also plays a role in the remodelling of cell 
membranes at the leading edge, that this is crucial for the adhesive properties of the 
cells during dorsal closure. The presence of Myosin VI in filopodia and lamellipodia 
indicates that Myosin VI functions within those cell extensions. Myosin VI could 
either be needed for the adhesion of the filopodia to the opposite cells. The presence 
of Myosin VI could also be necessary for the organisation of the actin filaments or 
for the synthesis of the cell membrane. 
In this chapter two Myosin VI mutants, jar R39  and jar R235 were characterized, by 
defining their molecular structure and their mRNA transcription pattern. In a mutant 
rescue experiment it was shown that the embryonic lethal phenotype of the mutants 
is related to the lack of Myosin VI. Disruption of Myosin VI function by the 
expression of Myosin VI dominant negative caused similar abnormalities to the 
mutants: the embryos failed to complete dorsal closure and sometimes germ band 
retraction; the cells in the amnioserosa and the epidermis were detached and lost their 
stringency, causing rupture of the tissues. Myosin VI seems to play a role in the 
localisation of DE-cadherin and Armadillo to the cell membrane, and in the 
organisation of actin filaments in the cells membranes. These results suggest that 
Myosin VI is necessary for mediating the adhesion properties and contributes to the 
maintenance of the actin cytoskeleton during dorsal closure. 
Chapter 6: 
The genetic interactions between Myosin VI and 
other proteins during oogenesis 
£ 
- 	 I 
I 	 .,. 
j 	 I  
owl 
This work was undertaken in collaboration with Vasiliki Lazou. 
6.1 Introduction 
Previous research showed that Myosin VI is necessary for the migration of all the 
follicle cells during oogenesis (Deng et al., 1999; Geisbrecht and Montell, 2002) and 
that disruption of the expression of Myosin VI causes abnormal organisation of the 
follicle cell epithelium and deformation of the cells. We asked what the function of 
Myosin VI is in maintaining the organisation of the follicle cell epithelium. Does it 
play a role in the adhesion of the cells as they move or does it participate in the 
actual movement of every single cell? 
In order to answer these questions, it was necessary to examine the genetical 
interaction of Myosin VI with several proteins. Initially the interaction of Myosin VI 
with proteins that were found to contact with Drosophila Myosin VI during other 
stages of development, or in other species was tested. We investigated the expression 
of CLIP-190 (cytoplasmic linker protein-190), Clatbrin, a-adaptin, and Dig (Discs 
Large) (Buss et al., 2001; Lantz and Miller, 1998; Wu et al., 2002). After finding an 
interaction between Dlg and Myosin VI, the interaction of Myosin VI was tested 
with a protein that functions downstream to Dlg in the follicle cells, Bazooka. 
Another approach was to test the interaction of Myosin VI with proteins that 
participate in cell adhesion. This approach relates to previous experiments that 
showed that during oogenesis Myosin VI interacts genetically with DE-cadherin and 
Armadillo - two proteins that are implicated in cell-cell adhesion (Geisbrecht and 
Montell, 2002). The interaction of Myosin VI with other cell adhesion proteins was 
tested, and with proteins interacting with DE-cadherin and Armadillo namely a-
spectrin and Ankyrin. 
And finally, the effect of Myosin VI function was also tested on proteins necessary 
for the adhesion of cells to extracellular matrix: the position-specific (PS) integrins 
2a-integrin and 3-integrin comprising the PS2 integrins (Brown, 2000). 
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The result for each of the proteins selected is described, followed by a discussion 
about the possible roles of Myosin VI in epithelial morphogenesis in view of the 
results obtained. 
6.2 	Disruption of Myosin VI expression in groups of follicle 
cells during oo genesis. 
The expression of Myosin VI was disrupted in groups of columnar follicle cells using 
a site-directed gene silencing technique (Deng et al., 1999). Then, a comparison was 
made between the expression pattern of proteins that were suspected to interact with 
Myosin VI in the Myosin VI knock-out cells and in wild-type follicle cells. If the 
expression pattern of a protein changed in the Myosin VI knock-out cells, then it is 
possible that this protein interacts genetically with Myosin VI. 
In previous experiments, the induction of Myosin VI antisense was generated in most 
of the follicle cells (apart from the border cells), using C532-Ga14 line (Deng et al., 
1999). A more accurate way to examine the effect of Myosin VI is by comparing 
groups of cells depleted for Myosin VI to wild-type follicle cells within the same egg 
chamber. In order to induce the knock-out of Myosin VI in a small population of 
columnar follicle cells, a Myosin VI antisense line, Am 8-2 was crossed with the E4-
Ga14 line. The plasmid insert in the line Am 8-2 contains a UAS target sequence 
upstream of the Myosin VI antisense sequence. The binding of Ga14 protein with the 
UAS target sequence triggers the transcription of Myosin VI antisense and the 
knock-out of Myosin VI in the specific groups of cells that express Ga14. 
In all the figures in the following pages, cells with disrupted Myosin VI 
expression were marked with an asterisk. 
Figure 6.2.1: The expression pattern of the E4-Ga14 line, as shown after crossing with UAS-PGM 
line, 17-1. E4 is expressed in patches of follicle cells: Figure A shows an egg at approximately stage 
7-8, and figure B shows an egg at later stage of development, approximately stage 10. Frequently, 
expression is in groups of cells at the posterior part of the egg chamber (B), although PGM also 
appeared in groups of cells in the whole egg chamber (A). 
Figure 6.2.2: The antibodies Drosophila Myosin VI (A) and porcine Myosin VI (B) are equally 
specific. The two antibodies have a weak expression only in cells where Myosin VI is knocked-out 
(asterisk). 
Figure 6.2.3: In some mature eggs, the knock-out of Myosin VI in a group of cells disrupts the 
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At late stages of oogenesis, E4 expresses Ga14 in patches of follicle cells, mainly at 
the posterior part of the egg, but during early staged eggs (stage 8 approximately), 
Ga14 is also expressed in more anterior regions (Fig.6.2.1). 
In many cases, the induction of Myosin VI antisense by E4-Ga14 disrupted the 
expression of Myosin VI in follicle cells in the anterior part of the oocyte rather then 
in the posterior region. It seems that there is a time delay between the expression of 
Myosin VI antisense and the total depletion of the protein. Therefore, the expression 
of Gal4 in the posterior part of the egg chamber affects the expression of Myosin VI 
only in later stages, while the disruption of Myosin VI expression in cells located 
anteriorly could be derived from the induction of Myosin VI antisense in groups of 
follicle cells located in anterior regions, during earlier stages (stages 8-9). The 
misexpression of Myosin VI in Am 8-2; E4-Ga14 flies did not interfere with the 
organisation of the follicle cell epithelium. However, since the chorion layer was not 
created at this area (Fig. 6.2.3), in several cases the posterior part of the egg remained 
open .This can be possibly explained by the fact that the disruption of Myosin VI 
prevented the proper migration of the follicle cells to this area and for that reason the 
chorion could not be secreted there properly. Another possibility is that the 
disruption of Myosin VI interfered with the secretion of the chorion by the follicle 
cells. 
The antibody used to detect Drosophila Myosin VI was raised in mice. Some of the 
antibodies that were tested were also raised in mice. In order to make double staining 
of Myosin VI with other proteins, it is necessary to use antibodies that were raised in 
two different host species. For this reason a Myosin VI antibody was needed that 
would be specific for Drosophila Myosin VI but who not raised in mouse. The 
porcine Myosin VI antibody was raised in rabbit. This antibody was raised against 
the whole Myosin VI tail, having 61% identity with Drosophila Myosin VI tail. In 
order to test its specific binding to Drosophila Myosin VI, a double staining was 
made with anti-Drosophila and anti-porcine Myosin VI, in Am8-2; E4-Ga14 egg 
chambers (Fig. 6.2.2). The expression of the two antibodies appeared in wild-type 
cells, while the expression in Myosin VI knocked-out cells was significantly reduced. 
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Therefore the porcine Myosin VI antibody is specific for Drosophila Myosin VI and 
could be used as a substitute for the experiments. 
6.3 	The effect of Myosin VI knock-out on the expression of 
CLIP-190, ci-adaptin, Clathrin and Dig 
As discussed in the previous section, the first approach used in the experiments was 
to examine the interaction of Myosin VI during oogenesis with proteins that were 
found to interact with Myosin VI at different stages of development or in other 
species. 
Previous experiments show that CLIP-190 (cytoplasmic linker protein-190) was 
found to interact with Myosin VI and co-localise in the central nerve system and in 
the posterior pole, in Drosophila embryos (Lantz and Miller, 1998). In the follicle 
cells, CLIP-190 is expressed in the cytoplasm. The results of the co-localisation 
experiments show that the knock-out of Myosin VI does not affect the expression or 
the localisation of CLIP-190 (Fig. 6.3.1). 
Myosin VI interacts physically a-adaptin and Clathrin with and was found to be 
associated with Clathrin coated pits in polarized cells containing microvilli (Buss et 
al., 2001). During oogenesis, these proteins had already been found to be expressed 
in follicle cells, mainly at the interface between the follicle cells and the oocyte 
(Dollar et al., 2002; Richard et al., 2001). Clathrin is expressed in the cell cytoplasm, 
and excluded from the nucleus (Fig. 6.3.2). When the expression of Myosin VI is 
disrupted, the organisation of Clathrin around the nucleus is not as clear as in the 
wild-type follicle cells (Fig. 6.3.2). This could suggest that Myosin VI plays a role in 
the localisation of Clathrin. However, because the change in the localisation of 
Clathrin is very small, the slight change in Clathrin localisation could be related to a 
physiological change in cell shape in the absence of Myosin VI. 
The disruption in Myosin VI expression had a more significant effect on the 
expression of a-adaptin (Fig. 6.3.3). In figures 6.3.3. A-C, three groups of follicle 
cells that show a reduced expression of Myosin VI are marked with asterisks. 
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In figures 6.3.3. D-F, the upper left group of cells are magnified, and viewed on a 
focus level closer to the basal side of the cells. 
On the lateral surface of the cells the expression of a-adaptin in the cell membrane is 
reduced significantly. The disruption of Myosin VI expression also reduced the 
expression of a-adaptin in the area between the follicle cells and the region facing 
the oocyte (Fig. 6.3.6. J-K). These results seem to suggest that Myosin VI and a-
adaptin co-localise in the cell membrane and in the follicle cell-oocyte interphase, 
and that Myosin VI plays a role in the localisation of ct-adaptin to the cell membrane. 
The reduction of Myosin VI expression did not always affect the expression of a-
adaptin (Fig. 6.3.3 G-I). This result may indicate that the interaction of Myosin VI 
with a-adaptin is not direct, but rather is mediated by other proteins. 
Myosin VI was found to interact with SAP97 (synapse-associated protein) in rat 
nerve cells and to form a complex with G1uR1 (Wu et al., 2002). The Drosophila 
homologue of SAP97 is Discs Large (Dig). Dig is a tumour suppressor protein that is 
necessary to block follicle cell invasion and to maintain cell polarity (Goode and 
Perrimon, 1997). Loss of Dlg function causes invasion of follicle cells (which are not 
border cells) to the nurse cells cluster as a result of abnormal cell proliferation and 
migration (Goode and Perrimon, 1997). The invasive follicle cells were also found to 
lose their polarity. It was tested if Myosin VI and Dlg have related functions during 
the formation of the follicle cell epithelium. In columnar follicle cells, Myosin VI 
and Dlg co-localise to the cell membrane (Fig. 6.3.4.1 and 6.3.4.2 A-C). In migrating 
cells, the expression of the two proteins increases and Dlg is also expressed in the 
cytoplasm (Fig. 6.3.4.1, arrows). When the expression of Myosin VI is disrupted 
(Fig. 6.3.4.2 A-F, area marked in asterisk), Dlg is mislocalised to the cytoplasm and, 
in severe cases, the expression of Dig is reduced noticeably (Fig. 6.3.4.2 G-I, area 
marked in asterisk). These results show that Myosin VI is crucial for the expression 
and the localisation of Dlg to the follicle cell membrane. 
In addition, Myosin VI plays a role in the localisation of the endocytic proteins: 
Clathrin and ct-adaptin, although the affect of Myosin VI knock-out on the 
expression pattern of these proteins is less significant. The disruption of Myosin VI 
did not seem to affect the expression of CLIP-190. 
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In all the figures in the following pages, cells with disrupted Myosin VI 
expression were marked with an asterisk. 
Figure 6.3.1: The expression of Myosin VI and CLIP-190 in ovaries expressing Myosin VI antisense 
directed by E4-Ga14. Myosin VI (A) and CLIP-190 (B) co-localise in the follicle cell cytoplasm (C), 
however disruption in Myosin VI expression does not affect the expression of CLIP-l90 (area marked 
with asterisk). Figures D-F are magnification of figures A-C. 
Figure 6.3.2: The expression of Myosin VI (A, D) and Clathrin (B, E) in ovaries expressing Myosin 
VI antisense directed by E4-Ga14. Myosin VI and Clathrin co-localise in the cell membrane and 
cytoplasm (C, F), segregated from the nucleus. In cells where Myosin VI expression is disrupted, the 
exclusion of Clathrin from the nucleus is less obvious. 
Figure 6.3.3: The expression of Myosin VI (A, D, G) and a-adaptin (B, E, H) in ovaries expressing 
Myosin VI antisense directed by E4-Gal4. Myosin VI and a-adaptin co-localise mainly at the cell 
membrane (C, F, I). In many cases, the disruption in Myosin VI expression had only a slight effect on 
a-adaptin expression (B, H). However, in some cells the knock-out of Myosin VI significantly 
reduced the expression of a-adaptm at the lateral cell membrane (E), and at the apical side of the 
follicle cells (J, K, arrows). 
Figure 6.3.4.1: Myosin VI (A) and Dlg (B) show a strong expression in the migrating dorsal-anterior 
follicle cells during stage Ii. Dlg is localised to the cell membrane in most of the follicle cells, and in 
the migrating cells. Dlg is also expressed in the cytoplasm (arrow). 
Figure 6.3.4.2: The expression of Myosin VI (A, D, G) and Dlg (B, E, H) in ovaries expressing 
Myosin VI antisense by E4-Ga14. Myosin VI and Dlg co-localise at the cell membrane (C, F, I). Cells 
in which Myosin VI expression is disrupted, Dig is misiocaiised to the cytoplasm (E, asterisk) or not 
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6.4 	The genetic interaction of Myosin VI with Bazooka 
After finding the affect of Myosin VI on Dig expression, possible interactions of 
Myosin VI with proteins that interact with Dig were investigated. Dig interacts 
genetically with Bazooka in the follicle cells (Abdelilah-Seyfried et al., 2003). In dig 
mutants, Bazooka loses its apical polarity. In the double mutant for the dig and 
bazooka genes, the invasion of the follicle cells is prevented, suggesting that 
Bazooka acts as a permissive factor in invasive follicle cells created in dig mutants, 
possibly by stabilising the adhesion between the follicle cells and the nurse cells 
(Abdelilah-Seyfried et al., 2003). Mutation in the bazooka gene increases the 
proliferation of the follicle cells (Huynh et al., 2001). In the border cells, Bazooka 
does not play a permissive role, but rather regulates the adherence of cells within the 
cluster. 
When examining the basal surface in wild-type follicle cells, Bazooka is expressed 
strongly in a punctate form, possibly attached to cytoplasmic vesicles that co-localise 
with Myosin VI (Fig. 6.4.1 A-F). A strong expression of Bazooka also appears in the 
cell membrane and around the nucleus. In Myosin VI knock-out follicle cells, the 
strong expression of Bazooka in vesicles at the cell cytoplasm is reduced 
significantly (Fig. 6.4.1 A-F, area marked in asterisk). 
These results suggest that a genetic interaction between Myosin VI and Bazooka 
takes place. Because Dlg was shown to function upstream of Bazooka in the follicle 
cells, and the affect of Myosin VI on the expression and localisation of Dig, it is 
possible that the reduced expression of Bazooka in Myosin VI knock-out cells is 
related to the mislocalisation of Dig. 
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Figure 6.4.1: The expression of Myosin VI (A, D) and Bazooka (B, E) in ovaries, expressing Myosin 
VI antisense directed by E4-Ga14. Figures D-E are magnifications of figures A-C. Myosin VI and 
Bazooka are expressed at the cell cytoplasm in a punctuated manner (C, F). Disruption of Myosin VI 
expression reduces the strong punctate expression of Bazooka in the cell cytoplasm (E, asterisk). 
6.5 	The effect of Myosin VI depletion on the expression of 
a-spectrin, Ankyrin, PS2a-inte grin and PSfl-inte grin 
It was investigated if Myosin VI could interact with proteins implicated on the 
organisation of follicle cell monolayer by mediating adhesion or polarity properties 
of the cells. Previous experiments have shown that during oogenesis, Myosin VI 
interacts in the follicle cells (border and columnar cells) with the adhesion proteins 
DE-cadherin and Armadillo (Geisbrecht and Montell, 2002). It is also known that 
Myosin VI is necessary for the adhesion of the cells during dorsal closure (chapter 5, 
(Millo et al., 2004). These results seem to suggest that during oogenesis, Myosin VI 
maintains the cells attached to each other as they migrate. Alternatively, it may be 
that Myosin VI is necessary for maintaining cell polarity. 
a-spectrin is an actin binding protein located in the follicle cells that creates a 
network of ccP heterodimers (attachment of a and J3 spectrin subunits) to the lateral 
plasma membrane, and heterodimers with a larger 3-spectrin subunit (PH)  at the 
apical surface (Lee et al., 1997). The formation of the network appears to be essential 
for the maintenance of the follicle cell monolayer (Deng et al., 1995). When the 
expression of a-spectrin is disrupted in follicle cell clones, the organisation of the 
follicle cell monolayer is disturbed from stage 9 onwards, causing overlap of cells in 
certain areas and absence of cells in other areas (Deng et al., 1995; Lee et al., 1997). 
In the areas where follicle cell organisation is disrupted, the cells lose their shape and 
their polarity, which suggests that a-spectrin is necessary for determining the 
orientation of the follicle cells in the monolayer (Lee et al., 1997). 
Figure 6.5.1: The expression of Myosin VI (A) and cx-spectrin (B) in ovaries, expressing Myosin VI 
antisense directed by E4-Gal4. Myosin VI and a-spectrin co-localise at the lateral membrane (C). 
















In Armadillo mutants follicle cells that lost the organisation of the adherens 
junctions, the expression of ct-spectrin in the lateral membrane was reduced 
(Tanentzapfet al., 2000). The upstream effect of Myosin VI on Armadillo expression 
in the follicle cells could also affect the expression of spectrin (Geisbrecht and 
Montell, 2002). In order to examine whether Myosin VI participates in the 
polarisation of the follicle cells, during the follicle cell epithelium formation, the 
expression of cc-spectrin in the absence of Myosin VI was tested. 
In Madin-Darby canine kidney (MDCK) cells, during the assembly of the cells to an 
epithelial tissue, a complex containing E-cadherin, Ankyrin, Na, K-ATPase and 
Fodrin was formed (Nelson et al., 1990). In Drosophila S2 cells, Ankyrin and 3-
spectrin were recruited to sites of cell-cell adhesion, when the cells expressed the 
homophilic adhesion molecule neuroglian, however DE-cadherin did not affect the 
recruitment of Ankyrin (Dubreuil and Grushko, 1999). Taken together, the 
localisation of Ankyrin at cell-cell adhesion sites might suggest that Ankyrin plays a 
role in cell-cell adhesion. 
Previous experiments showed that Ankyrin functions as a peripheral membrane 
protein that connects the spectrin network with the plasma membrane in red blood 
cells (Bennett and Baines, 2001). In Drosophila embryos, an c43-spectrin complex 
was found to co-immunoprecipitate when using Ankyrin antiserum, although in the 
a-spectrin mutant larvae, the expression levels of Ankyrin and 13-spectrin was not 
affected (Dubreuil and Yu, 1994). In the follicle cells, Ankyrin was found in the 
lateral plasma membrane of the follicle cells, where it co-localises with a3-spectrin 
(Lee et al., 1997). The disruption in the expression of a-spectrin in the follicle cells 
affected the expression and localisation of Ankyrin in two ways: in stage 7, the 
expression of Ankyrin in posterior follicle cells that lost their organisation was 
shifted from the lateral membrane to the entire cell surface, and at stage 10, the 
expression of Ankyrin was reduced (Lee et al., 1997). In the light of these results, if 
the disruption of Myosin VI affects a-spectrin expression, then the expression of 
Ankyrin could be affected as well. 
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The figures in the following pages: 
Figure 6.5.2: The expression of Myosin VI (A, D) and Ankyrin (B, E) in ovaries, expressing Myosin 
VI antisense directed by E4-Gal4. Myosin VI and Ankyrin co-localise at the cell membrane (C, F). In 
cells where Myosin VI expression is disrupted, Ankyrin expression is reduced (B) or absent from the 
cell membrane (E, asterisk). 
Figure 6.53: The expression of Myosin VI (A) and PS2a-integrin (B) in ovaries expressing Myosin 
VI antisense directed by E4-Gal4. Myosin VI and PS2a-integrin co-localise at the cell cytoplasm (C). 
Disruption of Myosin VI expression reduces the expression of PS2c-integrin in the cell cytoplasm (B, 
asterisk). 
Figure 6.5.4: The expression of Myosin VI (A, D) and PSf3-integrin (B, E) in ovaries expressing 
Myosin VI antisense directed by E4-Ga14. Myosin VI and PS3-integrin co-localise at the cell 
cytoplasm (C, E). Disruption of Myosin VI expression reduces the expression of PS-integrin in the 
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Disrupting the expression Myosin VI did not affect the expression of a-spectrin at 
the cell membrane (Fig. 6.5.1). However, misexpression of Myosin VI reduced the 
expression of Ankyrin significantly, at the lateral membrane (Fig. 6.5.2). 
In addition, the interaction of Myosin VI was tested with the position-specific 
integrins. Integrins are membrane proteins that participate in cell-cell adhesion by 
binding to the extracellular membrane (ECM). PS2 integrin is a heterodimer 
composed of an a. subunit and a 13  subunit (PS2a-integrin and PS13-integrin). PS2 
integrins belong to one of three groups of integrins found in Drosophila 
melanogaster: PSI, PS2 and PS3. Each of these proteins interacts with actin 
filaments (Brakebusch and Fassler, 2003). PS-13 integrin was found to be associated 
with basal actin filaments in the follicle cell epithelium, mainly in areas of cell-cell 
contact and where actin filaments terminate. When follicle cell clones are created, 
containing mutations in the gene encoding PS-13 integrin (mysopheroid), the 
organisation of the basal actin filaments is disrupted, as found in stage 8 and stage 12 
egg chambers (Bateman et al., 2001). PS-13 integrin was found to function in 
coordination with the receptor tyrosine phosphatase Dlar, where a double mutation in 
the genes encoding the two proteins caused failure in oocyte elongation. This 
phenomenon is correlated to the loss in actin cytoskeleton organisation. Similar 
results were obtained in mutant follicle clones that were made for the genes encoding 
a integrin subunits: PS1a-integrin and with PS2a-integrin. The proper organisation 
of the cytoskeleton is a crucial factor for maintaining the integrity of the follicle cell 
monolayer. In the Drosophila individualization complex, Myosin VI was shown to 
interact with proteins necessary for actin dynamics. Following these findings the 
interaction of Myosin VI with PS13-integrin and with PS2a-integrin was tested. 
Originally it was intended to test the expression of PS  a-integrin as well, but it was 
impossible to obtain the antibody for this protein. 
The expression of PS2a-integrin and P513-integrin at the cell membrane and cell 
cytoplasm was reduced substantially when Myosin VI was absent from the follicle 
cells (Fig. 6.5.3-6.5.4). Therefore, we can conclude that Myosin VI regulates the 
expression of PS2a and PS13-integrin. 
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6.6 Conclusions 
In this chapter, a search was conducted for proteins that are necessary for the 
morphogenesis of the follicle cell epithelium, and that have an expression that is 
dependent on Myosin VI. 
The results show that Myosin VI was necessary for the expression and localisation of 
Dlg and Bazooka, two proteins necessary for controlling the follicle cells invasion 
and polarisation, during the early stages of oogenesis. Myosin VI was found to 
interact with PS2a-integrin and PSf3-integrin, which are implicated in actin filament 
organisation on the basal side of the follicle epithelium. When interaction of Myosin 
VI with cc-spectrin was tested the, it was revealed that the depletion of Myosin VI 
does not affect the localisation of ct-spectrin to the cell membrane. In spite of the 
interaction between x-spectrin and Ankyrin during embryogenesis, the depletion of 
Myosin VI reduced significantly the expression of Ankyrin at the lateral membrane. 
The experiments also showed that Myosin VI affected the expression of the 
endocytic proteins Clathrin and ct-adaptin, although the connection between those 
proteins and Myosin VI seems to be indirect. Finally, the depletion of Myosin VI did 
not affect CLIP-190 expression in the follicle cells. 
When Myosin VI antisense was expressed under the C532 driver, the organisation of 
the follicle cell epithelium was disrupted completely (Deng et al., 1999), while the 
silencing of Myosin VI in follicle cells patches by E4-Ga14 did not affect the 
organisation maintaining of the follicle cells. It is possible that the expression of 
Myosin VI in the follicle cells surrounding the antisense targeted cells prevented the 
total disorganization of the follicle cell epithelium. 
In stage 9, the follicle cells that migrate posteriorly to cover the oocyte are 
interconnected. The cells move in relation to their positions in the egg chamber, but 
not in relation to the adjacent follicle cells (Spradling, 1993). When the expression of 
Myosin VI was disrupted in the whole follicle cell epithelium from stage 9, the 
epithelium lost its uniform monolayer shape - the follicle cells gathered in groups 
and changed their shape. In severe cases, several follicle cells invaded the nurse 
cluster (Deng et al., 1999). 
The invasion of the follicle cells in severe cases of Myosin VI silencing could be 
related to the interaction of Myosin VI with Dig and Bazooka discovered in this 
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study. Bazooka and Dig function in concert to allow the follicle cells to migrate 
without invasion. Perhaps the strong expression of Myosin VI that appears in 
migrating follicle cells is necessary for regulating the migration of the cells while 
preventing their invasion by controlling the expression and localisation of Dig and 
Bazooka. This assumption is consistent with the strong expression and the co-
localisation of Myosin VI and Dlg in migrating follicle cells. It must be stated, 
however, that Dlg and Bazooka were found to mediate the invasion of the follicle 
cells before the migration of the follicle cells around the oocyte (Abdelilah-Seyfried 
et al., 2003; Goode and Perrimon, 1997). Furthermore, the disruption of Dlg 
expression did not affect the migration of the follicle along the egg chamber at stage 
9. Nevertheless, the expression of these proteins in the follicle cell membranes after 
stage 9, combined with the strong expression during the cells migration may indicate 
that Dlg and Bazooka are still necessary for maintaining the epithelium. 
In Drosophila, Dlg is necessary for blocking cell invasion and for maintaining cell 
polarity and cell adhesion in embryonic and adult epithelial tissues (De Lorenzo et 
al., 1999a; Humbert et al., 2003). In the imaginal discs, mutations in Dlg cause loss 
of septate junctions and formation of ectopic adherens junctions, suggesting that Dlg 
is necessary for cell adhesion and polarity (Woods et al., 1996). The loss of Dlg also 
changes the distribution of Fasciclin III and Neuroglian (two proteins involved in cell 
adhesion) (Woods et al., 1996), and DE-cadherin, while the expression of Armadillo 
in Dlg mutants significantly decreased (Woods et al., 1997). This may indicate that 
the upstream function of Myosin VI on DIg in the follicle cells mediates the adhesive 
properties of the follicle cells. 
Previously it was shown that Dlg does not have a physical interaction with Myosin 
VI in Drosophila ovaries (Geisbrecht and Montell, 2002). In addition, the 
mammalian homologue of Dlg, SAP97 showed to interact physically with Myosin VI 
in nerve cells but not in colonic epithelial cells (Wu et al., 2002). It seems that the 
interaction between Dlg and Myosin VI is indirect and the upstream effect of Myosin 
VI on Dig is mediated via additional proteins. 
The reduced expression of Bazooka could also explain the disruption in follicle cell 
adhesion and migration in the absence of Myosin VI. It was suggested that Bazooka 
permits invasion in wild-type follicle cells by stabilising the adhesion between the 
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invading follicle cells and the germ cells, or by mediating the migration of the 
follicle cells (Abdelilah-Seyfried et al., 2003). Further tests are necessary to establish 
the role of Bazooka in the migration or adhesion of the follicle cells, and the 
necessity of the interaction between Bazooka and Myosin VI in the follicle cells. 
The interaction of Myosin VI with PS2a-integrin and PS-integrin suggests that 
Myosin VI participates in maintaining the integrity of an epithelial tissue through the 
adhesion of the epithelial cells at their basal side to the extracellular matrix. The 
adhesion of the cells to the extracellular matrix contributes to cell movement and 
provides an additional dimension to maintain the integrity of follicle cells monolayer 
(Brown, 2000). 
The findings seem to indicate that the Myosin VI connects between DE-cadherin and 
PS-integrins, hence connecting between the adhesion of cells to adjacent cells and 
the adhesion of cells to other tissues through the extracellular matrix. Any molecule 
that is proposed to mediate a strong adhesion between cadherins and integrins should 
have to bind not only to these molecules, but also to the cytoskeleton (Brown et al., 
2000). Myosin VI, which directly interacts with actin filaments, is an ideal molecule 
for such a role. 
The role of PS integrins in the organisation of the basal actin filaments in the follicle 
cells could help maintain the integrity of the epithelium and the adhesion of the 
follicle cells. This suggests the possibility that the maintenance of a uniform 
epithelium by Myosin VI is made by the control of actin dynamics. In order to 
examine this possibility, the actin filaments in the follicle cell cortex should be 
tested. 
In Drosophila, PS integrins were found to be necessary for the connection between 
epithelial sheets in the wing (Bateman et al., 2001; Brown, 2000). PSI and PS2 
integrins are expressed at the dorsal and the ventral epithelia, respectively, where 
they mediate the adhesion between the epithelia. Mutations in PSI and PS2 integrin 
cause a separation of the epithelial sheets and blistering of the wing (Brabant et al., 
1998; Brabant et al., 1996). The expression of Myosin VI in the basal part of the 
epithelial cells in the wings, the connection area between the epithelial sheets, and 
the similar function that was found in this study for Myosin VI raises the possibility 
that the interaction of Myosin VT and integrins could be crucial in wings. When 
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Myosin VI antisense was induced by C532-Ga14 line, the wings in the adult flies 
were unfolded and malformed although no blistering was observed. It seems that in 
this case Myosin VI antisense was induced after the adhesion of the wing sheets was 
completed (30 hours after pupariation (Brabant et al., 1996). PS integrins are also 
required for the development of the trachea and for dorsal closure (Brown, 2000), 
two processes during which Myosin VI was found to be expressed (and in dorsal 
closure Myosin VI is essential). 
Although Myosin VI did not affect the expression of a-spectrin, the expression of 
Ankyrin was significantly reduced in the absence of Myosin VI. This finding might 
be related to previous evidence showing that the accumulation of Ankyrin is not 
affected in a-spectrin mutant larvae. In addition, the reduced expression of c'-
spectrin in the anterior columnar follicle cells did not affect the localisation of 
Ankyrin in the lateral membrane (Lee et al., 1997). These results indicate that in spite 
of a possible physical interaction between a-spectrin and Ankyrin during 
embryogenesis, the expression of the two proteins is controlled separately, and that 
the interaction between the proteins is probably not direct. 
In the Drosophila S2 cells, the cell adhesion molecule Neuroglian recruits Ankyrin to 
cell-cell contact sites. In the follicle cells and the salivary gland cells, Ankyrin was 
found to co-localise with Neuroglian in the lateral membrane (Dubreuil et al., 1997). 
This seems to suggest that the signalling by Neuroglian is dependent on extracellular 
adhesion and that the binding of Ankyrin plays a role in stabilising the adhesion 
between the cells (Hortsch et al., 1998). It would be interesting to test the 
relationship between Myosin VI and Neuroglian. 
The expression of Neuroglian and the assembly of Ankyrin and c43-spectrin were 
found to concentrate Na, K-ATPase at sites of cell-cell contact (Dubreuil et al., 
1997). Previous studies showed that Ankyrin interacts directly with Na, K-ATPase 
(Nelson and Veshnock, 1987). The presumed interaction between the two proteins 
could suggest that a connection exists between cell adhesion and cell polarity 
mediated by Ankyrin. The interaction of Myosin VI with Ankyrin suggests that 
during the creation or the maintenance of the follicle epithelium Myosin VI mediates 
the contact between the cells and perhaps their polarity as well. Even if Ankyrin does 
not directly affect the cell polarity, the reduced expression of Ankyrin at the lateral 
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membrane in the absence of Myosin VI could indicate that Myosin VI plays a role in 
cell polarity. 
E-cadherin, integrins and the human homologue of Dlg are all necessary for 
mediating the organisation of epithelial tissues in mammals. Interestingly, in ovarian 
carcinomas the expression levels of integrins and E-cadherin in the surface of the 
epithelial cells increase. These proteins are proposed increase the cells invasiveness 
(Skubitz, 2002; Sundfeldt et al., 1997). The homologue of Drosophila Dig, Ne-Dlg 
was also found to be up-regulated in ovarian carcinomas (Tapper et al., 2001). It was 
also found that Myosin VI was expressed at elevated levels in ovarian cancer cells 
(Montell, 2003). This may indicate that Myosin VI is also involved in tumour 
spreading. In collaboration with Leanne McGurk in our group, Myosin VI was 
shown to be expressed strongly in the granulosa cells of the mouse ovary (data not 
shown). Following these findings, it would be interesting to test the interaction of 
Myosin VI with these proteins during the organisation of the granulosa cells around 
the oocyte in mammalian ovaries. 
Clathrin and a-adaptin are expressed at the boundary between the follicle cells and 
the developing oocyte at the early stages of vitellogenesis (stages 8-9) (Richard et al., 
2001). Richard et al. claimed that when the development of the ovaries is arrested at 
the pre-vitellogenic stage, the expression of Clathrin, a-adaptin and yolk protein 
receptors in the follicle cells are reduced. It should be noted, however, that the data 
for these results are not shown in the article. In the results shown here, the expression 
of a-adaptin at the boundary between the follicle cells and the oocyte is reduced in 
the absence of Myosin VI. When the function of Myosin VI was inhibited in normal 
kidney cells, by over-expression of the tail domain, the endocytosis of Transferrin (a 
protein that undergoes endocytosis in mammalian cells) was reduced by 
approximately 70% (Buss et al., 2001). In Drosophila, ct-adaptin also plays a role in 
the recycling of pre-synaptic vesicles in the nervous system through Clathrin-
mediated endocytosis (Gonzalez-Gaitan and Jackie, 1997). It would be interesting to 
test whether Myosin VI is also necessary for the transport of yolk proteins from the 
follicle cells to the oocyte via Clathrin mediated endocytosis. 
Previous experiments showed that the migration of the border cells is not established 
through endocytosis (Geisbrecht and Monteii, 2002). Therefore the connection of 
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Myosin VI with the endocytic proteins would probably related to the transport of 
proteins to the oocyte and not to the migration of the follicle cells. 
Finally, an attempt was made to test the interaction between Myosin VI and 
Disabled. In mammals, Myosin VI was found to interact with Dab-2 (Inoue et al., 
2002), the mammalian homologue of Drosophila Disabled. Dab-2 is a tumour 
suppressor linked to cell signalling and endocytosis. The expression pattern of 
Disabled in the follicle cells could not be tested since the antibody for Drosophila 
Disabled was not available. I therefore tested the genetic interaction between Myosin 
VI and Disabled, by crossing the Myosin VI mutant flies: jar?39/TM3,  Sb, and 
jar?235/TM3, Sb with a Disabled mutant: dabM54/  TM3, Sb. In this cross, 66% of the 
flies were suspected to be heterozygous with Stubble phenotype, and 33% of the flies 
would be suspected to be non-Stubble, containing the Disabled and Myosin VI 
mutants on the two copies of the third chromosome (iar839/ dab M54  and jar?235/ 
dab M54).  If the combination of the two mutants would be lethal, then non-Stubble 
flies would not survive. The results of the cross showed no significant change 
between the observed and the expected ratios, suggesting that the two mutants did 
not significantly affect the viability of the flies. The morphology of the legs and 
wings looked normal, however the morphology of the ovaries and the fertility in the 
double mutant should be further tested. Interestingly, when the double mutant of 
Abelson and disabled (abl dab 22 '/ TM3, Sb) was crossed with Myosin VI mutants, all 
the flies were stubble, and non-stubble flies did not survive. The interaction of 
Myosin VI and Abelson should be further tested. 
In this study, the absence of Myosin VI was shown in to disrupt the creation of the 
chorion. This could suggest that Myosin VI is necessary for the transport of the 
chorion proteins, although it would probably interact with different proteins since the 
expression of Clathrin and a-adaptin in the follicle cells decreases by stage 10 
(Richard et al., 2001) and the secretion of the chorion starts at stage 12a (Papassideri 
and Margaritis, 1996). 
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The results shown here propose several potential ways in which Myosin VI could 
function in the migration of the follicle cells epithelium while preserving epithelial 
integrity: 
Myosin VI could maintain the adhesion between the cells via Ankyrin, Dig, 
Bazooka, and the proteins that were previously found to interact with Myosin 
VI: DE-Cadherin and Armadillo. 
Myosin VI could play a role in binding the follicle cells to the basal 
extracellular matrix (ECM) via PS2a-Integrin and PSI3-Integrin. The 
interaction with the ECM could be necessary for maintaining the follicle cells 
as a monolayer, and for the migration of the whole epithelium while 
maintaining epithelial integrity. The interaction of Myosin VI with PS2 
integrins could also affect the integrity of the actin cytoskeleton in the ECM. 
Myosin VI could mediate the migration of the follicle cells while preventing 
their invasion into the germ line derived cells via an interaction with Bazooka 
and Dig. 
Myosin VI might affect the polarity of the follicle cells either directly or via 
Ankyrin and Dlg. 
NE 
Chapter 7: 
Discussion and summary 
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This thesis has explored the role of Myosin VI in the patterning of epithelial tissues. 
The main results are mostly discussed in each chapter and we only briefly 
summerised here, considering options for future research. 
7.1 	The molecular function of Myosin VI 
Myosins are motor proteins that move along actin filaments. Myosins are composed 
of a head domain (termed the motor domain), a neck domain (which serves as a lever 
arm), and a tail domain (which binds to the cargo). Myosin VI is unique as it moves 
to the minus end of the actin filament which is the opposite direction to the other 
myosins. In order to examine the function of the whole Myosin VI molecule in 
epithelial tissues, the whole Myosin VI molecule or its separate domains (the head+ 
neck domains or the tail domain) tagged to GFP were expressed in somatic cells 
under the control of Ga14 protein and their localisation in the cells was observed. 
Previous experiments showed that the head and the tail domain are sufficient to drive 
the movement of Myosin VI towards the minus end (Homma et al., 2001; Wells et 
al., 1999). Consistent with these results, the head + neck domains were found in the 
nucleus of salivary gland and columnar follicle cells, where the minus end is 
localised. 
In spite of the tendency of Myosin VI towards the cell interior, the localisation of the 
molecule was found to be determined by the tail domain. In all the cells examined, 
Myosin VI was anchored away from the cell nucleus, by the tail domain. These 
results suggest that Myosin VI tends to move towards the cell interior, but at least in 
some regions in the cell, the localisation of the molecule is determined by the tail 
domain, probably via interaction with other proteins. In the border cells, the 
anchoring of Myosin VI to the leading edge of cells by the tail domain could be one 
of the ways to control the direction of cell migration. 
Prior to the observation of Myosin VI-GFP tagged protein (PGM) in the cells, it was 
crucial to test whether this protein preserved the normal function of the native 
Myosin VI. This was established by two mutant rescue tests, as described in chapter 
4, which proved that the tagging of Myosin VI to GFP did not disrupt its function. It 
also proved that the male sterility and embryonic lethal phenotypes of the Myosin VI 
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mutants were due to defects in Myosin VI gene, jaguar. The rescue of Myosin VI 
mutants by the expression of PGM will be a useful tool to verify existence of a 
mutation in the jaguar gene, in novel mutations, or to test upstream factors that 
control Myosin VI expression. 
When the tail domain-GFP tagged protein (PGMT) was expressed, it appeared in all 
the tissues in a punctate pattern. In the ovaries it was found that the PGMT clusters 
were co-localised with proteins that interact with Myosin VI during oogenesis: 
Ankyrin, armadillo, Bazooka and PS2-integrin. This suggests that the tail domain 
gathers around proteins that interact with Myosin VI. However, the physical 
interactions need to be investigated by immunoprecipitation. 
The tail domain of Myosin VI contains no recognizable motifs and it is a globular tail 
domain. Also, the binding sites of Myosin VI in Dab2 and SAP97 did not have any 
common features. The Dab2 binding site is serine and proline rich, and the binding 
site in SAP97 at the N domain of the molecule in a region which targets the molecule 
to cell adhesion sites in epithelial cells, (Hasson, 2003), though it does not contain 
any specific amino acid at a high concentration. Finding the specific site of Myosin 
VI binding in additional proteins will enable us to build a better picture about the 
nature of interactions between Myosin VI and other proteins. 
7.2 	The maintenance of epithelial tissue integrity by Myosin 
VI during migration 
During oogenesis and dorsal closure, the epithelial tissues migrate while maintaining 
their uniform structure. The cells remain inter-connected without changing their 
location in comparison to their neighbouring cells. The maintenance of the integrity 
of the tissues is essential for the completion of morphogenic changes and indeed the 
loss of the cell adhesion or shape change arrests dorsal closure and the migration of 
the follicular epithelium. 
In the light of the results obtained in this thesis and previous results it seems that 
Myosin VI maintains tissue integrity by preserving the adhesion between the 
epithelial cells and by mediating the adhesion between the epithelial cells and the 
extracellular matrix. Myosin VI, by being a molecule that moves along the actin 
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cytoskeleton and connects the cytoskeleton and membrane proteins, could serve as a 
good mediator for cell-cell and cell-matrix adhesion. 
The requirement for Myosin VI for cell-cell adhesion is shown during dorsal closure 
when the absence of Myosin VI and the expression of a Myosin VI dominant 
negative caused detachment of the cells in the leading edge and the amnioserosa 
(Millo et al., 2004). Also during oogenesis the follicle cells lost their monolayer 
arrangement and tended to separate from each other in the absence of Myosin VI 
(Deng et al., 1999). In both morphogenic events DE-cadherin and Armadillo 
expression and localisation was disrupted in the absence of Myosin VI, and during 
oogenesis Armadillo was found to interact physically with Myosin VI (Geisbrecht 
and Montel!, 2002). 
In this thesis we show evidence that Myosin VI plays a role in the connection of the 
epithelial cells to the extracellular matrix. In Myosin VI mutant embryos, the leading 
edge is often separated from the amnioserosa and appears loose and folded (Millo et 
al., 2004). The separation of the germ band from the amnioserosa gives additional 
evidence that Myosin VI is essential for the connection of epithelial cells to an 
extracellular matrix. 
During oogenesis the depletion of Myosin VI reduced the expression of PS2 
integrins. These integrins were found to be crucial for the maintenance of the actin 
cytoskeleton in the basal extracellular matrix. The upstream affect of Myosin VI on 
PS2 integrins could have an indirect role in the organization of actin filaments in the 
basal lamina. The interaction of Myosin VI with the PS integrins as well as with 
proteins implicated in cell adhesion (DE-cadherin, Ankyrin, Armadillo, Dlg and 
Bazooka) makes Myosin VI a potential mediator between cell-cell adhesion and cell-
matrix adhesion. As discussed in chapter 5, PS integrins are necessary for dorsal 
closure and germ band retraction (Brown et al., 2000; Narasimha and Brown, 2004). 
The possible interaction between PS integrins during embryogenesis and Myosin VI 
should be investigated. 
The expression of Myosin VI in the cell membranes connecting the wing epithelial 
sheets and the creation of wing blisters in the absence of Myosin VI provides 
additional evidence for the function of Myosin VI in the connection of epithelial cells 
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to the extracellular matrix. This is an additional developmental stage that requires PS 
integrins for holding together the two epithelial cell layers that form the adult wing. 
Apart from maintaining the epithelial sheets intact, Myosin VI seems to be necessary 
for maintaining cell shape and rigidity. During oogenesis the absence of Myosin VI 
changes the cell shape (Deng et al., 1999). During dorsal closure the changes were 
even more obvious when the expression of a Myosin VI dominant negative caused a 
folding-in of the tissue at the lateral epidermis (Millo et al., 2004). The changes in 
the cells shape and strength indicate that Myosin VI preserves cell shape as cells 
migrate. The strong expression of Myosin VI at the apical surface of the cells in the 
leading edge could serve as a shield that protects the cells from folding-in. The 
abnormal organization of the actin filaments in cortex of cells that tend to fold-in at 
the lateral epidermis may also suggest that Myosin VI preserves cell rigidity by 
maintaining the cytoskeleton. 
The migration of the border cells during oogenesis is arrested in the absence of 
Myosin VI, indicating that Myosin VI is also necessary for the migration itself. 
Moreover, the increase of DE-cadherin expression in Myosin VI depleted ovaries 
restored the migration of the cells. Therefore Myosin VI seems to control the 
migration of the cells through the interaction with the adhesion molecules DE-
cadherin and Armadillo (Geisbrecht and Montell, 2002). Ankyrin is localised at sites 
of cell adhesion and the interaction of Myosin VI with it could also be necessary for 
the cells migration (Dubreuil et al., 1997). The interaction of Myosin VI with DIg 
and Bazooka, as described in chapter 6, could suggest additional roles for Myosin VT 
in controlling cell invasion and polarity (Lee et al., 1997). As previous studies 
showed, Myosin VI is not involved in endocytosis during the migration of the follicle 
cells (Geisbrecht and Montell, 2002). 
Interestingly, as the migration of the border cells is arrested at the nurse cell-oocyte 
border, the Myosin VI molecule was found to be anchored to the leading edge, by the 
tail domain. The arrest of Myosin VI movement in the cells by anchoring the Myosin 
VI seems to be one of the ways of controlling the migration of the cells. 
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7.3 	Myosin VI and actin dynamics 
The expression of the Myosin VI head domain in salivary gland cells not only 
showed that the head domain tends to concentrate in the cell nucleus, but also 
showed that in the same regions where the head domain was concentrated, actin 
filaments were synthesized. The accumulation of the actin filaments in the cell 
nucleus did not appear when the tail domain or the whole Myosin VI was expressed, 
although in these cases actin filaments were co-localised with the tagged molecules. 
These results led to the conclusion that the head domain participates in the synthesis 
of actin filaments, perhaps by stabilizing the synthesized filaments. The co-
localisation of actin filaments with the tail clusters around the nucleus shows that this 
domain also affects filament polymerisation. 
Previous results showed that Myosin VI is necessary for the organization of actin 
filaments in the individualization complex (IC), of the testes (Hicks et al., 1999). 
While the mutant Myosin VI jarmm4  exhibited abnormal organization of the actin 
filaments in the IC, no actin filaments could be observed in the heteroallelic male 
flies jarmmi4/jarR39  and 	 Possibly, the presence of the two alleles 
significantly reduced the stability of the filaments in the IC. The expression of 
Myosin VI tagged to GFP restored fertility and the formation of the actin filaments in 
the IC of male flies, indicating that Myosin VI is necessary for the organization and 
stability of the filaments. 
A recent study suggests that the actin cone contains long filaments at the cone cortex, 
while in the centre of the cortex the filaments are short and cross-linked (Noguchi 
and Miller, 2003). Two roles were proposed for the actin filaments at the cone 
cortex. First the filaments are thought to push the cystic bulge foreword, through 
actin polymerisation. Second, the filaments must attach the cell membrane around 
them and shape it into a tubular structure (Noguchi and Miller, 2003). The 
organization of Myosin VI as a ring at the base of the cone indicates that Myosin VI 
would normally interact with the cortical actin filaments, which are adjacent to the 
formed membrane. This is also the initial contact region between the cell membrane 
of the spermatids and the actin filaments. Inhibition of ATPase did not prevent the 
movement of the cystic bulge; therefore it is likely that Myosin VI participates only 
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in the association of the cell membrane to the sites of actin filaments. This 
assumption is also supported by the interaction of Myosin VI with Cortactin and 
Dynamin, two proteins that associate with actin at sites of membrane assembly 
(Rogat and Miller, 2002). 
Our results show that when the head + neck domains are expressed, they are 
localised along the whole actin cone. However the whole Myosin VI molecule is 
anchored to the base of the cone (the plus end) by the tail domain, probably due a 
specific cargo binding to the tail domain. The anchoring of Myosin VI to the base of 
the cone is possibly necessary for the organization and stabilization of the cortical 
actin filaments at the site of interaction with the membrane. The possible role of the 
head domain in actin polymerisation as described above suggests that the head 
domain of Myosin VI may stabilize actin filaments. Accordingly, the tail domain 
would anchor the whole molecule to the base of the cone in order to allow the head 
domain to bind to the actin filaments and mediate their polymerisation. Alternatively, 
the attachment of the head domain to the plus end of the actin filaments could bring 
the filament end in contact with other proteins involved in actin polymerisation that 
are attached or located in close proximity to the tail domain. 
The recovery of fluorescent actin filaments from bleaching in the whole cone 
indicates that the synthesis of new actin filaments occurs in the entire cone, and no 
flow of actin filament was observed towards the minus end (Noguchi and Miller, 
2003). Therefore Myosin VI might be necessary for the stabilization of actin 
filaments rather than the synthesis itself. 
The involvement of Myosin VI in the organization of actin filaments was also 
observed in embryos during dorsal closure. As described in chapter 5, in the jarR39 
and jar R235  mutant embryos, the tight organization of the actin cable at the leading 
edge was disrupted. In several places along the cable aggregates of actin filaments 
were formed. These aberrations were even more obvious in embryos that expressed a 
Myosin VI dominant negative. Very often, cell stripes expressing Myosin VI 
dominant negative tended to fold-in. In these cells the organization of the actin 
filaments in the cell cortex was aberrant: the filaments were spread and lost their 
tight organization. These results suggested that the folding-in of the cells might be 
connected to the abnormal organization of the cytoskeleton. 
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During oogenesis, staining of egg chambers lacking Myosin VI with a-spectrin, 
which binds to actin filaments, revealed that the shape of the cells was changed 
(Deng et al., 1999). 
7.4 	Myosin Viand secretion 
Disruption of Myosin VI in the columnar follicle cells interfered with the creation of 
the chorion layer. The depletion of Myosin VI also reduced the expression of a-
adaptin, a protein participating in endocytosis, at the interface between the follicle 
cells and the oocyte. These results suggest a possible role for Myosin VI in chorion 
secretion. This could be verified by examining the effect of Myosin VI depletion on 
the transport of choriogenic proteins to the oocyte. Vitelline membrane proteins and 
choriogenic proteins were found to be localised in the same vesicles that secrete yolk 
proteins, therefore, Myosin VI could be needed for the secretion of yolk proteins as 
well (Butterworth et al., 1999; Trougakos et al., 2001). 
When PGM was expressed under the control of a Myosin VI-Ga14 line (C865), strong 
expression of Myosin VI was observed in the salivary gland. The expression 
gradually increased in the area close to the salivary ducts, and it was often possible to 
observe PGM clusters within the duct of the salivary gland. The salivary gland is the 
largest secretory tissue in the larvae, and many genes involved in the secretory 
pathways such as vesicular transport from the ER to the Golgi, are highly expressed. 
In mammalian cells, Myosin VI is localised in the Golgi complex as a peripheral 
membrane protein and is necessary for secretion from the Golgi complex, and for 
preserving its proper morphology (Buss et al., 1998; Warner et al., 2003). The strong 
expression of PGM in the salivary gland, mainly in the salivary duct could suggest a 
role of Myosin VI in secretion from the salivary glands, and the clustering of PGM in 
the duct could be related to particles secreted into the duct by a mechanism including 
Myosin VI. When the expression of Myosin VI is disrupted in the salivary glands by 
targeted expression of Myosin VI antisense, the size of the salivary glands 
significantly decreases (data not shown); therefore Myosin VI is needed for the 
proper development of the salivary glands. It would be interesting to test the effect of 
Myosin VI depletion on the release of secretory vesicles at the apical surface of the 
216 
salivary glands. The transport of membrane vesicles by Myosin VI could also be 
observed in vivo, by using membrane markers such as FM 1-43 in live salivary glands 
expressing PGM (Noguchi and Miller, 2003). 
7.5 Future research 
Dig, Bazooka, PS2 integrin, Ankyrin Clathrin and a-adaptin were found to function 
downstream of Myosin VI during dorsal closure and oogenesis. In order to test the 
mutual effect of these proteins on Myosin VI, the expression of Myosin VI could be 
examined in the egg chambers and embryos lacking these proteins. For example, in 
the heteroallelic dig mutant dig hJ321  /dig 1v55  the expression of Myosin VI could be 
tested and compared, especially in follicle cells that become invasive (Goode and 
Perrimon, 1997). The morphology of the tissues could also be tested in heterozygous 
mutants containing a mutation in jaguar and in the gene encoding one the other 
proteins. 
The cooperative function of Myosin VI and the interacting proteins could also be 
observed in live cells expressing PGM and the examined proteins tagged to a 
different fluorophore. The physical interaction of these proteins with Myosin VT 
should be tested by immunoprecipitation and two-hybrid screens. 
The proteins that were found to be affected by Myosin VI depletion are localised to 
different regions in the cell. DE-cadherin and Armadillo are localised in the adherens 
junction, while DIg is localised in the septate junction. The disruption in the 
expression of proteins localised at different sites could be established if the whole 
structure of the junctions in the lateral membrane is changed. This could also explain 
how the expression of Dig is disrupted by Myosin VI in the absence of a physical 
connection between the two proteins (Geisbrecht and Monte!!, 2002). In order to 
verify this possibility, the structure of the junctions and the organization of the 
cytoskeleton in the lateral membrane should be examined. 
A search for additional proteins that could interact with Myosin VI could clarify the 
cascade in which Myosin VI functions (i.e. the proteins that function upstream and 
downstream of Myosin VI). The search could be made for proteins that interact with 
the proteins found here, and that are expressed in the follicle cells during oogenesis 
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or in the amnioserosa and the epidermis during dorsal closure. For example, one 
candidate is Scribble, which interacts with Dig, and it is expressed in the follicle cells 
(Mathew et al., 2002). 
The screen for proteins that could interact with Myosin VI could be done according 
to genes that were found to have a similar phenotype to Myosin VI mutants. One of 
the genes that could be examined is Dcdc-42. During dorsal closure the expression of 
the Drosophila cdc42 dominant negative, Dcdc42Nl7 creates similar abnormalities 
in tissues shape and actin filament organisation to those observed when Myosin VI 
dominant negative is expressed (folding-in of the tissue and disorganization of actin 
filaments) (Ricos et al., 1999). During germ band retraction, there are several 
mutants which have similar phenotypes to Myosin VI mutants, including: scab 
(encoding aPS3-integrin), mysopheroid (encoding PPS-integrin), wing blister, u-
shaped, and tail-up (Frank and Rushlow, 1996; Schock and Perrimon, 2003). A 
complementation test of Myosin VI with these genes and expression analysis could 
indicate if some of these genes function in cooperation with Myosin VI. 
In the experiments described in the thesis, the expression of PGMT and PGMH was 
established in wild-type flies that express myosin, the native Myosin VI. Because the 
function of Myosin VI is normal in these cells, the tail domain could be localised at 
its final destination (where the cargo was transferred by the normal Myosin VI). The 
observation of PGMT in mutant cells lacking Myosin VI and the comparison with 
the results obtained here could give additional information about the localisation of 
the cargo prior to its transport by Myosin VI, and the region in the cell where the 
cargo is transported. 
The observation of Myosin VI and its domains tagged to GFP in live images could 
provide a better understanding of the function of Myosin VI in different organs. 
During dorsal closure Myosin VI is expressed in filopodia and lamellipodia in the 
leading edge cells, examination in vivo of how the expression of Myosin VI 
dominant negative affects the adhesion of the filopodia to opposite epithelial cells, 
and the adhesion of adjacent cells in the lateral epidermis and the amnioserosa could 
be of a value. This could be done by expressing Myosin VI dominant negative and 
actin-GFP simultaneously. This experiment could also enable us to test the change in 
the organization of actin filaments at the leading edge. 
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The expression of the tagged proteins under the control of a Myosin VI-Ga14 line 
allowed us to observe all the organs and tissues that express Myosin VI during the 
life cycle. In some of the organs, the expression of Myosin VI was not previously 
known, such as the trachea, the brain, and eye-antenna imaginal disc and the salivary 
gland. This opens the possibilities of a new research on the role of Myosin VI in the 
development of these organs. 
In Drosophila melanogaster 8 myosins have been identified previously and five new 
myosins have been identified and classified by our group when the Drosophila 
genome was published. Chapter 3 describes the characterization of the new myosins. 
Apart from Myosin VI, there are other myosins that are expressed in oogenesis, 
including myosin I, II, and V. Their role in oogenesis is described in the 
Introduction. In situ hybridisation experiments showed that the new myosins, 
MyolOA, Myo29 and Myo95E are also expressed during oogenesis. Their function 
in oogenesis could be further examined, and it would also be interesting to test their 
expression and function in other epithelial tissues. Each myosin has a unique 
structure that fits a specific function. It would be interesting to test the separate 
function of each myosin and their interacted functions and expression in vivo. 
Finally, the results obtained in this thesis could be investigated in other species, for 
example the role of Myosin VI in wound healing. Dorsal closure serves as a model to 
study wound healing. Previous studies showed that myosin II, which is crucial for the 
process of dorsal closure, is strongly expressed at the leading edge of wounds in 
chick embryos and at the wound borders in Xenopus oocytes, creating the purse 
string during the wound closure (Bement et al., 1999; Brock et al., 1996). Myosin II 
was also expressed in wounds created in Drosophila embryos with a laser (Wood et 
al., 2002). The localisation of Myosin VI and myosin II at the leading edge of the 
lateral epidermis, and the interaction of Myosin VI with cell adhesion molecules 
could make Myosin VI crucial for the healing process of wounds. 
The elevation of Myosin VI expression levels in ovarian cancer cells (Montell, 2003) 
indicates that Myosin VI is necessary for the development of epithelial tissues in 
humans. The publication of the human and mouse genome enabled to find the genes 
responsible for various diseases. Several mutations in Myosin VI were already found 
to be connected with hearing loss. One of the mutations in Myosin VI that was found 
NK 
recently was associated with sensorineural deafness and hypertrophic 
cardiomyopathy (cardio-auditory syndrome) (Mohiddin et al., 2004). Antibody 
staining of mice ovaries revealed that Myosin VI is present in the granulosa cells, 
prior to ovulation (the experiment was established in our lab by Leeanne McGurk). 
This could indicate a role for Myosin VI in the morphogenesis of the granulosa 
epithelium. It is planned to investigate if Myosin VI is also expressed after ovulation 
and if it is necessary for the healing process of the ovarian follicle. 
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Identification and Phylogenetic Analysis of Drosophila melanogaster Myosins 
George Tzolovsky, Hadas Millo, Stephen Pathirana, Timothy Wood, and Mary Bownes 
Institute of Cell and Molecular Biology, University of Edinburgh 
Myosins constitute a superlamily of motor proteins that convert energy from ATP hydrolysis into mechanical 
movement along the actin filaments. Phylogenetic analysis currently places myosins into 17 classes based on class-
specific features of their conserved motor domain. Traditionally, the myosins have been divided into two classes 
depending on whether they form monomers or dimers. The conventional myosin of muscle and nonmuscle cells 
forms class If myosins. They are complex molecules of four light chains bound to two heavy chains that form 
bipolar filaments via interactions between their coiled-coil tails (type II). Class I myosins are smaller monomeric 
myosins referred to as unconventional myosins. Now, at least 15 other classes of unconventional myosins are known. 
How many myosins are needed to ensure the proper development and function of eukaryotic organisms? Thus far, 
three types of myosins were found in budding yeast, six in the nematode Caenorhabdiris elegans, and at least 12 
in human. Here, we report on the identification and classification of Drosophila inelanogasler myosins. Analysis 
of the Drosophila genome sequence identified 13 myosin genes. Phylogenetic analysis based on the sequence 
comparison of the myosin motor domains, as well as the presence of the class-specific domains, suggests that 
Drosophila myosins can be divided into nine major classes. Myosins belonging to previously described classes I, 
II, III, V, VI, and VII are present. Molecular and phylogenetic analysis indicates that the fruitfly genome contains 
at least live new myosins. Three of them fall into previously described myosin classes I. VII, and XV. Another 
myosin is a hornolog of the mouse and human PDZ-containing myosins, forming the recently defined class XVIII 
myosins. PDZ domains are named after the postsynaptic density, disc-large, ZO- I proteins in which they were first 
described. The fifth myosin shows a unique domain composition and a low homology to any of the existing classes. 
We propose that this is classified when similar myosins are identified in other species. 
Introduction 
The past decade has seen a significant increase in 
research on myosins. A major effort has been put into 
finding novel members of this family of actin-based mo-
tor proteins. More than 16 classes of myosins have been 
discovered and characterized, and this number is still 
rising (Hodge and Cope 2000; Sellers 2000). These my-
osins are often referred to as unconventional (Mooseker 
and Cheney 1995). The total number of known myosins 
is 17 if the conventional two-headed filament forming 
myosin It is included in the classification. Myosins have 
been identified in a wide variety of eukaryotic organ-
isms. Some myosin classes are found in phylogeneti-
cally diverse organisms, whereas others, which have 
arisen later in evolution, have been found in only a sin-
gle organism (Hodge and Cope 2000). 
Current research concentrates on the functional 
analysis of these new types of myosins. A number of 
studies suggest that these motors play important roles in 
a variety of cellular functions, including organelle, RNA 
and protein transport, maintenance of the cell architec-
ture, cell movements, and signal transduction (table 1). 
All known myosins comprise an N-terminal head 
domain, a neck regulatory domain, and a specific car-
boxy-terminal tail domain (fig. 1) (Mooseker and Che-
ney 1995). The head or motor domain contains ATP-
and actin-binding sites and is responsible for the mech-
anochemical properties of the protein (Gilbert and 
Mackey 2000). Myosins show an actin-stimulated Mg 
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ATPase activity, thus converting the energy stored in 
ATP into mechanical force (Volkmann and Hanein 
2000). The latter is used to move the myosin molecules 
along the actin filaments or to translocate other mole-
cules (Hasson and Mooseker 1995; Langford 1995). 
The neck domain contains regulatory sites, com-
posed of IQ (isoleucine-glutamine) motifs, repeats of 
23-30 aa (Mercer et al. 1991; Rhoads and Friedberg 
1997). Each IQ motif provides a binding site for a cal-
modulin or a related protein of the EF-hand family (Ka-
wasaki, Nakayma, and Kretsinger 1998). EF proteins 
have helix-loop-helix motifs in which the loop contains 
highly conserved residues that bind Ca2 ions. The size 
of the neck domain varies from one to seven IQ tandem 
repeats. In addition, the neck is often the site of alter-
native splicing. This produces necks with variable 
lengths (variable number of IQ repeats), which are as-
sociated with the regulatory function. In general, cal-
modulin activates a diverse group of target cellular pro-
teins when bound to Ca2-. Interestingly, most of the 
unconventional myosins carry IQ motifs that bind cal-
modulin with higher affinity in the absence of Ca 21 
After the neck domain, each myosin has a highly 
divergent tail domain. A subset of myosin tails has pre-
dicted coil-coil cd-helical domains, which promote the 
formation of dimmers, a typical example being the two-
headed conventional myosin II. Some other myosins 
lack coiled-coil domains but contain structural domains 
found in other proteins (table 1). 
The classification of myosins is based on the se-
quence comparison of their core motor domains (myosin 
head), equivalent to amino acids 88-780 of chicken 
skeletal myosin II (Cope et al. 1996). The motor domain 
is highly conserved among all myosins, reflecting the 
high conservation of its function. However, they have a 
number of class-specific features (characteristic inserts 
1041 
1042 Tzolovsky et al. 
Table I 





Number of Heavy 
Chains 
Other (N- and C-terminal) 
Domains Function 
Subclass 	I ......One or two IQ I (monomer) THI. CPA or GPQ, and SH3 Vesicle transport, cell growth, 
and cell motility 
Subclass 2 ......Three to six IQ I (monomer) TH I Function in the microvilli ol the 
brush border 
Subclass 3 ......Three IQ I (monomer) TI-Il Epithelial morphogenesis and 
hair cells function 
Subclass 4 ......Two IQ I (monomer) TI-Il Epithelial niorphogenesis 
II 
Muscle .........Two IQ 2 (dimer) CC Smooth or skeletal muscle con- 
traction 
Nonmuscle ...... Two IQ 2 (dimer) CC Mainlainance of the cell archi- 
tecture, cell motility, and 
phagocylosis 
III 	...............One or two IQ I (monomer) N-terminal protein kinase Role in prototransduction 
IV ...............One IQ I (monomer) MyTH4 and SH3 ? (Only in Acanthatnoeho spe- 
cies) 
V................Six IQ 2 (dimer) CC, transmembrane, specific C- Membrane trafficking, polarized 
terminal globular domain cell growth, vesicle, protein 
and/or mRNA transport 
VI ...............One IQ 2 (dimer) ? CC, reverse gear. specific C-ter- Vesicle transport, epithelial 
minal globular domain morphogenesis, and stereocil- 
ia function. Spermatid mdi- 
vidualizaliots. Moves toward 
the "-" end of actin fila- 
ments 
VII 	..............Four or five IQ 2 (dimer) '7 CC, MyTH4, FERM, and SH3 Membrane trafficking, hair and 
photoreceptor cells function 
VIII 	.............Three or four IQ 2 (dimer) ? CC, serine rich domain, specific Cell wall function in plants, in- 
C-terminal domain tracel I ular transport 
IX ...............Four to six IQ I (monomer) N-terminal extension, zinc bind- Signaling (GTPase activating) 
ing, and Rho-CAP domains 
X................Three IQ 2 (dimer) '7 CC. PH, MyTH4, FERM Localized to regions of dynamic 
actin. Signal transduction 
XI ...............Five to six IQ 2 (dimer) '7 CC Vesicular transport in plants 
XII 	..............IQ '? 2 (dimer) '/ CC, N-terminal extension. and 7 (In C. r'/egalt.s only) 
MyTH4 domains 
XIII 	.............Four to seven IQ I (monomer) '7 (In plants only). 
XIV .............IQ '7 I (monomer) '7 (In Toxoplasma and P/as,no- 
dijon species) 
XV ..............Two to three IQ I (monomer) N-terminal extension MyTH4. Hair cell function 
FERM, and SH3 
XVI 	.............Two IQ I (monomer) Ankyrin repeats Neuronal cell migration 
XVII ............. IQ '7 1 (monomer) Chitin synthase domain '7 (In Pw'iculr,ria and E,,tiricella 
species) 
XVIII ............One or two IQ 2 (dimer) 7 CC, KE, and PDZ domain '? Maintenance of the stromal 
cell architecture 
Norij.—The number of heavy chains reflects their ability to dimerize (based on coiled-coil predictions). Key to domain abbreviations: TI-Il. Tail Homology 
Basic 1 domain; CPA. glycinc-proline-alanine-rich domain; GPQ, glycine-pro!ine-glutansine-rich domain; SH3. Tail Homology 3 domain (hinds to proline-rich 
motifs); CC. coiled-coil: MyTH4. Myosin Tail Homology 4 domain: Rho-GAP domain (activates small GTPases of the Rho family): PH, Pleckstnn Homology 
domain; KG. lysine-glutarnate--rich domain: PDZ or DHR (DIg homologous region). For recent reviews on the structure and properties of the unconventional myosins 
see Wu, Jung, and Hammer (2000). Oliver. Berg, and Cheney (1999). Baker and Titus (1998). and Mermahl, Post, and Mooseker (1998). In the construction of this 
table, data were used from these reviews, the myosin home page, and Cope et al. (1996). 
or substitutions), which might be important in defining 
the precise function of a given myosin. For further in-
formation see the Myosin home page at http://www. 
rnrc-lmb.cam.ac.uk/myosin/myosin.html (Hodge and 
Cope 2000). Phylogenetic analysis of the tail domain 
sequences produces similar results, indicating that heads 
and tails have coevolved (Korn 2000). 
Five myosin genes have been identified in yeast 
(Sacc/laronl)ces cerevisiae), falling into three classes: 
two class I myosins, one class 11 myosin, and two class 
V myosins (Brown 1997). It was suggested that the 
whole yeast genome had undergone a duplication in an-
cient times, followed by a number of modifications. As 
a result, a small fraction of the genes were retained in 
duplicate (most of them being deleted), thus explaining 
the loss of the second myosin II gene (Wolfe and Shields 
1997). Saccharomvces ('erevisiae is the organism with 
the lowest known number of myosin genes. This dem-
onstrates that a eukaryote can function with a set of only 
three types of myosins. 
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Fm. I —Schematic diagram of the domain structure of Drosophila myosins. (A) The previously described Drosophila myosins. Their sequence 
and structure have been studied and confirmed. For DNA and Protein  accession numbers see table 2. (B) The five new or previously unchar-
acterized Drosophila myosins. Their domain sti-ucture is based on the predicted cDNAs for these myosins (see table 2). The presence of sonic 
domains (e.g. the PDZ domain in Mhcl myosin) was verified with RT-PCR. A color key to the domain names is given on the left. Some of 
the names are abbreviated: MyTH4, Myosin Tail Homology 4 domain; FER M, Band 4. I . c/ri a, radix in. moesi n-homology domain QPA, 
glutami ne-proline-alanine—rich domain; PDZ, a domain with potential for targeting membrane sites. 
Multicellular organisms have the ability to express 
some 10-40 myosin genes encoding at least six types 
of myosins. It seems that multicellular organisms require 
a multitude of specialized myosins. This has raised the 
question of what is the degree of functional redundancy 
between the classes and between the members of a given 
myosin class. 
So far, 11 myosin genes have been identified in the 
slime mould Dictvostelium discoideum. Despite the fact 
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FIG. 2.—Polytene chromosome position of D. llie/anogaster my-
osin genes (based on the data provided by the Berkeley Drosophila 
Genome Project). The figure presents allmyosin genes, new and pre-
viously identified, in relation to their chromosomal locations. So far. 
no myosin genes have been found on the fourth chromosome. 
that this is one of the simplest multicellular organisms, 
it expresses a diverse set of myosin genes (Soldati. Geis-
sler, and Schwarz 1999). They encode at least six dif-
ferent classes of highly specific myosins. There are six 
class I myosins (MyoA, B, C. D, E, K. and probably 
MyoF) and one member each of class 11 (MhcA), class 
VII (Myol) (Titus 1999), and class XI (MyoJ) (Hammer 
and Jung 1996). The highly divergent MyoM is still to 
be classified (Schwarz, Geissler. and Soldati 1999). 
Fourteen myosin genes have been identified in the 
nematode Caenorliabditis elegans (Baker and Titus 
1997). They encode two structurally distinct class I, six 
class II, one class V, two class VI, one class VII, and 
one class IX myosins. It was found that C. elegans has 
a highly divergent type of myosin, which is the founding 
and only member of class XII myosins. 
The situation with vertebrates appears even more 
complex. They express some 40 myosin genes grouped 
into 12 classes. In humans, there are 8 class I, 16 class IL 
2 class III, 3 class V. I class VI, 2 class VII, 2 class IX, 
1 class X, 2 class XV, and I class XVI myosins (Hasson 
et al. 1996; Berg et al. 2000; Berg, Powell, and Cheney 
2001). Recent studies have discovered two PDZ-contain-
ing myosins (Furusawa et al. 2000), as well as a novel 
unclassified myosin (Berg, Powell, and Cheney 2001). 
PDZ domains are named after the postsynaptic, disc-large, 
ZO- I proteins in which they were first described. 
In Drosophila eight different myosin genes have 
been described thus far (figs. 1A, 2, and table 2). There 
are two class I myosins, members of subclass 3 (myosin 
IB) and subclass 4 (myosin IA) (Morgan et al. 1994: 
Mooseker and Cheney 1995: Morgan. Heinzelman. and 
Mooseker 1995). Only a single muscle myosin II gene 
was found in Drosophila (Hastings and Emerson 1991; 
Bernstein and Milligan 1997). It encodes more than 13 
protein isoforms with complex temporal and spatial ex- 
AAAI9590. AAF52966 
((.0!)) 
AAA 19591 (1.026) 
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Table 2 
A List of Drosophila melanogaster Myosins 
Chromosome Genomic DNA 	mRNA 	 Protein 
Gene-Protein 	Class 	Position 	Length )hp) Length (bp) Length (aa) 	- 	 EST 
Myo3IDF I 	21- (31 E3-6) 	AE003628 
(CG7438)r (15,084) 
Myosin JA 
MvoO/P I 	3L (61F6-7) 	AE003471. 
(CG9 I 55)* AC005847 
Myosin 113 . . . (51057) 
Mv05E I 	3R (95E I-4) 	AE003746 
(CG550 I) (4,604) 
Myosin IC .... 




Men (CG17927) 5 11 2L (36A8-9) M61229. 
Myosin heavy AE003652. 
chain ACOOS 119 
(22.663) 
ninaC (CG5 l25)' 111 2L (27F5-6) AE003617, 
(Nina C J03131 
protein) (7.220) 
didunt (CG2146)5  V 2R (43Dl-3) AC004280, 
Myosin V AE003841 
(8,217) 
jar (jaguar) VI 3R (95F1-2) AE003747 
(CG5695) 5 (6.312) 
Myosin VI . 
ck (crinkled) VII 2L (35C I) AE003646 
(CG7595) 5 (12.392) 
Myosin 
VIIA ......... 
Mra2881 VII 2L (28133- AE0036I8, 
(CG6976) Cl) AC005834 
Myosin VIIB . (10.519) 
Mvo IDA X  X (I OA I) AE003484 
(CG2 174) (10.235) 
Myosin XV 
MInI (CG 10218) XVIII 3R (89137) AE00371 I 




IV! vo29D ? 2L (29D1) AE003621 
(CG 10595) (5.732) 
Myosin ....... 




































NcrtE.-Myosins denoted with * have been previously identified and characterized. The others resulted from the analysis of published genomic sequence for 
Drosophila ,nelanoga,ster and molecular studies undertaken in this study. The classification is based on domain and phylogenetic analysis of the predicted mRNAs 
for these myosins. In several cases the presence or absence of certain motifs was verified by RT-PCR (for detailed explanation of this, see text). The accession 
numbers show the most recent and complete sequence reports on the presented myosins. ESTs for all of the predicted genes have been identified and partially 
sequenced. In the case of Mhcl the presented mRNA sequences were combined and the three longest transcripts shown. 
pression patterns (Bernstein and Milligan 1997; Zhang minal tails and show differential expression patterns (Por-
and Bernstein 2001). Drosophila has a second myosin II ter ci al. 1992; Li, Porter, and Monte]] 1998). A single 
gene that encodes a cytoplasmic nonmuscle myosin (Kie- myosin V gene, with at least two different splice forms, 
hart and Feghali 1986; Mansfield et al. 1996). The found- was identified in Drosophila (Bonafe and Sellers 1998; 
ing member of class III myosins was discovered in Dro- Maclver et al. 1998). Kellerman and Miller (1992) cloned 
sopliila (Montell and Rubin 1988). The ninaC-ill gene a novel unconventional myosin from Drosophila-the 
encodes two isoforms resulting from alternative RNA first member of class VI myosins. The gene produces 
splicing. These differ in the composition of their C-ter- multiple protein isoforms, which are present throughout 
Myosins of Drosophila inelanogaster 1045 
Drosophila development (Kellerman and Miller 1992; 
Mermall and Miller 1995; Deng, Leapet; and Bownes 
1999 Hicks et al. 1999). Drosophila myosin VIIA was 
the first member of this class to he described (Cheney, 
Riley, and Mooseker 1993; Kiehart et al. 1998). 
While this manuscript was in preparation. another 
paper cleating with Drosophila myosins was published 
(Yamashita. Sellers, and Anderson 2000). The data from 
both research groups is complementary, with our man-
uscript focusing in detail on the molecular analysis and 
domain structure of the myosins. 
Materials and Methods 
Analysis of the Drosophila Genome—Analysis and 
Manipulation of Sequences 
We have used the completed D. melanogaster Ge-
nonie Project to determine the number of myosin-en-
coding genes in this species and to classify them. The 
new myosin genes were identified by comparing the 
Drosophila genome sequence with the conserved head 
(equivalent 10 amino acids 88-780) of the chicken skel-
etal myosin 11. Comparison with the GenBank Data Base 
was done using the BLASTP algorithm of the National 
Center for Biotechnology Information (NCBI) (http:// 
www.nchi.nlm.nih.gov/BLAST/), the Pole Bio-lnfor-
matique Lyonnaism server (http://pbil.univ-lyonl.fr/ 
BLAST/hlast.html). and The Berkeley Drosophila Ge-
nome Project BLAST (http://www.fruitfly.org/hlast/). 
This search retrieved the eight previously described my-
osin genes as well as three new genes: Mvo 28B1 
(AAF52536), Myo/OA. (AAF47980), and Mhcl (or 
Myoo1 9B) (AAF5527 I). Subsequent detailed analysis 
was done using the conserved head or specific tails from 
all known classes of myosins to search the translated 
Drosophila genome sequence (TBLASTN on the NCBI 
server). These searches identified two other sequences 
highly similar to myosins: Mvo29D (AAF52683, 
AF454348) and Mv05E (AAF56246. AF454350). 
Domain Analysis—Multiple Sequence Alignment 
The domain structure was predicted with the Simple 
Modular Architecture Research Tool (SMART) server 
at http:i/smart.embl-heidelberg.dei (Schultz et al. 1998), 
the Pfarn HMM database at http://pfam.wustl.edu/ 
hmmsearch.shtml or http:iiwww.sangerac.uklSoftware/ 
Pfam/search.shtrnl (The Sanger Centre), and the ProFile 
Scan Server of ISREC (Swiss Institute for Experimental 
Cancer Research) at http://www.isrec.isbsib.chisoftware/ 
PFSCAN_form.html. Alignments of the detected do-
mains were performed with CLUSTAL W (Thompson, 
Higgins. and Gibson 1994) available from the Gene 
Jockey II software package distributed by Biosoft or 
from the WEB-based package at http://www2.ebi.ac.uk/ 
clustalw/. Subsequently, the sequences were run on 
WEB-based BoxShacle Server (http://ludwig-sun 1 .unil. 
ch: 8O80isoftwareiBOXform.html) and manually adjust-
ed in Microsoft Word 98. 
Coiled-coil regions were predicted with the Paircoil 
program developed by Berger and coworkers (Berger et 
al. 1995) at http://nightingale.lcs.mit.edu/cgi-bin/score.  
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Flo. 3.—Molecular organization ol MoO5L, Mvo IdA, Mhr-1, and 
Mro29D myosin genes. The exon structure of the myosin genes is 
represented by gray boxes. Arrows indicate the primers used in the 
RT-PCR analysis of the gene structure. The length of the predicted 
n1RNAS is noted on the left side of the transcript maps. Shaded boxes 
represent ORFs: solid boxes represent untranslated sequences (S'IJTR 
or 3'UTR): dotted boxes represent the intion sequence in the spliced 
niRNA: Wave pattern boxes represent exons from genes located within 
the myosin gene. The gene depicted by IF] and IRI primers is at least 
a three-exon gene, but for simplicity it is presented with a single box 
here (for more information see text). 
RNA Extraction and RT-PCR 
Total RNA from larvae and adult flies was isolated 
using RNAeasy-Total RNA Kit (QIAGEN. Cat #: 74104). 
The RNA (4 fcg) was primed with Oligo-p(dT)18 and re-
verse transcribed by Superscript76 II (GIBCO BRL), fol-
lowing the supplier's protocol. For subsequent DNA am-
plification, 2 p.1 out of 20 pA of the first-strand reaction 
mix was used. The PCRs were carried out with appro-
priate pairs of forward and reverse primers. The position 
of the primers is indicated in figure 3. Primers for 
Mvo95E: EF1 (TGT TGC TCG CCA GCA CAT G), EF2 
(ATG GAG CAG GAA ATC GGC AC). EF3 (CAT CAG 
COG CCT TCC TGA AT). EF4 (GAA GTA CAT AAG 
CGC TGC CT), ER  (AGG CAG CGC TTA TGT ACT 
TC). ER2 (ACA ATT ATC TCC ATG CGG TTC G), 
ER3 (ACG TAG ATG CCT GAA CTA TC). Primers for 
MvoIOA: AFI (GCA GCA ATG AAT CAA CCG GT). 
AF-_) (TGA TCT GGT CTG GTT CGA TC). AF3 (TCA 
GTG TCC AGA GGC ATG TG). AF4 (TOG AGT GGC 
GTG CCT GGA). AR I (CAT CTT GTA CGG ATT CAC 
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CG), AR2 (TCC GCA CGC GCA ACT TCC A), AR3 
(CTT GCG GAA CTC CTG GAC A). Primers for Mhcl: 
MFI (CAA CTT TAT GAA GAA GAG CGC), MF2 
(AAG GCA GCT AGT GAT CAG GC), MF3 (TCG 
CAT AGG ACC CAG CCA G), MF4 (ATG TGG TCG 
GAT AAA AGT GCA), MF5 (GCT CTC AGA TCG 
CAT TAT ACA G), MR  (AGC TCG CAG ATG TCC 
TCG A), MR2 (ACA TGG AGA CAA CCT TCT CG), 
MR3 (TAT ACG GAC GCA GGC GAT AG), MR4 
(TCT TCC AGA TCA CTG ATA GAG). Primers for 
Mvo29D: DFI (ATC CGC ACA ACA TTC TGC AC), 
DF2 (ATG CAT CTT CAT CCA ACG AG), DF3 (AAT 
CAC AGC TTC AGC CAC AC), DF4 (GAG ACT GAT 
GCC TTC AAG CAC), DF5 (ACT TTG TGC GCT 
GCA TCC G), DR  (GTC CCG ACA AGT GGA TCA 
G), DR2 (GTG CTT GAA GGC ATC AGT CTC), DR3 
(AGG AAG AGT TGA ACA GAT GGA). Primers for 
genes in the Mhcl gene: IFI (TTA CCT CCA TAA ACC 
TGC GG), 1F2 (GTC GCC GAG CCC GAA GAG), 1F3 
(AAC GTC GCG TTC GCA AGA GG), IRI (AAC GAT 
TCG GAG GTG CAC G), 1R2 (CTA GCT CTG CGA 
AGA TCT CA), 1R3 (CGT TCA TGG CTG CTA GTA 
CG). QIAGEN Taq and Stratagene Pfu Turbo Polymer-
ase in a 3:1 ratio were used in the PCR reactions. The 
QIAGEN PCR protocol designed to work with Q-Solu-
tion was followed. The PCR reactions were carried out 
as follows: one cycle at 94°C for 4 mm; 35 cycles, step 
one-94°C for 40 s, step two-60°C for 40 s, step 
three-72°C for 1.8 miii per expected kilobase pair of the 
PCR product; and one cycle at 72°C for 10 mm. The 
obtained PCR products were isolated from Tris-acetate/ 
Ethylenediaminetetra-acetate (TAE) gels, purified, and se-
quenced on a 373A automated DNA sequencer (ABI). 
Results 
The BLASTP and BLASTN searches with the con-
servative chicken skeletal niyosin II head, against the 
completed Drosophila genome sequence, retrieved the 
previously identified genes and five new myosin genes 
(fig. I). We selected a limit of 30%-40% identity for a 
myosin to fall into a given myosin class, and 25%-30% 
was considered as the lower threshold for a protein to be 
classified as a myosin. The new myosins (fig. IB) were 
named according to their chromosome position (fig. 2). 
Interestingly, half of the myosin genes are located be-
tween polytene bands 27F-36A, thus forming a myosin 
hot spot on the left arm of the second chromosome. 
In the cases of Myo 95E, Myo]OA, Mhcl, and 
Myo29D, we did a detailed analysis of the molecular 
structure of the genes and the transcripts they produced. 
The main reason for this was that the predicted sequenc-
es for these genes encode proteins that produced low 
homology scores to other myosins. They were obviously 
myosins, containing all the conserved sequences and 
structural parts defining them as myosins and at the 
same time showing no more than 15%-29% identity to 
other myosins. This implied either incorrectly predicted 
genes or incorrectly predicted splicing of the transcripts. 
Open reading frames (ORF). S'untranslated regions 
(UTRs), 3'UTRs, and the presence or absence of given  
motifs were tested by RT-PCR and subsequent sequenc-
ing of the products obtained. In these experiments we 
employed an ovarian Uni-ZAP XR library produced in 
our lab, along with cDNAs produced by reverse tran-
scription of RNAs from larvae and adult flies (see Ma-
terials and Methods). As a result, we determined a num-
ber of new myosin sequences and submitted them to the 
MEDLINE Database. The accession numbers for these 
are—Mvo95E: AF454350, AF45435 I, and AF454352; 
MyoIOA: AF454346 (presents a part of the first three 
exons including the 5'UTR) Mhcl: AF454347 (presents 
a part of the first four exons including the sequence 
encoding the PDZ domain); Myo29D: AF454348 and 
AF454349. Mvo28B was not subjected to detailed anal-
ysis because it was found to be almost identical to the 
other myosin VII (crinkled) from Drosophila at both the 
DNA and protein levels. 
To examine the evolutionary relationships between 
members of the myosin family in Drosophila and other 
phylogenetically diverse species, we used two different 
phylogenetic methods. We applied Distant-matrix and 
Maximum-Parsimony methods (PROTDIST and PROT-
PARS from the PHYLIP package) to compare the con-
served head domains. These methods were chosen because 
they tend to outperform other methods (i.e., lower vari-
ance), such as the Maximum Likelihood, when dealing 
with large data sets. The two programs produced trees with 
similar topology (see the unrooted consensus tree in fig. 
4). Multiple sequence alignments were performed with 
CLUSTAL W without corrections for gaps or multiple 
substitutions. Excluding the positions with gaps would 
have omitted a significant proportion of the data, a prob-
lem that occurs when large amounts of input sequences 
are dealt with. CLUSTAL W (GCG software package) is 
provided by the Human Genome Mapping Project Re-
source Centre, Cambridge, at http://www.hgmp.mrc.ac.ukl 
(Thompson, Higgins, and Gibson 1994). The reliability of 
the tree structure was checked by bootstrapping (1,000 tri-
als) and reordering the alignments randomly (bootstrap-
ping was performed with SEQBOOT from the PHYLIP 
package). The tests produced trees with similar branching 
order. A consensus tree was produced by the CONS ENSE 
program of the PHYLIP package and graphically drawn 
with the TREEVIIEW program (Page 1996), and was then 
transferred to and manipulated with PowerPoint. 
The protein sequences for the new Drosophila my-
osins are theoretical predictions. Myosins are large mul-
tiexon genes and are difficult to assemble with 100% 
accuracy from sequence data. There are also various iso-
forms of some myosins, which can lead to some mis-
alignments; hence, it is unlikely that the tree shown per-
fectly reflects the evolution of the Drosophila myosins. 
It is possible that some of the new Drosophila my-
osins could be pseudogenes. However, we found that the 
probability for this was low. Pseudogenes generally lack 
introns and are not transcribed into mRNA. We identified 
expressed sequence tags (ESTs) for all the myosin genes 
we predicted (the accession numbers for these are given 
in table 2), which confirmed their in vivo expression. The 
new myosins are described in detail subsequently. 
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FiG. 4.-Phylogenetic analysis of the myosin superfamily in D. Isle-
lanogoster. The head domains of Drosophila myosins (equivalent to 
amino acids 88-780 of chicken skeletal myosin) were compared with 
selected myosins representing phylogenetically diverse organisms. 
The alignment of 67 myosins (performed with the CLUSTAL W 
package) was used to generate data for an unrooted tree to scale 
based on sequence divergence (for details see text). Each Myosin 
class is defined by the first node represented in >95% of the boot-
strap trials (starting from the tree center) and is color coded. The 
accession numbers for the myosins used in the alignment are given 
subsequently. These are produced for the protein sequences, except 
in the case of Drn95E (Mv05E gene) and Dm29D (Mvo29D gene), 
where the eDNA accession numbers are given. Myosin class 1: Ac-
lB (AAA27708), Ac-ICy (AAA27707), ScMyo3-IA (AAB34124). 
ScMyo5-IB (CAA89745). Cchum5-IA (CAA53244), Cehuml-113,1 
Dni3lD- IA (AAAI9590), Dm6IF-lB (AAAI959I). Dni95E 
(AF454350). Re-lB (AAA57192). Gg-Bb (AAB38373), Gg-113 
(CAA49850). Rnmyrl-IA (CAA48287), Rnmyr2-I13 (CAA52807). 
Rnmyr3-lC (CAA52815). Rnmyr4-I131 (CAA50871). Myosin class II: 
ScMYOI-IIA (CAA37894), ScMYS1-IIB (P08964), Dd-nmlI 
(AAA33227). Ce myo3-IIA (CAA30856). Cernyo4-II13 
(AAA28 124). Censyo2-11C (CAA30855). Cemyol-IID (CAA30854). 
Dm-nihcll (AAA28686). Dmzip-nmII (AAF473 11), XI-nrnllb 
(AAA49915). Gg-FSkII (P13538). Gg-nrnII (AAA48974). Gg-snill 
(CAA29793), Hs-FSkEII (CAA32167). Hs-CaA (BAA0079I). Hs 
nmIIA (AAA59888). Myosin class III: Lp-III (AAC16332). Din-
NinaC-lIl (AAA28718), HsMY03A (AAF70861). Myosin class V: 
ScMyo2p-Va (AAA348I0). ScMyo4p-Vb (AAC37409), Cehum2 
(AAA97926). SpMyo-Va (AAF78910). Dmdidum-Va (AAC99496). 
G.-Va (CAA77782). Mmdilute-Va (CAA40651). Rnmyo5-Va 
(BAA88350). Rnmyr6-Vb (AAB38840). HsMY05A (AAD00702). 
HsMYOSC (AAF78783). Myosin class VI: SpMyo-VI (AAF72 176). 
Cehum3 (AAC67447), Dnijar-VI (CAA47462), Ms-VIA 
(AAD52005). Ms-VIB (AAD52006). OgMyoVI )CAB96536). 
MmWaltzerVl (AABOO 194). HsMY06 (AAC5 1654). Myosin class 
VII: Cehumô-VII (AAB37988). Dmck-lIA (AAF53435). Dm2813-
VI lB (AAF52536). DrMvo-VIIA (CAC054 18). Mmshaker-VIIA 
(AAB40708), HsUsherlb-VIIA (AAB03679). Myosin class XV: 
DmIOA-XV (AAF47980). Mm-MyolS (AAF05904). HsMY0I5 
(AAF05903). Myosin class XVIII: Dm89B-PDZ (AAF55271). Mm-
PDZ (BAA93660). Hs-PDZ (BAA 13206.2 Myosin class 2: D11129D 
(AF454348). 
Myo95E (Myosin IC) 
This myosin was not found during the initial searches 
of the fly genome. It was subsequently identified in the 
AE003746 genome scaffolding. The predicted sequence 
for this gene is unusually short, resulting in only a 59-aa 
protein (accession number AAF56246). Detailed analysis 
showed that the gene was not predicted correctly by the 
Genome Project. The sequence for Myo95E was manually 
assembled, taking into account the reported sequence for 
this gene along with the identified ESTs (table 2), as well 
as the homology of the translated genomic DNA to other 
myosins (preserving the exon-intron spacing). To test our 
theoretical predictions, we used two splice-site prediction 
programs: The Neural Network at http://www.fniitfly.org/ 
seq_tools/splice.htrnl and the GENSCAN Server at MIT-
http://genes.mit.edu/GENSCAN.htmI. Using the artificially 
assembled sequence, we were able to design primers, am-
plify a PCR product, and hence sequence the eDNA for 
Myo95E (see Materials and Methods). The resulting se-
quence differed from the predicted sequence, showing the 
presence of an unusually long exon 3 and variations in 
exon 4. RT-PCR analysis showed that the gene produces 
at least three different transcripts expressed during oogen-
esis, and larval and adult stages (fig. 3). Two of the tran-
scripts (I-AF454350 and ll-AF45435 I), which represent 
5%-10% of the total amount of Mvo95E transcripts, trans-
late into two protein isoforms of 1,278 and 1,258 aa, re-
spectively. Transcript I (5.285 bp) comprises all 16 exons 
of the gene. Transcript 11(5,225 bp) lacks exon 12. The 
major third transcript (III-AF454352) has a longer exon 4 
(a downstream extension of 16 bp. GTG CAC ATT ACC 
CAT T). This shifts the ORF and produces a stop codon 
TGA in exon 5. The third transcript (5301 bp) encodes 
two putative truncated proteins. The first is a 464 aa se-
quence containing only the GESGAGKT conserved region 
from the P-loop of the myosin head domain. It does not 
contain the Switch-I (NxxSSR) and Switch-2 (DxxGxE) 
regions which together with the P-loop have been impli-
cated as having a role in the hydrolysis of ATP The second 
is an 864 aa protein containing a large part of the head 
domain, two IQ motifs and a myosin tail domain. The head 
of this myosin form contains only the Switch-2 (DFYGFE) 
conserved sequence, which prevents it from converting 
ATP, probably rendering the form inactive. Homology 
searches with the protein sequence for the head domain 
showed 33% identity (53% similarity) to vertebrate brush 
border class I myosins. Three ESTs were found for 
Mv05E. A search with them revealed up to 37% identity 
to vertebrate brush border myosins and less to other my-
osin classes. Analysis of Myosin 95E with domain-scan-
ning programs confirmed its structural similarity to class I 
myosins (fig. IB). It was found to contain two IQ domains 
(928-974 aa), the second being poorly conserved (fig. 5). 
This is a joint sequence from the first 72 amino acids of T21544 
and from the 11th amino acid to the end of AAA97925. 
The sequence for the human PDZ-containing myosin is truncat-
ed. This does not seem to affect its evolutionary position in the phy-
logenetic tree. 
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Flu. 5.-Alignment of the IQ moths for the live newly identified 
myosins from I). ,neliinogoster: Myosin IC (Mv0$E), Myosin VIIB 
(Mi'o28B), Myosin XV (MvoIOA), Myosin 89B (Mud), and Myosin 29D 
(Mvo29D). The consensus sequence is shown below the alignment, and 
the highly conservative positions are shaded. Residues in bold indicate 
similarity to the consensus sequence. Myosin IC has two different var-
iants (A and B) of its second IQ motif, a result of alternative splicing. 
and a Basic Tail domain (974-1,278 aa for isoform I and 
974-1,258 aa for isoform 11) (fig. lB and table 1). The 
latter is thought to be involved in membrane binding. Re-
cent studies have shown that it can also bind to actin fil-
aments (Lee et al. 1999; Liu, Brzeska, and Korn 2000). 
This changes the number of class I myosins in Drosophila 
to three, hence Myosin 95E was renamed Myosin IC. The 
Drosophila Myosin IC does differ from other myosins of 
class I. The unusually long exon 3 results in a 281-aa 
insertion into the head domain. This insertion contains a 
partial AAA domain, a conserved region that contains an 
ATP-binding site. So far, no other myosins from class I 
have been identified which contain such an insertion. 
Mvo28B (Myosin VIIB) 
The amino acid sequence of the Myosin 28B head 
showed 610/c identity (74% similarity) to ck-Drosophila 
myosin VIIA. It also exhibited a very high identity of 
58% (72% similarity) to Myosin VIIA from zebrafish and 
to other class VII myosins. Analysis of Myosin 28B re-
vealed that it has four IQ motifs (753-845 aa), the third 
being poorly conserved (figs. LB and 5). Two Myosin 
Tail Homology 4 (MyTH4) (1,070-1,246 and 1,681-
1,826 aa), two FERM (1.246-1.454 and 1.826-2.039 aa), 
and one SH3 (Src homology 3) (1,561-1,626 aa) domains 
were identified (fig. 6A and B). The function of the 
MyTH4 domains is unknown. The FERM domain (the 
name stands for Band 4. 1, ezrin, radixin, moesin-homol-
ogy) is believed to be involved in linking cytoskeletal 
proteins to the membrane as well as in dimerization. Tal-
in, merlin, and philopodin are other major members of 
the FERM superfamily. These deserve mentioning, es-
pecially the Talin, because the FERM domain exhibits 
the highest homology to the FERM domain in Talins (fig. 
7) and less homology to FERM domains from other 
members of the FERM family. The SH3 domain has been 
identified in many proteins involved in signal transduc-
tion. It is believed that the 5H3 domains mediate protein-
protein interactions by binding to proline-rich domains. 
Other myosins, such as IV, X, and XV, also contain this 
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FIG. 7—Sequence comparison of the FERM domains found in 
I)ro.soplola Myosin VII and XV. These were aligned separately to the 
Talin domain from C. elegans Talin protein. Multiple alignment was not 
appropriate in this case because the similarity between FERM I and 
FERM 2 to the Talin domain (from the Talin protein) is very low and 
results in unordered alignment. The comparison was performed by 
CLUSTAL W (http://www2.ebi.ac.uk/clustalw/). In addition, the FERM 
domains from Mus inusculus Myosin XV were included in the diagram. 
In general. FERMI motifs from Myosin VII show —12%-21% similar-
ity to proteins from the FERM family and 161/r to the band 4.1 protein. 
FERM2 domains (Myosin VII) show a higher similarity of - 17%-18% 
to band 4.1 protein and —18%-20%, to proteins from the FERM family. 
FERM domains from Myosin XV show less similarity of 9%-17% to 
FERM proteins and -14%, to the band 4.1 protein. Accession numbers 
are—C. elegons (Talin): AAA74747: D. mcla,iogo.vter (Myosin VIIA): 
CAC054I8. (Myosin VIIB): AAF52536. (Myosin lOA-XV): 
AAF47980: M. ,nu,oulus (myosin XV): AAF05904. 
motif. A short coiled-coil domain (849-908 aa) was pre-
dicted by the Paircoil program (fig. 8). 
MvoiOA (Myosin XV) 
An RT-PCR analysis was used to verify the exon 
composition and the exon length of MvoJOA transcripts. It 
was found that there are at least two transcripts, which are 
expressed from the larval stage onward (fig. 3). The longer 
transcript (7,462 bp) consists of all the previously known 
five exons and represents no more than 5% of the total 
amount of niRNA for this myosin. The shorter transcript 
(7.189 bp) lacks exon 2 and is expressed abundantly. The 
two transcripts translate into two protein isoforms of 2,424 
and 2,333 aa, respectively. A BLAST search with the con-
served head domain showed significant 47% identity (64% 
similarity) to mouse and human myosin XV. MvolOA is 
also related to human and mouse myosin VITA with an 
identity of 42% (59% similarity). A specific N-terminal 
domain was identified in Myosin lOA (1-149 aa). The 
latter showed no similarity to the characteristic N-terminal 
domain found in other class XV myosins. The shorter pro-
tein isoform lacks this N-terminal domain. In the neck 
region three IQ domains (841-910 aa) were identified (fig. 
5). Immediately after the IQ motifs there is a short coiled-
coil region (919-946 aa) (fig. 8). Analysis of the tail re-
vealed the presence of one MyTH4 domain (1,014-1,173 
aa) (fig. 6), a glutamine-proline-alanine (QPA)-rich do-
main, a proline-rich domain (the borders of QPA and the 
proline-rich domain were not clearly defined), a short 
transrnembrane motif (2.194 aa) (fig. IB), and an FERM 
domain (2.220-2,424 aa). The latter showed a very high 
identity of 40% (59% similarity) to the first and 13% iden-
tity (30% similarity) to the second FERM domain from 
mouse myosin XV and a limited similarity of 38C/c  (17% 
identity) to Talin itself (fig. 7). 
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FIG. 8.—Predicted coiled-coil structures in the tails of the newly 
identified Drosophi la myosins. Only three of the live myosins are like-
ly to form coiled-coils, these being myosin 2813-VIIB. myosin IDA-
XV. and Mhcl-PDZ. Both myosin 2813-VIIB and IOA-XV produced 
scores close to the lower threshold. Whether they form coiled-coils or 
not can only be determined experimentally. 
Mhcl (Myosin XVIII) 
A partial sequence of this gene has been submitted 
to the GenBank Data Base by Biru (1999). It shows high 
similarity to the Mhc type II of myosins and was termed 
Myosin heavy chain—like. Subsequently, the full length 
for this myosin was published by Celera (Adams et al. 
2000). The RT-PCR analysis we have undertaken shows 
that Mhcl has a very complex structure and expresses 
multiple transcripts throughout the Drosophila life cycle 
(fig. 3). Data from the available ESTs for Mhcl, PCR 
analysis, and a Promoter-predicting program (http:// 
www.fruitfly.org/seq_tools/promoter.htrnl) suggest that 
the seven identified transcripts are transcribed from four 
putative promoters. Transcripts 1(6,603 bp) and III (6,909 
bp) are highly expressed. The other five identified tran-
scripts are expressed at comparatively lower levels. Tran-
scripts I and III are composed of 18 exons (the gene 
comprises 19 exons), lacking exon 15. The difference 
between them is that transcript III has the second intron 
spliced out, which introduces a stop codon in the ORE 
One unusual feature of Mhcl is the fact that it contains 
three other genes within it (fig. 3). The exons of these 
genes are not found in combination with any of the exons 
of the myosin gene. Importantly, there are ESTs for each 
of the three genes. One of the genes has been previously 
1050 Tzo!ovsky et al. 
identified as phosphatidylserine-specific phospholipase 
Al (CG4979). It is located in intron 9, and its reading 
frame is in the opposite direction to that of the Mhcl 
reading frame (EST: GH 15759). The other two genes 
have ORFs in the same direction as the main (Mhcl) gene. 
The gene in intron 10 (ESTs: RE41368. RE44374) is a 
novel gene and does not show any significant homology 
to previously characterized genes. The gene in intron 12 
(ESTs: LP08646, LP053 15) shows a limited identity of 
35% (46% similarity) to bovine synaptojanine I protein 
(synaptic inositol- I ,4,5-trisphosphate 5-phosphatase I). 
The Mhcl transcripts translate into a set of protein iso-
forms—I: 2,200 aa; II: 2,139 aa: III: 439 aa; IV: 899 aa; 
V: 730 aa; VI: 512 aa: and VII: 479 aa. Only the isoforms 
produced by transcripts I and II contain the conserved 
motor domain. BLAST analysis showed that Myosin 
heavy chain-like is most closely related to mouse PDZ-
Myosin (41% identity) and human PDZ-Myosin (40% 
identity). It showed a limited identity of 28%-29% to 
smooth muscle and nonmuscie myosins and less than 
25% to skeletal muscle myosin. BLAST searches re-
vealed that the tail domain shows the highest similarity, 
32%. to PDZ-containing myosins and less than 25% sim-
ilarity to other types of myosins. Interestingly, this my-
osin was not predicted to contain a PDZ domain. We used 
the DNA sequence encoding the mouse PDZ domain to 
search the genomic sequence (AE0037 II) surrounding 
Mhcl (approximately 10 kb in each direction). This de-
tected a PDZ domain 4,810 bp upstream of the predicted 
start for the Mhcl mRNA (the domain was found in the 
borders of the predicted genomic DNA for this gene but 
has not been previously included in its ORF). The pres-
ence of the PDZ domain was verified by RT-PCR, and 
the sequence was submitted to the NCBI database 
(AF454347). A sequence alignment of the PDZ domains 
from Drosophila, mouse, and human is given in figure 6. 
Interestingly, transcript III translates into a truncated pro-
tein containing only this PDZ domain (349-429 aa). PDZ 
domains are known to bind C-terminal or internal (non-
C-terminal) polypeptides. Two IQ domains were found in 
Mhcl (1,379-1,428 aa) (figs. lB and 5), although the sec-
ond differed slightly from the consensus sequence. The 
Paircoil program predicted two coiled-coil domains at 
1,439-1,549 and 1,616-2,121 aa (fig. 8). 
Myo29D 
Database searches suggested that the first three ex-
ons of Mvo29D are probably part of a gene adjacent to 
the myosin. Subsequent RT-PCR showed that they splice 
together with the other three myosin exons to produce 
at least two different transcripts. Transcript I (4,402 bp) 
contains all the six exons, whereas transcript II (2,530 
bp) lacks exon 5. Transcripts I and II are present during 
all the stages of Drosophila development, with transcript 
I being expressed at the higher levels. Transcript II pro-
duces a truncated form of the protein, lacking most of 
the motor head domain. Analysis of the conserved head 
domain revealed that Myosin 29D is not similar to any 
of the known classes of myosins. It showed 29% identity 
(45% similarity) to myosin VII, X, and V from different  
species, which is sufficient for it to be considered as a 
myosin but not enough to be related to a given class. A 
search with the available ESTs for this myosin showed 
36%-39% identity to myosin V from different species 
and 31%-36%  to vertebrate Myosin heavy chains (my-
osin II). Motif search programs detected in Myosin 29D 
a specific N-terminal extension (1-338 aa), two IQ mo-
tifs (1,089-1,136 aa), the second being poorly con-
served, and a short transmembrane motif in the tail 
(1,144-1,279 aa) (fig. I B). 
The detailed search of the translated Drosophila 
genonie sequence produced several low-score hits. 
Close analysis of these (searches up and downstream of 
the respective sequences) revealed that they are not true 
myosins. Despite exhibiting certain similarities to given 
parts of the myosins, none of them showed high ho-
mology to a larger part of the head domain. AE003I 12 
showed similarity to the highly conserved region (GES-
GAGKT) from the P-loop of the head domain. Its poly-
tene chromosome location remains undetermined. 
AE003614 (CGI 1199) showed homology to the myosin 
tail, containing coiled-coil and FERM domains. It is lo-
cated on the chromosome arm 2L (27E), next to the 
ninaC gene. AE003495 (CGI2047) also showed simi-
larity to the myosin tail, containing coiled-coil and 
FERM domains. This is located on the X chromosome 
(12El). close to the newly identified lVIyo]OA. 
The BLAST search retrieved one more myosin-like 
gene CG15831 in the AE002795 genonle scaffolding. 
This is a single-exon gene, 219 bp long. The chromo-
some position of AE002795 has not been determined 
previously. The program showed similarity to a highly 
conservative part of the myosin head domain (LGV 
LDI FG FEN FS HNSFEQ LC I NYTNEKLHKFFN H). 
We found that the DNA surrounding the gene shows no 
similarity to the myosin genes (at the DNA or protein 
level). This suggests that AE002795 is either incorrectly 
assembled in the genome or that the gene CG15831 is 
a partial duplication of a myosin gene (this might be 
either a part of We I muscle myosin Ill or diduin [My-
osin VI, which produced the highest score for this se-
quence. 59% and 54% identity, respectively). 
Discussion 
The myosin family has grown significantly in the 
past decade to encompass more than 177 myosins these 
days. All these myosins, with a few exceptions, fall into 
18 classes. Myosins are expressed in both prokaryotes 
(though these have not been well studied) and eukaryotes. 
The annotation of the genome sequences for S. cer-
evisiae, Dictvosteliuni discoideurn, Arcibidopsis thaliana, 
C'. dc grins, Drosophila melanogaster, and Hoino sapiens 
made it possible to identify the complete sets of myosin 
genes in these organisms. It appears that all eukaryotes 
have an essential set of three myosin genes, these being 
from classes I, II, and V. as well as a number of species-
specific myosins. In Drosophila 13 different myosin genes 
were identified. The fruitfly has three I, two II (one en-
coding for muscle and one for nonmuscle myosins), one 
Ill, one V, one VI, two VII, one XV, and one XVIII myosin 
Myosins of Drosophila inelanogaster 1051 
genes, and one yet to be classified myosin gene. These 
classes of myosins have been found in a wide range of 
invertebrate and vertebrate animals. It has been shown that 
they have a role in a variety of cell lunctions, including 
membrane trafficking, signal transduction, and mainte-
nance of the cell architecture. Several new myosin genes 
were identified in the fruitfly. The genome data provided 
cDNA sequences for four of them (Mvo28B, MvolOA, 
Mhcl, and Mv029D). The sequences and the ORF for these 
myosins were verified by RT-PCR and sequencing. In ad-
dition, a fifth myosin was found (Mvo95E). Using the fruitf-
ly genomic sequence, we were able to predict and subse-
quently isolate and sequence this gene. 
Only two of the live newly identified genes in Dro-
sophila fell directly into previously known classes, these 
being Myosin VIIB (Mvo28B) and Myosin heavy chain—
like (Mud). Myosin VIIB is from the well-studied class 
VII myosins with a role in the membrane trafficking and 
stereoci I ia function. 
Mhcl is 'a member of the recently defined class 
XVIII of myosins, which consists of only two other 
members, mouse and human PDZ-containing myosins. 
The PDZ domain, also called DHR (Dl- g homologous 
region), is known to bind either C-terminal or internal 
(non—C-terminal) polypeptides. These domains have 
been identified in a broad range of signaling proteins 
from bacteria, yeast, plants, insects, and vertebrates. 
PDZ domains have been implicated in targeting signal-
ing molecules to submembranous sites. 
Myosin IC (Mv05E) is the third member of class 
I myosins in Drosophila. It contains the Basic Tail do-
main (TH I) specific to all class I myosins. It is thought 
that TH I binds to acidic phospholipids and actin fila-
ments. Interestingly. this myosin contains an additional 
N-terminal insertion, which is similar to the AAA motif, 
a conserved region of about 220 aa that contains an 
ATP-binding site. This domain is inserted in the region 
of the loop I of the motor domain, the other region 
associated with the hydrolysis site for ATP, and probably 
modulates its activity. 
MvoJOA is closely related to class XV myosins. This 
myosin has a short N-terminal extension, which differs 
from the N-teniinal domain characteristic for vertebrate 
myosins of class XV. It also lacks the SH3 and the second 
MyTH4 domain found in other myosin XV tails. Instead, 
the Drosophila Myosin XV tail contains three addition 
motifs, a glycine-proline-glutamine—rich domain, a pro-
line-rich domain, and a small transmembrane domain. 
The proline-rich sequences have been demonstrated to 
bind to SH3, a small 50-aa motif. SH3 domains have 
been identified in a wide variety of intracellular and 
membrane-associated proteins and are implicated in sig-
nal transduction, linking signals transmitted from the cell 
surface by protein tyrosine kinases to effector proteins 
located downstream on the hierarchical pathways. 
Myosin 29D is a highly divergent member of the 
myosin superfamily. Presently, it forms a class of its 
own. This myosin contains an unusual N-terminal ex-
tension, which shows no homology to other proteins. It 
also has a small transniembrane domain in its tail rich 
in proline residues. 
Drosophila me/anogasler expresses many myosins 
genes. Apart from the essential myosins (classes I, II, 
and V), it also has myosins from classes III, VI, VII, 
XV, and XVIII, as well as a novel type of myosin. This 
new data should help to design experiments to investi-
gate the roles of these newly identified myosins in the 
cell histology and development of Drosophila. 
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Abstract 
Myosin VI is an unconventional Myosin that has been implicated in vesicle transport and membrane trafficking. We isolated lethal mutants 
of Myosin VI, which lack protein once maternal supplies have been utilised during embryogenesis. Dorsal closure, where there is a ring of 
Myosin VI at the edge of the migrating epithelial sheet, is often abnormal. The sheet of migrating cells is irregular, rather than a smooth 
epithelium and cells begin to detach. Some embryos hatch into larvae, containing detached cells loose in the haemolymph. Myosin VI is 
crucial for correct cell morphology and maintenance of adhesive cellular contacts within epithelial cell layers. 
© 2004 Elsevier Ireland Ltd. All rights reserved. 
Keywords: Cell migrations; Epithelial morphogenesis; Unconventional Myosins 
1. Introduction 
Unconventional myosins are motor proteins that move 
along actin filaments. There are many classes of myosins in 
this superfamily and they have been identified in a wide 
variety of organisms. The head domains are well conserved 
and contain the motor, ATP and actin-binding domains that 
allow the protein to move. The tails vary dramatically 
between classes of myosins and often carry cargoes. 
Myosins play a variety of roles in organelle, RNA and 
protein transport, cell movements, signal transduction, 
maintaining the morphology of cells, and membrane 
trafficking (Wu et al., 2000; Oliver et al., 1999; Baker and 
Titus, 1998; Mermall et al., 1998). 
In mammals Myosin VI is encoded by the mouse Snell's 
Waltzer deafness gene (Hasson and Mooseker, 1994; 
Avraham et al., 1995, 1997). The protein is thought to be 
necessary for anchoring the stereocilia membrane into the 
cuticular plate of the inner ear (Avraham et al., 1995; 
Hasson et al., 1997). This region is active in transporting 
vesicles to the apical surface of cells. It would seem that in 
the mouse, without Myosin VI the structural integrity of hair 
cells is lost, leading to a loss of hearing. The connection 
* Corresponding author. Tel.: + 44-131-650-5369; fax: + 44-131-650-
5371. 
E-mail address: mary.bownes@ed.ac.uk (M. Bownes). 
between hearing loss and Myosin VI was found also in 
humans, where patients suffering from a non-syndromic 
dominant form of deafness (NSAD), were found to have a 
missense mutation in the human Myosin VI gene, MY06 
(Melchionda et al., 2001; Ahmed et al., 2003; Mohiddin 
et al., 2004). In rat brain, Myosin VI interacts with SAP97, a 
member of the MAGUK (membrane-associated guanylate 
kinase homologue) family, which plays a role in synaptic 
localisation and membrane trafficking of GluRl, a subunit 
of a-amino-3-hydroxy-5-methylsoxazole-4-propionic acid 
(AMPA)-type glutamate receptors. It seems that Myosin VI 
translocates AMPA receptors via connection to SAP97 to 
and from postsynaptic plasma membranes (Wu et al., 2002). 
Myosin VI has been shown to be associated with the 
Golgi complex and the leading edge of the cell. In cultured 
rat and human cells Myosin VI is specifically 
phosphorylated and then translocated to the ruffles that 
form as the cells move (Buss et al., 1998). Furthermore, 
Myosin VI associates with the adaptin complex on 
clathrin-coated vesicles (Buss et al., 2001), and with 
Disabled 2 (DAB2), which connects Myosin VT to clathrin 
coated pits (Morris et al., 2002). These results suggest that 
Myosin VI has a key role in membrane trafficking, both in 
secretion and endocytosis. 
Myosin VI (Myosin 95F) is encoded in Drosophila by the 
J aguar (jar) gene (Hicks et al., 1999). It has been shown to 
be expressed at a variety of developmental stages and is 
0925-4773/$ - see front matter © 2004 Elsevier Ireland Ltd. All rights reserved. 
doi: 10.101 6/j.rnod.2004.06.007 
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essential for several developmental events (Kellerman and 
Miller, 1992; Kellerman et al., 1992; Lantz and Miller, 
1998; Deng et al., 1999). A partial loss of function mutant 
causing male sterility demonstrated a key role for Myosin 
VI in sperm individualisation (Hicks et al., 1999). In the 
testes Myosin VI interacts with Cortactin and the Arp213 
complex, which is necessary for regulation of actin 
polymerisation, and also with Dynamin, a protein promot-
ing the transition of clathrin-coated pits into clathrin-coated 
vesicles (Rogat and Miller, 2002). It is proposed that 
Myosin VI is important for the assembly of actin filaments 
in the region where membranes are assembled within the 
individualization complex, during sperm morphogenesis. 
Myosin VI is also essential in C. elegans spermatogenesis, 
where it is involved in the unequal distribution of 
organelles and cytoskeletal components during the 
formation of the Residual body and the budding spermatids 
(Kelleher et al., 2000). 
During oogenesis Myosin VI is required for all the cell 
migrations undertaken by the follicle cells. By interfering 
with Myosin VI expression using an antisense RNA in vivo, 
the formation of the follicle cell epithelium by the columnar 
and centripetal cells was disrupted (Deng et al., 1999). 
Recently it has been shown that the migration of the border 
cells is disrupted when the expression of Myosin VT is 
blocked, and that the migration is coordinated with 
E-cadherin and Armadillo (Geisbrecht et al., 2002). 
Deng et al. (1999) also showed that Myosin VI was needed 
for epithelial morphogenesis at a variety of developmental 
stages. Using inhibition of Myosin VI by antibody injection 
it was shown that the invaginations of membranes needed 
for blastoderm cell formation in the embryo required 
Myosin VI (Mermall et al., 1994; Mermall and Miller, 
1995). Using a similar method Myosin VI has been shown to 
be important for transport of material from the nurse cells to 
the oocyte during oogenesis (Bohrmann, 1997). 
Finally, since the work in this paper was completed 
Myosin VI was found to interact with Miranda. Myosin VI 
is necessary for the basal localisation of Miranda, and for 
spindle orientation in the metaphase neuroblast. 
In homozygous null mutant embryos, jar 322,  Miranda is 
mislocalized to cortical patches and to the cytoplasm rather 
than the basal crescent of the metaphase neuroblast and the 
spindle was misorientated (Petritsch et al., 2003). 
We demonstrate, using newly isolated mutants, 
that Myosin VI is crucial for viability and maintenance of 
cells in epithelial cell layers. 
2. Results 
We have generated lethal mutants of the jar gene 
encoding Myosin VI. They die as late embryos and larvae. 
The mutants are shown to lack Myosin VI by antibody 
staining of embryos and by Western blotting. 
Mutant embryos survive well into embryogenesis using  
the supply of maternally stored mRNA but in later stages 
specific transcripts are depleted. When the epithelial sheets 
migrate during normal dorsal closure they express a tight 
Myosin VI band at the moving front. The mutants lack this 
Myosin VI band and fold inside the embryos, some cells are 
loose and begin to detach from the epithelium and 
embryos frequently fail to complete dorsal closure. Similar 
results were obtained when a Myosin VT dominant negative 
was expressed. 
2.1. Isolation of new jar mutants 
Previous mutant screens in our laboratory had generated 
a male sterile mutation in the jar gene which encodes 
Myosin VI. The jar mmwl4  mutant lacks transcripts in the 
testis, but generates transcripts in other tissues and at other 
developmental stages (Hicks et al., 1999), due to a 
deletion of non-coding exon 1 (Fig. IC). To generate 
further mutants we used a similar strategy and remobilised a 
gal4 insertion in the jar gene (C865). Fig. IA shows the 
intron-exon organisation of jar, which we determined by 
sequence analysis and by using the published Drosophila 
genome sequence (Adams et al., 2000). 
Mutations were created by remobilising the P element 
insertion line C865 and 480 new lines were established. 
Five red-eyed lines were homozygous lethal. Two of the 
red-eyed lines jar R23  and jar R70  failed to complement the 
deficiency line for the jar region, Df87-5, resulting in 
embryonic lethality. Two other red-eyed lines, jar R39  and 
jar 8235  failed to complement the mutant jar 	resulting 
in male sterility. The complementation tests along with the 
protein expression analysis (described in the following 
section) suggests that all the four lines are homozygous 
lethal due to mutations in the jar gene. 
2.2. Molecular analysis of jar' 39 and jar' 235 mutants 
The P element in the C865 line which was used for the P 
hop mutagenesis is located in the 5' UTR of jar mRNA 
(Fig. 113). When we undertook PCR with primers flanking 
the location of the original P element location, we found that 
the P element was excised from the 5' UTR region in all the 
mutants, jar R23  jar R39  jar R70  and jar R235  (Fig. 2). jar R39 
and jar R235  were the mutants that showed the most severe 
phenotypes, therefore we decided to determine the molecu-
lar basis of the mutations in these lines. The details of how 
this was undertaken are presented in the Materials and 
Methods. As the alternations were small, they were 
established by sequencing the mutant DNA in the region 
deleted in jar ""14  mutants. This revealed that in 
the jar ?39Ijarmmw4  heterozygotes the sequence: GTA 
TACOTG (347-340 bp upstream of the first exon) 
was deleted, while the sequence: TTTATATATACTGA-
TATG (341-322 bp upstream of the first exon) was 
duplicated (Fig. 1D). In 	 the sequence: 
GTATAC (347-342 bp upstream to the first exon) was 
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Fig. I. Organisation of the wild type and mutated jar genes. (A): The canonical transcript which encodes the EM3 isoform of jar. (B): C865 contains a single 
P[ GawB] element inserted at bp 306 in exon 1. It is located in the 5' UTR and causes no observable phenotype. The number of P[GawB] elements was 
determined by Southern blots, and the position of the insertion by plasmid rescue. (C):jar "14  was created by imprecise excision of P[GawB], removing the 
whole first exon along with 485 bp flanking the 5' end and 47 bp flanking the 3' end (total deletion of 862 bp). The primers used to locate the deletion are: 
C865For, C865 Rev, EXC2For and EXC2Rev (see Materials and Methods). After finding the precise location of the deletion in jar
' ', a pair of primers were 
designed to replicate the whole deletion region. In that way, only the mutant genomic DNA was amplified by PCR, and the specific mutation (marked by a red 
asterisk) was located in this region by sequencing. (D): The mutation found in jar 139/jar " : the sequence marked by a dashed line was deleted and the 
sequence marked in the box was duplicated. (E): The mutation found injarR2S5/jar " the sequence GTATAC was changed to GTTfl'C, the nucleotide A, 
438 bp upstream to the first exon was deleted, and the nucleotide G (38 bp upstream to the first exon) was replaced with an A. 
changed to: GTTTTC, possibly by deletion of the sequence: 
ATA and duplication of the sequence: TTT (341-339 bp 
upstream of the first exon, see Fig. IE). This mutation is 
located in the same region as the mutation in jar R39  and ex-
plains why the two new mutant lines fail to complement each 
other, jar R235  also has a missing nucleotide, A, 438 bp up-
stream of the first exon (Fig. 1E), and the nucleotide G (38 bp 
upstream of the first exon) was replaced by A (Fig. I E). 
In spite of the excision of the P element from the 5' 
UTR in the two mutants, the flies are red-eyed, therefore a P 
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R23 R39 R70 R235 C865 OrR 
Fig. 2. Search for the P element in the 5' UTR region in the mutant genomic 
DNA. The genomic region where the P element was originally located in 
line C865 (5' UTR) was amplified by PCR, in the heterozoygous mutant 
lines: jar R23/TM3  jar R39/TM3 jar  R70/TM3 jar R235/TM3  in C865and in 
OrR, using primers flanking the insert region: C865For and C865Rev. 
In C865 two bands appeared: the upper band (arrow) corresponds to the P 
element, 14 kb, and the lower band corresponds to the same region in the 
chromosome that does not contain the P element (as in OrR). In all the 
mutants, the P element band is not detected indicating that the P element 
was excised from the 5' UTR. 
element must have been inserted into a different region of 
the genome. Inverse PCR revealed that in jar R39  a P 
element has inserted into the third chromosome, within the 
hypothetical gene CG5991, upstream of jar. The P element 
in jar  R235  was also re-inserted into the third chromosome, 
upstream of jar, in a region between the hypothetical 
genes: CG6 164 and CG 6173. The two new jar mutants fail 
to complement each other and the deletion mutant 
jar ""4 but we needed to be sure that the lethality 
associated with jar R39/jar R235 trans-heterozygous 
embryos and larvae are due to the mutations in Myosin 
VI and not in the other genes where the P element has 
inserted. We investigated the expression of Myosin VI and 
analysed the phenotype of the trans-heterozygous mutant 
jar R39Ijar R235 Because the insertion sites of the P element 
in jar R39  and jar R235  are different, the cross of the 
two mutants will complement any mutations caused by 
the re-insertion of chromosome 3, allowing us to test the 
phenotype of the mutations within jaguar only. The trans-
heterozygous mutants had a similar phenotype to the 
homozygous mutants: i.e. Myosin VI was absent late in 
embryogenesis and many embryos failed to complete 
dorsal closure (Fig. 5E—I). Those which completed 
dorsal closure died during the first larval instar. Thus we 
can attribute the phenotypes to a deficiency in Myosin VI 
late in embryogenesis. 
2.3. The transcription of the 5' end of the mRNA 
is disrupted in homozygous mutants 
Previously it was shown that jar mrnwl4  mRNA is 
disrupted in the 5' region: up to 517 nucleotides are not 
transcribed at the 5' end of the mRNA (Hicks et al., 1999). 
Since jar ,nmw14  does not complement jar R39  or jar R235  we 
wanted to test if transcription is also disrupted in these 
mutants. RTPCR was undertaken, using RNA templates 
from homozygous mutant and OrR larvae (1st instar), 
for two regions at the 5' end of the jar mRNA: the first 1027 
nucleotides and the region between nucleotides 517 and 
1027 were investigated (Fig. 3A). An additional RTPCR 
was made for a region located further downstream, 
2850-4100 bp from the 5' end. The RTPCR of the two 5' 
regions was very weak in the homozygous mutant larvae, 
compared to OrR larvae (Fig. 3B). It seems that as in 
jar"' 4, there is reduced transcription of jar mRNA at the 
5' end in jar R39  and jar R235  mutants. When RTPCR 
undertaken at the 3' end (Fig. 3C), a high level of product 
was observed, although not to the same level as in OrR. 
This is to be expected since transcripts initiated at the 5' end 
of the gene are absent. This suggests that only some of the 
transcripts are affected. When RTPCR was made for mRNA 
of ribosomal protein (Fig. 313) and myosin 29D (Fig. 3E) as 
a control, the expression level in the homozygous mutants 
was similar to the expression in OrR, therefore the 
disruption in mRNA expression is unique to jar. 
Given that there are at least some transcripts present 
in larvae in the jar R39  and jar R235  it seems unlikely either 
are nulls. 
2.4. Mutants lack or have reduced ,nyosin VI protein 
We next tested if these mutations led to a reduction or 
loss of Myosin VI expression during embryogenesis, 
since studies of the mutants indicated that they died as 
late embryos and during early larval development. 
Since there is a supply of maternal mRNA we collected 
late embryos, and analysed them by Western blotting. 
We used the yolk proteins as a loading control. The results 
in Fig. 3F show that wild type OrR and jart?1mI4  embryos 
have high levels of several isoforms of Myosin VI. jar R23 
has slightly reduced Myosin VI, jar R70  has much reduced 
Myosin VI and in jar R39  and jar R235  no Myosin VI could be 
detected by Western blotting. This demonstrated that two of 
the mutants we had isolated affected the expression of 
Myosin VI in late embryogenesis dramatically. Taken 
together with the complementation analysis and our 
molecular studies these two mutants are identified as jar 
mutants and have thus been called jar R39  and jar R235 
Using Myosin VI antibody the temporal and spatial 
distribution of Myosin VI protein was analysed in wild type 
and homozygous mutant embryos. Myosin VI could be seen 
in the forming blastoderm cells. This was observed in both 









H. Mi/la ci al. / Mechanisms of Development 121 (2004) 1335-1351 
	
1339 
A P1 	P517 P1027 	 TAN 	 MYC2 
4- 
1 	517 	1027 	2850 	 4100 
B 	 C 
R39 R235 OrR R39 R235 OrR 	R39 R235 OrR 
P1 + P1027 	P517 + P1027 
D 	 E 
P39 R235 OrR 
1.6 kb 1.6 kb 
I kb 	 1 kb 
0.5 kb 0.5 kb 
Ribosomal protein L32 
TAN + MYC2 
R39 R235 OrR 
F 	 Western blot of late embryos 
OrR mmw14 R23 R39 P70 R235 
Myosin VI 	$ 	 . 	 145kDa 
YP .. 	 45kDa 
Loading 
control 
Fig. 3. Analysis of Myosin VI expression in wild type and mutant embryos. (A—D): RTPCR analysis of jar'39,jar R235  homozygous mutant and OrR larvae. (A): 
A diagram of the primers used for the RTPCR analysis of jar mRNA. (B): RTPCR for the 5' region of jar mRNA, using the primers p1 + p1027, 
and p512 + p1027. In jar'?3Y  andjar R235  the PCR gave a signal which is much weaker compared to OrR, suggesting that these transcripts are not synthesized in 
the larvae and the weak signal obtained was probably from remaining maternal transcripts. (C): RTPCR of thejar tail encoding domain (located downstream, see 
3A). The 3' transcripts in the mutants exist, although not to the same extent as in OrR. The transcription of a fragment in ribosomal protein, L32 (D) and of Myosin 
29D mRNA (E) was used as acontrol. (F): Western blotting wild type and mutant embryos. Lane 1: OrR. Lane 2:jar 	14 male sterile allele exhibits higher levels 
of Myosin VI expression during embryogenesis. Lane 3 and 5: homozygous lethal lines, jar R2$  and jar R70  that fail to complement Dj87-5, but do complement 
jar"" ".Myosin VI protein expression is detected in bothjarR23  andjar 1?70 Lane 4 and 6: homozygous lethal lines,jar 
839  andjar R235,  that do not complement 
jar ""''4. No Myosin VI protein expression is detected in either jar'539 or jar'5235. In each case there is yolk protein present to show that similar numbers of 
embryos were loaded on the tracks. The three bands near Myosin VI correspond to the three isoforms bearing molecular weights of 120, 140 and 145 kDa, and the 
three lines near the YP correspond to the yolk polypeptides YP I, YP2, and YP3, having a molecular weight of 47, 46 and 45 kDa, respectively. 
component of maternal Myosin VI (data not shown). 
Once the embryo begins to develop Myosin VI is seen in 
many cells. In OrR flies, Myosin VI expression is strong 
during germ band extension (Fig. 4A) and during 
dorsal closure there is a very tight ring of expression in 
the cells migrating to close the gut (Fig. 413), and a strong 
expression of myosin VI is observed along the apical side of 
the cells at the leading edge (Fig. 4D). There are two 
patches of expression of Myosin VI in the posterior of the 
larva and late embryo possibly in the posterior spiracle 
(Fig. 4C). In the mutants, by the time dorsal closure 
commences there is no detectable Myosin VI (Fig. 4E) 
and this loss of Myosin VI continues into the fully 
formed larvae (Fig. 4F). Myosin VI was also below 
detectable levels in late embryos of heteroallelic mutants 
jar ?39/jar?235  (Fig. 4G). 
X 
B 
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OrR 	 mutant faiR39 
A 	 myoVi 
Y 
mutant jaiR39" 235 
Fig. 4. Analysis of Myosin VI expression in wild type and mutant embryos by antibody staining of tissues. (A—F): Comparison of Myosin VI expression 
between OrR and jar mutant at different embryonic stages. (A—D) are OrR and (E,F) are jaguar mutant jar R39  and (G) is the trans-heterozygous mutant 
jar R3sljar'5235.  (A): Lateral view of an extended germ band stage embryo. Myosin VI expression is present in the labial, labral and maxillary segments and in 
all posterior segments on the inner edge. (B): Dorsal view of a contracted germ band stage embryo. Myosin VI is expressed in abdominal segments and 
in leading edge of epithelial cells during dorsal closure. (C): Notice the two small groups of cells in the posterior spiracle expressing very high levels of Myosin 
VI. (D): At the leading edge of the lateral epidermis Myosin VI is strongly expressed at the apical side of the cells. Expression of Myosin VI is also observed in 
the amnioserosa and the lateral epidermis. (E): Lateral view of ajar R39 germ band stage embryo. Myosin VI expression is absent and the morphology of the 
embryo is abnormal at positions marked X. (F): A jar R39   embryo when the gut has formed. Note there is no Myosin VI expression in the segment nor in the 
small groups of cells at the posterior (See C in wild type). (G): Myosin VI is also absent in the heteroallelic mutant jar '539/jar '5235. myo VI = Myosin VI 
protein. X = abnormalities in the organisation of the embryo. Y = note the absence of Myosin VI in these regions. 
2.5. Myosin VI is necessary for dorsal closure 
and germ band retraction 
Most homozygous mutant embryos developed into late 
embryos which failed to hatch. A few hatched into larvae, 
but soon died. The anterior/posterior and dorsal/ventral 
polarity and segment number was normal. A number of 
embryos failed to complete dorsal closure and thus there 
was exposed yolk and free floating yolk between the 
cuticle and the vitelline membrane and many embryos had 
loose cells inside the vitelline membrane. The cells in the 
amnioserosa were detached. The leading edge of the 
epithelial sheets lost their tight and organised shape 
(Figs. 5E—I), and the tissue was folded inside. 
In some of embryos the germ band remained elongated 
and detached from the amnioserosa, indicating that germ 
band retraction was incomplete (Fig. 51-1—I). Many of the 
mutant embryos that died and larvae that hatched had 
completed dorsal closure but had loose cells floating in the 
haemolymph in the dorsal aorta. These were best visualised 
in living embryos. Fig. 6A—D shows the same larva 
photographed at 2 s intervals and the different location of 
a group of the floating cells can be seen. Each larva often 
contained several clumps of cells and lots of individual 
loose cells. No such loose cells were ever observed in wild 
type embryos. 
Similar results were obtained when the function of 
Myosin VI was disrupted by the expression of a Myosin VI 
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Fig. 5. Phenotypes of mutant embryos and larvae. (A—D): Dorsal closure in OrR flies. The leading edges of the lateral epidermis are connected along the 
anterior and the posterior sides, towards the centre (arrows), to cover the amnioserosa. (E): Failure of dorsal closure in jar R39  mutant embryos, the cells in the 
amnioserosa are detached (arrows), leaving loose yolk. (F) and (G): Two focal planes of ajar 839  mutant which has failed in dorsal closure. F shows a view of 
the dorsal surface. There is still exposed yolk and an abnormal and irregular attempt at dorsal closure and loose cells are escaping. (G): Germ band shortening is 
complete, the mouthparts are normal and the correct number of segments exists but there is a gap in the epithelium, and segments are incomplete on the 
dorsal/ventral axis. Figures H and I show trans-heterozygous mutant embryos jar R39/jar R35 stained with myosin II antibody. They fail to complete dorsal 
closure and germ band retraction. In figures E and I the 'purse string' around the amnioserosa is absent and the expression of Myosin II at the leading edge is 
absent as well, although Myosin II is present in the cells of the lateral epidermis and the amnioserosa. The amnioserosa sheet has lost its organised uniform 
sheet, having loose cells with a changed shape and holes (arrows). The cells at the leading edge have been folded inside thus it is impossible to observe the 
actin-myosin cable. The embryos in A-D, H-I are stained with nonmuscle Myosin II. AS - amnioserosa. LE = leading edge. 
dominant negative, ATP-jar (Fig. 7). When AATP-jar was 
expressed by engrailed-gal4 (en-gal4) at the posterior 
stripes of each segment, the tissue was ruptured, the cells 
at the leading edge and in the amnioserosa were 
detached and in certain areas the two tissues were 
disconnected (Figs. 7A and 9B). Embryos that reached the 
final stages of dorsal closure had holes in the dorsal midline, 
suggesting that Myosin VI is necessary for the adhesion of 
the cells at the leading edge and in the amnioserosa and for 
the adhesion of the opposite leading edges along the 
dorsal midline, during the final 'zipping' of the epidermis 
(Fig. 7C). The changes in cell shape and the tendency of the 
cells to fold inside in stripes of cells expressing 2ATP-jar 
indicates that Myosin VI is involved in maintaining cell 
shape and rigidity in the lateral epidermis (Fig. 7D,E). 
Finally, many embryos failed to complete germ band 
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Fig. 6. Phenotypes of mutant larvae. Figures A— D show some ol the loose cells in ajar R  mutant. Note that they are in a different position in each frame. This 
is a living embryo photographed at 2-second intervals to show these detached cells moving in the embryo. 
retraction, leaving the germ band tissue loose and separated 
from the amnioserosa (Fig. 7F), and the retraction arrested 
(Fig. 7G). 
2.6. Myosin VI cDNA rescues the lethal phenotype 
of jar R39  and jar R235  mutant embryos 
In order to determine whether or not the embryonic lethal 
phenotype in  jar  R39  and jar R235  mutants was caused by the 
reduction in Myosin VI expression, we tested the ability of 
ectopic Myosin VI expression to rescue jar R39  and jar R235 
embryonic lethality. 
In this experiment, a cross was undertaken between 
heterozygous flies, to create two groups of mutant embryos: 
the first group express Myosin VI tagged to GFP (PGM) 
throughout the embryo; therefore the embryos of this group 
are fluorescent. The second group, which does not 
express PGM were non-fluorescent. In every group, 25% 
of the flies are homozygous mutant (the details of the cross 
and the corresponding progeny genotypes are described in 
the Materials and Methods, and summarised in Fig. 81)). In 
the non-fluorescent group, many of the homozygous mutant 
flies will fail to hatch. However, if the expression of PGM 
rescues the embryos, the number of fluorescent larvae 
hatching from the eggs will be higher than the number of 
non-fluorescent larvae. A reciprocal cross was established to 
test the effect of maternal PGM. As a control, heterozygous 
flies were crossed with the balancer line TM3/TM6: this 
cross is expected to create progeny with a similar survival 
rate in the fluorescent and the non-fluorescent group. 
The results are shown in Fig. 8E. In both the control and 
the experimental groups the survival of fluorescent 
embryos was slightly higher, but the difference between 
the survival of fluorescent and non fluorescent embryos in  
the experimental group was significantly higher, than the 
control group thus the expression of PGM significantly 
increased the survival of the mutant embryos. When female 
fluorescent heterozygous flies were crossed, the embryonic 
survival was slightly higher than in the reciprocal cross; 
however, the differences are not significant. The survival 
rate of all the embryos was lower than the expected 
presumably due to the manual collection and frequent 
handling of the embryos, to assess their fluorescence signal. 
The survival rate of OrR embryos with similar handling is 
74% (data not shown). Taken together these results show 
that the expression of PGM rescues the embryonic lethal 
phenotype of jar R39  and jar R235  mutants. Therefore the 
embryonic lethal phenotype results from the disruption in 
Myosin VI expression. 
2.7. Disruption of Myosin V/function affects DE-cadherin 
expression 
Epidermal cells expressing of lATP-jar had altered cell 
adhesion properties. Cell—cell adhesion in the Drosophila 
embryonic epidermis is mediated by DE-cadherin. Myosin 
VI was found to interact with DE-cadherin during the 
migration of border cells during oogenesis (Geisbrecht and 
Montell, 2002). This raises the possibility that Myosin VI 
interacts with cadherin during embryogenesis and that the 
loss of cell—cell adhesion Myosin VI function is disrupted 
could lead to changes in DE-cadherin expression or 
localisation. 
Embryos expressing ATP-jar by en-gal4 during 
dorsal closure were stained with DE-cadherin antibody 
(Fig. 9A,B). In some of the embryos, DE-cadherin levels 
were significantly reduced in cells expressing ATP-jar 
(Fig. 9A). In other embryos the localisation of DE-cadherin 
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Fig. 7. The effect of dominant-negative Myosin VI expression. ATP-jar was controlled by en-Ga14, as this expressed at the posterior of every segment. Figs. 
A-C and E are stained with phalloidin to view the actin filaments and the cell shape. (A): The disruption of Myosin VI function caused detachment of the cells at 
the leading edge and the amnioserosa. The actin cable at the leading edge is disrupted in all the areas where ATP-jar was expressed. (B): In some embryos, 
cells expressing ATP-jar in the lateral epidermis changed their shape and the actin filaments lost their tight organization at the cells cortex. (C): In the final 
stage of dorsal closure, when Myosin VI is disrupted, dorsal closure is not completed, and holes are left. (D,E): Some embryos show 'folding-in' of the lateral 
epidermis in the stripes expressing the dominant-negative. (D): staining with Myosin VI antibody: the stripes expressing the dominant negative Myosin VI have 
stronger stain of Myosin VI (arrows), and tend to fold inside the embryo. (E): In severe cases the actin cable disappears and filament aggregates are formed (see 
arrows). A milder version of this phenotype appeased in the mutants (see Fig. 11). (F,G): In many cases germ band retraction is not completed, the germ band 
tissue is loose and folded, and the posterior spiracles are not formed. In (F), the process of dorsal closure was progressed in spite of the incomplete process of 
germ band retraction (DE-cadherin stain). In (G) germ band retraction ceased in very early stage: the embryo is totally folded, and the germ band tissue is 
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Myosin VI  
PGM 43-2 X C865: stage 15 
	
PGM 75-5-2 X C865 stage 14 
Test (groups 1, 2) Control (groups 3, 4) 
Fo: +; +;jar' 39/TTvf3 	X 	I'GM e22C:jar'39/1M3 Fo: +; +; TM3/TM6 X PGM: e22C;jar't39/Til13 
Fl: Third chromosome genotype: F!: Third chromosome genotype: 
Genotype 	Probability 	Viability Genotype 	Probability 	Viability 
7M3/TM3 25% 	Lethal TM3/TM3 25% 	Lethal 
jar439/TM3 	50% Viable jar539/TM3 	25% Viable 
ja,-°/jat 39 25% 	Lethal in non- jar539/TM6 25% 	Viable 
fluorescent TM3/TM6 	25% Viable 
embryos. 
Expected: Expected: 
50% viability in non-fluorescent flies 75% viability in fluorescent and non- 
fluorescent flies 
Larvae hatched from eggs (%) 
mull 
1 fluorescent 
Ea 1 non-fluorescent 





1J 4 non-fluorescent 
Test 	Control 	 Test 	Control 
jar R39 	 jar'235 
Fig. 8. The expression of Myosin VI-GFP tagged protein in embryos rescues lethality. (A): A diagram representing the fusion protein Myosin VI-GFP (PGM) 
expressed by the DNA construct created. The whole Myosin VI is fused in-frame at its C terminus to GFP. (B): The cross of PGM lines with Myosin VI gal4 
line C865 triggers the expression of PGM fusion protein during dorsal closure at the leading edge (LE) and in the amnioserosa (AS). (C): The expression of 
Myosin VI as dorsal closure progresses (stage 15). (D): Mutant rescue test: the table describes the crosses undertaken in the test and the control groups, and the 
expected genotype of the progeny. (E): Mutant rescue analysis of the mutant fiiesjar Ri')  and jar R235. Crosses I and 2 were the experimental group and crosses 
3 and 4 were the control group (see description in the Materials and Methods). Crosses 1 and 3 (the first two columns) were made with heterozygous female 
mutants expressing PGM protein (fluorescent) and non-fluorescent male. Crosses 2 and 4 were created with fluorescent heterozygous male and non-fluorescent 
females. The difference between the survival of fluorescent and non-fluorescent embryos was compared between groups I and 3, and between groups 2 and 4 
and examined statistically with a chi-squared test. The asterisks indicate a significant increase in the survival rate of fluorescent embryos (P < 0.005). 
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jar R235  /jar R235 
Fig. 9. Expression of jar dominant negative molecules disrupts the expression and localization of DE-cadherin within the cells. (A): In some of the areas 
expressing ATP-jar, DE-cadherin is absent from the cell membrane (see arrow in the magnified picture in A), in other areas the localisation of DE-cadherin to 
the cell membrane is disrupted and DE-cadherin is present in the cell cytoplasm (B, arrow). In some areas of the lateral epidermis the tissue is "folding in" (A, 
asterisk). (C): In homozygous jar R235  embryos, no disruption in DE-cadherin expression was observed. 
was disrupted and the protein appeared in the cell cytoplasm 
and not in the cell membrane as in the wild-type cells 
(Fig. 9B). In the mutant embryos, the localisation of 
DE-cadherin in the lateral epidermis, the leading edge and 
the amnioserosa cells was not altered (Fig. 9C). It is possible 
that the maternal Myosin VI leads to the correct localisation 
of cadherin. Similar results were observed when the 
expression of DE-cadherin was examined in RhoA 
homozygous mutant embryos and in embryos expressing 
the dominant-negative of RhoA, RhoN19: In the 
homozygous mutant RhoA embryos, no defect was observed 
in the localisation of DE-cadherin, while the in cells 
expressing RhoN19 the expression of DE-cadherin was 
significantly reduced (Bloor and Kiehart, 2002). In the 
embryos expressing ATP-jar, the defects observed in 
the epidermal cells were more severe than the ones observed 
in the homozygous mutants (possibly due to the maternal 
contribution of Myosin VI in the mutant embryos). 
To test if Myosin VI is also involved in the maintenance 
of cell shape we examined the effect of Myosin VI on the 
expression of Myosin II, which is necessary for preserving 
cell shape at the leading edge and in the amnioserosa during 
the morphogenic changes of the tissues during dorsal 
closure (Young et al., 1993). The expression of Myosin II 
did not change significantly in the jar R39  and jar R235 
mutants, nor in embryos expressing Myosin VI dominant 
negative (Fig. 5E,H, and I and unpublished results). 
These results are consistent with previous studies showing 
that Myosin VI and Myosin H do not have a physical 
interaction during embryogenesis (Petritsch et al., 2003). 
2.8. Myosin VI is present in the filopodia and lamellipodia 
during dorsal closure 
As the epidermis covers the amnioserosa during dorsal 
closure, the epithelial cells at the leading edge show 
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extensive activity of filopodia and lamellipodia, which are 
crucial for zipping together the epithelial sheets and for the 
precise matching of the cells in the zipping process (Jacinto 
et al., 2000; Martin and Wood, 2002). Filopodia and 
lamellipodia are created through membrane remodelling. 
The involvement of Myosin VI in the creation of 
the pseudocleavage furrows in the cyncitial blastoderm 
(Mermall and Miller, 1995), and the separating membrane 
in the stereocilia of the in mice cochlear cells (Avraham 
et al., 1995; Avraham et al., 1997) raises the possibility that 
Myosin VI is also involved in the creation of filopodia and 
lamellipodia at the leading edge. PGM was therefore, 
expressed during dorsal closure, using an en-gal4 line, and 
filopodia and lamellipodia were observed in living embryos. 
There is strong expression of PGM in the cell membrane at 
the edge of epithelial cells facing the opposite edge 
(Fig. 10A—C, yellow arrows). PGM is also present in 
filopodia (Fig. 10A—C, white arrows) and lamellipodia 
(Fig. 10D, asterisks). As the cells meet, PGM expression 
increases in the adhesion area (Fig. 1OB,C, yellow arrows). 
When the adhesion between the cells is completed, the 
expression of PGM is reduced (Fig. bE). The expression of 
PGM in the filopodia and lamellipodia suggests that Myosin 
VI is necessary for the migration of the cells as well as for 
cell adhesion; however the expression in lamellipodia could 
be necessary for the initial attachment of the cells. 
2.9. The effect of Myosin VI depletion on actin organisation 
in the amnioserosa and leading edge cells 
Myosin VI was shown to be necessary for the 
organisation of actin filaments in the individualisation 
complex in the testes. To test if Myosin VI plays a role in 
actin dynamics during dorsal closure, actin filaments were 
stained in mutant embryos with phalloidin. In OrR flies, 
Myosin VI and actin generally have a similar localisation; 
however, in the leading edge the actin cable is concentrated 
mainly around the amnioserosa, whereas the strongest 
expression of Myosin VT is in a layer of cells between 
the actin cable and the epithelial sheet (Fig. 1 lA—C). 
Fig. 10. Expression of Myosin V1-GFP in live embryo during dorsal closure. Myosin V1-GFP (PGM) was expressed in the posterior stripes of the embryo by 
en-gal4. A—C shows the expression of PGM in the leading edge as the opposite tissues meet. (A): When the epithelial tissues migrate, PGM is strongly 
expressed in the leading edge (yellow arrows) and is also present in the filopodia of the epithelial cells (white arrows). PGM is also expressed in lamellipodia 
(D, asterisks). (B,C): As the contacts between the opposite cells were created, the presence of PGM in the leading edge increases. (E): Once the adhesion 
between the cells is complete, the expression of PGM in the connection declines (right stripe of cells). 
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Fig. 11. Cell shape and actin organisation in the amnioserosa and the leading edge of OrR and jar 539 mutants. (A—C): Localisation of actin (A) and Myosin VI 
(B) in the embryo prior to dorsal closure. Actin is localised at the leading edge of the migrating epithelial sheet (C, white arrowhead), while Myosin VI is 
localised in a layer of cells surrounding actin cables (C, yellow arrowhead). Note the strong expression of actin and Myosin VI in the posterior spiracle (arrow). 
(D): In OrR, the cells in the leading edge are elongated, the actin cable is intact and the cells in the amnioserosa are intact and form a uniform layer. (E): A 
mutant embryo jar R39  The cells in the amnioserosa lose their organised shape, in the leading edge the actin cable is broken in several places (asterisk), and 
some of the cells still have a polygonal shape and do not elongate. Note the abnormalities in segment organisation, near the asterisk. 
In the leading edge the cells are elongated (Fig. 1 lD), and 
connected to the actin cable surrounding the amnioserosa at 
a uniform width. Not all the mutant embryos showed defects 
in actin organisation, however in some of the mutant 
embryos that failed to complete dorsal closure, the actin 
filaments in the amnioserosa are disassociated (Fig. liE). 
At the leading edge, some regions of the actin cable are 
destroyed, many of the cells are not elongated and the 
organisation of the row of cells at the front is disrupted 
(Fig. I 1E). The aberrant shape of the cells also appears in 
the border regions between the segments, suggesting that the 
disruption in cell shape and movement appear not just in 
the leading edge of the epithelia during dorsal closure, but 
also in other epithelial cells in the lateral epidermis. When 
ATP-jar is expressed, the loss in cell shape and actin cable 
organisation was even more dramatic (Fig. 7 A—C,E). In 
severe cases the actin cable disappears, and the cells at the 
leading edge connect remnants of actin cables that appear  
as aggregates of filaments (Fig. 7E, arrows). It seems that cell 
shape in the leading edge and in the amnioserosa changed 
significantly as a consequence of loss of cell adhesion. In 
some embryos the cells at the lateral epidermis changed their 
shape and the tight organisation of the actin filaments at the 
cell membrane was disrupted (Fig. 713). Therefore the change 
in the cytoskeletal organisation could be the reason why the 
cells expressing ATP-jar lose their rigidity and fold in. 
These results suggest that during dorsal closure Myosin VI 
plays a role not only in the adhesion of the cells, but also in the 
arrangement of the actin cytoskeleton. 
3. Discussion 
Previous studies showed that in Drosophila Myosin VI 
plays a role in cell migration during oogenesis (Deng et al., 
1999; Geisbrecht and Montell, 2002), actin dynamics during 
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sperm individualisation (Hicks et al., 1999; Rogat and 
Miller, 2002), membrane synthesis during cellularization 
(Mermall and Miller, 1995) and spindle orientation in the 
metaphase neuroblast (Petritsch et al., 2003). In this 
study we provide evidence that Myosin VI is necessary 
for cell—cell adhesion and maintaining cell rigidity during 
dorsal closure. Disruption in Myosin VI function caused 
folding-in of the migrating epithelial tissue and rupture of 
the tissue, which suggests that Myosin VI is necessary not 
only for the cell—cell adhesion but also for keeping the cells 
rigid as they migrate. 
We have isolated lethal mutants in the jar gene of 
Drosophila which encodes Myosin VI. The resulting 
embryos die late in embryogenesis failing to complete 
dorsal closure or as early larvae. The expression of 
fluorescent tagged Myosin VI in the mutant embryos 
rescued the lethal phenotype of embryos indicating that 
the lethality is caused due to the jaguar mutation. 
Genetic and molecular analysis revealed that the two 
mutants have been disrupted in the sequence: AGTATACT. 
In jar  R235  this sequence has been changed and injarR39  the 
sequence is deleted. This is a palindromic sequence and as 
such could potentially regulate the transcription of jar. 
In Drosophila palindromic sequences located within the 
promoter region are often necessary for accurate 
transcription (Cho et al., 1998; Oh et al., 1999; Okada 
et al., 2001).The palindromic region might be a specific 
binding site for transcription factors (Hirose et al., 1993). 
Not all the embryos failed to complete dorsal closure and 
some hatched as larvae. RTPCR results showed that in 
homozygous mutant embryos (stage 14 onwards) Myosin 
VI transcripts are still observed. However, in the 
homozygous mutant larvae, the expression level of Myosin 
VI transcripts is lower than OrR (these results are consistent 
with the Western Blot and antibody localization results). 
These results suggest that survival throughout embryogen-
esis is due largely to the use of maternal Myosin VI. 
In the three mutants: jar ""'14 jar R39  and jar R235  the 5' 
end of the mRNA was truncated, however the truncated 
region in jar R39  and jar R235  is bigger than that observed in 
jarmflw]4 (1027 bp compared with 517 bp). This could 
explain why jar mmwl4  mutants survive until adulthood 
while the jar R39  and jar R235  mutants die during 
embryogenesis and the first larval instar. 
Analysis of the null mutant jar 322, published after 
completion of our experiments (Pertrisch et al., 2003), 
showed that it affected the embryonic neuroblasts but there 
is no mention of any defects in cell shape in the lateral 
epidermis, or of some embryos failing in dorsal closure. 
However, we have shown that the same dominant negative 
Myosin VI that caused mislocalisation of Miranda 
and misorientation of the spindle in neuroblasts is shown 
to disrupt the cell attachment in the amnioserosa and the 
leading edge epidermis during dorsal closure. 
Therefore, Myosin VI is necessary for both neuroblasts 
morphogenesis and dorsal closure during embryogenesis. 
It is surprising to find that the null mutant jar 322  lives until 
the early stages of second instar, while the homozygous 
mutants jar R39  and jar R235  die during embryogenesis and 
during first instar. Since no protein was detected in the 
mutants jar R39  and jar R235  the severe effect of the mutants 
might be expected to be the same as in a null mutant. 
Depletion and disruption in Myosin VI function caused 
detachment of cells and folding-in of the migrating 
epidermis during dorsal closure. In en-Ga14/i.A TP-jar 
embryos these affects were dramatic; if the cells expressing 
ATP-jar are not as robust as the wild type they might not 
be able to bear the multiple forces applied to them during 
dorsal closure, which could lead to the rupture of the tissue 
caused initially by the detachment of cells. 
Cells that express LATP-jar and mutant cells had an 
aberrant organisation of the actin filaments in the cell cortex 
at the leading edge, and the cells lost their elongated shape. 
This is the area that was found to fold-in in many embryos. 
The connection between the change in cell shape and the 
disorganisation of the cytoskeleton could suggest that the 
cytoskeleton is necessary for maintaining cell rigidity. This 
suggests that Myosin VI preserves cell shape by participating 
in the synthesis or the patterning of the actin filaments during 
the migration of the epithelial cells. This is consistent with 
previous studies showing the role of Myosin VII in actin 
dynamics in the individualisation complex in the testes 
(Rogat and Miller, 2002). 
The creation of multiple wounds by laser beams in 
embryos did not prevent their quick recovery (Kiehart et al., 
2000). Disruption caused by Myosin VI prevents recovery 
of the ripped tissues, probably due to the loss of cell 
adhesion properties. This suggests a potentially important 
role for Myosin VI in wound healing. 
The failure in dorsal closure which we observed 
corresponds well with our antisense experiments during 
development which led to failures in all the cell migrations 
of follicle cells during oogenesis. In each case Myosin VI is 
needed for the correct movement of a sheet or tight cluster 
of follicle cells (Deng et al., 1999; K. Leaper and 
M. Bownes, unpublished), and in each case the cells lost 
their shape, therefore Myosin VI might also be needed for 
the preservation of cell shapes as they migrate. We also 
observed that the follicle cell layer was disorganised and 
did not remain as a unicellular sheet (Deng et al., 1999). 
The phenotype is similar in the lethal embryos, where cells 
detach from sheets and are found loose in the haemolymph 
and the cells in the leading edge loose their tight 
organisation. The reduced expression and mislocalisation 
of DE-cadherin in the follicle cells and the lateral epidermis 
following the disruption in Myosin VI expression and 
function support the assumption that Myosin VI might play 
similar roles in the organisation of the two tissues 
(Geisbrecht et al., 2002). 
During spermatogenesis in Drosophila male sterile jar 
mutants fail in sperm individualisation, (Hicks et al., 1999) 
an event which requires separation of sperm by membranes. 
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It is possible that Myosin VI also plays a role in the 
remodelling of cell membranes at the leading edge and that 
this is crucial for the adhesive properties of the cells during 
dorsal closure. The presence of Myosin VI in the filopodia 
and lamellipodia in epithelial cells at the leading edge could 
be necessary for the remodelling of the cell membrane. 
It seems that Myosin VI is crucial for maintaining 
epithelial sheets and keeping cells in the correct spatial 
relationship to one another. This could be achieved by 
Myosin VI anchoring cells to the basement membranes that 
surround epithelial sheets, or perhaps if Myosin VI is absent 
from the apical surface of cells, cell polarity is not correctly 
defined and cell contacts are thus lost. 
We need to identify additional potential cargoes carried 
by the Myosin VI tail by protein—protein interaction 
experiments in vitro. Although the jar mutants are lethal, 
we can still investigate the abnormal phenotypes they cause 
at later developmental stages by producing clones of mutant 
cells failing to express Myosin VI at various times and in 
various tissues. 
4. Experimental procedures 
4.1. Generation of jar mutants and fly crosses 
The stocks used in these experiments are: C865 (Deng 
et al., 1997); jarmP4  (Hicks et al., 1999); y 'w; TM3, 
Sb '/TM6B, Tb ; w-; P[L.2-3]DrIw-, TM6, Tb; Ly 'I 
TM6B, P1w +rnW.hs = UbiGFP.S65TJ PAD2, Tb'; 
Df(3R)crb87-5, St 'e 1/TM3, Ser', (Bloomington Stock 
Center), UAS-iXATPjar (Pertrisch et al., 2003), engrailed-
gal4 (Brand A) e22c (Deng et al., 1999). 
The jar mutants were generated by mobilising a single P 
element insertion located in the 5' UTR of the jar locus in 
strain C865, which contains a P element P[GawB] at 95F on 
the third chromosome (w-; P [Ga14 w +] Y; P [Ga14 
w + ]), located at bp 306 in exon 1 (Fig. 113) Homozygous 
mutant embryos and larvae were distinguished from their 
heterozygous siblings by using the fluorescent balancer 
chromosome Ly '!TM6B, GFP Tb. 
For the expression of dominant negative Myosin VI, 
virgin female of the en-gal4 line were crossed with male 
UAS-..ATP-jar flies. Statistical analysis used the chi square 
test (P < 0.005). 
4.2. Molecular analysis of mutants 
The new mutants jar I?39  and jarR23S  do not complement 
the mutant jar ?n,nwl4  (jar !nmwl4/jarR39/R235  heterozygotes 
are male sterile), therefore the mutations were potentially 
located in the same area as the I kb deletion in jar m,flWI4 
(Fig. 1C). The precise location of the deletion in jar mnn14 
was first identified by sequencing jar """4/TM3 hetero-
zygous flies (Fig. 1C), and the mutations in jar R39  and 
jar R235  were identified by sequencing the deletion area of  
jar tnmw/4  (this contains only the copy of the mutant genes, 
as shown in Fig. IC). 
4.3. Generation of Myosin VI-GFP (PGM) DNA construct 
The DNA construct expressing Myosin VI fused in-frame 
to Green Fluorescent Protein (GFP) was prepared by two 
cloning steps. In the first step the 0.8 kb EGFP gene was 
isolated from pEGFPNI plasmid (Clontech), using EcoRl 
and Noti restriction sites, and cloned into a pUAST plasmid 
(restricted with the same enzymes) to form the pUAST-GFP 
plasmid. In the second step, a full-length eDNA encoding the 
EM3 isoform of Myosin VI (95F MHC) was cloned in the 
pUAST-GFP plasmid, connected in-frame with the EGFP 
gene at its 3' end (see Fig. 8A). The 4.1 kb Myosin VI eDNA 
was amplified by proof-reading PCR, with a 5' primer that 
added an EcoRl restriction site upstream of the initiator 
methionine, and a 3/  primer, designed to contain Agel 
restriction site downstream of the Myosin VI eDNA, and 
connected in-frame with the EGFP gene. 
The proof-reading PCR used the pfu turbo polymerase kit 
(Stratagene), according to the manufacturer's instructions. 
The PCR product was digested with EcoRl and Agel 
and cloned into the pUAST-GFP plasmid (restricted 
with the same enzymes), to form the DNA construct: 
pUAST-Myosin VI-GFP (PGM) DNA construct. The DNA 
construct was injected into w k  fly embryos as described 
previously (Deng et al., 1999). The fly line selected for use 
in this experiment is PGM 45-I, as the insert is located on 
the X chromosome. 
4.4. Mutant rescue 
Transgenic flies, containing the Myosin VI eDNA fused 
in-frame to the EGFP gene (PGM), driven by a UAS 
(upstream activating sequence) target sequence, were 
generated by p element-mediated transformation. The PGM 
transgene was crossed with the e22C-Ga14 line and with the 
mutant flies jar R391TM3  Sb, or jar 12351TM3  to create the 
fluorescent heterozygous fly lines: PGM; e22C; jar 't39/TM3, 
Sb and PGM; e22C;  jar  R235ITM3,  Sb. e22C fly line express 
the Ga14 protein ubiquitously during embryogenesis and 
hence triggers the expression of PGM throughout the embryo 
during late stages of embryogenesis, when the maternal 
supplies of Myosin VI begin to disappear. The fluorescent 
heterozygous flies were crossed with the non-fluorescent 
heterozygous flies, as described for jar R39: 
4.4.1. PGM; e22 C,- jar139ITM3,  Sb X jarl?391[M3,  Sb 
This cross created fluorescent and non-fluorescent 
progeny; each group will contain the same genotype 
composition, as described in the table on Fig. 8D, for the 
test group. In non-fluorescent flies, because the homozygous 
mutants are embryonic lethal and the flies homozygous for 
the balancer chromosome are lethal as well, only the 
heterozygous embryos are expected to survive, yielding 
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a survival rate of 50%. If the expression of PGM rescues the 
embryonic lethal phenotype, the fluorescent homozygous 
embryos will survive and the number of fluorescent 
larvae hatching from the eggs will be significantly higher 
than the non-fluorescent embryos. As a control the effect of 
PGM expression on the survival of embryos which are not 
homozygous Myosin VI mutants was examined by the 
following cross (described for jar R39): 
4.4.2. PGM: e22C; jarR39ITM3,  Sb X TM3, Sb/TM6, Tb 
This cross created fluorescent and non-fluorescent 
progeny; each group will contain the same genotype 
composition, as described in the table in Fig. 8D, for 
the control group. Each group contains theoretically 75% 
viable embryos, heterozygous and non-mutant. 
In every group a reciprocal cross was established in order 
to test the maternal contribution of PGM on the survival of 
the embryos. The fluorescent and non-fluorescent 
embryos obtained from every cross were selected separately 
(100 eggs from each group) and the survival of embryos was 
calculated as the number of larvae hatching from the eggs 
within the following two days. 
mRNA was primed with oligo-p(dT)18 and reverse 
transcribed by SuperscriptTM II (GIBCO BRL). 
When cDNA was used as a template and for PCR of small 
DNA fragments (up to 5 kb), the Qiagen PCR kit was used 
(201203). Large DNA fragments were amplified using the 
Expand Long Template PCR kit of Roche (1681834), 
according the manufacturers' instructions. 
The primers used were: for jar mRNA: P1: gagttcgactc 
gactcatccaac; P517-1: ate acgatgacaactgcgaac; P1027: 
tagtgcgatatgtaaccaccgacc; TAN: catttccgaattcggcaagatcaa 
caagatccgg; MYC2: atttaccggtccttgtttctgcattgctgc. 
For myosin 29D mRNA: TRIF: aatcacagcttcagccacac; 
529R: gtcccgacaagtggatcag. For ribosomal RNA: PR491: 
aagcccaagggtatcgacaac; PR492: attgaactcggcactggcaca. 
For jar genomic DNA: HKC865F: tgttgctacccattgcttttcaatc; 
5k3C865: cgggctgaaaagggaaaag; C865 for: gcggatc 
caaatcttcttgctttgctg, C865 Rev: tttgaacaggaaactgaaacg, 
EXC2Rev: acatggaatagggtgcatgg, EXC2For: gtgcttgttgtt 
tttcgg, 	mmw 14 	delfor: 	tgcaggtgttgcagaagagtg; 
mmwl4delrev: ttatccccttacccctattcc. For jaguar cDNA 
amplification: MYN: atttccgaattcttcgactcgactcatccaacg; 
and MYC2. 
The PCR products obtained were isolated from 
Tris-acetate/Ethylenediaminetetra-acetate (TAE) gels, 
purified, and seqenced. 
4.6. Antibodies 
The Myosin VI monoclonal antibody 3C7 (Kellerman 
and Miller, 1992) was diluted 1:50 and Myosin VI 
polyclonal antibody was diluted 1:3. Nonmuscle Myosin II  
(Edwards and Kiehart, 1996) was diluted 1:50. 
Phalloidin (molecular probes, A12380) was diluted 1:50, 
rat anti-Drosophila E-Cadherin (Uemura, T.) was diluted 
1:20. Alexafluor 568 conjugated anti mouse (molecular 
probes) was diluted 1:500, FITC-cojugated anti-mouse IgG 
and anti rabbit IgG was diluted 1:100. HRP conjugated 
anti-mouse IgG was diluted 1:500. 
For the Western Analysis, 3C7 was diluted 1:200, and the 
anti-mouse secondary antibody diluted 1:10000. The YP 
control antibody (Bownes and Nothiger, 1981) was diluted 
1:1000 with the HRP conjugated anti-rabbit IgG secondary 
antibody diluted 1:10000 (Promega). 
4.7. Western analysis 
20 embryos were homogenised in 40 p.l of 2 X loading 
buffer. Western Blot was performed as described previously 
(Deng et al., 1999). 
4.8. In situ antibody staining of embryos 
Embryos were collected at four hour intervals after laying. 
They were dechorionated, fixed and devitilinated manually 
or with methanol. The staining of the embryos was performed 
according to standard protocols (Sullivan et al., 2000). 
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